data_5uj5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5uj5 _Structure_validation_residue.Date_analyzed 2017-01-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.77 0.319 . . . . 74.209999999999994 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.96 132.95 33.04 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.178 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.84 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.718 2.279 . . . . 71.329999999999998 112.375 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.26 157.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.87 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 160.12 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 64.120000000000005 110.934 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.9 176.74 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.439999999999998 111.115 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -117.1 135.55 53.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 75.340000000000003 110.831 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.92 173.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.147 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -128.53 132.73 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.94 104.84 15.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.819 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.4 129.39 44.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.937 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 p -122.15 -177.71 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 70.430000000000007 111.141 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.3 mmt -75.76 -17.37 59.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 110.895 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -96.33 -37.89 10.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 74.150000000000006 110.858 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 179.71 176.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 65.340000000000003 110.884 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 131.44 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 111.16 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -121.62 150.89 56.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.546 0.689 . . . . 73.409999999999997 111.126 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 153.02 69.78 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.655 2.237 . . . . 73.0 112.325 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.48 28.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.200000000000003 111.119 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -104.88 126.87 52.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.894 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.18 116.34 31.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 111.081 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.04 142.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 111.173 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 p -54.19 120.25 6.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 53.420000000000002 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.54 -4.55 37.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.817 -0.706 . . . . 51.299999999999997 112.481 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.76 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 73.340000000000003 110.897 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.2 p -138.04 155.06 49.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 111.183 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.57 -59.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 70.420000000000002 111.15 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -35.45 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 110.896 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -72.66 -26.6 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.530000000000001 110.904 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -76.18 -47.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.200000000000003 111.081 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.83 -29.79 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 62.219999999999999 111.082 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -69.89 -36.72 75.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.864 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -76.35 -42.66 44.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.845 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -72.27 -27.08 62.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.87 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.14 -12.07 34.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 74.549999999999997 112.457 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.86 127.55 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 55.409999999999997 111.151 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -81.04 80.83 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.847 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.834 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.832 0.349 . . . . 31.109999999999999 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -150.08 112.83 4.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.86 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -128.6 158.03 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.151 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 83.6 mt -89.99 131.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 71.150000000000006 111.143 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.02 160.88 25.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 72.319999999999993 110.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.77 143.96 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 71.019999999999996 110.916 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.1 mt-10 -57.4 -59.14 13.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.631 0.729 . . . . 74.019999999999996 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.76 -46.73 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 64.209999999999994 112.306 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -51.67 -45.69 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 110.924 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -72.28 -41.01 67.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 74.450000000000003 110.908 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -53.85 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 110.898 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -33.23 67.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.87 -25.0 68.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.843 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.87 142.5 4.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 71.329999999999998 112.507 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -110.71 156.84 39.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 65.310000000000002 110.854 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.81 13.76 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 72.109999999999999 112.362 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -99.29 -170.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -56.61 -47.77 78.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -53.74 -59.74 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 73.140000000000001 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.2 -28.58 69.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 71.530000000000001 110.858 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -55.64 27.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.893 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.41 -37.37 82.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 110.844 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.32 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.94 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -74.97 -34.38 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 111.116 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -58.99 -21.43 58.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 110.858 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -75.95 -25.67 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.883 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.71 163.97 27.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 111.065 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -84.2 113.63 21.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.89 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.82 52.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.535 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.14 129.41 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 111.121 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.42 146.36 27.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 111.083 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.4 -23.46 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 75.129999999999995 112.487 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 p -73.82 -1.84 21.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.16 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 9.4 t -88.9 -12.8 40.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 71.409999999999997 110.884 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -117.39 132.62 56.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 73.340000000000003 110.816 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.27 179.88 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 110.944 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.77 -155.67 15.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 73.239999999999995 112.491 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -140.44 53.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 65.200000000000003 110.856 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -179.07 98.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.019999999999996 110.912 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.25 160.73 33.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.030000000000001 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -115.9 170.26 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.209999999999994 110.825 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.76 118.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 111.129 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -137.05 177.1 8.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.049999999999997 110.906 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -60.63 -31.5 70.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -65.04 -19.54 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 70.340000000000003 110.92 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -85.7 4.41 36.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.03 123.39 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 110.857 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 59.55 26.03 14.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 54.210000000000001 110.879 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.51 136.72 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 74.299999999999997 111.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.5 t -109.74 123.03 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 75.049999999999997 111.15 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.47 103.9 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.897 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.9 m -93.79 118.72 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 73.439999999999998 111.168 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.1 t -108.57 89.29 5.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.719 . . . . 72.129999999999995 111.133 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -39.06 6.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.615 2.21 . . . . 74.120000000000005 112.343 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 110.848 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.2 133.04 90.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.111 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -170.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 71.329999999999998 112.38 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.8 156.82 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.219999999999999 110.871 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.81 159.56 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 64.120000000000005 110.919 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.83 176.76 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 64.439999999999998 111.102 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.76 129.19 47.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.855 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.59 172.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.167 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.9 131.5 52.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.912 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -99.63 103.07 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -94.24 135.34 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.340000000000003 110.865 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -133.39 177.69 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.430000000000007 111.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.9 tpt -75.36 -8.33 56.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.884 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -104.18 -37.91 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 179.21 176.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 65.340000000000003 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.9 124.69 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.010000000000005 111.132 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 151.01 51.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.714 . . . . 73.409999999999997 111.17 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 156.03 64.26 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 73.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.93 104.29 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 111.077 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -79.34 132.04 36.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.91 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.35 116.53 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.133 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 150.8 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.05 116.26 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 53.420000000000002 110.861 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 2.01 37.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.733 . . . . 51.299999999999997 112.487 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -99.17 -176.15 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 73.340000000000003 110.818 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.93 146.01 40.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.147 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.48 -62.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 111.111 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.81 -33.54 56.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 72.549999999999997 110.946 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -72.68 -27.27 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 72.530000000000001 110.883 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.87 -45.44 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 73.200000000000003 111.119 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.51 -29.93 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.121 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -71.4 -37.99 71.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.894 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -44.24 63.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.08 -25.2 61.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.2 -12.26 44.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 74.549999999999997 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.8 t -53.36 129.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 55.409999999999997 111.119 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -77.3 80.67 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.209999999999994 110.915 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.176 -0.466 . . . . 74.409999999999997 110.926 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.94 0.4 . . . . 31.109999999999999 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -135.94 77.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 65.439999999999998 110.851 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 t -128.73 157.64 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 111.135 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 85.4 mt -90.02 131.24 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.150000000000006 111.151 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 tp -127.0 160.65 30.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.927 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 143.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -58.11 -60.23 10.76 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.64 0.733 . . . . 74.019999999999996 110.908 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.78 -48.32 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.699 2.266 . . . . 64.209999999999994 112.348 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.81 -45.26 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.329999999999998 110.929 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -70.79 -49.61 44.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.904 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -54.09 -41.62 68.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -71.36 -46.27 60.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.35 -24.43 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.878 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.06 130.98 2.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.733 . . . . 71.329999999999998 112.505 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -115.78 157.66 44.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 65.310000000000002 110.871 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.3 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.699 2.266 . . . . 72.109999999999999 112.356 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -104.12 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.885 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -57.87 -44.12 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.877 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -53.58 -59.71 4.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.73 -28.21 69.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.530000000000001 110.86 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -52.88 62.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.898 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.02 -39.2 75.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 71.120000000000005 110.891 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.2 -50.81 70.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.219999999999999 110.931 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.2 mt -74.96 -34.3 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 75.239999999999995 111.161 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.76 -20.0 53.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 110.898 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.84 -26.0 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.897 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 145.01 36.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.439999999999998 111.107 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -65.92 121.81 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.18 45.17 57.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.504 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -111.37 125.37 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 70.219999999999999 111.075 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.06 147.66 38.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.119 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.49 -23.4 35.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 75.129999999999995 112.519 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -73.93 -1.81 21.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 64.239999999999995 111.15 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.1 t -88.95 -13.49 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 71.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -141.39 167.85 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.340000000000003 110.839 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.38 44.9 20.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.54 111.75 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 73.239999999999995 112.47 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.0 t -163.02 156.85 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 65.200000000000003 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -170.05 -179.53 3.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 74.019999999999996 110.913 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -139.5 -61.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.030000000000001 110.931 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -59.65 158.7 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.867 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.16 134.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 111.099 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.57 170.06 16.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 74.049999999999997 110.891 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -59.22 -34.16 71.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.903 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -20.2 65.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 70.340000000000003 110.878 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.38 6.59 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 110.834 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.32 124.48 19.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.95 24.32 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 54.210000000000001 110.915 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.1 126.76 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.139 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.91 121.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 75.049999999999997 111.161 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -111.98 103.17 11.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.885 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.7 m -96.08 119.41 34.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 111.124 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.65 89.11 5.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.098 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -34.23 14.99 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 74.120000000000005 112.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.833 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.761 0.315 . . . . 74.209999999999994 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -115.17 133.22 22.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 72.400000000000006 111.122 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 178.85 4.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.723 2.282 . . . . 71.329999999999998 112.288 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.83 157.51 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 74.219999999999999 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.45 145.59 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 64.120000000000005 110.922 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.18 171.2 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.084 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 130.11 56.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.17 173.74 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 111.157 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.6 131.78 49.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 75.219999999999999 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.22 102.95 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -94.82 140.02 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.898 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -140.48 175.79 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.418 . . . . 70.430000000000007 111.188 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.9 ttm -75.65 -11.67 60.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.877 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.25 -37.78 9.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 110.91 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 179.86 176.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 65.340000000000003 110.936 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 t -119.16 121.68 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 111.107 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.7 150.31 55.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 111.163 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 166.72 26.66 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.765 2.31 . . . . 73.0 112.343 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.86 145.06 21.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 74.200000000000003 111.078 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -111.78 121.95 46.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.9 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.11 116.63 28.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 111.133 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.38 153.8 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 75.430000000000007 111.097 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -62.94 121.61 13.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.506 . . . . 53.420000000000002 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.38 0.64 86.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 51.299999999999997 112.473 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.93 -169.81 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 73.340000000000003 110.847 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 154.46 44.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.19 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.8 -59.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 70.420000000000002 111.103 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.32 -34.26 60.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 72.549999999999997 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.68 -26.86 61.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.91 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.5 -45.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.105 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.34 34.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 62.219999999999999 111.101 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -66.96 -35.14 79.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 110.893 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -66.88 -49.37 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.895 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -72.01 -24.56 61.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.94 -12.05 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 74.549999999999997 112.484 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -55.86 129.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 55.409999999999997 111.136 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -86.23 80.85 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.409999999999997 110.898 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.892 0.377 . . . . 31.109999999999999 110.9 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -164.53 109.43 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 65.439999999999998 110.847 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -128.48 155.0 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 74.439999999999998 111.119 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.4 mt -90.76 129.44 41.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 71.150000000000006 111.139 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.5 161.8 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 110.937 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.95 143.7 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 71.019999999999996 110.846 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -58.31 -59.52 13.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.702 . . . . 74.019999999999996 110.808 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -47.92 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.661 2.241 . . . . 64.209999999999994 112.303 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.0 -42.59 65.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.915 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -71.85 -54.11 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.851 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.34 -34.81 58.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -78.03 -41.8 34.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.15 -25.76 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.992 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.36 140.08 5.33 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 71.329999999999998 112.508 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.74 160.3 28.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.66 0.743 . . . . 65.310000000000002 110.9 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 166.62 27.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.661 2.241 . . . . 72.109999999999999 112.326 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.0 t -58.09 171.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.817 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -59.96 -37.32 79.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.858 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -62.57 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.92 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -67.54 -35.63 79.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.837 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.27 -53.49 56.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.897 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.73 -42.58 90.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.936 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -37.44 67.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.857 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.52 -52.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 75.239999999999995 111.172 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.68 -21.59 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.819 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -76.18 -24.16 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 110.908 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.15 164.28 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 111.132 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -74.47 113.69 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.907 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.22 40.56 52.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.506 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.58 114.87 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 70.219999999999999 111.112 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.67 142.82 27.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.178 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.36 -23.68 34.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.812 -0.709 . . . . 75.129999999999995 112.471 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 p -74.22 -0.93 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 64.239999999999995 111.105 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 45.3 t -90.63 -12.21 37.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.837 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.98 133.67 55.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.888 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 pp -179.06 -178.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.26 -133.12 4.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 73.239999999999995 112.501 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -144.78 -42.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 65.200000000000003 110.936 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.33 101.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.019999999999996 110.913 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -134.99 127.08 29.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 73.030000000000001 110.948 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -84.41 168.95 15.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 70.209999999999994 110.86 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.45 119.24 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.239999999999995 111.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.05 172.98 12.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.049999999999997 110.866 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -29.7 68.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.834 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.8 m -65.65 -22.65 66.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 70.340000000000003 110.86 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -81.77 -0.15 41.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.857 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.65 123.77 16.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.409999999999997 110.92 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.75 27.18 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 54.210000000000001 110.915 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.19 151.07 47.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 111.024 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.28 120.99 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.049999999999997 111.146 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -114.19 98.96 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.908 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.3 m -91.41 116.65 29.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.133 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.64 89.19 5.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.597 0.713 . . . . 72.129999999999995 111.132 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -35.53 12.65 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.726 2.284 . . . . 74.120000000000005 112.354 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.794 0.33 . . . . 74.209999999999994 110.877 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 64.72 148.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 72.400000000000006 111.139 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.27 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.385 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.66 157.41 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 74.219999999999999 110.875 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.21 133.25 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 64.120000000000005 110.872 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.12 176.96 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 64.439999999999998 111.098 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -113.79 140.9 47.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.861 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.69 175.09 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.15 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -133.03 126.77 32.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -108.77 103.16 12.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.882 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 132.15 34.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.9 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -115.32 176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 70.430000000000007 111.136 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.0 tpt -75.64 -8.29 56.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 73.099999999999994 110.918 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -103.44 -37.95 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.826 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 179.39 176.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 65.340000000000003 110.966 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.62 147.63 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 111.148 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.6 t -141.38 87.79 10.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 73.409999999999997 111.169 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 152.59 69.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.612 2.208 . . . . 73.0 112.396 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.63 144.28 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.428 . . . . 74.200000000000003 111.079 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.88 147.87 29.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 73.430000000000007 110.857 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.75 143.58 45.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 111.078 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.45 151.4 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.430000000000007 111.117 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 p -53.38 116.29 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 53.420000000000002 110.841 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.31 71.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 51.299999999999997 112.483 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.7 p -77.83 -169.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 110.839 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.87 143.1 42.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.149 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.11 -63.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 70.420000000000002 111.116 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.85 -32.84 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 72.549999999999997 110.927 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.72 -27.52 62.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 72.530000000000001 110.815 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -77.22 -44.93 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 73.200000000000003 111.121 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.16 -28.33 52.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 111.121 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.55 -26.39 61.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.78 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.31 -53.78 6.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.872 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 3.42 37.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 15.82 59.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 74.549999999999997 112.459 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.26 127.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 55.409999999999997 111.135 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.37 80.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.86 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.409999999999997 110.938 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.91 0.386 . . . . 31.109999999999999 110.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.43 94.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 t -128.67 156.41 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 111.111 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.1 mt -89.98 131.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.150000000000006 111.15 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.6 tp -127.77 159.74 33.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.937 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.54 141.23 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.499 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.1 mt-10 -57.48 -59.52 12.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.019999999999996 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.79 -48.63 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.601 2.201 . . . . 64.209999999999994 112.38 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.83 -41.17 61.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 75.329999999999998 110.965 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -73.37 -51.38 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.834 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -34.32 63.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -78.29 -44.65 24.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.23 -21.35 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.851 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.12 131.74 2.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.813 -0.708 . . . . 71.329999999999998 112.47 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -112.6 157.31 40.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 110.885 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -177.98 2.15 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.637 2.225 . . . . 72.109999999999999 112.332 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.1 m -101.09 -176.23 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 75.409999999999997 110.872 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -55.71 -44.03 77.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 72.409999999999997 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -53.93 -59.56 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 73.140000000000001 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -30.78 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 71.530000000000001 110.92 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -56.09 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.936 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.57 -39.44 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.36 -52.32 63.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.61 -34.42 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 111.149 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.54 -17.86 56.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.877 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -75.77 -26.06 57.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.29 164.03 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 71.439999999999998 111.065 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -82.87 113.66 20.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.94 41.15 51.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.129999999999995 112.478 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -105.66 126.48 52.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 70.219999999999999 111.069 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 148.34 24.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.059 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.63 -25.6 43.56 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 75.129999999999995 112.526 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -74.06 -1.38 19.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 64.239999999999995 111.192 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.7 t -90.61 -11.87 38.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.838 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.6 ttt-85 -91.96 168.88 11.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 73.340000000000003 110.846 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.3 tp -49.56 146.71 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.943 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.89 33.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 73.239999999999995 112.519 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.5 p -110.98 138.81 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 65.200000000000003 110.818 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -114.43 7.86 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 74.019999999999996 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 51.91 55.64 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 73.030000000000001 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -152.39 126.53 9.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.91 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.3 t -97.39 120.07 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 72.239999999999995 111.085 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -176.78 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 74.049999999999997 110.878 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -56.9 -36.0 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.510000000000005 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 m -64.85 -24.05 67.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 70.340000000000003 110.804 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.2 0.72 39.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 110.915 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.01 119.2 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 110.86 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.61 22.01 12.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 54.210000000000001 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.58 145.11 29.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 74.299999999999997 111.116 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.27 115.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.049999999999997 111.15 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -111.08 98.15 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 m -87.47 119.22 27.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 111.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.73 88.25 5.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.058 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -42.65 3.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 74.120000000000005 112.4 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.852 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.745 0.307 . . . . 74.209999999999994 110.836 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -137.96 133.11 17.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.661 0.743 . . . . 72.400000000000006 111.087 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.219 . . . . 71.329999999999998 112.378 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.91 156.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 74.219999999999999 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -73.89 158.14 35.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 64.120000000000005 110.911 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.2 177.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -124.61 132.21 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.921 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.36 169.51 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.129 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.88 129.0 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.901 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -99.49 103.38 15.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 74.319999999999993 110.866 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -95.44 143.52 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.839 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 p -138.09 179.58 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 70.430000000000007 111.137 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -8.15 55.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.099999999999994 110.905 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -107.15 -38.03 6.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.436 . . . . 74.150000000000006 110.853 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 179.36 176.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 65.340000000000003 110.925 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -118.04 134.86 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.010000000000005 111.137 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.92 150.73 69.9 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.565 0.697 . . . . 73.409999999999997 111.179 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 153.21 68.96 Favored 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.642 2.228 . . . . 73.0 112.292 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.55 105.74 3.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 111.079 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -70.13 125.16 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 110.911 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 123.2 43.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.113 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.21 147.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 75.430000000000007 111.19 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.8 p -52.89 114.76 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 53.420000000000002 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 19.79 52.57 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.815 -0.707 . . . . 51.299999999999997 112.465 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 p -93.18 -175.63 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 110.785 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.2 m -143.66 152.0 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 73.310000000000002 111.12 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -57.99 -45.79 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.153 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.87 -37.63 88.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 72.549999999999997 110.925 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.7 -27.99 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.874 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.39 -36.77 24.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 73.200000000000003 111.118 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.09 55.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.027 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -73.7 -27.69 61.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -51.76 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.530000000000001 110.855 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -71.89 -25.73 62.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.41 52.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.655 -0.783 . . . . 74.549999999999997 112.495 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -51.5 135.15 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.775 0.321 . . . . 55.409999999999997 111.154 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.88 82.78 6.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.883 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.409999999999997 110.931 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.9 m . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.832 0.348 . . . . 31.109999999999999 110.822 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -102.38 96.76 7.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 65.439999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.69 157.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.439999999999998 111.129 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 89.9 mt -90.51 129.68 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 71.150000000000006 111.166 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.33 163.02 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.81 147.2 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.877 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -61.33 -59.71 12.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.605 0.716 . . . . 74.019999999999996 110.9 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.76 -42.44 3.4 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.638 2.225 . . . . 64.209999999999994 112.349 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -44.52 88.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 75.329999999999998 110.929 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -70.88 -52.34 20.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.883 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -36.45 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.140000000000001 110.862 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -73.86 -44.32 55.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 75.0 110.927 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.25 -52.66 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 75.209999999999994 110.89 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.42 142.96 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 71.329999999999998 112.524 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.83 157.56 42.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.659 0.743 . . . . 65.310000000000002 110.874 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 173.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.64 2.227 . . . . 72.109999999999999 112.323 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -102.49 -169.84 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.409999999999997 110.855 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.71 -46.81 81.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.843 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.99 -59.55 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.09 -27.75 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.862 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -53.75 48.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.918 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -69.74 -37.14 76.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 71.120000000000005 110.871 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 mt -62.49 -48.47 79.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.91 -35.41 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 75.239999999999995 111.087 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.97 -20.68 64.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 74.030000000000001 110.904 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.15 -25.78 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.914 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.47 146.09 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.069 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.2 121.63 18.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.847 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 44.63 60.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.29 129.38 50.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 70.219999999999999 111.143 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 144.5 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.095 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.44 -22.74 32.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 75.129999999999995 112.511 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.7 p -73.89 -2.25 23.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.086 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.9 t -88.43 -13.35 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 110.786 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -123.33 167.45 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.908 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 58.71 46.64 14.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.854 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.34 40.71 2.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 73.239999999999995 112.462 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 2.9 t -92.02 66.98 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 65.200000000000003 110.855 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.13 138.29 46.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.019999999999996 110.927 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.54 35.37 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.030000000000001 110.896 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -132.96 135.95 45.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 70.209999999999994 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 t -109.61 119.58 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -136.46 178.73 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.049999999999997 110.891 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -58.31 -37.21 74.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 110.948 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -63.64 -19.44 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 70.340000000000003 110.862 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -89.62 9.92 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.851 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.87 125.76 24.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 110.889 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 60.52 21.9 11.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 54.210000000000001 110.872 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.71 136.33 57.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.299999999999997 111.088 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.44 119.42 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.049999999999997 111.1 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.2 98.44 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.430000000000007 110.895 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.4 m -93.8 119.82 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 111.133 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.87 88.57 5.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.165 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -36.26 11.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.274 . . . . 74.120000000000005 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.873 -179.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.807 0.336 . . . . 74.209999999999994 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.0 mt -98.53 132.99 23.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 72.400000000000006 111.177 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -174.4 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.334 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -53.05 156.67 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 155.0 39.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 64.120000000000005 110.84 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.85 176.82 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 111.103 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -122.8 138.63 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.82 172.56 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 75.129999999999995 111.126 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -127.53 133.28 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.887 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -104.52 106.03 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.819 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -97.25 144.26 27.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.975 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -139.1 178.72 6.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 70.430000000000007 111.113 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -8.1 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.88 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -106.31 -37.66 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 74.150000000000006 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 179.82 175.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 65.340000000000003 110.949 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.77 127.67 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.010000000000005 111.155 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.91 150.84 47.96 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.107 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 156.17 63.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 73.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.97 138.2 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 111.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -100.54 130.67 46.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 73.430000000000007 110.902 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.73 117.04 32.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 111.115 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.4 t -104.61 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.122 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -51.74 116.2 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 53.420000000000002 110.849 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 7.38 50.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 51.299999999999997 112.486 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -100.95 -169.97 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.995 0.426 . . . . 73.340000000000003 110.852 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.58 142.65 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 111.153 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.4 t -52.45 -63.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 70.420000000000002 111.1 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.49 -33.16 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 72.549999999999997 110.895 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.73 -27.4 62.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 72.530000000000001 110.845 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.82 -43.06 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 73.200000000000003 111.151 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.06 -30.13 14.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.056 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -73.62 -37.8 65.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 110.855 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -40.22 50.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 74.530000000000001 110.848 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.11 -21.78 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 74.420000000000002 110.87 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.0 -12.26 55.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 74.549999999999997 112.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.7 t -57.8 113.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.337 . . . . 55.409999999999997 111.135 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.47 80.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.929 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.899 -179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 31.109999999999999 110.857 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -100.8 118.35 36.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 65.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.23 155.53 39.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 111.17 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.38 132.98 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 71.150000000000006 111.195 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.7 tp -127.37 159.31 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 72.319999999999993 110.929 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.15 146.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.915 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -59.38 -60.25 11.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 74.019999999999996 110.914 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.86 -46.22 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 64.209999999999994 112.28 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.13 -48.32 70.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.909 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -68.23 -47.43 67.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.450000000000003 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -55.62 -43.7 76.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 72.140000000000001 110.917 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.16 -26.95 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.83 -62.56 1.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.937 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.17 3.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 71.329999999999998 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -132.34 157.31 78.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.683 0.754 . . . . 65.310000000000002 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 166.28 28.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 72.109999999999999 112.318 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.19 170.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.874 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -58.78 -37.19 75.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.879 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -52.51 -62.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.7 -35.11 78.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 71.530000000000001 110.845 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -56.89 -53.34 59.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.945 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.95 -42.16 90.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.838 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tp -55.8 -37.55 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 110.954 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 mt -74.57 -52.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.239999999999995 111.13 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -59.04 -21.67 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.854 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -76.04 -24.99 55.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.933 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.05 162.96 27.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.439999999999998 111.053 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -70.23 117.34 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.07 42.84 55.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 73.129999999999995 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -113.61 121.86 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.086 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.7 144.1 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.135 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.59 -23.47 36.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.488 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -73.92 -2.24 23.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 64.239999999999995 111.136 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.6 t -90.24 -13.97 34.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.841 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.55 158.31 34.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.854 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 56.45 67.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.954 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.21 61.68 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 73.239999999999995 112.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.1 t -133.96 -74.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 65.200000000000003 110.91 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.27 93.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.844 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.6 mt -146.18 165.52 28.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 73.030000000000001 110.858 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -112.03 170.61 8.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 70.209999999999994 110.868 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.42 115.3 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.127 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.93 176.01 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.049999999999997 110.794 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -57.2 -36.25 70.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.510000000000005 110.873 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -22.35 66.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 110.885 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.76 5.27 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 73.439999999999998 110.922 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.8 123.0 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 110.898 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.37 22.58 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 54.210000000000001 110.939 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 133.64 52.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 74.299999999999997 111.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.17 118.86 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.049999999999997 111.128 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -109.4 102.97 11.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 71.430000000000007 110.889 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -95.2 125.77 40.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.182 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.59 133.33 21.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.602 0.715 . . . . 72.129999999999995 111.154 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.28 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.699 2.266 . . . . 74.120000000000005 112.304 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 72.140000000000001 110.841 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.72 0.295 . . . . 74.209999999999994 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -136.33 133.18 19.25 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.63 0.729 . . . . 72.400000000000006 111.148 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 178.1 4.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.696 2.264 . . . . 71.329999999999998 112.353 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.68 156.25 1.42 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.249 -0.432 . . . . 74.219999999999999 110.856 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 149.52 41.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.939 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.07 175.84 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 64.439999999999998 111.186 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -124.98 139.17 54.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.1 pt -125.83 164.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.12 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -121.37 138.93 54.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 75.219999999999999 110.892 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -117.0 102.76 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 74.319999999999993 110.917 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 144.48 28.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.937 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 p -114.4 -157.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 70.430000000000007 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.4 ttp -50.52 -50.35 53.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.904 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -138.09 -33.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 74.150000000000006 110.842 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.12 151.93 21.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 65.340000000000003 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.9 120.62 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 72.010000000000005 111.095 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.09 136.99 20.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 73.409999999999997 111.216 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 169.57 18.67 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.638 2.225 . . . . 73.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -159.38 108.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.075 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -74.1 138.0 43.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 73.430000000000007 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.59 116.59 29.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.086 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.1 t -102.57 141.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.132 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.83 114.85 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 53.420000000000002 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.55 50.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 51.299999999999997 112.488 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -94.08 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.979 0.419 . . . . 73.340000000000003 110.806 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.2 p -142.65 154.78 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 73.310000000000002 111.149 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.5 t -52.4 -59.62 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.420000000000002 111.15 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -34.94 61.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 110.903 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.81 -26.94 61.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 72.530000000000001 110.862 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.31 -47.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 111.104 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.61 -28.48 55.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.059 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -69.49 -32.93 72.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 75.200000000000003 110.824 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -53.76 21.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.918 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -72.38 -26.6 61.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.869 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.44 -4.26 40.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.813 -0.708 . . . . 74.549999999999997 112.483 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.79 141.41 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 55.409999999999997 111.127 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -88.3 80.79 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.832 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.876 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 31.109999999999999 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -117.39 101.66 8.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.54 164.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.439999999999998 111.105 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.84 133.2 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 71.150000000000006 111.148 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.6 tp -126.55 153.93 44.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 72.319999999999993 110.907 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.8 146.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.852 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -54.86 -60.46 7.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.674 0.749 . . . . 74.019999999999996 110.829 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.69 -44.75 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.7 2.267 . . . . 64.209999999999994 112.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.48 -45.31 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 75.329999999999998 110.951 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -72.79 -49.91 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.0 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -53.14 -37.85 62.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -76.07 -46.21 30.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.2 -22.81 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.869 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.7 136.17 3.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 71.329999999999998 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -112.2 157.41 39.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.634 0.73 . . . . 65.310000000000002 110.931 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.258 . . . . 72.109999999999999 112.379 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.5 t -120.94 -170.67 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.854 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.27 -46.4 76.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.898 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -54.43 -58.84 5.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.87 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -28.18 69.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.874 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -55.48 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 74.329999999999998 110.902 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.95 -40.91 87.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 110.861 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.07 -50.86 69.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 64.219999999999999 110.923 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -74.08 -35.04 40.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 111.128 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.48 -17.65 60.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.915 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.18 -24.42 54.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.909 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.2 164.37 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.069 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.85 113.84 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.866 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.83 52.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 73.129999999999995 112.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -96.53 125.17 40.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 70.219999999999999 111.12 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.8 30.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.203 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.35 -23.98 36.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.798 -0.715 . . . . 75.129999999999995 112.481 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -73.42 -3.27 26.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.146 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -86.83 -16.02 37.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.821 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.62 157.91 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.855 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -166.34 -179.46 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.933 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.82 -130.51 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 73.239999999999995 112.489 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.78 84.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 65.200000000000003 110.853 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -122.45 132.77 54.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 74.019999999999996 110.968 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -126.84 67.25 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 73.030000000000001 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -152.26 160.25 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 70.209999999999994 110.819 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.5 129.89 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 111.132 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.39 167.94 20.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 74.049999999999997 110.883 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -57.05 -31.06 64.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 72.510000000000005 110.866 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -28.24 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.340000000000003 110.851 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.98 -6.12 49.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 73.439999999999998 110.936 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 124.15 18.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 75.409999999999997 110.893 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 61.01 22.85 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 54.210000000000001 110.915 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.15 138.32 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 74.299999999999997 111.091 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t -107.32 111.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 75.049999999999997 111.145 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -105.89 104.62 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 110.895 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 m -93.35 125.52 38.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 73.439999999999998 111.134 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.01 133.45 43.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.63 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.374 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.926 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 110.909 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.98 124.65 70.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.629 0.728 . . . . 72.400000000000006 111.131 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -169.64 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.659 2.239 . . . . 71.329999999999998 112.399 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -51.02 157.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 110.93 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 136.37 38.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 64.120000000000005 110.987 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.58 176.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 64.439999999999998 111.142 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -120.42 136.78 54.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.819 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.97 169.21 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 75.129999999999995 111.186 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.6 126.72 52.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.83 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -96.56 103.12 15.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 122.84 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 75.340000000000003 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 -178.12 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 70.430000000000007 111.124 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.8 ttm -75.8 -8.18 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.871 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -108.21 -37.89 5.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 74.150000000000006 110.893 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 179.79 176.18 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.932 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 p -108.46 132.76 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 111.086 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.48 151.03 59.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 73.409999999999997 111.161 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.26 62.48 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.687 2.258 . . . . 73.0 112.302 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.83 104.2 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 111.129 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -76.46 132.22 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.953 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.64 133.65 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.052 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.08 152.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 111.079 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -52.4 111.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 53.420000000000002 110.932 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.16 17.15 35.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 51.299999999999997 112.49 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.0 p -107.52 163.56 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.922 0.392 . . . . 73.340000000000003 110.879 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 154.07 39.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 73.310000000000002 111.126 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.83 -44.72 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.420000000000002 111.111 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.76 -44.17 81.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 72.549999999999997 110.908 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -72.72 -26.83 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.530000000000001 110.929 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.23 -31.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 73.200000000000003 111.164 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.28 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 111.118 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -73.43 -35.83 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.839 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -64.72 -46.96 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.832 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.31 -24.62 59.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.938 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.85 40.37 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.742 -0.742 . . . . 74.549999999999997 112.471 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -51.48 136.24 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 55.409999999999997 111.177 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.84 80.96 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.834 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.93 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.918 0.39 . . . . 31.109999999999999 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -69.36 90.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.806 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.59 157.4 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 74.439999999999998 111.193 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.63 134.72 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 71.150000000000006 111.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.3 tp -129.03 158.52 38.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 72.319999999999993 110.876 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.45 142.74 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.4 mt-10 -56.91 -60.16 10.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.708 0.766 . . . . 74.019999999999996 110.879 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.82 -48.95 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.721 2.28 . . . . 64.209999999999994 112.288 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -41.9 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 75.329999999999998 110.941 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -72.51 -52.72 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.966 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.26 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 110.83 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -77.94 -44.54 26.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.951 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.24 -24.3 67.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.874 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.24 156.31 6.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.811 -0.709 . . . . 71.329999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -119.99 157.62 52.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 65.310000000000002 110.865 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 156.6 62.79 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 72.109999999999999 112.296 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.9 t -90.36 -169.66 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.867 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.62 -47.51 76.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -54.02 -59.75 4.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.869 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.11 -27.94 68.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.909 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -56.35 17.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.924 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.98 -40.34 91.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 71.120000000000005 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 mt -56.93 -51.38 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 64.219999999999999 110.904 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.7 mt -73.59 -35.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 75.239999999999995 111.171 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -61.84 -18.07 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.863 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -76.01 -24.13 55.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.886 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.5 146.71 27.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 71.439999999999998 111.158 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.2 122.23 19.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 110.859 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.98 45.08 56.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 73.129999999999995 112.479 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.8 124.86 47.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 111.111 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 144.02 25.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.139 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.77 -24.82 42.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 75.129999999999995 112.423 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.2 p -74.09 -2.18 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 64.239999999999995 111.071 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -90.72 -13.03 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.933 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -144.05 136.67 26.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 73.340000000000003 110.947 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -134.36 -61.25 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.889 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.17 -90.46 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.668 -0.777 . . . . 73.239999999999995 112.446 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.92 110.42 2.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 65.200000000000003 110.916 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.17 118.79 20.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 74.019999999999996 110.894 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.2 37.18 3.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.030000000000001 110.904 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -137.22 147.81 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 70.209999999999994 110.908 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -104.18 129.94 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.128 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -136.74 164.16 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.049999999999997 110.894 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -54.84 -26.4 35.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 72.510000000000005 110.873 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -29.2 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 70.340000000000003 110.825 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -91.21 12.52 19.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.922 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -59.65 111.89 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 110.89 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 63.76 20.61 12.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 54.210000000000001 110.883 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.99 151.07 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 74.299999999999997 111.128 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.73 115.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 75.049999999999997 111.178 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -108.87 104.36 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.825 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.2 m -95.08 130.86 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.187 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.48 133.21 23.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.195 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.6 -47.79 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.695 2.263 . . . . 74.120000000000005 112.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.862 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.759 0.314 . . . . 74.209999999999994 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.59 132.92 87.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.659 0.742 . . . . 72.400000000000006 111.133 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.34 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 71.329999999999998 112.359 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.86 156.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 74.219999999999999 110.865 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.74 132.93 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 64.120000000000005 110.875 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.12 177.27 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.137 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -112.18 151.78 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.872 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.34 165.45 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.064 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.2 125.17 53.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.949 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.29 103.14 15.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.899 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -101.35 118.3 36.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.843 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -124.6 171.2 10.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 70.430000000000007 111.158 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mmm -75.83 -7.96 55.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 73.099999999999994 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.7 -38.04 9.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 110.93 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 179.45 176.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 65.340000000000003 110.933 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -111.74 124.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.010000000000005 111.113 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 150.49 76.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.111 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 155.38 65.92 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.65 2.233 . . . . 73.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.45 141.46 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.200000000000003 111.099 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -106.15 131.65 53.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.929 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.78 116.54 32.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 111.059 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.36 151.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 75.430000000000007 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -52.93 109.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 53.420000000000002 110.925 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.02 31.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 51.299999999999997 112.485 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.3 p -100.8 163.32 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.415 . . . . 73.340000000000003 110.877 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.6 p -130.99 152.92 49.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 73.310000000000002 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -60.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.131 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -34.25 59.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 72.549999999999997 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -72.46 -26.77 61.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 72.530000000000001 110.789 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.8 t -76.94 -45.06 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 73.200000000000003 111.142 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.64 -29.95 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 111.037 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -71.66 -36.77 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 110.943 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -79.38 -45.23 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.886 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -72.19 -25.4 61.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.66 -12.19 56.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 74.549999999999997 112.462 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.66 105.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 55.409999999999997 111.136 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -81.77 81.11 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.839 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.409999999999997 110.907 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.883 0.373 . . . . 31.109999999999999 110.91 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.88 113.77 21.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 65.439999999999998 110.875 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.38 157.16 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.073 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -89.81 137.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 111.058 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.46 158.36 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.865 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.52 142.4 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.863 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -58.64 -59.23 14.3 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.53 0.681 . . . . 74.019999999999996 110.876 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.81 -47.97 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 64.209999999999994 112.364 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.47 -48.78 65.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 110.957 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.11 -51.7 59.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.924 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.11 44.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 72.140000000000001 110.843 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -75.49 -52.34 10.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.07 -23.19 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.12 151.7 5.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 71.329999999999998 112.525 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.13 157.63 77.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 65.310000000000002 110.872 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.667 2.245 . . . . 72.109999999999999 112.334 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 p -111.24 -176.92 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.851 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -55.77 -44.84 78.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -53.79 -59.7 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 73.140000000000001 110.854 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -28.07 69.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.878 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -55.16 31.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.949 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.94 -41.03 83.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 110.821 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.62 -52.24 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 110.917 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.7 -35.02 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 111.101 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.79 -19.17 58.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 110.856 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -76.07 -24.0 55.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.924 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.96 151.44 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.439999999999998 111.061 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -69.73 120.26 15.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.519999999999996 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.67 44.09 54.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.726 -0.75 . . . . 73.129999999999995 112.537 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.11 132.64 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 70.219999999999999 111.082 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.93 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 111.145 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.86 -26.77 48.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 75.129999999999995 112.453 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -74.09 -0.99 18.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.133 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 25.5 t -90.89 -14.0 32.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 71.409999999999997 110.858 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -102.93 160.81 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.887 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.6 125.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.895 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.13 -166.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 73.239999999999995 112.467 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 21.8 m -89.07 49.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 65.200000000000003 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -128.92 41.89 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.919 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.88 65.05 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 73.030000000000001 110.911 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -109.46 158.43 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 70.209999999999994 110.913 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.93 127.23 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.157 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 161.14 36.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 74.049999999999997 110.838 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -36.82 67.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.885 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -21.44 66.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 70.340000000000003 110.849 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.73 1.82 40.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.845 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.88 124.14 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.914 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 59.11 26.26 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 54.210000000000001 110.895 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.07 130.42 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 111.03 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.3 t -97.91 126.78 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 75.049999999999997 111.099 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -120.74 132.61 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 71.430000000000007 110.867 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.8 m -104.72 130.9 52.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 111.16 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.31 133.3 28.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 72.129999999999995 111.105 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -165.45 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.28 . . . . 74.120000000000005 112.355 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 72.140000000000001 110.794 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.746 0.308 . . . . 74.209999999999994 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 mp -81.61 133.0 53.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.591 0.71 . . . . 72.400000000000006 111.152 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.271 . . . . 71.329999999999998 112.308 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -52.3 156.76 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.883 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.04 159.27 32.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 64.120000000000005 110.859 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 pt -139.66 176.78 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 111.134 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -124.08 130.59 52.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.836 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 pt -114.5 162.66 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 75.129999999999995 111.103 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.5 136.18 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -106.18 108.31 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 74.319999999999993 110.896 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 134.56 38.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 75.340000000000003 110.923 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -125.18 -178.95 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.175 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.1 ttp -75.78 -8.03 55.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.918 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -37.97 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.150000000000006 110.911 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 179.26 176.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 65.340000000000003 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.42 135.78 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.010000000000005 111.113 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.87 150.18 70.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.687 . . . . 73.409999999999997 111.183 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 150.75 68.66 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 73.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -148.5 116.22 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 111.054 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -74.22 131.52 41.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.898 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.1 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.102 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.93 147.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.430000000000007 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -52.41 113.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 53.420000000000002 110.884 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.44 25.19 51.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 51.299999999999997 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -97.27 163.28 12.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 73.340000000000003 110.891 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 p -121.14 165.28 15.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 111.087 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -52.02 -56.26 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 111.137 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -56.77 -35.6 68.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 72.549999999999997 110.789 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.62 -26.76 61.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 72.530000000000001 110.893 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.67 -41.39 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.126 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.96 -30.2 58.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 62.219999999999999 111.115 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -74.13 -24.84 59.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.834 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -76.62 -54.2 6.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 110.896 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -77.82 -14.22 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.883 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.76 -12.42 69.42 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 74.549999999999997 112.463 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.9 t -57.33 143.15 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 55.409999999999997 111.124 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.88 81.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.84 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.869 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.871 0.367 . . . . 31.109999999999999 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -77.13 78.69 3.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.439999999999998 110.791 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.7 t -128.46 157.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 111.17 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 3.2 mp -90.18 130.91 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 71.150000000000006 111.134 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.03 163.9 22.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.91 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -40.65 138.45 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.019999999999996 110.91 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -60.77 -58.64 17.85 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 74.019999999999996 110.945 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.4 Cg_endo -69.71 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.749 2.299 . . . . 64.209999999999994 112.327 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.25 -49.05 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 110.918 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.9 -51.33 62.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.88 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -27.24 62.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 72.140000000000001 110.862 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -75.9 -54.66 6.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.04 -21.48 66.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.02 142.77 3.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.742 -0.742 . . . . 71.329999999999998 112.508 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 157.57 77.05 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 65.310000000000002 110.872 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 157.27 60.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 72.109999999999999 112.316 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.2 m -58.14 157.34 8.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -51.73 -35.78 44.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.896 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -62.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.909 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.71 -35.82 81.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 110.923 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.61 -56.6 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.9 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -62.15 -41.29 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.908 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.21 -38.26 73.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.219999999999999 110.936 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.5 mt -75.04 -36.75 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.239999999999995 111.078 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.18 -22.26 27.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.857 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -29.7 59.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.891 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.67 131.09 39.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.439999999999998 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -54.44 130.08 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.48 48.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.718 . . . . 73.129999999999995 112.458 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 70.219999999999999 111.162 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.74 153.01 22.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.174 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.64 -27.39 48.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.453 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -73.94 -1.43 19.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 111.174 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.0 t -87.61 -13.88 41.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 131.92 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.814 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tt -135.07 -64.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 110.879 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.94 -176.68 41.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 73.239999999999995 112.511 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.12 109.27 20.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 65.200000000000003 110.866 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -163.81 134.68 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.019999999999996 110.891 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -126.78 83.79 2.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.924 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -152.0 146.63 25.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.884 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.88 131.68 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.203 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.42 167.47 21.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.049999999999997 110.835 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.59 -22.05 54.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.926 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -29.46 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 70.340000000000003 110.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -90.78 7.54 39.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 73.439999999999998 110.868 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -57.63 123.15 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 110.878 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.4 25.36 14.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 54.210000000000001 110.907 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -86.23 162.52 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.078 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.72 125.29 69.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 111.175 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -111.76 94.72 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.904 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.1 m -89.32 130.97 35.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.158 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.4 133.35 20.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.6 0.715 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -41.15 4.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 74.120000000000005 112.303 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.831 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.772 0.32 . . . . 74.209999999999994 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.62 133.07 91.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.604 0.716 . . . . 72.400000000000006 111.088 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -170.57 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.383 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.24 156.89 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 74.219999999999999 110.89 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -74.03 144.01 45.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 64.120000000000005 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.93 176.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.136 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -114.68 138.71 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.896 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.22 167.81 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 111.189 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -113.08 125.3 54.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.865 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.37 101.87 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.51 128.56 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 p -127.23 175.85 7.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 70.430000000000007 111.171 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 6.1 tpt -74.42 -8.06 55.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 73.099999999999994 110.893 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.08 -38.35 6.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.150000000000006 110.824 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 178.81 176.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 65.340000000000003 110.881 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.78 146.44 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.129 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.3 t -142.51 129.78 11.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.112 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.64 7.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.633 2.222 . . . . 73.0 112.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.21 115.94 23.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 111.064 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -73.91 137.22 43.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 110.898 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.22 145.87 37.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.138 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.01 152.36 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 75.430000000000007 111.117 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.51 109.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 53.420000000000002 110.833 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.47 23.49 33.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 51.299999999999997 112.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -97.19 177.52 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 73.340000000000003 110.86 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 p -134.69 152.21 51.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.310000000000002 111.168 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -61.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 70.420000000000002 111.073 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.01 -34.05 58.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.549999999999997 110.921 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.4 -27.07 62.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 72.530000000000001 110.805 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.0 -43.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.200000000000003 111.125 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.98 -28.13 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 62.219999999999999 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -73.1 -27.43 61.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.806 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -53.4 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.884 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.59 -24.73 61.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.420000000000002 110.908 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.02 15.75 43.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.783 -0.722 . . . . 74.549999999999997 112.452 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.31 147.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.338 . . . . 55.409999999999997 111.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -88.83 80.8 7.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.904 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 110.935 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.862 0.363 . . . . 31.109999999999999 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -146.68 112.99 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 65.439999999999998 110.832 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.32 156.66 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 111.133 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.31 137.72 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.150000000000006 111.159 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.77 157.88 39.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 72.319999999999993 110.952 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.48 141.45 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.879 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -57.27 -59.63 12.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 74.019999999999996 110.906 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.79 -48.86 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.744 2.296 . . . . 64.209999999999994 112.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.83 -42.82 62.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 75.329999999999998 110.996 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -72.51 -51.64 19.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.87 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -36.23 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.140000000000001 110.852 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -78.18 -43.06 29.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.26 -28.1 69.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.944 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.07 160.55 8.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.737 -0.744 . . . . 71.329999999999998 112.457 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.55 157.37 77.48 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 65.310000000000002 110.876 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 72.109999999999999 112.425 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -102.57 -175.7 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 110.871 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -56.45 -45.2 80.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -59.65 4.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.868 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.43 -28.55 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.530000000000001 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -56.96 13.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.901 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -42.09 89.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.822 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.08 -51.93 62.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 110.963 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.74 -35.26 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.239999999999995 111.105 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.55 -17.04 62.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.83 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -76.28 -25.38 54.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.869 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.46 143.84 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 71.439999999999998 111.087 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -64.03 123.17 18.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 75.519999999999996 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.93 43.92 55.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.711 -0.756 . . . . 73.129999999999995 112.551 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -108.9 118.02 35.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 70.219999999999999 111.179 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 148.71 26.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 111.122 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.82 41.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 75.129999999999995 112.45 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -73.96 -1.99 22.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 64.239999999999995 111.171 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.7 t -91.05 -12.94 34.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 71.409999999999997 110.9 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -118.24 132.73 56.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 73.340000000000003 110.906 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.17 -69.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 110.874 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.36 -142.04 7.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 73.239999999999995 112.456 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -129.87 33.44 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 65.200000000000003 110.884 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -139.41 133.95 31.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.019999999999996 110.968 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -128.82 109.15 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 73.030000000000001 110.918 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -137.4 145.35 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 70.209999999999994 110.863 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.1 t -92.94 130.18 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.106 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.48 167.53 21.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.049999999999997 110.932 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -41.76 79.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 72.510000000000005 110.874 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.64 -17.09 59.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 70.340000000000003 110.898 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.26 11.26 21.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.931 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.5 123.27 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 75.409999999999997 110.897 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 59.6 25.88 14.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 54.210000000000001 110.84 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.85 127.92 34.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.097 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.12 120.52 51.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.049999999999997 111.117 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -120.46 126.41 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.876 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -101.4 131.35 47.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.192 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.18 133.34 37.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.681 0.753 . . . . 72.129999999999995 111.089 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -43.56 2.58 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.709 2.273 . . . . 74.120000000000005 112.312 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.948 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.734 0.302 . . . . 74.209999999999994 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.52 133.06 94.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.658 0.742 . . . . 72.400000000000006 111.105 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.742 2.295 . . . . 71.329999999999998 112.293 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -51.74 156.75 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.219999999999999 110.876 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -73.94 144.41 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 64.120000000000005 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.7 176.88 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 64.439999999999998 111.143 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -121.43 141.65 50.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.877 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 pt -114.39 164.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.05 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -120.77 130.36 53.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 110.877 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.35 102.95 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.33 30.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 75.340000000000003 110.934 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 p -113.8 -176.45 2.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 70.430000000000007 111.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -8.6 57.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 110.924 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -110.6 -38.32 5.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.885 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 178.67 176.49 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 65.340000000000003 110.902 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.05 148.14 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.158 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.44 132.52 24.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.117 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 129.37 17.56 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 73.0 112.382 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.01 107.51 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.105 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.94 149.06 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.430000000000007 110.91 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.68 121.67 25.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.069 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.3 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.145 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 p -51.21 111.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 53.420000000000002 110.852 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.84 14.16 35.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.703 . . . . 51.299999999999997 112.429 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.1 p -95.01 -178.92 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.009 0.433 . . . . 73.340000000000003 110.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.9 159.86 42.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 111.124 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -58.73 -45.3 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 111.069 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.75 -36.07 81.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 72.549999999999997 110.937 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.66 -27.44 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 110.892 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.0 t -77.08 -49.9 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 73.200000000000003 111.092 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 111.082 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -69.74 -34.19 73.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 110.854 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -87.12 -37.41 17.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.973 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.26 -24.92 61.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.912 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.9 -12.13 70.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 74.549999999999997 112.542 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.54 130.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 55.409999999999997 111.206 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.59 81.29 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.854 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.887 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.854 0.359 . . . . 31.109999999999999 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -161.95 112.09 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.864 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.92 157.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 111.133 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.79 132.37 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.150000000000006 111.099 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 tp -127.28 159.87 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.946 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.79 142.06 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.864 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -57.5 -59.83 11.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 74.019999999999996 110.867 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.61 2.206 . . . . 64.209999999999994 112.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -43.33 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.892 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -71.44 -51.63 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.945 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -35.39 61.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.873 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -78.1 -40.84 37.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -26.33 68.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.877 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.7 167.57 11.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.23 157.82 77.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 65.310000000000002 110.91 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -178.1 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.702 2.268 . . . . 72.109999999999999 112.334 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -98.32 -173.3 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.879 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -58.5 -43.8 89.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.858 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -53.93 -59.65 4.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 73.140000000000001 110.899 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -28.16 69.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.530000000000001 110.958 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -52.36 64.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -41.83 70.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 71.120000000000005 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -50.01 69.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.954 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.29 -42.58 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.138 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.51 -23.11 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.13 -24.17 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.56 142.17 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 111.049 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 130.99 43.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.904 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 40.36 59.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 73.129999999999995 112.56 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -108.64 123.61 49.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.32 144.2 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 75.109999999999999 111.1 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.91 -26.11 47.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 75.129999999999995 112.445 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -74.07 -1.23 19.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 64.239999999999995 111.155 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 t -90.76 -12.71 35.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.869 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -112.59 143.57 43.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.879 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 130.63 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.948 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.59 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 73.239999999999995 112.515 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.6 m -101.44 27.69 6.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 65.200000000000003 110.911 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.21 59.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.889 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 112.56 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 73.030000000000001 110.889 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -119.21 136.36 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.95 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -80.06 115.43 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.137 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 178.54 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.049999999999997 110.819 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -54.88 -40.28 69.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.510000000000005 110.889 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 t -64.44 -25.09 67.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 70.340000000000003 110.914 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -79.85 -2.21 42.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.869 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -58.15 124.94 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 110.935 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.3 m120 58.72 23.81 11.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 54.210000000000001 110.902 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.63 151.24 46.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 111.147 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.07 113.02 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 75.049999999999997 111.184 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -108.95 95.06 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.804 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.6 m -87.82 130.91 34.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 111.169 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.53 133.4 25.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.631 0.729 . . . . 72.129999999999995 111.165 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -41.89 3.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.76 2.306 . . . . 74.120000000000005 112.321 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.843 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.735 0.302 . . . . 74.209999999999994 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.61 132.96 21.04 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.758 . . . . 72.400000000000006 111.071 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -168.09 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 71.329999999999998 112.412 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -50.25 157.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 110.86 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.44 147.0 44.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.493 . . . . 64.120000000000005 110.95 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 177.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 111.205 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -122.75 136.79 54.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.946 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.44 172.02 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 111.13 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -118.74 128.74 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.894 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -105.31 104.18 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.922 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -93.64 122.25 35.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -113.36 -177.83 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 70.430000000000007 111.074 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -75.95 -9.36 58.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -106.09 -37.74 6.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 74.150000000000006 110.944 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.13 176.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.911 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.36 134.58 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.102 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.41 150.66 76.21 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.63 0.729 . . . . 73.409999999999997 111.101 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 155.06 66.96 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 73.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.92 136.18 25.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 111.141 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -96.78 134.56 39.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.430000000000007 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.35 125.66 53.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 t -95.23 156.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 75.430000000000007 111.114 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.5 m -55.55 99.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 53.420000000000002 110.802 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.95 24.6 11.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 51.299999999999997 112.476 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 m -94.83 174.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 73.340000000000003 110.844 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.73 146.71 52.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 111.133 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.52 -62.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 111.158 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.45 -32.98 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 72.549999999999997 110.876 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.25 -27.02 62.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.863 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.55 -43.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.200000000000003 111.108 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.82 -27.8 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 62.219999999999999 111.131 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -73.36 -34.66 65.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 75.200000000000003 110.822 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -83.28 -40.73 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.898 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -72.02 -26.95 62.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.812 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.69 83.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 74.549999999999997 112.438 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.66 156.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 55.409999999999997 111.135 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -72.1 80.02 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.859 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.829 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.865 0.364 . . . . 31.109999999999999 110.893 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -94.55 112.21 23.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 65.439999999999998 110.87 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.66 157.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 111.074 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 63.9 mt -90.08 132.79 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 71.150000000000006 111.134 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -125.63 159.63 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 72.319999999999993 110.902 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.78 142.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.019999999999996 110.815 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -60.11 -58.67 17.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.731 . . . . 74.019999999999996 110.965 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.85 -47.58 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.741 2.294 . . . . 64.209999999999994 112.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 tp -53.24 -51.16 63.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.329999999999998 110.957 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -63.46 -53.74 47.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.931 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -31.63 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 72.140000000000001 110.809 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.13 -53.78 13.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.3 -23.59 67.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.835 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.14 148.04 4.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.478 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.45 78.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.636 0.731 . . . . 65.310000000000002 110.842 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 165.45 30.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.648 2.232 . . . . 72.109999999999999 112.343 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -93.68 -170.92 2.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 110.842 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -56.96 -45.23 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.837 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -53.76 -59.79 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.57 -29.98 70.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.530000000000001 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -54.0 50.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.02 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.905 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.82 -51.95 61.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.936 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -74.92 -34.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.089 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.76 -20.02 45.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.030000000000001 110.799 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -75.52 -16.31 60.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.918 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.67 144.31 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 111.094 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -64.96 122.28 16.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.934 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.5 45.1 53.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 73.129999999999995 112.539 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -108.06 143.93 36.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.902 0.382 . . . . 70.219999999999999 111.092 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 150.56 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.149 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.18 49.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.742 . . . . 75.129999999999995 112.479 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -73.92 -1.28 19.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.384 . . . . 64.239999999999995 111.154 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.3 t -89.34 -13.61 37.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 110.879 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.22 165.65 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 73.340000000000003 110.848 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.65 65.88 0.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.03 19.88 10.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.753 . . . . 73.239999999999995 112.438 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.66 165.18 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 65.200000000000003 110.897 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 56.67 42.11 27.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.913 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.25 156.56 16.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.45 . . . . 73.030000000000001 110.879 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -118.55 163.47 16.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 110.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.0 t -102.03 122.71 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 111.107 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.28 173.61 11.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.927 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -59.26 -36.02 74.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 110.919 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -65.81 -19.53 65.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 70.340000000000003 110.909 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.02 -0.19 43.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.831 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -59.01 124.28 19.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 75.409999999999997 110.904 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.38 22.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 54.210000000000001 110.881 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 141.99 58.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.05 116.77 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 75.049999999999997 111.116 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.26 100.31 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.905 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.5 m -88.22 124.83 34.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 111.174 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.4 t -116.89 92.27 38.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.59 12.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.728 2.285 . . . . 74.120000000000005 112.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.843 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.767 0.318 . . . . 74.209999999999994 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.76 133.06 22.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 72.400000000000006 111.062 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -170.63 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 71.329999999999998 112.364 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.54 156.64 1.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 74.219999999999999 110.893 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.98 158.99 33.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 64.120000000000005 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.2 176.43 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 111.091 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 127.59 53.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.798 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.27 163.0 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 111.112 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -119.53 127.53 53.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.26 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 74.319999999999993 110.882 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -86.1 115.17 23.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.340000000000003 110.926 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -103.91 -179.29 3.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 70.430000000000007 111.167 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.01 -17.14 59.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.099999999999994 110.946 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -93.98 -39.11 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.889 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 176.31 176.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 65.340000000000003 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.77 142.69 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 111.085 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.75 129.78 18.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.71 60.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.246 . . . . 73.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.84 113.31 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.118 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -79.44 122.97 27.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.848 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.27 116.42 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.029 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 m -87.8 144.38 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 111.109 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 p -54.78 121.35 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 53.420000000000002 110.889 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.0 -7.74 41.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 51.299999999999997 112.494 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -99.42 -178.06 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.993 0.425 . . . . 73.340000000000003 110.85 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.93 154.77 50.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 111.135 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 m -57.91 -45.55 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.420000000000002 111.118 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.33 -37.35 87.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 110.931 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.73 -27.3 61.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 72.530000000000001 110.886 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.42 -43.59 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.077 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.96 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 62.219999999999999 111.108 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -73.42 -36.84 66.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 110.848 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -40.84 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.530000000000001 110.909 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.1 -25.45 61.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.903 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.88 76.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 74.549999999999997 112.449 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -51.5 137.99 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 55.409999999999997 111.052 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.13 80.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.884 -179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.928 0.394 . . . . 31.109999999999999 110.855 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -60.81 117.27 5.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 65.439999999999998 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.2 155.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 111.105 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 70.3 mt -91.07 133.77 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.150000000000006 111.096 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.3 tp -125.67 162.54 24.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.933 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -41.0 139.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -60.1 -59.38 14.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.638 0.732 . . . . 74.019999999999996 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.75 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.723 2.282 . . . . 64.209999999999994 112.318 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.76 -48.83 63.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.329999999999998 110.941 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -66.99 -51.08 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.929 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -51.52 -51.66 53.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 72.140000000000001 110.881 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -61.62 -48.55 80.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.94 -18.68 63.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.209999999999994 110.912 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.03 130.35 2.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 71.329999999999998 112.507 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 157.75 60.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 65.310000000000002 110.866 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.94 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.709 2.273 . . . . 72.109999999999999 112.392 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.9 m -104.79 -174.89 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.852 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.9 -49.16 78.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.896 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -47.69 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.914 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.83 -28.38 64.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 71.530000000000001 110.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -53.3 55.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.851 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -43.28 68.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.22 -49.07 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.219999999999999 110.88 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.8 mt -75.06 -34.4 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 111.089 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.42 -15.64 58.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.85 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.33 -22.86 57.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.858 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.1 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 71.439999999999998 111.133 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -56.97 126.6 27.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.13 41.33 53.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.484 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.48 139.03 46.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 70.219999999999999 111.068 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 155.0 44.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.135 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.87 -27.08 49.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 75.129999999999995 112.427 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 p -73.79 -1.92 21.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.293 . . . . 64.239999999999995 111.158 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 39.1 t -87.88 -14.9 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.884 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.8 168.27 9.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 73.340000000000003 110.857 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 62.06 97.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 74.420000000000002 110.947 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.95 32.01 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 73.239999999999995 112.504 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.24 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.329 . . . . 65.200000000000003 110.871 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -88.26 51.7 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.019999999999996 110.911 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 tt -91.37 114.51 27.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 73.030000000000001 110.93 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -85.33 134.93 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 110.934 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.76 122.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 72.239999999999995 111.091 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -137.07 160.2 39.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 74.049999999999997 110.884 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -53.95 -27.24 29.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -29.29 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 70.340000000000003 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -89.99 12.07 18.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 73.439999999999998 110.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.22 120.74 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.873 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.71 21.26 12.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 54.210000000000001 110.887 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.2 153.39 36.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 111.104 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 t -105.51 127.16 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 75.049999999999997 111.091 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.16 98.48 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.887 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.0 m -85.21 124.86 32.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.145 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.32 92.48 8.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.687 0.756 . . . . 72.129999999999995 111.124 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -34.2 14.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.663 2.242 . . . . 74.120000000000005 112.273 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 110.842 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 mt -51.65 133.2 36.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.635 0.731 . . . . 72.400000000000006 111.136 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.02 157.45 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.902 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -73.41 143.58 46.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 64.120000000000005 110.864 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.92 176.88 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 64.439999999999998 111.062 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -114.2 136.83 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.872 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -120.23 169.4 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 111.111 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.17 137.91 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -108.81 103.12 12.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.852 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -90.19 130.0 36.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.887 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 p -119.08 -177.51 3.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 70.430000000000007 111.156 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 ptm -75.9 -8.13 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.871 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -38.51 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 74.150000000000006 110.913 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -178.56 176.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 65.340000000000003 110.947 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.94 135.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 111.163 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.09 150.9 60.7 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 73.409999999999997 111.099 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.67 60.98 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 73.0 112.377 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.8 108.46 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 111.111 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -74.83 128.0 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.986 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.31 119.97 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.047 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.4 154.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 75.430000000000007 111.161 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.8 t -56.21 109.8 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 53.420000000000002 110.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.35 56.85 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 51.299999999999997 112.489 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 142.11 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 110.818 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.8 p -96.82 158.38 15.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 111.07 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.86 -58.27 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.420000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -33.63 58.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 72.549999999999997 110.856 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -73.06 -27.59 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 72.530000000000001 110.796 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.13 -45.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.082 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.2 25.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.042 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -71.74 -38.93 70.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 75.200000000000003 110.916 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -66.46 -50.69 62.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.17 -32.86 67.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.862 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.7 44.01 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.791 . . . . 74.549999999999997 112.51 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -51.82 142.44 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 55.409999999999997 111.222 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.43 81.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.851 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 110.924 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.36 . . . . 31.109999999999999 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -145.56 125.14 13.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 65.439999999999998 110.853 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 p -127.94 149.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 74.439999999999998 111.166 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 17.3 mt -91.2 133.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 71.150000000000006 111.106 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.11 158.97 25.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 72.319999999999993 110.878 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.09 137.46 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.816 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.8 mt-10 -59.72 -55.81 42.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.67 0.748 . . . . 74.019999999999996 110.921 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.9 Cg_endo -69.81 -32.71 17.83 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.63 2.22 . . . . 64.209999999999994 112.326 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -63.01 -46.64 86.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 110.882 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.32 -48.62 40.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.942 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -36.65 68.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 72.140000000000001 110.905 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -76.37 -45.19 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.04 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.965 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.05 158.29 21.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 71.329999999999998 112.522 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -130.75 157.63 77.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.649 0.738 . . . . 65.310000000000002 110.904 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.62 2.4 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.249 . . . . 72.109999999999999 112.352 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -95.93 -176.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.94 -44.39 82.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.803 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -53.49 -60.12 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.02 -28.43 69.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 110.902 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -55.68 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.944 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.61 -43.59 84.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 71.120000000000005 110.857 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.66 -46.9 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.895 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.84 -34.63 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 75.239999999999995 111.103 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.53 -15.41 60.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.885 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.89 -6.05 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.981 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.59 135.6 46.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.129 -0.487 . . . . 71.439999999999998 111.059 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -55.14 124.89 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 75.519999999999996 110.891 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.41 42.49 50.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.47 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.44 26.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 70.219999999999999 111.166 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.7 153.56 43.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 111.155 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.2 -38.37 67.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.468 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -0.85 17.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 64.239999999999995 111.153 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 8.7 t -88.24 -16.52 32.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.409999999999997 110.873 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -118.31 148.62 42.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.340000000000003 110.845 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -121.4 -175.09 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.420000000000002 110.888 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.0 7.57 5.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 73.239999999999995 112.542 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.2 m 61.5 167.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 65.200000000000003 110.931 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 54.59 43.55 30.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.888 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.34 92.33 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.030000000000001 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 168.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.845 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -90.77 143.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.123 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.44 171.24 14.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.049999999999997 110.808 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -38.42 77.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -17.71 63.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 70.340000000000003 110.898 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.5 9.68 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 73.439999999999998 110.842 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.33 124.88 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.906 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 60.81 21.25 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 54.210000000000001 110.895 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.9 129.74 41.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 111.157 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.9 t -93.1 118.73 39.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 75.049999999999997 111.187 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -106.29 99.87 9.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.929 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.6 m -87.06 131.2 34.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.169 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.4 132.64 21.71 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.125 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -41.35 4.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.692 2.262 . . . . 74.120000000000005 112.371 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.84 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.843 0.354 . . . . 74.209999999999994 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -54.26 132.95 61.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.647 0.737 . . . . 72.400000000000006 111.179 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.711 2.274 . . . . 71.329999999999998 112.435 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -52.28 157.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 74.219999999999999 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -73.82 148.78 42.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 64.120000000000005 110.887 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.38 177.11 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 64.439999999999998 111.07 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -123.35 144.62 49.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.797 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pt -125.75 170.59 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 111.087 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.5 125.32 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.887 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 103.37 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.877 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.78 127.28 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 p -114.36 -167.45 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 70.430000000000007 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.7 mmm -54.34 -54.85 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -141.03 27.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 110.963 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.3 128.45 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 65.340000000000003 110.915 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.34 109.86 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 72.010000000000005 111.138 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.11 150.27 59.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 111.175 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 159.55 53.02 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.703 2.269 . . . . 73.0 112.389 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 136.51 25.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 111.119 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.21 133.5 43.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.924 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.37 117.48 33.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.155 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.49 149.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 75.430000000000007 111.168 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.04 117.99 3.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 53.420000000000002 110.805 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.91 19.7 64.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 51.299999999999997 112.457 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -94.57 -169.42 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.931 0.396 . . . . 73.340000000000003 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.02 142.92 26.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 111.083 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.38 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 70.420000000000002 111.147 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -53.5 -36.27 61.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 72.549999999999997 110.859 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -72.67 -26.81 61.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 72.530000000000001 110.87 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.4 t -76.44 -39.9 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 73.200000000000003 111.086 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.35 -32.18 24.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.15 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -73.66 -35.94 65.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.863 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -40.31 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.530000000000001 110.942 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -72.08 -24.95 61.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 74.420000000000002 110.937 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.8 -11.67 38.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.737 . . . . 74.549999999999997 112.514 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.59 110.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.347 . . . . 55.409999999999997 111.169 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.79 80.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.88 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.896 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.859 0.361 . . . . 31.109999999999999 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -177.0 114.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 65.439999999999998 110.835 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 155.91 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -90.45 137.46 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 71.150000000000006 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 tp -128.51 161.54 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 72.319999999999993 110.917 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.26 141.7 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 110.924 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.497 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 mt-10 -58.47 -59.51 13.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.609 0.718 . . . . 74.019999999999996 110.894 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -48.73 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.269 . . . . 64.209999999999994 112.279 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -51.73 -46.77 64.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.944 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -68.41 -50.43 52.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.82 -43.98 66.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.875 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -77.83 -28.01 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.88 -61.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.937 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.41 132.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.329999999999998 112.482 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -91.91 160.31 36.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.701 0.762 . . . . 65.310000000000002 110.859 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.93 62.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.719 2.28 . . . . 72.109999999999999 112.333 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -86.45 -169.85 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.898 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -56.96 -48.57 78.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.833 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -53.52 -59.44 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.140000000000001 110.924 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.46 -27.61 68.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.887 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -55.74 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.99 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.7 -37.88 82.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 110.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.97 -47.24 86.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 64.219999999999999 110.909 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.6 mt -73.0 -35.17 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 75.239999999999995 111.159 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -20.89 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 74.030000000000001 110.857 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -76.25 -24.37 54.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.926 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.36 148.79 29.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 71.439999999999998 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -76.65 120.39 21.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 75.519999999999996 110.872 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.5 44.15 59.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.695 -0.765 . . . . 73.129999999999995 112.443 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.37 130.56 45.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 111.064 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 146.22 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.136 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.8 -24.97 43.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.686 -0.769 . . . . 75.129999999999995 112.539 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.9 p -74.01 -2.26 23.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 64.239999999999995 111.189 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.4 t -91.35 -13.42 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 71.409999999999997 110.903 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -108.53 161.79 14.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.863 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt 64.9 110.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.879 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.69 25.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 73.239999999999995 112.462 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 59.4 m -78.25 -171.28 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 65.200000000000003 110.894 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 63.09 61.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.87 89.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 73.030000000000001 110.91 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -152.02 149.7 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 70.209999999999994 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.5 133.57 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -136.55 155.92 49.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 74.049999999999997 110.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -57.07 -37.49 71.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 72.510000000000005 110.904 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.1 m -65.08 -18.54 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 70.340000000000003 110.778 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.59 1.21 50.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.88 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -58.0 124.41 19.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 75.409999999999997 110.844 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 59.34 24.66 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 54.210000000000001 110.907 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 165.43 24.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 74.299999999999997 111.121 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.25 124.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.049999999999997 111.105 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -125.06 129.23 49.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.879 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.5 m -100.97 131.83 46.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 111.16 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.1 t -91.95 132.7 32.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.63 0.729 . . . . 72.129999999999995 111.107 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -39.89 5.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 74.120000000000005 112.382 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.83 -179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.767 0.318 . . . . 74.209999999999994 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -71.45 132.72 85.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 72.400000000000006 111.097 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.734 2.29 . . . . 71.329999999999998 112.307 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -50.96 157.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 74.219999999999999 110.875 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.6 155.35 39.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 64.120000000000005 110.892 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.89 176.88 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.178 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -130.48 137.19 49.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.869 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.3 pt -114.57 173.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 111.118 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -122.55 130.36 52.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.926 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.86 109.0 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.837 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -92.5 107.28 19.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 75.340000000000003 110.894 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -103.63 176.93 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 70.430000000000007 111.182 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.2 ttt -75.76 -8.08 55.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 73.099999999999994 110.831 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -38.28 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 74.150000000000006 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.44 176.4 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 65.340000000000003 110.977 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.15 121.92 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 72.010000000000005 111.129 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.03 150.39 45.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 73.409999999999997 111.162 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 153.97 67.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 73.0 112.299 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.2 103.74 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 111.09 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -75.58 137.44 40.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.33 116.47 21.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.064 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.42 149.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 75.430000000000007 111.164 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 p -49.13 112.78 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 53.420000000000002 110.927 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.83 7.56 33.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 51.299999999999997 112.465 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 m -96.08 -178.38 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.397 . . . . 73.340000000000003 110.883 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.16 147.82 42.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.198 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.23 -62.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 70.420000000000002 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.04 -33.65 57.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 72.549999999999997 110.886 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.67 -27.16 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 110.829 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.94 -43.3 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.200000000000003 111.118 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.28 47.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.106 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -73.75 -27.91 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.87 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -52.19 12.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.868 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.21 -25.22 61.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 110.916 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -6.96 43.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.688 -0.768 . . . . 74.549999999999997 112.52 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.4 144.47 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 55.409999999999997 111.09 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.17 83.93 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.891 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.844 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.878 0.37 . . . . 31.109999999999999 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -124.49 113.55 18.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.4 t -128.62 157.01 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 74.439999999999998 111.087 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mt -90.17 130.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 71.150000000000006 111.157 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 tp -125.07 164.7 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 72.319999999999993 110.901 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -39.12 137.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.891 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -60.89 -58.7 17.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.684 0.754 . . . . 74.019999999999996 110.922 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.72 -49.6 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.75 2.3 . . . . 64.209999999999994 112.284 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -51.96 -51.9 53.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 75.329999999999998 111.002 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -63.58 -41.97 98.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.925 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -52.03 -62.0 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 72.140000000000001 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -63.9 -26.82 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -57.25 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.918 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.13 142.12 3.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.826 -0.702 . . . . 71.329999999999998 112.508 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -107.33 160.34 26.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.678 0.751 . . . . 65.310000000000002 110.862 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 172.16 13.06 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.249 . . . . 72.109999999999999 112.364 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -58.0 167.81 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.899 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -56.81 -39.74 74.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.819 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -52.33 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 73.140000000000001 110.869 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.04 -35.2 79.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.59 -53.63 55.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.863 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.56 -41.72 92.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.859 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -56.45 -37.35 70.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.908 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.61 -51.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 111.087 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.24 -23.13 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.834 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 -32.49 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.899 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.78 163.89 6.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 71.439999999999998 111.066 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.65 114.81 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 75.519999999999996 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.55 41.56 56.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.129999999999995 112.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.69 117.36 33.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 70.219999999999999 111.085 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 142.4 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 111.068 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.64 -24.95 41.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 75.129999999999995 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.0 p -73.91 -2.03 22.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 111.209 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 t -89.12 -12.45 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.867 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -94.06 154.51 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.785 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 tp -147.48 167.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 74.420000000000002 110.856 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.02 19.14 9.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.674 -0.774 . . . . 73.239999999999995 112.467 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.9 t 60.38 25.73 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 65.200000000000003 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.41 136.47 22.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -177.13 129.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 73.030000000000001 110.877 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.66 170.31 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.62 120.44 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.103 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.71 173.61 11.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.469 . . . . 74.049999999999997 110.874 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -59.66 -33.87 72.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 110.922 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.3 m -64.91 -19.32 65.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 70.340000000000003 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.74 5.69 38.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 110.907 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -59.58 124.31 19.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.862 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.53 20.29 12.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 54.210000000000001 110.848 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.59 149.23 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 74.299999999999997 111.074 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.51 119.86 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 75.049999999999997 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -110.61 94.81 5.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.815 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -88.26 126.37 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 111.116 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -96.45 133.25 25.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.136 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -41.64 4.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.686 2.257 . . . . 74.120000000000005 112.36 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.865 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.82 0.343 . . . . 74.209999999999994 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -51.87 133.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.686 0.755 . . . . 72.400000000000006 111.148 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -170.05 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 71.329999999999998 112.256 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.5 157.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.89 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.29 151.52 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 64.120000000000005 110.889 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.35 176.81 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 111.099 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -120.33 133.91 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 pt -114.34 172.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.087 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.46 128.39 45.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.219999999999999 110.9 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.12 103.17 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.834 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.53 136.15 38.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 75.340000000000003 110.92 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -130.43 177.25 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 70.430000000000007 111.158 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 tpt -73.56 -8.76 57.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.898 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -104.98 -37.57 6.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -179.63 176.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 65.340000000000003 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.87 131.43 70.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.188 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.35 151.03 58.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 73.409999999999997 111.154 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.22 68.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.611 2.207 . . . . 73.0 112.304 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.0 139.49 29.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 111.03 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -100.68 128.9 46.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.67 116.37 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.137 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -97.33 139.16 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.430000000000007 111.149 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 p -51.7 111.1 0.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 53.420000000000002 110.881 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.43 13.81 34.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 51.299999999999997 112.493 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.6 p -101.63 -169.78 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 73.340000000000003 110.844 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 143.46 28.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 73.310000000000002 111.128 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.45 -59.41 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 111.127 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.38 -35.53 60.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 72.549999999999997 110.922 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.76 -27.5 62.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.912 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.56 -35.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.095 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.88 29.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 62.219999999999999 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -67.11 -32.61 73.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 75.200000000000003 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.05 -34.8 14.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.530000000000001 110.895 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -75.04 -24.4 58.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.951 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 -11.68 66.41 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 74.549999999999997 112.529 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.31 138.72 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 55.409999999999997 111.202 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.48 80.81 1.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.851 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.913 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.778 0.323 . . . . 31.109999999999999 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -71.21 111.79 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.439999999999998 110.862 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.62 157.28 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 74.439999999999998 111.187 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 88.5 mt -90.37 130.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 71.150000000000006 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.8 tp -124.65 159.37 30.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 72.319999999999993 110.908 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.56 146.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.883 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 mt-10 -59.27 -59.94 12.21 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.631 0.729 . . . . 74.019999999999996 110.896 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.5 Cg_endo -69.79 -46.78 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.653 2.235 . . . . 64.209999999999994 112.346 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.38 -49.15 67.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 110.927 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -64.34 -51.01 65.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 74.450000000000003 110.916 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -25.53 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 72.140000000000001 110.809 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.31 -50.54 12.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.91 -21.83 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 75.209999999999994 110.932 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.58 158.96 9.49 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 71.329999999999998 112.497 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.31 157.53 77.29 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.642 0.734 . . . . 65.310000000000002 110.877 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.03 32.34 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.725 2.284 . . . . 72.109999999999999 112.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 p -58.09 158.52 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -52.43 -36.06 53.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.409999999999997 110.926 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -52.33 -62.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.67 -35.79 79.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 110.922 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -56.14 -53.33 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.871 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.9 -42.97 89.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 110.878 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -55.2 -37.51 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.898 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.4 mt -74.53 -51.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.124 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.18 -18.59 58.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 110.869 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -76.14 -23.17 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.927 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.34 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 71.439999999999998 111.043 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -71.75 119.59 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.519999999999996 110.86 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.0 43.89 55.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.635 -0.793 . . . . 73.129999999999995 112.516 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.58 116.04 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 70.219999999999999 111.123 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.87 144.77 39.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 111.233 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.27 -23.88 35.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 75.129999999999995 112.459 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.9 p -73.96 -1.56 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 64.239999999999995 111.151 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.7 t -89.36 -12.83 39.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.91 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -112.07 144.21 41.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.864 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.47 164.05 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.420000000000002 110.989 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.06 -167.13 39.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 73.239999999999995 112.463 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.2 m -104.16 64.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 65.200000000000003 110.857 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -162.84 124.33 2.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 74.019999999999996 110.908 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 mp -156.13 150.9 26.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 73.030000000000001 110.924 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -146.0 129.94 17.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 110.9 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.84 117.62 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 72.239999999999995 111.13 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -136.83 178.36 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 74.049999999999997 110.911 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -37.16 76.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.93 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 t -65.54 -19.73 66.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 70.340000000000003 110.903 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -83.41 2.23 37.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 73.439999999999998 110.848 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.94 123.59 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.409999999999997 110.836 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 59.29 27.08 16.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 54.210000000000001 110.865 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.95 135.36 49.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 74.299999999999997 111.128 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.2 122.39 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 75.049999999999997 111.16 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -112.9 104.27 12.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.857 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -92.83 117.99 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.155 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.68 88.83 5.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.525 0.679 . . . . 72.129999999999995 111.13 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -36.24 10.96 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.698 2.265 . . . . 74.120000000000005 112.296 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 72.140000000000001 110.839 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.751 0.31 . . . . 74.209999999999994 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mm 63.5 136.8 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.558 0.694 . . . . 72.400000000000006 111.143 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.78 2.52 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 71.329999999999998 112.362 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -52.07 157.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.878 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.75 143.7 45.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 64.120000000000005 110.956 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -128.75 176.8 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 64.439999999999998 111.094 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.81 136.26 52.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pt -116.98 157.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.118 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -119.98 126.5 50.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.926 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -105.0 102.9 12.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.927 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 117.78 26.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.95 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 p -105.33 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 70.430000000000007 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 29.8 mmt -75.72 -7.99 55.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.921 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtm -102.97 -38.39 7.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.150000000000006 110.889 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 178.28 176.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 65.340000000000003 110.925 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.3 t -79.1 147.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 111.058 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.93 87.84 9.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.64 0.734 . . . . 73.409999999999997 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 135.0 29.33 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 73.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.22 159.93 40.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 111.085 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -99.7 127.98 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.943 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.3 131.81 40.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.115 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.85 146.51 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.430000000000007 111.107 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.2 p -57.49 119.8 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 53.420000000000002 110.892 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.01 39.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 51.299999999999997 112.473 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.32 161.02 13.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.340000000000003 110.859 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 p -114.46 159.23 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.116 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.27 -58.4 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.54 -35.82 63.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 72.549999999999997 110.968 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.530000000000001 110.881 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.43 -44.05 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.200000000000003 111.167 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.13 -29.22 57.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.219999999999999 111.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -73.37 -26.6 61.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 75.200000000000003 110.869 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -69.73 -52.15 27.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.86 -25.1 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.863 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.07 -12.22 34.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 74.549999999999997 112.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.64 115.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 55.409999999999997 111.087 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.84 80.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 74.409999999999997 110.924 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.903 0.382 . . . . 31.109999999999999 110.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -152.06 109.75 3.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.805 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.1 t -128.62 157.02 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.12 131.23 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 71.150000000000006 111.127 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 162.3 28.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.928 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -39.62 139.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.917 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -59.58 -59.05 15.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.696 0.76 . . . . 74.019999999999996 110.904 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.1 Cg_endo -69.78 -49.16 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.735 2.29 . . . . 64.209999999999994 112.319 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -52.09 -48.53 64.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 75.329999999999998 110.932 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -66.89 -42.71 85.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.93 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -51.88 -58.11 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 72.140000000000001 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -70.03 -28.73 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tp -63.56 -61.23 2.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.944 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.32 143.59 4.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 71.329999999999998 112.482 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -134.67 157.27 77.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.574 0.702 . . . . 65.310000000000002 110.886 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.743 2.295 . . . . 72.109999999999999 112.32 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.4 m -58.17 171.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.59 -38.13 77.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -52.3 -62.43 1.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 73.140000000000001 110.89 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.53 -35.41 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.530000000000001 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.42 -53.04 62.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 110.904 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -66.07 -42.37 89.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 71.120000000000005 110.832 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.13 -36.91 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.959 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.8 mt -74.61 -54.85 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 111.113 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.95 -24.53 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 74.030000000000001 110.855 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.15 -25.62 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 110.908 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.59 151.07 29.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 71.439999999999998 111.084 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -67.37 128.71 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 110.805 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.46 54.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.489 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.66 117.16 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 70.219999999999999 111.056 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 143.9 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 111.196 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -24.68 40.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.129999999999995 112.491 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.2 p -73.94 -1.73 21.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 64.239999999999995 111.188 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -89.79 -12.6 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.854 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -106.6 139.87 40.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 tp -158.87 164.89 35.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.878 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.94 -131.67 5.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 73.239999999999995 112.485 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m -122.62 -54.5 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 65.200000000000003 110.915 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -52.11 139.26 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 74.019999999999996 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.6 tp -176.64 140.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.030000000000001 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -141.94 154.07 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.848 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.7 124.97 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 72.239999999999995 111.131 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.67 168.15 20.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 74.049999999999997 110.88 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -57.22 -39.35 75.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.510000000000005 110.909 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 m -64.02 -20.46 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 70.340000000000003 110.895 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.75 7.67 29.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.851 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.14 125.19 22.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.839 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 60.0 22.19 11.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 54.210000000000001 110.897 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.38 136.63 57.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 111.061 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 t -98.76 117.08 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 75.049999999999997 111.134 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -109.39 94.82 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.926 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.2 m -89.42 130.92 35.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.172 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.44 133.29 20.27 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 72.129999999999995 111.086 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -41.25 4.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 74.120000000000005 112.308 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.854 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.722 0.296 . . . . 74.209999999999994 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 133.14 27.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.675 0.75 . . . . 72.400000000000006 111.104 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -170.34 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.746 2.297 . . . . 71.329999999999998 112.358 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -51.46 156.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 74.219999999999999 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -73.84 156.45 37.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 64.120000000000005 110.9 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.03 176.97 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 111.132 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -118.1 135.83 53.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.836 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.36 171.83 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 111.142 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.19 126.72 52.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.895 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.93 103.18 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.856 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -85.66 106.67 17.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 110.887 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -101.9 178.61 4.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 70.430000000000007 111.168 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 ttm -75.7 -8.05 55.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -106.05 -38.62 6.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.933 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 178.34 176.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 65.340000000000003 110.846 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.45 123.11 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.010000000000005 111.068 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.85 150.54 45.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.169 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 153.22 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 73.0 112.349 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.51 135.56 26.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 111.131 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -97.64 118.68 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.911 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.64 116.52 30.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.105 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.16 148.05 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 75.430000000000007 111.11 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.8 p -51.32 110.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 53.420000000000002 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.48 14.42 30.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 51.299999999999997 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -97.64 -170.61 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 73.340000000000003 110.878 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.91 140.92 32.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 111.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.1 t -52.41 -59.51 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 111.081 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -53.72 -35.57 61.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 72.549999999999997 110.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -72.7 -26.75 61.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 72.530000000000001 110.883 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.4 t -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 73.200000000000003 111.136 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.83 -29.71 20.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.072 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -70.23 -36.77 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 75.200000000000003 110.871 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -82.82 -34.9 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.879 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -72.35 -28.25 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.935 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.0 -12.25 34.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.743 . . . . 74.549999999999997 112.537 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.94 141.06 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 55.409999999999997 111.161 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -78.79 80.7 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.911 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.821 0.344 . . . . 31.109999999999999 110.849 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -68.81 100.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 65.439999999999998 110.841 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.7 t -128.63 159.04 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 74.439999999999998 111.15 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.9 mt -89.86 130.46 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.165 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLU . 16.8 tp -119.29 166.4 13.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.882 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HB2' ' CB ' ' A' ' 71' ' ' LEU . 5.9 mp0 -36.8 135.87 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 71.019999999999996 110.913 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tt0 -65.26 -56.73 18.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.595 0.712 . . . . 74.019999999999996 110.867 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.69 -51.82 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 64.209999999999994 112.387 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.459 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -51.93 -48.35 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.329999999999998 110.893 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -64.94 -53.57 44.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 110.918 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.6 -47.96 63.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.816 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.31 -36.62 83.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 75.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -62.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.85 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 160.35 20.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 71.329999999999998 112.429 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 157.55 77.44 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.658 0.742 . . . . 65.310000000000002 110.928 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 166.82 26.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 72.109999999999999 112.309 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 t -57.95 171.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.97 -37.48 79.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 72.409999999999997 110.898 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.35 -62.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.912 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.59 -35.54 79.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.34 -53.19 60.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.914 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.97 -42.79 89.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 71.120000000000005 110.858 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.48 -37.14 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 64.219999999999999 110.919 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.74 -52.68 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.152 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -59.3 -21.08 59.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.875 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -75.94 -23.27 55.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.924 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.18 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.439999999999998 111.144 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -74.4 118.99 17.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 75.519999999999996 110.847 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.66 43.73 53.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.678 -0.772 . . . . 73.129999999999995 112.52 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.98 143.5 34.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.083 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.85 145.72 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 111.125 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.59 53.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 75.129999999999995 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.0 p -73.53 -3.31 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.333 . . . . 64.239999999999995 111.149 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 48.1 t -85.44 -13.77 48.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.857 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.74 143.26 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 73.340000000000003 110.87 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.23 142.38 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.96 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.76 158.14 3.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.788 -0.72 . . . . 73.239999999999995 112.467 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.6 t -55.62 -26.97 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 65.200000000000003 110.885 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.58 114.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.019999999999996 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mt -141.78 95.34 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.030000000000001 110.945 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.99 147.47 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.936 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.6 t -96.02 128.31 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 72.239999999999995 111.169 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -136.56 167.77 20.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 74.049999999999997 110.899 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -55.49 -42.01 73.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.904 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -18.97 58.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 70.340000000000003 110.863 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -93.34 17.14 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 73.439999999999998 110.813 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.68 126.97 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 75.409999999999997 110.977 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 m120 58.85 24.23 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 54.210000000000001 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.61 126.14 26.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -84.98 118.76 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 75.049999999999997 111.117 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.01 102.74 10.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.430000000000007 110.88 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.9 m -88.55 130.14 35.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 111.205 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.06 133.24 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 72.129999999999995 111.065 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.649 2.233 . . . . 74.120000000000005 112.328 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.89 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 121.472 0.484 . . . . 71.299999999999997 112.552 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 101.86 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.676 2.251 . . . . 71.040000000000006 112.337 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.72 165.14 22.33 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.77 -0.729 . . . . 54.340000000000003 112.513 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 p -100.45 -62.45 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.911 0.386 . . . . 74.140000000000001 110.85 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.6 mmt 54.84 30.54 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 73.430000000000007 110.9 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -79.74 -50.27 10.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.915 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.8 ttp -80.76 152.6 28.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 75.420000000000002 110.9 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.29 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 72.129999999999995 110.937 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 26.85 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.838 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.3 68.27 9.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 71.430000000000007 111.085 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.62 -13.11 34.54 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 63.229999999999997 112.405 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.5 -23.09 66.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 110.86 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -67.79 93.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.866 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.96 132.95 33.04 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.178 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -169.84 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.718 2.279 . . . . 71.329999999999998 112.375 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.26 157.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 74.219999999999999 110.87 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 160.12 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 64.120000000000005 110.934 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.9 176.74 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.439999999999998 111.115 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -117.1 135.55 53.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 75.340000000000003 110.831 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.92 173.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.147 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -128.53 132.73 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -102.94 104.84 15.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.819 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.4 129.39 44.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.937 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 p -122.15 -177.71 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 70.430000000000007 111.141 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.3 mmt -75.76 -17.37 59.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 110.895 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -96.33 -37.89 10.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 74.150000000000006 110.858 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 179.71 176.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 65.340000000000003 110.884 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 131.44 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 111.16 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.8 m -121.62 150.89 56.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.546 0.689 . . . . 73.409999999999997 111.126 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 153.02 69.78 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.655 2.237 . . . . 73.0 112.325 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.14 140.48 28.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 74.200000000000003 111.119 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -104.88 126.87 52.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.894 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.18 116.34 31.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 111.081 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.04 142.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 111.173 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 p -54.19 120.25 6.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 53.420000000000002 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.54 -4.55 37.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.817 -0.706 . . . . 51.299999999999997 112.481 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.76 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 73.340000000000003 110.897 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.2 p -138.04 155.06 49.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 111.183 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.57 -59.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 70.420000000000002 111.15 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -35.45 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 72.549999999999997 110.896 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -72.66 -26.6 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.530000000000001 110.904 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -76.18 -47.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.200000000000003 111.081 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.83 -29.79 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 62.219999999999999 111.082 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -69.89 -36.72 75.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.864 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -76.35 -42.66 44.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.845 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -72.27 -27.08 62.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.87 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.14 -12.07 34.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 74.549999999999997 112.457 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.86 127.55 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 55.409999999999997 111.151 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -81.04 80.83 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.847 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 134.74 34.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 74.409999999999997 110.834 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -61.09 121.71 13.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 75.219999999999999 110.862 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.06 -113.27 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 73.239999999999995 112.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 54.87 26.43 7.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 55.299999999999997 111.082 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.9 142.84 50.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.329999999999998 110.924 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -121.42 56.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 71.510000000000005 110.933 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.72 30.8 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.811 -0.709 . . . . 75.319999999999993 112.435 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.59 179.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 73.329999999999998 110.849 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.2 mt -90.17 -25.51 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 110.923 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.06 75.16 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.329999999999998 111.13 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.28 110.78 3.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 74.540000000000006 110.868 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 p -95.15 -67.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 73.129999999999995 110.895 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -149.78 141.56 23.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 64.329999999999998 111.176 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.43 115.46 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 31.109999999999999 110.818 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -150.08 112.83 4.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.86 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -128.6 158.03 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 111.151 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 83.6 mt -89.99 131.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 71.150000000000006 111.143 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.02 160.88 25.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 72.319999999999993 110.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.77 143.96 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 71.019999999999996 110.916 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.1 mt-10 -57.4 -59.14 13.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.631 0.729 . . . . 74.019999999999996 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.76 -46.73 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 64.209999999999994 112.306 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -51.67 -45.69 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 110.924 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -72.28 -41.01 67.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 74.450000000000003 110.908 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -53.85 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 110.898 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -33.23 67.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.87 -25.0 68.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.843 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.87 142.5 4.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 71.329999999999998 112.507 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -110.71 156.84 39.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 65.310000000000002 110.854 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.81 13.76 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 72.109999999999999 112.362 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -99.29 -170.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -56.61 -47.77 78.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -53.74 -59.74 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 73.140000000000001 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.2 -28.58 69.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 71.530000000000001 110.858 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -55.64 27.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.893 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.41 -37.37 82.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 110.844 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.32 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.94 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 mt -74.97 -34.38 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 111.116 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -58.99 -21.43 58.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 110.858 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -75.95 -25.67 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.883 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.71 163.97 27.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 111.065 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -84.2 113.63 21.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.89 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.82 52.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.535 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -95.14 129.41 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 111.121 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.42 146.36 27.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 111.083 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.4 -23.46 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 75.129999999999995 112.487 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 p -73.82 -1.84 21.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.16 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 9.4 t -88.9 -12.8 40.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 71.409999999999997 110.884 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -117.39 132.62 56.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 73.340000000000003 110.816 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.27 179.88 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 110.944 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.77 -155.67 15.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 73.239999999999995 112.491 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -140.44 53.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 65.200000000000003 110.856 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -179.07 98.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 74.019999999999996 110.912 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.25 160.73 33.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.030000000000001 110.906 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -115.9 170.26 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.209999999999994 110.825 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.76 118.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 111.129 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -137.05 177.1 8.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 74.049999999999997 110.906 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -60.63 -31.5 70.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -65.04 -19.54 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 70.340000000000003 110.92 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -85.7 4.41 36.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 110.875 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.03 123.39 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 110.857 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 59.55 26.03 14.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 54.210000000000001 110.879 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.51 136.72 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 74.299999999999997 111.116 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.5 t -109.74 123.03 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 75.049999999999997 111.15 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.47 103.9 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.897 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 49.9 m -93.79 118.72 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 73.439999999999998 111.168 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.1 t -108.57 89.29 5.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.719 . . . . 72.129999999999995 111.133 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -39.06 6.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.615 2.21 . . . . 74.120000000000005 112.343 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -65.84 159.38 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 110.848 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.9 172.11 8.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.087 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 m -93.15 157.77 16.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 111.129 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -68.96 142.2 54.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 75.349999999999994 110.867 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -155.94 -177.0 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ptm -52.09 117.86 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 110.858 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.08 131.72 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 62.43 111.117 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.04 151.51 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.117 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -150.26 156.43 41.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 71.030000000000001 110.774 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.0 -20.63 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.801 -0.714 . . . . 73.430000000000007 112.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.21 66.4 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 74.310000000000002 110.885 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -148.91 69.57 10.0 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.579 0.704 . . . . 71.430000000000007 110.867 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -43.7 2.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.378 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 72.89 16.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.589 0.709 . . . . 73.329999999999998 110.919 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.38 4.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.693 2.262 . . . . 73.030000000000001 112.342 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 74.430000000000007 110.917 179.934 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.454 0.474 . . . . 71.299999999999997 112.522 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.636 2.224 . . . . 71.040000000000006 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.39 141.08 15.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 54.340000000000003 112.481 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -100.95 146.53 27.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 74.140000000000001 110.875 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mmt -114.52 -62.72 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 73.430000000000007 110.894 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -66.21 162.85 19.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 74.010000000000005 110.867 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.2 ptm -99.71 139.51 35.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 75.420000000000002 110.898 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -146.26 166.51 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 72.129999999999995 110.873 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 t -52.16 103.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.913 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -152.13 73.9 7.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 71.430000000000007 111.073 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -16.69 37.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 63.229999999999997 112.376 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.04 -22.98 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.873 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -104.07 103.68 13.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.209999999999994 110.851 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.0 mm -60.2 133.04 90.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.111 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 -170.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 71.329999999999998 112.38 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.8 156.82 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 74.219999999999999 110.871 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.81 159.56 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 64.120000000000005 110.919 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.83 176.76 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 64.439999999999998 111.102 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.76 129.19 47.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.855 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 pt -114.59 172.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.167 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.9 131.5 52.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.912 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -99.63 103.07 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.886 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -94.24 135.34 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.340000000000003 110.865 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -133.39 177.69 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 70.430000000000007 111.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.9 tpt -75.36 -8.33 56.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.884 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -104.18 -37.91 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 74.150000000000006 110.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 179.21 176.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 65.340000000000003 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.9 124.69 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.010000000000005 111.132 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.84 151.01 51.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.714 . . . . 73.409999999999997 111.17 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 156.03 64.26 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 73.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.93 104.29 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 111.077 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -79.34 132.04 36.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.91 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -121.35 116.53 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.133 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 150.8 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.05 116.26 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 53.420000000000002 110.861 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 2.01 37.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.733 . . . . 51.299999999999997 112.487 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -99.17 -176.15 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 73.340000000000003 110.818 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.93 146.01 40.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.310000000000002 111.147 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.48 -62.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 111.111 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.81 -33.54 56.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 72.549999999999997 110.946 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -72.68 -27.27 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 72.530000000000001 110.883 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.4 t -76.87 -45.44 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 73.200000000000003 111.119 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.51 -29.93 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.121 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -71.4 -37.99 71.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.894 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -44.24 63.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.08 -25.2 61.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.2 -12.26 44.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 74.549999999999997 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.8 t -53.36 129.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 55.409999999999997 111.119 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -77.3 80.67 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.209999999999994 110.915 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 106.71 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.176 -0.466 . . . . 74.409999999999997 110.926 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -129.0 113.93 15.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 110.878 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.5 110.76 0.84 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.715 -0.755 . . . . 73.239999999999995 112.505 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.89 103.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 55.299999999999997 111.119 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.02 -27.56 9.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 72.329999999999998 110.905 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.18 119.68 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 71.510000000000005 110.903 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.47 -177.5 18.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 75.319999999999993 112.471 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.8 -73.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 73.329999999999998 110.871 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.02 -29.33 28.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.439999999999998 110.933 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -50.05 56.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 111.076 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 t -87.35 53.27 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 74.540000000000006 110.92 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -81.16 -170.49 2.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 110.92 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.83 100.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 64.329999999999998 111.159 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.6 m -57.28 146.31 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 31.109999999999999 110.844 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -135.94 77.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 65.439999999999998 110.851 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.0 t -128.73 157.64 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 111.135 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 85.4 mt -90.02 131.24 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 71.150000000000006 111.151 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.2 tp -127.0 160.65 30.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 110.927 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.79 143.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -58.11 -60.23 10.76 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.64 0.733 . . . . 74.019999999999996 110.908 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.78 -48.32 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.699 2.266 . . . . 64.209999999999994 112.348 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.81 -45.26 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.329999999999998 110.929 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -70.79 -49.61 44.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.904 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -54.09 -41.62 68.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -71.36 -46.27 60.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -63.35 -24.43 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.878 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.06 130.98 2.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.733 . . . . 71.329999999999998 112.505 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -115.78 157.66 44.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 65.310000000000002 110.871 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.3 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.699 2.266 . . . . 72.109999999999999 112.356 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -104.12 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.885 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -57.87 -44.12 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.877 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -53.58 -59.71 4.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 73.140000000000001 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -62.73 -28.21 69.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.530000000000001 110.86 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -52.88 62.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.898 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.02 -39.2 75.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 71.120000000000005 110.891 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.2 -50.81 70.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.219999999999999 110.931 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.2 mt -74.96 -34.3 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 75.239999999999995 111.161 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.76 -20.0 53.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 110.898 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.84 -26.0 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.897 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.95 145.01 36.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.439999999999998 111.107 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -65.92 121.81 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.18 45.17 57.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.504 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -111.37 125.37 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 70.219999999999999 111.075 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.06 147.66 38.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.119 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.49 -23.4 35.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 75.129999999999995 112.519 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.2 p -73.93 -1.81 21.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 64.239999999999995 111.15 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.1 t -88.95 -13.49 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 71.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -141.39 167.85 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.340000000000003 110.839 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 57.38 44.9 20.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.899 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.54 111.75 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 73.239999999999995 112.47 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.0 t -163.02 156.85 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 65.200000000000003 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -170.05 -179.53 3.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 74.019999999999996 110.913 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -139.5 -61.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.030000000000001 110.931 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -59.65 158.7 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.867 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.4 t -109.16 134.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 111.099 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.57 170.06 16.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 74.049999999999997 110.891 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -59.22 -34.16 71.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.903 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.25 -20.2 65.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 70.340000000000003 110.878 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.38 6.59 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 110.834 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.32 124.48 19.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.95 24.32 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 54.210000000000001 110.915 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.1 126.76 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 74.299999999999997 111.139 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.1 t -99.91 121.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 75.049999999999997 111.161 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -111.98 103.17 11.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.885 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.7 m -96.08 119.41 34.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 111.124 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.65 89.11 5.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.098 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -34.23 14.99 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 74.120000000000005 112.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -76.38 148.45 37.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.833 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.61 -176.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 63.43 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.1 p -124.72 176.92 6.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 111.13 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -112.13 -171.83 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 75.349999999999994 110.895 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -106.49 167.33 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.329999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.5 mtt -104.23 179.27 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 110.845 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.43 172.82 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 62.43 111.058 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.9 146.38 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 74.319999999999993 111.145 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -175.25 149.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 71.030000000000001 110.818 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.62 -38.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 73.430000000000007 112.48 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 59.08 27.21 16.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 74.310000000000002 110.891 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.1 tptt 57.35 73.63 0.75 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.592 0.711 . . . . 71.430000000000007 110.942 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 129.08 17.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.652 2.235 . . . . 73.120000000000005 112.355 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -172.09 69.19 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.594 0.712 . . . . 73.329999999999998 110.901 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -173.16 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 73.030000000000001 112.318 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.8 m170 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.859 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.449 0.472 . . . . 71.299999999999997 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -174.73 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.74 2.293 . . . . 71.040000000000006 112.284 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.77 -117.07 1.7 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 54.340000000000003 112.453 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m 56.67 39.51 29.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.854 0.359 . . . . 74.140000000000001 110.864 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.1 132.04 43.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 110.901 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -104.19 30.8 4.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 74.010000000000005 110.898 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.9 mmm -136.62 -178.99 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 75.420000000000002 110.872 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -119.72 139.27 52.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.5 p -175.83 147.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 72.439999999999998 110.841 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.52 160.39 2.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 71.430000000000007 111.118 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 79.96 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.682 2.255 . . . . 63.229999999999997 112.301 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -118.46 25.11 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -130.79 116.02 17.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 110.864 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.9 mt -115.17 133.22 22.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 72.400000000000006 111.122 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 178.85 4.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.723 2.282 . . . . 71.329999999999998 112.288 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.83 157.51 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 74.219999999999999 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.45 145.59 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 64.120000000000005 110.922 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.18 171.2 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.084 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 130.11 56.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pt -117.17 173.74 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 111.157 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.6 131.78 49.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 75.219999999999999 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -103.22 102.95 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.915 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -94.82 140.02 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.898 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -140.48 175.79 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.418 . . . . 70.430000000000007 111.188 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.9 ttm -75.65 -11.67 60.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.877 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.25 -37.78 9.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 110.91 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 179.86 176.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 65.340000000000003 110.936 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.4 t -119.16 121.68 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 111.107 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.7 150.31 55.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 111.163 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 166.72 26.66 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.765 2.31 . . . . 73.0 112.343 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.86 145.06 21.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 74.200000000000003 111.078 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -111.78 121.95 46.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.9 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.11 116.63 28.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 111.133 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.38 153.8 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 75.430000000000007 111.097 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -62.94 121.61 13.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.506 . . . . 53.420000000000002 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.38 0.64 86.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 51.299999999999997 112.473 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.93 -169.81 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 73.340000000000003 110.847 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 154.46 44.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.19 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.8 -59.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 70.420000000000002 111.103 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.32 -34.26 60.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 72.549999999999997 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.68 -26.86 61.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 110.91 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.5 -45.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.105 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.77 -33.34 34.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 62.219999999999999 111.101 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -66.96 -35.14 79.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 110.893 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -66.88 -49.37 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.895 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -72.01 -24.56 61.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.94 -12.05 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 74.549999999999997 112.484 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.5 t -55.86 129.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 55.409999999999997 111.136 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -86.23 80.85 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.08 121.0 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 74.409999999999997 110.898 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -59.35 140.12 56.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 75.219999999999999 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.24 -110.49 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 73.239999999999995 112.522 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 53.23 46.98 25.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 55.299999999999997 111.099 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.42 -32.5 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 110.815 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 52.45 35.06 16.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 110.873 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.58 140.9 8.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.749 -0.739 . . . . 75.319999999999993 112.536 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -82.19 -27.55 32.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 73.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.25 169.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 75.439999999999998 110.91 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 133.67 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 64.329999999999998 111.062 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.63 179.68 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 74.540000000000006 110.865 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -170.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 73.129999999999995 110.868 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.61 99.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 64.329999999999998 111.158 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -98.94 116.07 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 31.109999999999999 110.9 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -164.53 109.43 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 65.439999999999998 110.847 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -128.48 155.0 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 74.439999999999998 111.119 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.4 mt -90.76 129.44 41.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 71.150000000000006 111.139 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.6 tp -124.5 161.8 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 72.319999999999993 110.937 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.95 143.7 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 71.019999999999996 110.846 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -58.31 -59.52 13.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.702 . . . . 74.019999999999996 110.808 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -47.92 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.661 2.241 . . . . 64.209999999999994 112.303 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.0 -42.59 65.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.915 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -71.85 -54.11 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.851 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.34 -34.81 58.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -78.03 -41.8 34.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.15 -25.76 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.992 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.36 140.08 5.33 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 71.329999999999998 112.508 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.74 160.3 28.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.66 0.743 . . . . 65.310000000000002 110.9 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 166.62 27.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.661 2.241 . . . . 72.109999999999999 112.326 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.0 t -58.09 171.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.817 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -59.96 -37.32 79.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.858 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -62.57 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.92 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -67.54 -35.63 79.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.837 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.27 -53.49 56.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.897 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.73 -42.58 90.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.936 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.52 -37.44 67.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.857 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.52 -52.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 75.239999999999995 111.172 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.68 -21.59 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.819 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -76.18 -24.16 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 110.908 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.15 164.28 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 111.132 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -74.47 113.69 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.907 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.22 40.56 52.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.506 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.58 114.87 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 70.219999999999999 111.112 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.67 142.82 27.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.178 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.36 -23.68 34.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.812 -0.709 . . . . 75.129999999999995 112.471 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.8 p -74.22 -0.93 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 64.239999999999995 111.105 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 45.3 t -90.63 -12.21 37.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.837 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.98 133.67 55.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.888 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 pp -179.06 -178.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.26 -133.12 4.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 73.239999999999995 112.501 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -144.78 -42.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 65.200000000000003 110.936 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.33 101.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 74.019999999999996 110.913 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -134.99 127.08 29.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 73.030000000000001 110.948 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -84.41 168.95 15.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 70.209999999999994 110.86 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.45 119.24 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.239999999999995 111.111 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.05 172.98 12.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.049999999999997 110.866 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -29.7 68.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.834 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.8 m -65.65 -22.65 66.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 70.340000000000003 110.86 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -81.77 -0.15 41.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.857 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.65 123.77 16.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 75.409999999999997 110.92 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.75 27.18 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 54.210000000000001 110.915 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.19 151.07 47.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 111.024 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.28 120.99 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.049999999999997 111.146 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -114.19 98.96 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.908 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 43.3 m -91.41 116.65 29.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.133 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.64 89.19 5.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.597 0.713 . . . . 72.129999999999995 111.132 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -35.53 12.65 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.726 2.284 . . . . 74.120000000000005 112.354 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.08 108.84 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.842 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -163.09 179.48 7.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 63.43 111.077 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 t -99.25 173.51 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 74.450000000000003 111.09 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -54.05 173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 75.349999999999994 110.863 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.5 146.61 24.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 110.892 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -144.43 105.45 4.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.895 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.81 139.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 62.43 111.069 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.1 143.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.12 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -172.95 130.55 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 71.030000000000001 110.912 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.39 101.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 73.430000000000007 112.47 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.89 124.3 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 74.310000000000002 110.875 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -143.33 161.29 48.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.473 0.654 . . . . 71.430000000000007 110.928 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 94.18 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.636 2.224 . . . . 73.120000000000005 112.299 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -138.37 157.88 71.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 73.329999999999998 110.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 174.67 9.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.757 2.305 . . . . 73.030000000000001 112.321 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.82 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 CA-C-O 121.466 0.481 . . . . 71.299999999999997 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 158.89 55.34 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 71.040000000000006 112.318 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.05 145.08 9.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 54.340000000000003 112.464 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.45 -179.94 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 74.140000000000001 110.832 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 tpt -120.85 -64.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 73.430000000000007 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -171.38 -179.93 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.010000000000005 110.872 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -131.07 168.98 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -155.56 161.11 40.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 72.129999999999995 110.816 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 p -73.15 166.15 23.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 110.835 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.32 74.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 111.051 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 78.05 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 63.229999999999997 112.334 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -121.55 25.31 9.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.858 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 63.35 30.52 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.877 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 64.72 148.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 72.400000000000006 111.139 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.27 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.385 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.66 157.41 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 74.219999999999999 110.875 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.21 133.25 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 64.120000000000005 110.872 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.12 176.96 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 64.439999999999998 111.098 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -113.79 140.9 47.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.861 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.69 175.09 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.15 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -133.03 126.77 32.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -108.77 103.16 12.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.882 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 132.15 34.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.9 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -115.32 176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 70.430000000000007 111.136 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.0 tpt -75.64 -8.29 56.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 73.099999999999994 110.918 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -103.44 -37.95 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.826 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 179.39 176.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 65.340000000000003 110.966 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.62 147.63 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 111.148 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.6 t -141.38 87.79 10.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 73.409999999999997 111.169 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 152.59 69.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.612 2.208 . . . . 73.0 112.396 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.63 144.28 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.428 . . . . 74.200000000000003 111.079 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.88 147.87 29.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 73.430000000000007 110.857 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -116.75 143.58 45.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 111.078 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.45 151.4 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.430000000000007 111.117 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 p -53.38 116.29 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 53.420000000000002 110.841 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.15 25.31 71.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 51.299999999999997 112.483 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.7 p -77.83 -169.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 110.839 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.87 143.1 42.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 111.149 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.11 -63.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 70.420000000000002 111.116 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.85 -32.84 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 72.549999999999997 110.927 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.72 -27.52 62.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 72.530000000000001 110.815 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -77.22 -44.93 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 73.200000000000003 111.121 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.16 -28.33 52.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 111.121 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.55 -26.39 61.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.78 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.31 -53.78 6.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.872 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 3.42 37.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 15.82 59.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 74.549999999999997 112.459 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.26 127.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 55.409999999999997 111.135 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.37 80.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.86 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tt -126.63 105.13 8.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 74.409999999999997 110.938 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -106.41 141.17 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.219999999999999 110.805 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.35 66.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 73.239999999999995 112.496 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.03 120.73 5.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.362 . . . . 55.299999999999997 111.144 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -25.01 58.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.329999999999998 110.844 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -124.91 132.55 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 71.510000000000005 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.26 163.73 12.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.767 -0.73 . . . . 75.319999999999993 112.491 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -63.76 125.09 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 73.329999999999998 110.871 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.85 25.95 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 75.439999999999998 110.92 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.27 163.59 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 64.329999999999998 111.123 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t 56.24 25.8 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.866 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -70.97 -46.37 62.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 73.129999999999995 110.866 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 p -131.16 99.77 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 64.329999999999998 111.144 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 7.7 t -96.21 30.84 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 31.109999999999999 110.894 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.43 94.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 t -128.67 156.41 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 111.111 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.1 mt -89.98 131.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 71.150000000000006 111.15 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.6 tp -127.77 159.74 33.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.937 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.54 141.23 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.499 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.1 mt-10 -57.48 -59.52 12.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 74.019999999999996 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.79 -48.63 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.601 2.201 . . . . 64.209999999999994 112.38 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.83 -41.17 61.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 75.329999999999998 110.965 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -73.37 -51.38 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.834 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -34.32 63.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -78.29 -44.65 24.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -63.23 -21.35 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.851 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.12 131.74 2.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.813 -0.708 . . . . 71.329999999999998 112.47 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -112.6 157.31 40.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 110.885 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -177.98 2.15 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.637 2.225 . . . . 72.109999999999999 112.332 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.1 m -101.09 -176.23 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 75.409999999999997 110.872 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -55.71 -44.03 77.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 72.409999999999997 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -53.93 -59.56 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 73.140000000000001 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -30.78 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 71.530000000000001 110.92 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -56.09 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.936 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.57 -39.44 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.36 -52.32 63.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.61 -34.42 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 111.149 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.54 -17.86 56.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.877 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -75.77 -26.06 57.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.29 164.03 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 71.439999999999998 111.065 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -82.87 113.66 20.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.94 41.15 51.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.129999999999995 112.478 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -105.66 126.48 52.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 70.219999999999999 111.069 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 148.34 24.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.059 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.63 -25.6 43.56 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 75.129999999999995 112.526 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -74.06 -1.38 19.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 64.239999999999995 111.192 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.7 t -90.61 -11.87 38.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.838 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.6 ttt-85 -91.96 168.88 11.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 73.340000000000003 110.846 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.3 tp -49.56 146.71 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.943 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.89 33.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 73.239999999999995 112.519 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.5 p -110.98 138.81 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 65.200000000000003 110.818 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -114.43 7.86 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 74.019999999999996 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 51.91 55.64 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 73.030000000000001 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -152.39 126.53 9.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.91 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.3 t -97.39 120.07 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 72.239999999999995 111.085 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -176.78 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 74.049999999999997 110.878 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -56.9 -36.0 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.510000000000005 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 m -64.85 -24.05 67.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 70.340000000000003 110.804 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.2 0.72 39.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 110.915 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.01 119.2 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 110.86 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.61 22.01 12.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 54.210000000000001 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.58 145.11 29.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 74.299999999999997 111.116 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t -116.27 115.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.049999999999997 111.15 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -111.08 98.15 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 31.0 m -87.47 119.22 27.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 111.128 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.73 88.25 5.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.058 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -42.65 3.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 74.120000000000005 112.4 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -108.46 141.85 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.852 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -174.68 -177.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 63.43 111.139 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.3 m -62.17 135.42 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 111.129 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 60.92 31.06 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.349999999999994 110.893 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -140.84 172.16 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.881 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -170.47 173.71 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.814 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.65 176.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.074 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.99 -36.79 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.19 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -175.37 -179.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 110.84 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.97 95.18 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.448 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -173.33 143.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 74.310000000000002 110.899 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.82 157.89 43.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 110.878 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.699 2.266 . . . . 73.120000000000005 112.309 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.42 68.39 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.518 0.675 . . . . 73.329999999999998 110.894 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 -170.95 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 73.030000000000001 112.302 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 26.2 p80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 110.861 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 121.44 0.467 . . . . 71.299999999999997 112.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 109.89 2.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 71.040000000000006 112.37 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.42 71.05 0.43 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.791 -0.719 . . . . 54.340000000000003 112.537 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -108.92 140.65 42.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 74.140000000000001 110.822 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -157.28 178.5 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.954 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 74.010000000000005 110.854 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ptp -88.9 -175.39 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 110.821 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -147.08 166.39 27.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 72.129999999999995 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.3 m -77.34 -178.64 5.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.856 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -109.44 160.36 28.01 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.567 0.699 . . . . 71.430000000000007 111.125 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -14.93 37.02 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.774 2.316 . . . . 63.229999999999997 112.39 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.72 25.06 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 110.86 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -137.46 63.07 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.836 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 mm -137.96 133.11 17.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.661 0.743 . . . . 72.400000000000006 111.087 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.72 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.219 . . . . 71.329999999999998 112.378 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.91 156.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 74.219999999999999 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -73.89 158.14 35.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 64.120000000000005 110.911 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.2 177.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -124.61 132.21 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.921 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.36 169.51 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.129 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.88 129.0 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.901 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -99.49 103.38 15.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 74.319999999999993 110.866 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -95.44 143.52 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.839 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 p -138.09 179.58 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 70.430000000000007 111.137 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -8.15 55.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.099999999999994 110.905 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -107.15 -38.03 6.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.436 . . . . 74.150000000000006 110.853 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 179.36 176.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 65.340000000000003 110.925 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -118.04 134.86 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.010000000000005 111.137 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.92 150.73 69.9 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.565 0.697 . . . . 73.409999999999997 111.179 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 153.21 68.96 Favored 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.642 2.228 . . . . 73.0 112.292 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -149.55 105.74 3.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 111.079 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -70.13 125.16 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 110.911 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.91 123.2 43.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.113 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.21 147.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 75.430000000000007 111.19 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.8 p -52.89 114.76 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 53.420000000000002 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 19.79 52.57 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.815 -0.707 . . . . 51.299999999999997 112.465 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 p -93.18 -175.63 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 110.785 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.2 m -143.66 152.0 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 73.310000000000002 111.12 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -57.99 -45.79 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.153 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.87 -37.63 88.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 72.549999999999997 110.925 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.7 -27.99 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.874 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.39 -36.77 24.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 73.200000000000003 111.118 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.09 55.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.027 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -73.7 -27.69 61.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -51.76 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.530000000000001 110.855 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -71.89 -25.73 62.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.41 52.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.655 -0.783 . . . . 74.549999999999997 112.495 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -51.5 135.15 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.775 0.321 . . . . 55.409999999999997 111.154 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.88 82.78 6.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.883 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 tp -139.49 123.03 17.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 74.409999999999997 110.931 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.17 147.86 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 75.219999999999999 110.843 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.67 35.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 73.239999999999995 112.477 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 155.04 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 55.299999999999997 111.139 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.8 m -98.12 111.99 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.939 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.89 121.16 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 71.510000000000005 110.863 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.93 -177.98 21.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 75.319999999999993 112.481 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -103.6 27.76 7.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.0 mt -141.08 178.61 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 110.911 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 102.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 64.329999999999998 111.115 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.0 p -54.27 -36.02 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.540000000000006 110.89 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.7 t -174.42 162.26 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.864 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -53.27 123.47 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 64.329999999999998 111.169 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.9 m -97.18 25.65 5.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 31.109999999999999 110.822 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -102.38 96.76 7.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 65.439999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.69 157.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 74.439999999999998 111.129 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 89.9 mt -90.51 129.68 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 71.150000000000006 111.166 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 tp -125.33 163.02 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 110.912 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.81 147.2 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.877 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -61.33 -59.71 12.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.605 0.716 . . . . 74.019999999999996 110.9 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.76 -42.44 3.4 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.638 2.225 . . . . 64.209999999999994 112.349 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -44.52 88.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 75.329999999999998 110.929 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -70.88 -52.34 20.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.883 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -36.45 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.140000000000001 110.862 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -73.86 -44.32 55.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 75.0 110.927 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.25 -52.66 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 75.209999999999994 110.89 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.42 142.96 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 71.329999999999998 112.524 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.83 157.56 42.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.659 0.743 . . . . 65.310000000000002 110.874 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 173.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.64 2.227 . . . . 72.109999999999999 112.323 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -102.49 -169.84 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.409999999999997 110.855 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.71 -46.81 81.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.843 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.99 -59.55 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.09 -27.75 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.862 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -53.75 48.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.918 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -69.74 -37.14 76.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 71.120000000000005 110.871 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 mt -62.49 -48.47 79.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -73.91 -35.41 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 75.239999999999995 111.087 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.97 -20.68 64.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 74.030000000000001 110.904 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.15 -25.78 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.914 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.47 146.09 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.069 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.2 121.63 18.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.847 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 44.63 60.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -103.29 129.38 50.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 70.219999999999999 111.143 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 144.5 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.095 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.44 -22.74 32.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 75.129999999999995 112.511 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.7 p -73.89 -2.25 23.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.086 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.9 t -88.43 -13.35 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 110.786 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.6 mtp85 -123.33 167.45 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.908 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 58.71 46.64 14.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.854 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.34 40.71 2.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 73.239999999999995 112.462 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 2.9 t -92.02 66.98 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 65.200000000000003 110.855 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.13 138.29 46.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.019999999999996 110.927 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.54 35.37 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.030000000000001 110.896 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -132.96 135.95 45.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 70.209999999999994 110.907 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.3 t -109.61 119.58 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.117 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -136.46 178.73 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 74.049999999999997 110.891 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -58.31 -37.21 74.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 110.948 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -63.64 -19.44 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 70.340000000000003 110.862 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -89.62 9.92 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.851 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.87 125.76 24.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 75.409999999999997 110.889 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 60.52 21.9 11.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 54.210000000000001 110.872 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.71 136.33 57.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.299999999999997 111.088 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 45.8 t -104.44 119.42 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 75.049999999999997 111.1 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.2 98.44 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.430000000000007 110.895 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 46.4 m -93.8 119.82 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 111.133 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.2 t -108.87 88.57 5.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.165 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -36.26 11.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.274 . . . . 74.120000000000005 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -62.18 166.1 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.873 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.52 176.87 7.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 63.43 111.083 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 t -103.63 173.01 6.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 74.450000000000003 111.152 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -115.26 -64.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.349999999999994 110.863 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -54.49 172.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 73.329999999999998 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -122.21 -42.56 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.819 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 55.74 35.62 25.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.3 t -62.09 -33.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.074 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -54.99 -69.62 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 110.916 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 52.42 -139.39 30.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.698 -0.763 . . . . 73.430000000000007 112.545 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -158.97 172.98 17.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 74.310000000000002 110.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -122.36 68.72 29.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.604 0.716 . . . . 71.430000000000007 110.891 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -48.1 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.698 2.265 . . . . 73.120000000000005 112.288 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -157.9 137.71 8.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.552 0.691 . . . . 73.329999999999998 110.893 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.98 2.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 73.030000000000001 112.346 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 74.430000000000007 110.837 179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 CA-C-O 121.458 0.477 . . . . 71.299999999999997 112.421 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 123.63 10.28 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.651 2.234 . . . . 71.040000000000006 112.342 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.35 87.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 54.340000000000003 112.499 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 t -161.78 160.52 28.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.332 . . . . 74.140000000000001 110.885 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.7 ttt -61.93 162.61 8.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 73.430000000000007 110.857 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -120.5 120.05 34.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.825 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtt -95.54 164.3 12.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 75.420000000000002 110.849 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -121.7 136.34 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 72.129999999999995 110.905 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 p -178.46 174.51 1.24 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 72.439999999999998 110.815 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.09 43.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 71.430000000000007 111.126 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -171.04 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.652 2.234 . . . . 63.229999999999997 112.341 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.37 25.06 10.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 73.209999999999994 110.902 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -137.45 121.82 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.855 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.0 mt -98.53 132.99 23.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 72.400000000000006 111.177 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -174.4 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.334 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -53.05 156.67 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 74.219999999999999 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 155.0 39.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 64.120000000000005 110.84 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.85 176.82 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 111.103 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -122.8 138.63 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.82 172.56 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 75.129999999999995 111.126 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -127.53 133.28 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.887 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -104.52 106.03 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.819 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -97.25 144.26 27.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.975 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -139.1 178.72 6.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 70.430000000000007 111.113 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -8.1 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.88 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -106.31 -37.66 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 74.150000000000006 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 179.82 175.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 65.340000000000003 110.949 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.77 127.67 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.010000000000005 111.155 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.91 150.84 47.96 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.107 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 156.17 63.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 73.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.97 138.2 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 111.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -100.54 130.67 46.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 73.430000000000007 110.902 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.73 117.04 32.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 111.115 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.4 t -104.61 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.430000000000007 111.122 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -51.74 116.2 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 53.420000000000002 110.849 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.92 7.38 50.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 51.299999999999997 112.486 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -100.95 -169.97 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.995 0.426 . . . . 73.340000000000003 110.852 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.58 142.65 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 73.310000000000002 111.153 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.4 t -52.45 -63.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 70.420000000000002 111.1 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.49 -33.16 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 72.549999999999997 110.895 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.73 -27.4 62.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 72.530000000000001 110.845 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -76.82 -43.06 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 73.200000000000003 111.151 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.06 -30.13 14.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.056 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -73.62 -37.8 65.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 110.855 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -40.22 50.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 74.530000000000001 110.848 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.11 -21.78 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 74.420000000000002 110.87 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.0 -12.26 55.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 74.549999999999997 112.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.7 t -57.8 113.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.337 . . . . 55.409999999999997 111.135 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.47 80.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.929 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.3 tp -111.81 128.08 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.2 113.03 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 75.219999999999999 110.943 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -142.99 -108.68 0.67 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.712 -0.756 . . . . 73.239999999999995 112.428 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 51.76 47.6 24.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.749 0.309 . . . . 55.299999999999997 111.095 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.93 30.61 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 72.329999999999998 110.912 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -101.44 88.21 3.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 71.510000000000005 110.864 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.06 30.56 76.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 75.319999999999993 112.536 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -78.62 159.8 27.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 73.329999999999998 110.785 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.19 -35.15 5.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 75.439999999999998 110.931 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.67 57.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 64.329999999999998 111.114 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.74 82.9 1.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.903 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.6 m -73.89 175.72 7.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.87 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -51.54 136.65 25.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 64.329999999999998 111.116 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 p -122.38 121.58 37.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 31.109999999999999 110.857 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -100.8 118.35 36.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 65.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.23 155.53 39.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 74.439999999999998 111.17 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 mp -90.38 132.98 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 71.150000000000006 111.195 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.7 tp -127.37 159.31 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 72.319999999999993 110.929 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.15 146.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.915 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -59.38 -60.25 11.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 74.019999999999996 110.914 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.86 -46.22 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 64.209999999999994 112.28 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.13 -48.32 70.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.909 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -68.23 -47.43 67.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.450000000000003 110.881 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -55.62 -43.7 76.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 72.140000000000001 110.917 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.16 -26.95 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tp -72.83 -62.56 1.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.937 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.17 3.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 71.329999999999998 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -132.34 157.31 78.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.683 0.754 . . . . 65.310000000000002 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 166.28 28.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 72.109999999999999 112.318 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.19 170.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.874 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -58.78 -37.19 75.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.879 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -52.51 -62.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 73.140000000000001 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.7 -35.11 78.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 71.530000000000001 110.845 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -56.89 -53.34 59.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.945 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.95 -42.16 90.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.838 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tp -55.8 -37.55 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 110.954 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.3 mt -74.57 -52.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.239999999999995 111.13 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -59.04 -21.67 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.854 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -76.04 -24.99 55.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.933 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.05 162.96 27.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.439999999999998 111.053 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -70.23 117.34 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.07 42.84 55.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 73.129999999999995 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -113.61 121.86 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.086 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.7 144.1 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.135 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.59 -23.47 36.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.488 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -73.92 -2.24 23.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 64.239999999999995 111.136 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 36.6 t -90.24 -13.97 34.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.841 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.55 158.31 34.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 110.854 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 56.45 67.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 74.420000000000002 110.954 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.21 61.68 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 73.239999999999995 112.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.1 t -133.96 -74.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 65.200000000000003 110.91 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.27 93.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 74.019999999999996 110.844 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.6 mt -146.18 165.52 28.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 73.030000000000001 110.858 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -112.03 170.61 8.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 70.209999999999994 110.868 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 t -94.42 115.3 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.127 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.93 176.01 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 74.049999999999997 110.794 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -57.2 -36.25 70.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.510000000000005 110.873 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -22.35 66.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 110.885 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -85.76 5.27 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 73.439999999999998 110.922 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -58.8 123.0 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 110.898 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.37 22.58 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 54.210000000000001 110.939 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 133.64 52.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 74.299999999999997 111.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 36.7 t -106.17 118.86 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 75.049999999999997 111.128 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -109.4 102.97 11.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 71.430000000000007 110.889 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -95.2 125.77 40.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.182 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.59 133.33 21.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.602 0.715 . . . . 72.129999999999995 111.154 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -45.28 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.699 2.266 . . . . 74.120000000000005 112.304 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -129.45 130.18 45.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 72.140000000000001 110.841 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.73 119.24 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.032 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.72 100.57 7.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.450000000000003 111.144 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.25 138.18 58.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 75.349999999999994 110.903 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -140.47 61.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.835 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -118.19 -39.6 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 74.510000000000005 110.925 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.02 120.29 6.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 62.43 111.082 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.21 -29.92 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 111.158 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.57 170.18 10.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 110.861 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.74 91.03 2.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 73.430000000000007 112.495 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.8 28.25 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 110.823 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.68 73.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.506 0.669 . . . . 71.430000000000007 110.856 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 120.79 7.51 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.668 2.245 . . . . 73.120000000000005 112.367 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -51.52 156.87 1.98 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 73.329999999999998 110.92 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -46.1 1.34 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.669 2.246 . . . . 73.030000000000001 112.305 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 74.430000000000007 110.888 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 CA-C-O 121.381 0.434 . . . . 71.299999999999997 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -170.95 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.624 2.216 . . . . 71.040000000000006 112.35 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.19 -144.49 5.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.741 -0.743 . . . . 54.340000000000003 112.544 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.1 p -156.54 179.1 9.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 110.822 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mmt -129.02 -171.6 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.824 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -127.73 29.52 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 74.010000000000005 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.4 mtt -144.83 -175.5 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 75.420000000000002 110.847 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -114.35 138.43 50.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 72.129999999999995 110.897 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.24 -179.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.954 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.43 73.98 0.47 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.545 0.688 . . . . 71.430000000000007 111.11 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.651 2.234 . . . . 63.229999999999997 112.368 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -106.29 24.74 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.865 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -103.71 2.89 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.839 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -136.33 133.18 19.25 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.63 0.729 . . . . 72.400000000000006 111.148 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 178.1 4.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.696 2.264 . . . . 71.329999999999998 112.353 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.68 156.25 1.42 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.249 -0.432 . . . . 74.219999999999999 110.856 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 149.52 41.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 64.120000000000005 110.939 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.07 175.84 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 64.439999999999998 111.186 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -124.98 139.17 54.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.1 pt -125.83 164.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.12 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -121.37 138.93 54.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 75.219999999999999 110.892 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -117.0 102.76 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 74.319999999999993 110.917 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.44 144.48 28.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.937 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 p -114.4 -157.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 70.430000000000007 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.4 ttp -50.52 -50.35 53.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.904 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -138.09 -33.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 74.150000000000006 110.842 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.12 151.93 21.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 65.340000000000003 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.9 120.62 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 72.010000000000005 111.095 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -109.09 136.99 20.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 73.409999999999997 111.216 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 169.57 18.67 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.638 2.225 . . . . 73.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -159.38 108.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.075 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -74.1 138.0 43.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 73.430000000000007 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.59 116.59 29.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.086 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.1 t -102.57 141.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.132 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.83 114.85 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 53.420000000000002 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.55 50.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 51.299999999999997 112.488 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -94.08 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.979 0.419 . . . . 73.340000000000003 110.806 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.2 p -142.65 154.78 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 73.310000000000002 111.149 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.5 t -52.4 -59.62 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.420000000000002 111.15 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.93 -34.94 61.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 110.903 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.81 -26.94 61.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 72.530000000000001 110.862 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.1 t -76.31 -47.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 73.200000000000003 111.104 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.61 -28.48 55.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.059 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -69.49 -32.93 72.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 75.200000000000003 110.824 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -53.76 21.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.918 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -72.38 -26.6 61.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.869 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.44 -4.26 40.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.813 -0.708 . . . . 74.549999999999997 112.483 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.79 141.41 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 55.409999999999997 111.127 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -88.3 80.79 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.832 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 tp -93.5 114.34 26.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.876 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -62.43 151.51 36.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 75.219999999999999 110.876 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -142.72 23.73 2.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 73.239999999999995 112.445 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.33 112.6 25.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.804 0.335 . . . . 55.299999999999997 111.105 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.55 -26.02 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 72.329999999999998 110.958 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -75.91 -25.98 56.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 71.510000000000005 110.915 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.22 155.29 4.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.728 . . . . 75.319999999999993 112.457 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -101.51 -61.41 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 73.329999999999998 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.19 -28.76 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 75.439999999999998 110.854 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.22 123.37 8.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 64.329999999999998 111.157 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 t -103.84 66.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.540000000000006 110.839 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m 57.73 36.11 26.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 110.924 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.5 p 49.93 43.3 25.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 111.118 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 t -58.64 -27.15 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 31.109999999999999 110.856 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -117.39 101.66 8.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.54 164.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 74.439999999999998 111.105 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.84 133.2 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 71.150000000000006 111.148 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.6 tp -126.55 153.93 44.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 72.319999999999993 110.907 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.8 146.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.852 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -54.86 -60.46 7.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.674 0.749 . . . . 74.019999999999996 110.829 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.69 -44.75 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.7 2.267 . . . . 64.209999999999994 112.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.48 -45.31 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 75.329999999999998 110.951 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -72.79 -49.91 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.0 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -53.14 -37.85 62.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -76.07 -46.21 30.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -63.2 -22.81 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.869 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.7 136.17 3.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 71.329999999999998 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -112.2 157.41 39.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.634 0.73 . . . . 65.310000000000002 110.931 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.258 . . . . 72.109999999999999 112.379 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.5 t -120.94 -170.67 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.854 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.27 -46.4 76.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.898 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -54.43 -58.84 5.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.87 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -28.18 69.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.874 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -55.48 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 74.329999999999998 110.902 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.95 -40.91 87.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 110.861 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.07 -50.86 69.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 64.219999999999999 110.923 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.5 mt -74.08 -35.04 40.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 111.128 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.48 -17.65 60.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.915 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.18 -24.42 54.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.909 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.2 164.37 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.069 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.85 113.84 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.866 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.83 52.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 73.129999999999995 112.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -96.53 125.17 40.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 70.219999999999999 111.12 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.8 30.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.203 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.35 -23.98 36.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.798 -0.715 . . . . 75.129999999999995 112.481 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -73.42 -3.27 26.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.146 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -86.83 -16.02 37.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.821 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.62 157.91 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.855 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -166.34 -179.46 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.933 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.82 -130.51 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 73.239999999999995 112.489 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.78 84.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 65.200000000000003 110.853 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -122.45 132.77 54.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 74.019999999999996 110.968 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -126.84 67.25 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 73.030000000000001 110.885 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -152.26 160.25 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 70.209999999999994 110.819 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 99.4 t -105.5 129.89 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 111.132 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.39 167.94 20.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 74.049999999999997 110.883 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -57.05 -31.06 64.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 72.510000000000005 110.866 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -28.24 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 70.340000000000003 110.851 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -75.98 -6.12 49.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 73.439999999999998 110.936 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.72 124.15 18.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 75.409999999999997 110.893 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 61.01 22.85 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 54.210000000000001 110.915 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.15 138.32 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 74.299999999999997 111.091 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t -107.32 111.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 75.049999999999997 111.145 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -105.89 104.62 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 110.895 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.8 m -93.35 125.52 38.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 73.439999999999998 111.134 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.1 t -85.01 133.45 43.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -165.63 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.716 2.278 . . . . 74.120000000000005 112.374 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 149.84 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.926 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.02 103.2 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 63.43 111.094 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.5 t -138.19 172.61 12.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 111.128 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.18 169.12 18.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 75.349999999999994 110.882 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -122.22 -40.92 2.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 110.881 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.5 mtt 61.58 61.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.510000000000005 110.937 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.45 175.23 6.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.1 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.98 133.66 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 111.099 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -133.47 144.06 49.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 71.030000000000001 110.868 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -152.43 65.41 0.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 73.430000000000007 112.478 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -114.14 123.13 48.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 74.310000000000002 110.926 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.83 157.64 77.83 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 71.430000000000007 110.951 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 150.73 68.21 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.321 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -139.89 70.46 36.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.496 0.665 . . . . 73.329999999999998 110.868 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -46.24 1.3 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 73.030000000000001 112.359 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 74.430000000000007 110.803 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 121.48 0.489 . . . . 71.299999999999997 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -44.87 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.681 2.254 . . . . 71.040000000000006 112.35 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.73 -152.3 17.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 54.340000000000003 112.474 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -172.04 158.17 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 74.140000000000001 110.865 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -145.64 -177.65 5.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.855 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.02 107.04 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 74.010000000000005 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 tpp -145.63 119.47 9.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 75.420000000000002 110.891 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -149.84 166.56 29.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 72.129999999999995 110.937 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -115.07 -170.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.862 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.3 73.07 2.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.533 0.682 . . . . 71.430000000000007 111.128 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -173.46 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 63.229999999999997 112.298 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -120.78 25.09 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.876 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -156.17 131.75 9.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.909 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.5 mm -57.98 124.65 70.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.629 0.728 . . . . 72.400000000000006 111.131 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -169.64 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.659 2.239 . . . . 71.329999999999998 112.399 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -51.02 157.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 110.93 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 136.37 38.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 64.120000000000005 110.987 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -124.58 176.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 64.439999999999998 111.142 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -120.42 136.78 54.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.819 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.97 169.21 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 75.129999999999995 111.186 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -118.6 126.72 52.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.83 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -96.56 103.12 15.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 74.319999999999993 110.855 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.4 122.84 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 75.340000000000003 110.904 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 -178.12 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 70.430000000000007 111.124 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.8 ttm -75.8 -8.18 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.871 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -108.21 -37.89 5.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 74.150000000000006 110.893 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 179.79 176.18 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.932 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 p -108.46 132.76 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 111.086 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -122.48 151.03 59.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 73.409999999999997 111.161 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.26 62.48 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.687 2.258 . . . . 73.0 112.302 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.83 104.2 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 111.129 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -76.46 132.22 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.953 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -109.64 133.65 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.052 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.08 152.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 111.079 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -52.4 111.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 53.420000000000002 110.932 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.16 17.15 35.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 51.299999999999997 112.49 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 54.0 p -107.52 163.56 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.922 0.392 . . . . 73.340000000000003 110.879 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.4 154.07 39.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 73.310000000000002 111.126 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.9 m -55.83 -44.72 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.420000000000002 111.111 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.76 -44.17 81.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 72.549999999999997 110.908 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -72.72 -26.83 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.530000000000001 110.929 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -75.23 -31.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 73.200000000000003 111.164 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.28 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 111.118 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -73.43 -35.83 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.839 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -64.72 -46.96 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.832 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.31 -24.62 59.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.938 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.85 40.37 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.742 -0.742 . . . . 74.549999999999997 112.471 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -51.48 136.24 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 55.409999999999997 111.177 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.84 80.96 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.834 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.5 tp -144.18 109.51 5.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.93 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -106.47 138.84 41.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.888 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -148.98 45.37 0.71 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 73.239999999999995 112.439 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.68 94.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 55.299999999999997 111.117 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.29 41.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.329999999999998 110.926 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -106.93 124.55 49.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 71.510000000000005 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.39 -175.76 28.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.703 -0.761 . . . . 75.319999999999993 112.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -75.89 -42.58 48.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 73.329999999999998 110.881 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.78 101.14 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.917 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.4 174.34 4.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 64.329999999999998 111.055 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.5 p -58.62 162.58 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.540000000000006 110.839 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -131.38 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 73.129999999999995 110.838 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -85.68 125.38 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 64.329999999999998 111.129 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -93.32 60.07 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 31.109999999999999 110.88 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -69.36 90.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.806 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.5 t -128.59 157.4 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 74.439999999999998 111.193 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.63 134.72 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 71.150000000000006 111.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.3 tp -129.03 158.52 38.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 72.319999999999993 110.876 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.45 142.74 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.487 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.4 mt-10 -56.91 -60.16 10.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.708 0.766 . . . . 74.019999999999996 110.879 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.82 -48.95 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.721 2.28 . . . . 64.209999999999994 112.288 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -41.9 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 75.329999999999998 110.941 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -72.51 -52.72 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.966 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.26 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 110.83 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -77.94 -44.54 26.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.951 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.24 -24.3 67.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.874 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.24 156.31 6.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.811 -0.709 . . . . 71.329999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -119.99 157.62 52.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 65.310000000000002 110.865 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 156.6 62.79 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 72.109999999999999 112.296 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.9 t -90.36 -169.66 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.867 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.62 -47.51 76.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -54.02 -59.75 4.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.869 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.11 -27.94 68.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.909 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -56.35 17.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.924 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.98 -40.34 91.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 71.120000000000005 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 mt -56.93 -51.38 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 64.219999999999999 110.904 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.7 mt -73.59 -35.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 75.239999999999995 111.171 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -61.84 -18.07 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.863 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -76.01 -24.13 55.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.886 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.5 146.71 27.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 71.439999999999998 111.158 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.2 122.23 19.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 110.859 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.98 45.08 56.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 73.129999999999995 112.479 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -100.8 124.86 47.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 111.111 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 144.02 25.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.139 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.77 -24.82 42.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 75.129999999999995 112.423 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.2 p -74.09 -2.18 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 64.239999999999995 111.071 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -90.72 -13.03 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.933 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -144.05 136.67 26.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 73.340000000000003 110.947 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 tt -134.36 -61.25 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.889 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.17 -90.46 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.668 -0.777 . . . . 73.239999999999995 112.446 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.92 110.42 2.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 65.200000000000003 110.916 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.17 118.79 20.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 74.019999999999996 110.894 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.2 37.18 3.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 73.030000000000001 110.904 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -137.22 147.81 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 70.209999999999994 110.908 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.3 t -104.18 129.94 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.128 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -136.74 164.16 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.049999999999997 110.894 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -54.84 -26.4 35.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 72.510000000000005 110.873 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.43 -29.2 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 70.340000000000003 110.825 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -91.21 12.52 19.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.922 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -59.65 111.89 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 110.89 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 63.76 20.61 12.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 54.210000000000001 110.883 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.99 151.07 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 74.299999999999997 111.128 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -105.73 115.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 75.049999999999997 111.178 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -108.87 104.36 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.825 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.2 m -95.08 130.86 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.187 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.48 133.21 23.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.195 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.6 -47.79 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.695 2.263 . . . . 74.120000000000005 112.423 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -80.56 128.34 33.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.862 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -176.94 -179.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 63.43 111.061 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.55 117.5 2.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 74.450000000000003 111.155 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -110.23 109.53 20.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 75.349999999999994 110.926 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -108.05 54.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.879 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.0 ptm 39.62 41.56 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 110.836 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.64 79.84 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 62.43 111.076 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.11 123.08 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.136 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.5 115.14 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 71.030000000000001 110.894 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.79 -159.82 33.43 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.787 -0.721 . . . . 73.430000000000007 112.494 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -160.14 117.52 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 74.310000000000002 110.846 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -100.44 136.13 20.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.508 0.67 . . . . 71.430000000000007 110.876 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 177.75 5.25 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.66 2.24 . . . . 73.120000000000005 112.398 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.58 73.74 2.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.528 0.68 . . . . 73.329999999999998 110.91 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -172.71 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.696 2.264 . . . . 73.030000000000001 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 74.430000000000007 110.848 179.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 121.407 0.448 . . . . 71.299999999999997 112.451 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -179.29 2.77 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.701 2.267 . . . . 71.040000000000006 112.433 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.32 -161.21 28.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 54.340000000000003 112.483 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 m -146.64 111.84 5.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 74.140000000000001 110.813 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 tpp -107.79 160.68 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 73.430000000000007 110.855 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.45 99.24 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 110.886 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.1 mtm -140.96 151.4 44.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 75.420000000000002 110.903 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.35 136.07 37.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 110.851 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -170.56 -179.56 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.921 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.91 68.41 55.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.749 . . . . 71.430000000000007 111.123 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.24 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.63 2.22 . . . . 63.229999999999997 112.335 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -113.36 24.92 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 110.9 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 -165.0 136.65 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.896 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.7 mm -70.59 132.92 87.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.659 0.742 . . . . 72.400000000000006 111.133 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 -170.34 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 71.329999999999998 112.359 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.86 156.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 74.219999999999999 110.865 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.74 132.93 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 64.120000000000005 110.875 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -120.12 177.27 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.137 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -112.18 151.78 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.872 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.34 165.45 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.064 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -112.2 125.17 53.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.949 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.29 103.14 15.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.899 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -101.35 118.3 36.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.843 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -124.6 171.2 10.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 70.430000000000007 111.158 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mmm -75.83 -7.96 55.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 73.099999999999994 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.7 -38.04 9.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 74.150000000000006 110.93 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 179.45 176.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 65.340000000000003 110.933 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.9 t -111.74 124.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.010000000000005 111.113 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.62 150.49 76.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.111 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 155.38 65.92 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.65 2.233 . . . . 73.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.45 141.46 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.200000000000003 111.099 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -106.15 131.65 53.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.929 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.78 116.54 32.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 111.059 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.36 151.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 75.430000000000007 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -52.93 109.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 53.420000000000002 110.925 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.02 31.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 51.299999999999997 112.485 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.3 p -100.8 163.32 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.415 . . . . 73.340000000000003 110.877 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.6 p -130.99 152.92 49.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 73.310000000000002 111.146 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.02 -60.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.131 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.12 -34.25 59.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 72.549999999999997 110.922 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -72.46 -26.77 61.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 72.530000000000001 110.789 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.8 t -76.94 -45.06 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 73.200000000000003 111.142 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.64 -29.95 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 111.037 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -71.66 -36.77 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 110.943 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -79.38 -45.23 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.886 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -72.19 -25.4 61.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.66 -12.19 56.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 74.549999999999997 112.462 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.2 t -52.66 105.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 55.409999999999997 111.136 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -81.77 81.11 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.839 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -135.3 105.67 6.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 74.409999999999997 110.907 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.54 130.36 42.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.826 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.32 26.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.655 -0.783 . . . . 73.239999999999995 112.457 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.11 158.92 31.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 55.299999999999997 111.132 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 t -94.38 56.4 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.896 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -175.45 142.47 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 71.510000000000005 110.874 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.86 -96.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 75.319999999999993 112.518 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -60.41 -179.47 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 73.329999999999998 110.834 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -52.53 -29.62 26.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 75.439999999999998 110.89 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.47 144.26 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 64.329999999999998 111.121 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.7 96.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.540000000000006 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -99.36 27.38 5.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 73.129999999999995 110.85 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -117.39 24.67 10.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 64.329999999999998 111.144 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.89 -25.62 40.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 31.109999999999999 110.91 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.88 113.77 21.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 65.439999999999998 110.875 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.38 157.16 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.073 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -89.81 137.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 111.058 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.46 158.36 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 72.319999999999993 110.865 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.52 142.4 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.863 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -58.64 -59.23 14.3 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.53 0.681 . . . . 74.019999999999996 110.876 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.81 -47.97 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 64.209999999999994 112.364 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.47 -48.78 65.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 110.957 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -65.11 -51.7 59.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.924 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.11 44.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 72.140000000000001 110.843 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -75.49 -52.34 10.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.07 -23.19 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.12 151.7 5.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 71.329999999999998 112.525 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.13 157.63 77.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 65.310000000000002 110.872 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.667 2.245 . . . . 72.109999999999999 112.334 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 p -111.24 -176.92 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.851 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -55.77 -44.84 78.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -53.79 -59.7 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 73.140000000000001 110.854 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.33 -28.07 69.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.878 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -55.16 31.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.949 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.94 -41.03 83.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 110.821 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.62 -52.24 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 110.917 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 mt -73.7 -35.02 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 75.239999999999995 111.101 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.79 -19.17 58.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 110.856 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -76.07 -24.0 55.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.924 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.96 151.44 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.439999999999998 111.061 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -69.73 120.26 15.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.519999999999996 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.67 44.09 54.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.726 -0.75 . . . . 73.129999999999995 112.537 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -112.11 132.64 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 70.219999999999999 111.082 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.93 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 111.145 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.86 -26.77 48.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 75.129999999999995 112.453 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.5 p -74.09 -0.99 18.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.133 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 25.5 t -90.89 -14.0 32.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 71.409999999999997 110.858 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -102.93 160.81 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.887 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -176.6 125.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 110.895 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -61.13 -166.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 73.239999999999995 112.467 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 21.8 m -89.07 49.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 65.200000000000003 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -128.92 41.89 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.919 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -76.88 65.05 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 73.030000000000001 110.911 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -109.46 158.43 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 70.209999999999994 110.913 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.7 t -80.93 127.23 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.157 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 161.14 36.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 74.049999999999997 110.838 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -36.82 67.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.885 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -21.44 66.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 70.340000000000003 110.849 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.73 1.82 40.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.845 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.88 124.14 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.914 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 59.11 26.26 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 54.210000000000001 110.895 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.07 130.42 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 111.03 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.3 t -97.91 126.78 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 75.049999999999997 111.099 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -120.74 132.61 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 71.430000000000007 110.867 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 89.8 m -104.72 130.9 52.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 111.16 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.31 133.3 28.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 72.129999999999995 111.105 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -165.45 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.28 . . . . 74.120000000000005 112.355 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 104.15 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 72.140000000000001 110.794 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.56 -75.41 0.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 63.43 111.167 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 t -174.12 173.53 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 74.450000000000003 111.095 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -62.99 -171.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 75.349999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.34 179.27 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.842 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.1 ttm -131.45 157.96 42.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 74.510000000000005 110.831 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.9 173.47 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.117 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.95 141.6 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 111.059 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.65 172.98 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 71.030000000000001 110.929 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 169.3 -70.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 73.430000000000007 112.497 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -52.4 114.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.391 . . . . 74.310000000000002 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -174.15 71.56 0.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.548 0.689 . . . . 71.430000000000007 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.66 2.24 . . . . 73.120000000000005 112.374 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -175.66 73.6 0.28 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 73.329999999999998 110.852 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 122.17 8.83 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.615 2.21 . . . . 73.030000000000001 112.332 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 74.430000000000007 110.873 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 CA-C-O 121.454 0.475 . . . . 71.299999999999997 112.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 172.88 11.81 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.735 2.29 . . . . 71.040000000000006 112.332 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 94.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 54.340000000000003 112.549 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -130.39 133.3 46.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 74.140000000000001 110.878 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.2 ptp -146.87 135.51 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 73.430000000000007 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.852 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 34.8 mtt -55.34 171.63 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 75.420000000000002 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -141.81 141.47 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 72.129999999999995 110.854 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -137.98 140.19 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.439999999999998 110.841 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.91 69.67 81.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.508 0.671 . . . . 71.430000000000007 111.074 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -25.11 29.01 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.719 2.279 . . . . 63.229999999999997 112.353 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.17 25.11 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.881 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 58.39 54.71 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.851 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.6 mp -81.61 133.0 53.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.591 0.71 . . . . 72.400000000000006 111.152 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.271 . . . . 71.329999999999998 112.308 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -52.3 156.76 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.883 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.04 159.27 32.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 64.120000000000005 110.859 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 pt -139.66 176.78 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 111.134 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -124.08 130.59 52.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.836 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 pt -114.5 162.66 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 75.129999999999995 111.103 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.5 136.18 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -106.18 108.31 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 74.319999999999993 110.896 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 134.56 38.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 75.340000000000003 110.923 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -125.18 -178.95 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 70.430000000000007 111.175 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.1 ttp -75.78 -8.03 55.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.918 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -37.97 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.150000000000006 110.911 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 179.26 176.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 65.340000000000003 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.42 135.78 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.010000000000005 111.113 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.87 150.18 70.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.687 . . . . 73.409999999999997 111.183 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 150.75 68.66 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 73.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -148.5 116.22 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 74.200000000000003 111.054 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -74.22 131.52 41.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.898 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -107.1 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.102 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.93 147.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.430000000000007 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -52.41 113.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 53.420000000000002 110.884 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.44 25.19 51.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 51.299999999999997 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -97.27 163.28 12.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 73.340000000000003 110.891 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.1 p -121.14 165.28 15.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 73.310000000000002 111.087 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -52.02 -56.26 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 111.137 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -56.77 -35.6 68.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 72.549999999999997 110.789 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.62 -26.76 61.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 72.530000000000001 110.893 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.67 -41.39 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 73.200000000000003 111.126 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.96 -30.2 58.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 62.219999999999999 111.115 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -74.13 -24.84 59.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.834 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -76.62 -54.2 6.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 110.896 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.8 p30 -77.82 -14.22 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.883 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.76 -12.42 69.42 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 74.549999999999997 112.463 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.9 t -57.33 143.15 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 55.409999999999997 111.124 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.88 81.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.84 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.869 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -70.6 113.42 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.913 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.88 95.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.679 -0.772 . . . . 73.239999999999995 112.448 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.88 125.6 25.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 55.299999999999997 111.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.23 76.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.879 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.7 -27.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 71.510000000000005 110.924 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.04 -52.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 75.319999999999993 112.531 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.82 -176.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 73.329999999999998 110.881 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -51.94 166.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.439999999999998 110.943 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.5 146.27 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 64.329999999999998 111.075 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 p -85.31 -170.4 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.884 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -104.27 53.96 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 73.129999999999995 110.857 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.1 m -115.23 -35.92 4.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 64.329999999999998 111.145 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.2 m -82.53 -67.65 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 31.109999999999999 110.837 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -77.13 78.69 3.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.439999999999998 110.791 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.7 t -128.46 157.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 74.439999999999998 111.17 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 3.2 mp -90.18 130.91 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 71.150000000000006 111.134 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 tp -126.03 163.9 22.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.91 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -40.65 138.45 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.019999999999996 110.91 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.513 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -60.77 -58.64 17.85 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 74.019999999999996 110.945 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.4 Cg_endo -69.71 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.749 2.299 . . . . 64.209999999999994 112.327 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.25 -49.05 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 110.918 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.9 -51.33 62.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.88 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -27.24 62.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 72.140000000000001 110.862 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -75.9 -54.66 6.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.5 mt -63.04 -21.48 66.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.965 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.02 142.77 3.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.742 -0.742 . . . . 71.329999999999998 112.508 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 157.57 77.05 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 65.310000000000002 110.872 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 157.27 60.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 72.109999999999999 112.316 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.2 m -58.14 157.34 8.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -51.73 -35.78 44.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.896 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -62.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.909 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.71 -35.82 81.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 110.923 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.61 -56.6 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.9 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -62.15 -41.29 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.908 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.21 -38.26 73.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.219999999999999 110.936 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.5 mt -75.04 -36.75 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 75.239999999999995 111.078 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.18 -22.26 27.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.857 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -29.7 59.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.891 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.67 131.09 39.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.439999999999998 111.041 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -54.44 130.08 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.48 48.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.718 . . . . 73.129999999999995 112.458 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 70.219999999999999 111.162 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.74 153.01 22.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.174 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.64 -27.39 48.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.453 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.9 p -73.94 -1.43 19.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 111.174 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.0 t -87.61 -13.88 41.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 131.92 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.814 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tt -135.07 -64.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 110.879 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.94 -176.68 41.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 73.239999999999995 112.511 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.12 109.27 20.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 65.200000000000003 110.866 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -163.81 134.68 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.019999999999996 110.891 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -126.78 83.79 2.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.924 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -152.0 146.63 25.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.884 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 71.0 t -109.88 131.68 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.203 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.42 167.47 21.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 74.049999999999997 110.835 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.59 -22.05 54.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.926 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -29.46 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 70.340000000000003 110.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -90.78 7.54 39.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 73.439999999999998 110.868 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -57.63 123.15 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 110.878 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.4 25.36 14.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 54.210000000000001 110.907 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -86.23 162.52 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.078 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.5 t -112.72 125.29 69.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 111.175 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -111.76 94.72 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.904 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.1 m -89.32 130.97 35.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.158 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.4 133.35 20.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.6 0.715 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -41.15 4.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 74.120000000000005 112.303 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.29 124.11 28.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.831 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -162.16 -170.5 2.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 63.43 111.097 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -140.23 143.5 36.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 74.450000000000003 111.053 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -174.25 158.59 2.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.349999999999994 110.888 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -126.67 69.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.909 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.5 mmm -141.72 -169.96 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.862 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.12 114.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 62.43 111.078 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.6 p -174.65 150.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 74.319999999999993 111.144 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -123.95 147.37 47.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.030000000000001 110.905 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.62 130.89 1.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 73.430000000000007 112.508 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -120.55 -172.28 2.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 74.310000000000002 110.89 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -178.3 157.57 1.07 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 71.430000000000007 110.858 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.68 155.8 65.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.748 2.298 . . . . 73.120000000000005 112.353 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -173.93 70.68 0.34 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.601 0.715 . . . . 73.329999999999998 110.881 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -18.62 36.76 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.298 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.3 t60 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.817 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 121.432 0.462 . . . . 71.299999999999997 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.05 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 71.040000000000006 112.373 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.33 49.87 0.91 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 54.340000000000003 112.44 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 p -160.62 179.65 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 74.140000000000001 110.901 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 143.38 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.865 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -165.11 179.51 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 74.010000000000005 110.815 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 mmt -80.48 82.84 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.853 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -116.06 163.3 16.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 72.129999999999995 110.847 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -100.28 -65.56 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 72.439999999999998 110.847 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 59.31 73.78 0.65 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.639 0.733 . . . . 71.430000000000007 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -35.23 12.79 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.764 2.309 . . . . 63.229999999999997 112.289 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -100.8 24.56 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.876 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -157.78 121.26 4.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 110.865 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 56.3 mt -60.62 133.07 91.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.604 0.716 . . . . 72.400000000000006 111.088 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -170.57 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.383 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.24 156.89 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 74.219999999999999 110.89 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -74.03 144.01 45.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 64.120000000000005 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -129.93 176.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.136 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -114.68 138.71 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.896 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.22 167.81 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 111.189 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -113.08 125.3 54.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.865 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.37 101.87 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 74.319999999999993 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.51 128.56 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 p -127.23 175.85 7.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 70.430000000000007 111.171 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 6.1 tpt -74.42 -8.06 55.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 73.099999999999994 110.893 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.08 -38.35 6.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 74.150000000000006 110.824 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 178.81 176.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 65.340000000000003 110.881 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.78 146.44 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.129 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.3 t -142.51 129.78 11.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.112 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.64 7.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.633 2.222 . . . . 73.0 112.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -121.21 115.94 23.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 111.064 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -73.91 137.22 43.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.430000000000007 110.898 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.22 145.87 37.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.138 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.01 152.36 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 75.430000000000007 111.117 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.51 109.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 53.420000000000002 110.833 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.47 23.49 33.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 51.299999999999997 112.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -97.19 177.52 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 73.340000000000003 110.86 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 p -134.69 152.21 51.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.310000000000002 111.168 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -61.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 70.420000000000002 111.073 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.01 -34.05 58.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.549999999999997 110.921 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.4 -27.07 62.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 72.530000000000001 110.805 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.4 t -77.0 -43.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.200000000000003 111.125 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.98 -28.13 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 62.219999999999999 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -73.1 -27.43 61.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.806 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -53.4 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.884 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.59 -24.73 61.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.420000000000002 110.908 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.02 15.75 43.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.783 -0.722 . . . . 74.549999999999997 112.452 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.31 147.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.338 . . . . 55.409999999999997 111.135 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -88.83 80.8 7.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.904 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.7 123.12 32.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 110.935 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -116.12 149.68 38.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.903 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.94 83.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 73.239999999999995 112.453 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -69.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 55.299999999999997 111.101 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.9 t 53.13 44.78 29.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -63.64 -34.86 78.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 71.510000000000005 110.934 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.09 71.98 0.65 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.53 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -122.63 -47.04 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 110.921 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mp -138.4 158.19 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 75.439999999999998 110.967 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.67 112.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 64.329999999999998 111.114 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.8 p -106.4 163.02 13.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 74.540000000000006 110.932 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -128.97 73.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.129999999999995 110.894 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -133.4 29.7 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 64.329999999999998 111.177 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.14 32.33 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 31.109999999999999 110.886 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -146.68 112.99 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 65.439999999999998 110.832 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 t -128.32 156.66 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 111.133 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.31 137.72 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 71.150000000000006 111.159 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -127.77 157.88 39.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 72.319999999999993 110.952 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.48 141.45 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.879 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -57.27 -59.63 12.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 74.019999999999996 110.906 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.79 -48.86 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.744 2.296 . . . . 64.209999999999994 112.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 tp -51.83 -42.82 62.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 75.329999999999998 110.996 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -72.51 -51.64 19.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.87 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -36.23 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.140000000000001 110.852 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -78.18 -43.06 29.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -63.26 -28.1 69.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.944 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.07 160.55 8.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.737 -0.744 . . . . 71.329999999999998 112.457 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.55 157.37 77.48 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 65.310000000000002 110.876 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 72.109999999999999 112.425 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -102.57 -175.7 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 110.871 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -56.45 -45.2 80.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -59.65 4.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.868 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.43 -28.55 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.530000000000001 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -56.96 13.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.901 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -42.09 89.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.822 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.08 -51.93 62.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 110.963 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.74 -35.26 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 75.239999999999995 111.105 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.55 -17.04 62.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.83 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -76.28 -25.38 54.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.869 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.46 143.84 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 71.439999999999998 111.087 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -64.03 123.17 18.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 75.519999999999996 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.93 43.92 55.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.711 -0.756 . . . . 73.129999999999995 112.551 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -108.9 118.02 35.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 70.219999999999999 111.179 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 148.71 26.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 111.122 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.82 41.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 75.129999999999995 112.45 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.1 p -73.96 -1.99 22.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 64.239999999999995 111.171 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.7 t -91.05 -12.94 34.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 71.409999999999997 110.9 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -118.24 132.73 56.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 73.340000000000003 110.906 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.17 -69.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 74.420000000000002 110.874 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.36 -142.04 7.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 73.239999999999995 112.456 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -129.87 33.44 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 65.200000000000003 110.884 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -139.41 133.95 31.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 74.019999999999996 110.968 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -128.82 109.15 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 73.030000000000001 110.918 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -137.4 145.35 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 70.209999999999994 110.863 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.1 t -92.94 130.18 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.106 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.48 167.53 21.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 74.049999999999997 110.932 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -41.76 79.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 72.510000000000005 110.874 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.64 -17.09 59.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 70.340000000000003 110.898 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.26 11.26 21.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.931 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.5 123.27 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 75.409999999999997 110.897 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 59.6 25.88 14.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 54.210000000000001 110.84 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.85 127.92 34.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.299999999999997 111.097 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.12 120.52 51.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 75.049999999999997 111.117 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -120.46 126.41 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.876 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -101.4 131.35 47.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.192 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.0 t -88.18 133.34 37.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.681 0.753 . . . . 72.129999999999995 111.089 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -43.56 2.58 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.709 2.273 . . . . 74.120000000000005 112.312 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -62.37 144.96 55.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.948 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.96 162.28 29.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 63.43 111.103 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.0 m -160.51 136.25 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 111.149 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.74 136.71 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 75.349999999999994 110.922 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -144.03 166.36 25.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 73.329999999999998 110.885 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.2 ptp -59.47 -178.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.862 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.95 44.57 29.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.141 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.11 137.49 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 74.319999999999993 111.097 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.61 161.23 37.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.030000000000001 110.915 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -52.33 138.71 31.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.783 -0.722 . . . . 73.430000000000007 112.44 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -107.73 -179.61 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.945 0.403 . . . . 74.310000000000002 110.892 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -162.44 157.65 19.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 71.430000000000007 110.884 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -170.95 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.675 2.25 . . . . 73.120000000000005 112.399 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -135.46 157.6 76.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.504 0.668 . . . . 73.329999999999998 110.929 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.37 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.713 2.276 . . . . 73.030000000000001 112.343 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.848 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 CA-C-O 121.433 0.463 . . . . 71.299999999999997 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -174.71 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 71.040000000000006 112.322 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.88 -102.47 0.19 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 54.340000000000003 112.461 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -114.47 148.58 37.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 74.140000000000001 110.88 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.3 mtm -153.16 135.67 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.895 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.6 179.15 7.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.9 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.0 ttp -145.29 128.83 17.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -137.88 165.69 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 72.129999999999995 110.896 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.1 114.97 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 110.876 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.57 160.4 1.36 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.535 0.683 . . . . 71.430000000000007 111.125 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -28.54 25.05 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.643 2.229 . . . . 63.229999999999997 112.362 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -107.69 25.03 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -148.01 128.39 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 110.899 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.6 mm -62.52 133.06 94.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.658 0.742 . . . . 72.400000000000006 111.105 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.742 2.295 . . . . 71.329999999999998 112.293 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -51.74 156.75 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.219999999999999 110.876 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -73.94 144.41 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 64.120000000000005 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.7 176.88 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 64.439999999999998 111.143 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -121.43 141.65 50.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.877 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 pt -114.39 164.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.05 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -120.77 130.36 53.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 110.877 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.35 102.95 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.33 30.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 75.340000000000003 110.934 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 p -113.8 -176.45 2.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 70.430000000000007 111.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -8.6 57.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 110.924 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -110.6 -38.32 5.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.885 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 178.67 176.49 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 65.340000000000003 110.902 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.05 148.14 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.158 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.44 132.52 24.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.117 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.68 129.37 17.56 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 73.0 112.382 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.01 107.51 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.105 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.94 149.06 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.430000000000007 110.91 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -130.68 121.67 25.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.069 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.3 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.145 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 p -51.21 111.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 53.420000000000002 110.852 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.84 14.16 35.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.703 . . . . 51.299999999999997 112.429 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.1 p -95.01 -178.92 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.009 0.433 . . . . 73.340000000000003 110.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.9 159.86 42.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 111.124 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.7 m -58.73 -45.3 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 111.069 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.5 mp -66.75 -36.07 81.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 72.549999999999997 110.937 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.66 -27.44 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 110.892 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 72.0 t -77.08 -49.9 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 73.200000000000003 111.092 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 111.082 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -69.74 -34.19 73.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 110.854 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -87.12 -37.41 17.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.973 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -72.26 -24.92 61.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.912 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.9 -12.13 70.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 74.549999999999997 112.542 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -51.54 130.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 55.409999999999997 111.206 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.59 81.29 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.854 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.08 131.26 39.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 74.409999999999997 110.887 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.99 112.1 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.901 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.29 134.32 0.4 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 73.239999999999995 112.455 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.09 -26.67 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 55.299999999999997 111.095 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 63.38 44.21 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.899 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.02 -35.14 5.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 71.510000000000005 110.904 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.85 19.66 2.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 75.319999999999993 112.535 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.0 t30 53.43 63.32 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 73.329999999999998 110.849 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mt -123.55 -41.18 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 75.439999999999998 110.917 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.37 -29.66 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 64.329999999999998 111.14 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.9 t -82.63 59.96 4.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 110.949 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 p -100.1 28.05 5.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 73.129999999999995 110.849 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.02 140.19 18.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.329999999999998 111.133 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.2 m -126.78 79.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 31.109999999999999 110.917 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -161.95 112.09 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.864 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.92 157.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 111.133 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.1 mt -89.79 132.37 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.150000000000006 111.099 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 tp -127.28 159.87 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 72.319999999999993 110.946 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.79 142.06 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.864 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -57.5 -59.83 11.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 74.019999999999996 110.867 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.61 2.206 . . . . 64.209999999999994 112.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.47 -43.33 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 75.329999999999998 110.892 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -71.44 -51.63 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.945 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -35.39 61.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.873 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -78.1 -40.84 37.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -26.33 68.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.877 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.7 167.57 11.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.23 157.82 77.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 65.310000000000002 110.91 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -178.1 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.702 2.268 . . . . 72.109999999999999 112.334 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -98.32 -173.3 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.879 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -58.5 -43.8 89.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.858 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -53.93 -59.65 4.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 73.140000000000001 110.899 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -28.16 69.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.530000000000001 110.958 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -52.36 64.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -41.83 70.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 71.120000000000005 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -50.01 69.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.954 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 64.2 mt -73.29 -42.58 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.138 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.51 -23.11 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.13 -24.17 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.56 142.17 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 111.049 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 130.99 43.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.904 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 40.36 59.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 73.129999999999995 112.56 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -108.64 123.61 49.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.127 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.32 144.2 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 75.109999999999999 111.1 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.91 -26.11 47.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 75.129999999999995 112.445 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.3 p -74.07 -1.23 19.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 64.239999999999995 111.155 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.9 t -90.76 -12.71 35.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.869 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -112.59 143.57 43.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.879 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 130.63 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.948 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.59 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 73.239999999999995 112.515 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.6 m -101.44 27.69 6.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 65.200000000000003 110.911 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.21 59.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 110.889 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 112.56 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 73.030000000000001 110.889 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -119.21 136.36 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.95 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.3 t -80.06 115.43 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.137 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 178.54 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 74.049999999999997 110.819 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -54.88 -40.28 69.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.510000000000005 110.889 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 t -64.44 -25.09 67.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 70.340000000000003 110.914 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -79.85 -2.21 42.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 110.869 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -58.15 124.94 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 110.935 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.3 m120 58.72 23.81 11.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 54.210000000000001 110.902 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.63 151.24 46.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 111.147 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.07 113.02 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 75.049999999999997 111.184 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -108.95 95.06 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.804 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.6 m -87.82 130.91 34.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 111.169 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.53 133.4 25.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.631 0.729 . . . . 72.129999999999995 111.165 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -41.89 3.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.76 2.306 . . . . 74.120000000000005 112.321 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -132.79 120.25 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.843 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.85 -176.14 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 63.43 111.122 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.55 112.18 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 111.144 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -173.96 139.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 75.349999999999994 110.88 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -80.19 -26.81 39.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.88 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.2 mtt -117.41 -171.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.57 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 62.43 111.138 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 m -82.4 -177.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.09 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -98.94 -174.71 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.924 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.77 86.51 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 73.430000000000007 112.504 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -123.44 126.26 46.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.310000000000002 110.925 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -115.4 73.76 4.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 71.430000000000007 110.923 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 82.93 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.673 2.249 . . . . 73.120000000000005 112.317 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 131' ' ' PRO . 2.9 mtpp -67.75 -60.39 5.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.585 0.707 . . . . 73.329999999999998 110.888 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 53.5 Cg_endo -69.75 170.34 16.8 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.745 2.297 . . . . 73.030000000000001 112.307 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.877 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.516 0.509 . . . . 71.299999999999997 112.458 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 179.71 3.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.724 2.283 . . . . 71.040000000000006 112.345 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.38 170.84 12.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 54.340000000000003 112.506 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.59 -174.87 3.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.822 0.344 . . . . 74.140000000000001 110.868 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.7 tpp -126.46 138.64 53.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 73.430000000000007 110.859 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -158.29 -178.47 7.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.010000000000005 110.883 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.13 173.12 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 75.420000000000002 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -116.01 166.11 12.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.881 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -100.82 -175.05 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.838 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.8 71.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.594 0.711 . . . . 71.430000000000007 111.189 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 177.88 5.16 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.229999999999997 112.341 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.1 24.7 10.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.839 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -108.76 102.4 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.209999999999994 110.859 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 mp -109.61 132.96 21.04 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.758 . . . . 72.400000000000006 111.071 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -168.09 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 71.329999999999998 112.412 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -50.25 157.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 110.86 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.44 147.0 44.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.493 . . . . 64.120000000000005 110.95 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 177.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 111.205 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -122.75 136.79 54.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.946 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.8 pt -117.44 172.02 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 111.13 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -118.74 128.74 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.894 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -105.31 104.18 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 74.319999999999993 110.922 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -93.64 122.25 35.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -113.36 -177.83 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 70.430000000000007 111.074 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -75.95 -9.36 58.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -106.09 -37.74 6.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 74.150000000000006 110.944 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.13 176.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 65.340000000000003 110.911 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.36 134.58 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.102 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.41 150.66 76.21 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.63 0.729 . . . . 73.409999999999997 111.101 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 155.06 66.96 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 73.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.92 136.18 25.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 74.200000000000003 111.141 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -96.78 134.56 39.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 73.430000000000007 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.35 125.66 53.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.123 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.1 t -95.23 156.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 75.430000000000007 111.114 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 58.5 m -55.55 99.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 53.420000000000002 110.802 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.95 24.6 11.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 51.299999999999997 112.476 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 m -94.83 174.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 73.340000000000003 110.844 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -131.73 146.71 52.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 111.133 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -48.52 -62.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 111.158 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.45 -32.98 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 72.549999999999997 110.876 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.25 -27.02 62.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.863 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.55 -43.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.200000000000003 111.108 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.82 -27.8 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 62.219999999999999 111.131 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -73.36 -34.66 65.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 75.200000000000003 110.822 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -83.28 -40.73 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.898 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -72.02 -26.95 62.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.812 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.69 83.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 74.549999999999997 112.438 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -53.66 156.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 55.409999999999997 111.135 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -72.1 80.02 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.859 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.95 146.81 16.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 74.409999999999997 110.829 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.9 141.0 50.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.29 155.51 21.54 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 73.239999999999995 112.519 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.99 23.8 11.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 55.299999999999997 111.068 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 t 51.93 50.53 18.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 72.329999999999998 110.853 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -51.8 129.21 25.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 71.510000000000005 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.99 99.76 0.15 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 75.319999999999993 112.478 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -54.5 -28.41 44.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 73.329999999999998 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mt -125.16 -71.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.439999999999998 110.923 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.71 -176.9 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 64.329999999999998 111.08 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.5 m -122.67 114.92 21.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.540000000000006 110.924 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.83 -62.46 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 73.129999999999995 110.886 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -171.1 157.05 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.329999999999998 111.135 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.23 98.7 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 31.109999999999999 110.893 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -94.55 112.21 23.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 65.439999999999998 110.87 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.4 t -128.66 157.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 111.074 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 63.9 mt -90.08 132.79 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 71.150000000000006 111.134 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.0 tp -125.63 159.63 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 72.319999999999993 110.902 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.78 142.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.019999999999996 110.815 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -60.11 -58.67 17.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.731 . . . . 74.019999999999996 110.965 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.85 -47.58 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.741 2.294 . . . . 64.209999999999994 112.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 tp -53.24 -51.16 63.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.329999999999998 110.957 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -63.46 -53.74 47.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.931 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -31.63 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 72.140000000000001 110.809 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.13 -53.78 13.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.3 -23.59 67.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.835 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.14 148.04 4.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.478 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.45 78.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.636 0.731 . . . . 65.310000000000002 110.842 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 165.45 30.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.648 2.232 . . . . 72.109999999999999 112.343 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -93.68 -170.92 2.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 110.842 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -56.96 -45.23 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.837 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -53.76 -59.79 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.57 -29.98 70.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.530000000000001 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -54.0 50.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.02 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.905 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.82 -51.95 61.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.936 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -74.92 -34.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.089 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.76 -20.02 45.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.030000000000001 110.799 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -75.52 -16.31 60.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.918 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.67 144.31 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 111.094 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -64.96 122.28 16.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.934 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.5 45.1 53.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 73.129999999999995 112.539 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -108.06 143.93 36.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.902 0.382 . . . . 70.219999999999999 111.092 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 150.56 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.149 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.76 -27.18 49.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.742 . . . . 75.129999999999995 112.479 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.9 p -73.92 -1.28 19.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.384 . . . . 64.239999999999995 111.154 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.3 t -89.34 -13.61 37.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 110.879 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.22 165.65 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 73.340000000000003 110.848 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.65 65.88 0.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.03 19.88 10.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.753 . . . . 73.239999999999995 112.438 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.66 165.18 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 65.200000000000003 110.897 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 56.67 42.11 27.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.913 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.5 tp -98.25 156.56 16.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.45 . . . . 73.030000000000001 110.879 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -118.55 163.47 16.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 110.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 88.0 t -102.03 122.71 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 111.107 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.28 173.61 11.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 74.049999999999997 110.927 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -59.26 -36.02 74.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 110.919 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -65.81 -19.53 65.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 70.340000000000003 110.909 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.02 -0.19 43.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.831 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -59.01 124.28 19.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 75.409999999999997 110.904 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.38 22.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 54.210000000000001 110.881 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 141.99 58.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 111.127 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.05 116.77 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 75.049999999999997 111.116 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.26 100.31 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.905 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 39.5 m -88.22 124.83 34.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 111.174 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.4 t -116.89 92.27 38.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.097 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -35.59 12.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.728 2.285 . . . . 74.120000000000005 112.336 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.47 150.38 23.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.843 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.07 175.56 6.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.113 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.54 -19.99 62.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 74.450000000000003 111.126 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -51.26 113.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 75.349999999999994 110.853 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.39 174.11 11.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.935 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.6 mmt -117.75 -32.15 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 110.887 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 57.79 49.61 11.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 62.43 111.147 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.6 m -89.64 175.05 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 74.319999999999993 111.118 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 58.26 41.53 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 71.030000000000001 110.956 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -123.22 -10.47 5.6 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 73.430000000000007 112.428 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -53.18 123.13 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -83.22 159.21 62.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 110.921 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -21.98 32.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.120000000000005 112.354 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -154.35 162.66 26.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.713 . . . . 73.329999999999998 110.881 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -172.09 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.682 2.255 . . . . 73.030000000000001 112.378 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 74.430000000000007 110.926 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.496 0.498 . . . . 71.299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.77 2.313 . . . . 71.040000000000006 112.329 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.03 -19.69 0.65 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 54.340000000000003 112.506 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.55 66.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 74.140000000000001 110.832 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -175.36 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 73.430000000000007 110.922 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.97 179.45 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 74.010000000000005 110.871 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -115.95 -176.08 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 75.420000000000002 110.817 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -142.94 161.36 38.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 72.129999999999995 110.923 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.9 t -99.36 -171.43 2.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.842 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -137.27 160.36 65.99 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.569 0.7 . . . . 71.430000000000007 111.058 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -11.26 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.229999999999997 112.344 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.93 -23.11 66.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 110.848 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -169.16 140.37 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 74.209999999999994 110.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.76 133.06 22.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 72.400000000000006 111.062 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -170.63 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 71.329999999999998 112.364 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.54 156.64 1.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 74.219999999999999 110.893 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.98 158.99 33.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 64.120000000000005 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.2 176.43 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 111.091 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 127.59 53.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.798 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.27 163.0 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 111.112 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -119.53 127.53 53.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.26 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 74.319999999999993 110.882 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -86.1 115.17 23.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.340000000000003 110.926 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -103.91 -179.29 3.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 70.430000000000007 111.167 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.01 -17.14 59.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.099999999999994 110.946 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -93.98 -39.11 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.889 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 176.31 176.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 65.340000000000003 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.7 t -86.77 142.69 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 111.085 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.75 129.78 18.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.71 60.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.246 . . . . 73.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.84 113.31 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.118 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -79.44 122.97 27.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.848 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.27 116.42 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.029 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 m -87.8 144.38 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 75.430000000000007 111.109 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 p -54.78 121.35 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 53.420000000000002 110.889 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.0 -7.74 41.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 51.299999999999997 112.494 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -99.42 -178.06 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.993 0.425 . . . . 73.340000000000003 110.85 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.93 154.77 50.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 111.135 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.9 m -57.91 -45.55 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.420000000000002 111.118 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.4 mp -64.33 -37.35 87.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 110.931 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.73 -27.3 61.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 72.530000000000001 110.886 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.0 t -76.42 -43.59 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.077 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.96 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 62.219999999999999 111.108 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -73.42 -36.84 66.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 110.848 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -40.84 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.530000000000001 110.909 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.1 -25.45 61.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.903 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.88 76.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 74.549999999999997 112.449 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.2 t -51.5 137.99 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 55.409999999999997 111.052 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.13 80.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 tt -107.92 107.67 18.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.884 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.36 112.49 8.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.862 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.99 38.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 73.239999999999995 112.474 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.22 73.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 55.299999999999997 111.08 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 56.79 26.53 11.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.945 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -127.82 163.09 25.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 71.510000000000005 110.863 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.24 -162.19 53.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.729 -0.748 . . . . 75.319999999999993 112.531 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.28 163.04 25.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 110.931 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.79 62.88 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.439999999999998 110.87 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.73 143.01 33.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 111.12 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.7 p -102.35 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.947 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -92.21 -28.13 17.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 110.818 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 t -140.95 150.41 43.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 64.329999999999998 111.111 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.2 p -130.67 81.73 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 31.109999999999999 110.855 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -60.81 117.27 5.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 65.439999999999998 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.2 155.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 111.105 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 70.3 mt -91.07 133.77 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 71.150000000000006 111.096 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.3 tp -125.67 162.54 24.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.933 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -41.0 139.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -60.1 -59.38 14.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.638 0.732 . . . . 74.019999999999996 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.75 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.723 2.282 . . . . 64.209999999999994 112.318 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.76 -48.83 63.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.329999999999998 110.941 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -66.99 -51.08 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.929 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -51.52 -51.66 53.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 72.140000000000001 110.881 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -61.62 -48.55 80.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.94 -18.68 63.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.209999999999994 110.912 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.03 130.35 2.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 71.329999999999998 112.507 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 157.75 60.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 65.310000000000002 110.866 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.94 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.709 2.273 . . . . 72.109999999999999 112.392 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.9 m -104.79 -174.89 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.852 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.9 -49.16 78.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.896 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -47.69 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.914 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.83 -28.38 64.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 71.530000000000001 110.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -53.3 55.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.851 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -43.28 68.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.22 -49.07 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.219999999999999 110.88 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.8 mt -75.06 -34.4 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 111.089 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.42 -15.64 58.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.85 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.33 -22.86 57.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.858 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.1 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 71.439999999999998 111.133 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -56.97 126.6 27.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.13 41.33 53.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.484 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.48 139.03 46.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 70.219999999999999 111.068 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 155.0 44.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.135 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.87 -27.08 49.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 75.129999999999995 112.427 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 14.9 p -73.79 -1.92 21.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.293 . . . . 64.239999999999995 111.158 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 39.1 t -87.88 -14.9 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.884 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.8 168.27 9.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 73.340000000000003 110.857 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 62.06 97.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 74.420000000000002 110.947 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.95 32.01 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 73.239999999999995 112.504 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.24 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.329 . . . . 65.200000000000003 110.871 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -88.26 51.7 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.019999999999996 110.911 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 tt -91.37 114.51 27.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 73.030000000000001 110.93 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -85.33 134.93 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 110.934 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 83.8 t -59.76 122.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 72.239999999999995 111.091 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -137.07 160.2 39.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 74.049999999999997 110.884 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -53.95 -27.24 29.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.66 -29.29 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 70.340000000000003 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -89.99 12.07 18.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 73.439999999999998 110.898 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.22 120.74 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 110.873 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.71 21.26 12.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 54.210000000000001 110.887 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.2 153.39 36.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 111.104 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 t -105.51 127.16 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 75.049999999999997 111.091 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -113.16 98.48 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.887 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.0 m -85.21 124.86 32.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.145 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.32 92.48 8.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.687 0.756 . . . . 72.129999999999995 111.124 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -34.2 14.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.663 2.242 . . . . 74.120000000000005 112.273 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 144.08 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 110.842 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.89 166.73 20.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 63.43 111.125 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.8 t -69.9 131.93 45.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 74.450000000000003 111.182 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -175.33 171.59 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 75.349999999999994 110.887 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -93.77 -29.14 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 73.329999999999998 110.9 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 151.03 41.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 74.510000000000005 110.809 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.97 140.11 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.096 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.2 t -144.22 149.67 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 74.319999999999993 111.139 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -55.15 172.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.52 -150.43 25.31 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 73.430000000000007 112.463 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -150.2 -174.11 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 74.310000000000002 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 pttp 37.55 67.89 1.81 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.587 0.708 . . . . 71.430000000000007 110.861 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 138.82 38.78 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.696 2.264 . . . . 73.120000000000005 112.402 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -132.57 160.77 66.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.568 0.699 . . . . 73.329999999999998 110.914 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -44.01 2.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.312 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 74.430000000000007 110.879 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 121.383 0.435 . . . . 71.299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -175.95 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 71.040000000000006 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -146.7 -177.92 21.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 54.340000000000003 112.439 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -129.56 -179.16 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 74.140000000000001 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.9 mtm -143.57 165.71 26.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.866 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.24 178.46 8.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 74.010000000000005 110.826 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.1 mtp -106.2 176.6 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 110.855 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -152.02 156.56 40.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 72.129999999999995 110.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -91.09 -172.35 3.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.836 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.94 73.76 0.46 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 71.430000000000007 111.15 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 81.9 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.611 2.207 . . . . 63.229999999999997 112.361 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -117.61 25.29 10.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 73.209999999999994 110.85 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -124.15 -166.93 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 74.209999999999994 110.858 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.1 mt -51.65 133.2 36.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.635 0.731 . . . . 72.400000000000006 111.136 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.346 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.02 157.45 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.902 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -73.41 143.58 46.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 64.120000000000005 110.864 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.92 176.88 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 64.439999999999998 111.062 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -114.2 136.83 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.872 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 14.6 pt -120.23 169.4 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 111.111 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.17 137.91 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -108.81 103.12 12.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.852 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -90.19 130.0 36.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.887 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 p -119.08 -177.51 3.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 70.430000000000007 111.156 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 ptm -75.9 -8.13 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.871 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -38.51 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 74.150000000000006 110.913 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -178.56 176.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 65.340000000000003 110.947 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.94 135.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 111.163 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.09 150.9 60.7 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 73.409999999999997 111.099 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.67 60.98 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 73.0 112.377 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -147.8 108.46 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 111.111 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -74.83 128.0 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.986 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.31 119.97 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.047 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.4 154.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 75.430000000000007 111.161 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.8 t -56.21 109.8 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 53.420000000000002 110.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.47 -17.35 56.85 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 51.299999999999997 112.489 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 142.11 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 110.818 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 72.8 p -96.82 158.38 15.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.310000000000002 111.07 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.86 -58.27 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.420000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -33.63 58.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 72.549999999999997 110.856 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -73.06 -27.59 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 72.530000000000001 110.796 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.13 -45.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 73.200000000000003 111.082 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.2 25.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.042 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -71.74 -38.93 70.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 75.200000000000003 110.916 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -66.46 -50.69 62.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.17 -32.86 67.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.862 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.7 44.01 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.791 . . . . 74.549999999999997 112.51 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.0 t -51.82 142.44 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 55.409999999999997 111.222 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.43 81.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.851 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.98 112.28 17.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 110.924 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -52.04 145.36 10.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.847 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.66 32.83 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.78 -0.724 . . . . 73.239999999999995 112.517 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.8 86.45 2.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.321 . . . . 55.299999999999997 111.172 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 m -90.01 -40.58 12.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.852 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.41 138.41 46.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 71.510000000000005 110.925 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.46 -103.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 75.319999999999993 112.493 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.31 -171.87 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 73.329999999999998 110.913 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.44 68.93 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 75.439999999999998 110.899 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.54 -45.32 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 64.329999999999998 111.079 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 45.1 t -76.96 72.56 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.903 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -54.81 -65.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.856 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -159.88 146.68 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 64.329999999999998 111.145 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.3 p -116.75 155.31 29.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 31.109999999999999 110.88 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -145.56 125.14 13.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 65.439999999999998 110.853 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 p -127.94 149.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 74.439999999999998 111.166 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 17.3 mt -91.2 133.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 71.150000000000006 111.106 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.9 tp -120.11 158.97 25.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 72.319999999999993 110.878 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.09 137.46 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.816 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.567 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.8 mt-10 -59.72 -55.81 42.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.67 0.748 . . . . 74.019999999999996 110.921 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.9 Cg_endo -69.81 -32.71 17.83 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.63 2.22 . . . . 64.209999999999994 112.326 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 tp -63.01 -46.64 86.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 75.329999999999998 110.882 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.32 -48.62 40.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.942 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -36.65 68.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 72.140000000000001 110.905 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -76.37 -45.19 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -63.04 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.965 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.05 158.29 21.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 71.329999999999998 112.522 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -130.75 157.63 77.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.649 0.738 . . . . 65.310000000000002 110.904 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.62 2.4 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.249 . . . . 72.109999999999999 112.352 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -95.93 -176.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.94 -44.39 82.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.803 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -53.49 -60.12 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.02 -28.43 69.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 110.902 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -55.68 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.944 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.61 -43.59 84.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 71.120000000000005 110.857 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.66 -46.9 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.895 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.1 mt -74.84 -34.63 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 75.239999999999995 111.103 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.53 -15.41 60.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.885 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.89 -6.05 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.981 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.59 135.6 46.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.129 -0.487 . . . . 71.439999999999998 111.059 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -55.14 124.89 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 75.519999999999996 110.891 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.41 42.49 50.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.47 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -101.06 147.44 26.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 70.219999999999999 111.166 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.7 153.56 43.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 111.155 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.2 -38.37 67.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.468 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.98 -0.85 17.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 64.239999999999995 111.153 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 8.7 t -88.24 -16.52 32.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.409999999999997 110.873 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -118.31 148.62 42.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.340000000000003 110.845 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -121.4 -175.09 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 74.420000000000002 110.888 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.0 7.57 5.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 73.239999999999995 112.542 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 17.2 m 61.5 167.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 65.200000000000003 110.931 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 54.59 43.55 30.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.888 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.34 92.33 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.030000000000001 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 168.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.845 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.4 t -90.77 143.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.123 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.44 171.24 14.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 74.049999999999997 110.808 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -38.42 77.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -17.71 63.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 70.340000000000003 110.898 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.5 9.68 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 73.439999999999998 110.842 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.33 124.88 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.906 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 60.81 21.25 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 54.210000000000001 110.895 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.9 129.74 41.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 111.157 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.9 t -93.1 118.73 39.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 75.049999999999997 111.187 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -106.29 99.87 9.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.929 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.6 m -87.06 131.2 34.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.169 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.4 132.64 21.71 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.125 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -41.35 4.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.692 2.262 . . . . 74.120000000000005 112.371 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -125.22 103.53 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.84 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.03 -175.32 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 63.43 111.078 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 p -111.02 -173.83 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 74.450000000000003 111.173 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -81.98 -173.48 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 75.349999999999994 110.906 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -168.33 179.24 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.882 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.3 tpt -84.87 109.2 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.877 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.38 168.99 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 62.43 111.128 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.6 151.73 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 111.134 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -175.54 176.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.922 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.66 155.15 25.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.693 -0.765 . . . . 73.430000000000007 112.468 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -160.19 179.71 8.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 74.310000000000002 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -91.06 160.59 37.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 71.430000000000007 110.87 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.15 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.253 . . . . 73.120000000000005 112.407 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.48 73.47 0.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 73.329999999999998 110.893 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 142.87 49.39 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.64 2.227 . . . . 73.030000000000001 112.406 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 74.430000000000007 110.834 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 CA-C-O 121.395 0.442 . . . . 71.299999999999997 112.443 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 169.38 19.08 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.678 2.252 . . . . 71.040000000000006 112.373 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.04 120.49 0.65 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 54.340000000000003 112.503 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 m -130.55 159.18 37.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 74.140000000000001 110.903 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mtt -125.94 161.5 27.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.917 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.21 119.97 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 74.010000000000005 110.901 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -134.03 168.93 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.885 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -129.97 136.48 49.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.862 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.8 p -134.14 175.8 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 72.439999999999998 110.855 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.13 69.82 2.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.512 0.672 . . . . 71.430000000000007 111.098 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 111.36 2.78 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.754 2.303 . . . . 63.229999999999997 112.315 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.18 24.93 10.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.821 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.4 42.73 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.88 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.1 mm -54.26 132.95 61.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.647 0.737 . . . . 72.400000000000006 111.179 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.711 2.274 . . . . 71.329999999999998 112.435 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -52.28 157.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 74.219999999999999 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -73.82 148.78 42.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 64.120000000000005 110.887 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.38 177.11 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 64.439999999999998 111.07 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -123.35 144.62 49.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.797 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pt -125.75 170.59 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 111.087 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -114.5 125.32 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.887 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 103.37 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 74.319999999999993 110.877 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.78 127.28 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 p -114.36 -167.45 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 70.430000000000007 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.7 mmm -54.34 -54.85 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -141.03 27.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 110.963 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.3 128.45 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 65.340000000000003 110.915 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.7 t -119.34 109.86 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 72.010000000000005 111.138 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.11 150.27 59.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 111.175 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 159.55 53.02 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.703 2.269 . . . . 73.0 112.389 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.79 136.51 25.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 111.119 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.21 133.5 43.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.924 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -110.37 117.48 33.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.155 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.49 149.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 75.430000000000007 111.168 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.04 117.99 3.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 53.420000000000002 110.805 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.91 19.7 64.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 51.299999999999997 112.457 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -94.57 -169.42 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.931 0.396 . . . . 73.340000000000003 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.02 142.92 26.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.310000000000002 111.083 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.38 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 70.420000000000002 111.147 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mt -53.5 -36.27 61.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 72.549999999999997 110.859 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -72.67 -26.81 61.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 72.530000000000001 110.87 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.4 t -76.44 -39.9 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 73.200000000000003 111.086 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.35 -32.18 24.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.15 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -73.66 -35.94 65.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.863 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -40.31 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.530000000000001 110.942 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -72.08 -24.95 61.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 74.420000000000002 110.937 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.8 -11.67 38.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.737 . . . . 74.549999999999997 112.514 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -61.59 110.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.347 . . . . 55.409999999999997 111.169 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.79 80.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.88 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.76 146.43 48.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 74.409999999999997 110.896 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -93.98 152.06 19.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 75.219999999999999 110.845 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.52 147.25 18.52 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.726 . . . . 73.239999999999995 112.516 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.78 -75.43 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 55.299999999999997 111.098 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.6 m -57.74 142.72 44.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.887 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -100.37 -66.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 71.510000000000005 110.953 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.18 -94.05 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 112.422 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -87.29 -58.21 2.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 73.329999999999998 110.84 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -55.07 135.31 49.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 110.841 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.53 164.27 2.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 64.329999999999998 111.122 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.0 p -121.99 -176.97 3.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 110.868 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 m -76.61 -175.84 3.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.843 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 t -52.32 140.52 21.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 64.329999999999998 111.117 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 p -122.67 146.32 47.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 31.109999999999999 110.912 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -177.0 114.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 65.439999999999998 110.835 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 155.91 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -90.45 137.46 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 71.150000000000006 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 tp -128.51 161.54 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 72.319999999999993 110.917 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.26 141.7 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 110.924 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.497 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 mt-10 -58.47 -59.51 13.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.609 0.718 . . . . 74.019999999999996 110.894 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -48.73 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.269 . . . . 64.209999999999994 112.279 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -51.73 -46.77 64.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 75.329999999999998 110.944 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -68.41 -50.43 52.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.866 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.82 -43.98 66.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.875 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -77.83 -28.01 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.88 -61.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.937 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.41 132.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.329999999999998 112.482 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -91.91 160.31 36.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.701 0.762 . . . . 65.310000000000002 110.859 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.93 62.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.719 2.28 . . . . 72.109999999999999 112.333 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -86.45 -169.85 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.898 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -56.96 -48.57 78.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.833 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -53.52 -59.44 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 73.140000000000001 110.924 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.46 -27.61 68.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.887 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -55.74 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.99 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.7 -37.88 82.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 110.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.97 -47.24 86.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 64.219999999999999 110.909 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.6 mt -73.0 -35.17 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 75.239999999999995 111.159 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -20.89 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 74.030000000000001 110.857 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -76.25 -24.37 54.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.926 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.36 148.79 29.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 71.439999999999998 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -76.65 120.39 21.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 75.519999999999996 110.872 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.5 44.15 59.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.695 -0.765 . . . . 73.129999999999995 112.443 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -99.37 130.56 45.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 111.064 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 146.22 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.136 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.8 -24.97 43.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.686 -0.769 . . . . 75.129999999999995 112.539 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.9 p -74.01 -2.26 23.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 64.239999999999995 111.189 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.4 t -91.35 -13.42 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 71.409999999999997 110.903 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.0 tpt85 -108.53 161.79 14.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.863 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt 64.9 110.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.879 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.69 25.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 73.239999999999995 112.462 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 59.4 m -78.25 -171.28 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 65.200000000000003 110.894 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 63.09 61.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 72.6 mt -65.87 89.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 73.030000000000001 110.91 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -152.02 149.7 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 70.209999999999994 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 94.2 t -83.5 133.57 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 111.139 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -136.55 155.92 49.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 74.049999999999997 110.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -57.07 -37.49 71.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 72.510000000000005 110.904 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.1 m -65.08 -18.54 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 70.340000000000003 110.778 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.59 1.21 50.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.88 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -58.0 124.41 19.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 75.409999999999997 110.844 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 59.34 24.66 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 54.210000000000001 110.907 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 165.43 24.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 74.299999999999997 111.121 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.25 124.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.049999999999997 111.105 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -125.06 129.23 49.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.879 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.5 m -100.97 131.83 46.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 111.16 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.1 t -91.95 132.7 32.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.63 0.729 . . . . 72.129999999999995 111.107 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -39.89 5.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 74.120000000000005 112.382 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -86.52 166.37 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.83 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -167.57 173.99 8.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 63.43 111.112 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -102.42 144.54 30.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 74.450000000000003 111.122 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 88.68 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 75.349999999999994 110.877 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -88.64 62.57 6.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 73.329999999999998 110.895 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 58.5 mtt 57.92 49.65 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.510000000000005 110.944 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 -178.91 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.43 111.125 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.3 141.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.319999999999993 111.132 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -123.22 101.08 7.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.030000000000001 110.88 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -101.93 163.21 17.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 73.430000000000007 112.489 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.07 118.69 9.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 110.977 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.15 69.21 1.74 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.609 0.719 . . . . 71.430000000000007 110.937 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.21 33.87 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.385 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -123.44 160.69 49.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.53 0.681 . . . . 73.329999999999998 110.901 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.82 8.65 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 73.030000000000001 112.333 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.5 t60 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.861 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 121.391 0.439 . . . . 71.299999999999997 112.55 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 173.43 10.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.618 2.212 . . . . 71.040000000000006 112.382 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.3 158.09 22.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.742 . . . . 54.340000000000003 112.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 t -142.9 164.36 30.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.881 0.372 . . . . 74.140000000000001 110.837 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 74.7 mtp -117.44 -175.9 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 110.884 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -133.04 141.96 48.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 74.010000000000005 110.887 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.79 177.31 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 75.420000000000002 110.865 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -151.0 138.72 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 72.129999999999995 110.949 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.7 t -99.36 -28.63 13.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 72.439999999999998 110.84 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -105.87 160.58 25.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.7 . . . . 71.430000000000007 111.088 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 80.75 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.719 2.279 . . . . 63.229999999999997 112.371 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.3 24.94 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.835 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -136.52 121.26 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.89 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -71.45 132.72 85.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 72.400000000000006 111.097 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.734 2.29 . . . . 71.329999999999998 112.307 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -50.96 157.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 74.219999999999999 110.875 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -73.6 155.35 39.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 64.120000000000005 110.892 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.89 176.88 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.178 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -130.48 137.19 49.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.869 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.3 pt -114.57 173.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 111.118 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -122.55 130.36 52.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.926 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -97.86 109.0 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 74.319999999999993 110.837 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -92.5 107.28 19.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 75.340000000000003 110.894 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -103.63 176.93 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 70.430000000000007 111.182 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.2 ttt -75.76 -8.08 55.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 73.099999999999994 110.831 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -38.28 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 74.150000000000006 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.44 176.4 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 65.340000000000003 110.977 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.0 t -105.15 121.92 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 72.010000000000005 111.129 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.03 150.39 45.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 73.409999999999997 111.162 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 153.97 67.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 73.0 112.299 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.2 103.74 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 74.200000000000003 111.09 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -75.58 137.44 40.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -126.33 116.47 21.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.064 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -94.42 149.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 75.430000000000007 111.164 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 p -49.13 112.78 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 53.420000000000002 110.927 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.83 7.56 33.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 51.299999999999997 112.465 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 m -96.08 -178.38 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.397 . . . . 73.340000000000003 110.883 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.16 147.82 42.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 111.198 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.23 -62.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 70.420000000000002 111.102 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.04 -33.65 57.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 72.549999999999997 110.886 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.67 -27.16 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 110.829 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.3 t -76.94 -43.3 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.200000000000003 111.118 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.73 -28.28 47.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.106 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -73.75 -27.91 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.87 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -52.19 12.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.868 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.21 -25.22 61.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 110.916 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -6.96 43.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.688 -0.768 . . . . 74.549999999999997 112.52 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.1 t -51.4 144.47 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 55.409999999999997 111.09 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.17 83.93 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.891 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.7 129.08 36.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.844 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -53.41 112.63 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 75.219999999999999 110.878 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.42 36.7 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 73.239999999999995 112.426 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.87 71.22 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.328 . . . . 55.299999999999997 111.072 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.8 m -55.91 -26.4 47.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.329999999999998 110.887 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -84.01 -176.19 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 71.510000000000005 110.937 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.01 -172.88 29.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 75.319999999999993 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -99.4 26.91 5.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.329999999999998 110.888 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.0 mt -149.69 115.6 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.439999999999998 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.18 129.39 31.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 64.329999999999998 111.127 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.7 p -55.43 120.8 7.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 110.877 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.1 p -65.86 -172.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 73.129999999999995 110.871 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -51.89 139.54 21.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 64.329999999999998 111.086 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.5 m -91.77 86.17 5.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 31.109999999999999 110.897 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -124.49 113.55 18.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.4 t -128.62 157.01 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 74.439999999999998 111.087 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mt -90.17 130.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 71.150000000000006 111.157 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.0 tp -125.07 164.7 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 72.319999999999993 110.901 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -39.12 137.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.891 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -60.89 -58.7 17.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.684 0.754 . . . . 74.019999999999996 110.922 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.72 -49.6 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.75 2.3 . . . . 64.209999999999994 112.284 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.4 tp -51.96 -51.9 53.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 75.329999999999998 111.002 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -63.58 -41.97 98.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.925 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -52.03 -62.0 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 72.140000000000001 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -63.9 -26.82 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -57.25 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.918 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.13 142.12 3.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.826 -0.702 . . . . 71.329999999999998 112.508 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -107.33 160.34 26.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.678 0.751 . . . . 65.310000000000002 110.862 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 172.16 13.06 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.249 . . . . 72.109999999999999 112.364 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -58.0 167.81 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.899 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -56.81 -39.74 74.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.819 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -52.33 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 73.140000000000001 110.869 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.04 -35.2 79.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.59 -53.63 55.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.863 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.56 -41.72 92.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.859 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.4 mp -56.45 -37.35 70.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.908 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.1 mt -74.61 -51.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 111.087 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.24 -23.13 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.834 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 -32.49 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.899 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.78 163.89 6.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 71.439999999999998 111.066 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.65 114.81 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 75.519999999999996 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.55 41.56 56.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.129999999999995 112.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.69 117.36 33.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 70.219999999999999 111.085 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 142.4 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 111.068 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.64 -24.95 41.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 75.129999999999995 112.488 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.0 p -73.91 -2.03 22.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 111.209 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 t -89.12 -12.45 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.867 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -94.06 154.51 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.340000000000003 110.785 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 tp -147.48 167.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 74.420000000000002 110.856 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.02 19.14 9.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.674 -0.774 . . . . 73.239999999999995 112.467 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.9 t 60.38 25.73 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 65.200000000000003 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.41 136.47 22.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -177.13 129.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 73.030000000000001 110.877 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.66 170.31 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -100.62 120.44 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.103 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.71 173.61 11.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.469 . . . . 74.049999999999997 110.874 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -59.66 -33.87 72.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 110.922 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.3 m -64.91 -19.32 65.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 70.340000000000003 110.855 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.74 5.69 38.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 73.439999999999998 110.907 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -59.58 124.31 19.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 110.862 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.53 20.29 12.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 54.210000000000001 110.848 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.59 149.23 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 74.299999999999997 111.074 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.51 119.86 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 75.049999999999997 111.165 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -110.61 94.81 5.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.815 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -88.26 126.37 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 111.116 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.9 t -96.45 133.25 25.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.136 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -41.64 4.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.686 2.257 . . . . 74.120000000000005 112.36 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -80.93 167.69 19.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.865 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.39 -170.59 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 63.43 111.116 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.8 p -87.48 177.75 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 111.174 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 175.27 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 75.349999999999994 110.908 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -68.72 103.89 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.853 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 2.6 ttp -76.05 175.29 9.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.889 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.2 103.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.082 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 33.8 m -65.99 -176.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.17 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.07 -43.22 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.030000000000001 110.913 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -157.78 35.7 0.54 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 73.430000000000007 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -158.13 119.61 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 74.310000000000002 110.851 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -147.07 73.34 12.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.55 0.69 . . . . 71.430000000000007 110.995 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 92.24 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.732 2.288 . . . . 73.120000000000005 112.299 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -123.21 137.7 28.73 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.574 0.702 . . . . 73.329999999999998 110.919 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 151.62 68.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 73.030000000000001 112.348 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.8 t60 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.837 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 CA-C-O 121.453 0.474 . . . . 71.299999999999997 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 179.13 3.93 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.686 2.258 . . . . 71.040000000000006 112.326 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.12 170.16 32.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 54.340000000000003 112.479 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.0 m -147.26 148.59 31.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 74.140000000000001 110.847 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.6 mtm -152.05 -175.64 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.887 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -169.88 162.13 9.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 110.873 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -129.97 109.07 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.420000000000002 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.89 164.16 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 72.129999999999995 110.922 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.2 t -52.59 131.48 34.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.843 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -159.05 71.57 3.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 71.430000000000007 111.103 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 -16.63 37.6 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 63.229999999999997 112.394 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -114.09 24.92 11.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.864 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 -158.04 134.28 9.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.209999999999994 110.9 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.9 mp -51.87 133.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.686 0.755 . . . . 72.400000000000006 111.148 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -170.05 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 71.329999999999998 112.256 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.5 157.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.89 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.29 151.52 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 64.120000000000005 110.889 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pp -130.35 176.81 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 111.099 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -120.33 133.91 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 pt -114.34 172.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.087 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.46 128.39 45.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.219999999999999 110.9 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -97.12 103.17 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.834 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.53 136.15 38.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 75.340000000000003 110.92 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -130.43 177.25 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 70.430000000000007 111.158 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 tpt -73.56 -8.76 57.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.898 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -104.98 -37.57 6.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -179.63 176.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 65.340000000000003 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.87 131.43 70.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.188 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.35 151.03 58.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 73.409999999999997 111.154 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.22 68.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.611 2.207 . . . . 73.0 112.304 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.0 139.49 29.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 111.03 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -100.68 128.9 46.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.67 116.37 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.137 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -97.33 139.16 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.430000000000007 111.149 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 p -51.7 111.1 0.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 53.420000000000002 110.881 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.43 13.81 34.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 51.299999999999997 112.493 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.6 p -101.63 -169.78 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 73.340000000000003 110.844 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.04 143.46 28.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 73.310000000000002 111.128 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.45 -59.41 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 111.127 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.38 -35.53 60.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 72.549999999999997 110.922 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.76 -27.5 62.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.530000000000001 110.912 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.6 t -76.56 -35.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 73.200000000000003 111.095 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.88 29.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 62.219999999999999 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -67.11 -32.61 73.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 75.200000000000003 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.05 -34.8 14.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.530000000000001 110.895 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -75.04 -24.4 58.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.951 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 -11.68 66.41 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 74.549999999999997 112.529 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.31 138.72 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 55.409999999999997 111.202 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.48 80.81 1.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.851 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -127.05 144.35 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.913 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -54.3 143.68 22.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.856 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.94 -42.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 73.239999999999995 112.499 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.05 122.62 47.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 55.299999999999997 111.121 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.8 t -54.62 -58.74 6.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 72.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.33 131.5 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 71.510000000000005 110.85 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.4 -135.82 2.54 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.715 -0.755 . . . . 75.319999999999993 112.472 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.69 -47.51 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 73.329999999999998 110.849 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.2 177.74 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 75.439999999999998 110.881 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.69 161.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 64.329999999999998 111.086 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.8 m -67.72 105.82 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.911 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -115.72 -26.7 7.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 73.129999999999995 110.834 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 m -82.5 73.09 9.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 64.329999999999998 111.176 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.5 m -131.15 -46.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 31.109999999999999 110.88 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -71.21 111.79 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.439999999999998 110.862 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 t -128.62 157.28 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 74.439999999999998 111.187 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 88.5 mt -90.37 130.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 71.150000000000006 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.8 tp -124.65 159.37 30.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 72.319999999999993 110.908 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.56 146.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.883 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 mt-10 -59.27 -59.94 12.21 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.631 0.729 . . . . 74.019999999999996 110.896 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.5 Cg_endo -69.79 -46.78 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.653 2.235 . . . . 64.209999999999994 112.346 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.38 -49.15 67.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 110.927 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -64.34 -51.01 65.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 74.450000000000003 110.916 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -25.53 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 72.140000000000001 110.809 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.31 -50.54 12.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.2 mt -62.91 -21.83 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 75.209999999999994 110.932 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.58 158.96 9.49 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 71.329999999999998 112.497 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.31 157.53 77.29 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.642 0.734 . . . . 65.310000000000002 110.877 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.03 32.34 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.725 2.284 . . . . 72.109999999999999 112.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 p -58.09 158.52 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -52.43 -36.06 53.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.409999999999997 110.926 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -52.33 -62.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.67 -35.79 79.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 110.922 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -56.14 -53.33 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.871 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.9 -42.97 89.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 110.878 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -55.2 -37.51 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.898 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.4 mt -74.53 -51.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 75.239999999999995 111.124 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.18 -18.59 58.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 110.869 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -76.14 -23.17 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.927 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.22 164.34 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 71.439999999999998 111.043 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -71.75 119.59 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.519999999999996 110.86 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.0 43.89 55.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.635 -0.793 . . . . 73.129999999999995 112.516 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.58 116.04 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 70.219999999999999 111.123 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.87 144.77 39.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 111.233 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.27 -23.88 35.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 75.129999999999995 112.459 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.9 p -73.96 -1.56 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 64.239999999999995 111.151 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.7 t -89.36 -12.83 39.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.91 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -112.07 144.21 41.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 73.340000000000003 110.864 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.47 164.05 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 74.420000000000002 110.989 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.06 -167.13 39.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 73.239999999999995 112.463 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.2 m -104.16 64.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 65.200000000000003 110.857 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -162.84 124.33 2.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 74.019999999999996 110.908 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.8 mp -156.13 150.9 26.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 73.030000000000001 110.924 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -146.0 129.94 17.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 110.9 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.6 t -64.84 117.62 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 72.239999999999995 111.13 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -136.83 178.36 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 74.049999999999997 110.911 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -37.16 76.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.93 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 t -65.54 -19.73 66.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 70.340000000000003 110.903 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -83.41 2.23 37.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 73.439999999999998 110.848 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -56.94 123.59 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 75.409999999999997 110.836 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 59.29 27.08 16.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 54.210000000000001 110.865 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.95 135.36 49.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 74.299999999999997 111.128 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 t -104.2 122.39 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 75.049999999999997 111.16 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -112.9 104.27 12.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.857 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -92.83 117.99 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.155 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.68 88.83 5.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.525 0.679 . . . . 72.129999999999995 111.13 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -36.24 10.96 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.698 2.265 . . . . 74.120000000000005 112.296 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -139.51 125.45 19.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 72.140000000000001 110.839 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -171.73 179.97 2.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 63.43 111.157 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.8 p -134.0 -174.17 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 74.450000000000003 111.091 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -105.81 154.83 19.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 75.349999999999994 110.888 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -97.8 -173.94 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.886 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.1 tpt -80.27 -44.63 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.510000000000005 110.91 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.71 111.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 62.43 111.066 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.9 p -165.56 151.63 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 74.319999999999993 111.093 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 61.64 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.439 . . . . 71.030000000000001 110.919 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.95 -107.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.509 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -151.92 134.05 15.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.927 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -140.42 159.28 63.97 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.708 . . . . 71.430000000000007 110.85 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 130' ' ' LYS . 53.0 Cg_endo -69.74 150.06 67.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.675 2.25 . . . . 73.120000000000005 112.318 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 129' ' ' PRO . 10.0 ptmt 37.51 67.86 1.81 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 73.329999999999998 110.911 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.71 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.673 2.249 . . . . 73.030000000000001 112.338 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.5 t60 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 110.803 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 121.408 0.449 . . . . 71.299999999999997 112.508 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 79.58 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.653 2.235 . . . . 71.040000000000006 112.393 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.9 -96.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 54.340000000000003 112.497 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -110.37 82.98 1.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.889 0.376 . . . . 74.140000000000001 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mmt -142.46 123.81 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.934 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -76.32 85.46 3.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 74.010000000000005 110.872 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.4 ptm -145.02 164.83 29.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 110.919 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -124.58 166.54 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 72.129999999999995 110.909 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -149.22 176.25 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.822 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.78 69.93 0.89 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.718 . . . . 71.430000000000007 111.161 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -171.12 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 63.229999999999997 112.3 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.23 25.2 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.887 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -136.4 -167.18 2.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mm 63.5 136.8 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.558 0.694 . . . . 72.400000000000006 111.143 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.78 2.52 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 71.329999999999998 112.362 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -52.07 157.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.878 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.75 143.7 45.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 64.120000000000005 110.956 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -128.75 176.8 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 64.439999999999998 111.094 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.81 136.26 52.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pt -116.98 157.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.118 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -119.98 126.5 50.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.926 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -105.0 102.9 12.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.927 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 117.78 26.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.95 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 p -105.33 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 70.430000000000007 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 29.8 mmt -75.72 -7.99 55.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.921 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtm -102.97 -38.39 7.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.150000000000006 110.889 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 178.28 176.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 65.340000000000003 110.925 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.3 t -79.1 147.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 111.058 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.93 87.84 9.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.64 0.734 . . . . 73.409999999999997 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 135.0 29.33 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 73.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.22 159.93 40.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 111.085 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -99.7 127.98 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 110.943 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.3 131.81 40.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.115 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.85 146.51 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.430000000000007 111.107 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.2 p -57.49 119.8 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 53.420000000000002 110.892 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.01 39.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 51.299999999999997 112.473 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.32 161.02 13.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.340000000000003 110.859 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.9 p -114.46 159.23 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.116 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.27 -58.4 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.54 -35.82 63.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 72.549999999999997 110.968 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.530000000000001 110.881 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -76.43 -44.05 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 73.200000000000003 111.167 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.13 -29.22 57.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.219999999999999 111.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -73.37 -26.6 61.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 75.200000000000003 110.869 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -69.73 -52.15 27.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.86 -25.1 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.863 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.07 -12.22 34.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 74.549999999999997 112.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.64 115.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 55.409999999999997 111.087 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.84 80.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.1 119.71 20.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 74.409999999999997 110.924 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.93 118.03 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.861 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.37 112.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.689 -0.767 . . . . 73.239999999999995 112.456 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 55.299999999999997 111.127 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.64 97.38 6.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 72.329999999999998 110.966 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -138.3 153.48 49.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 71.510000000000005 110.863 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.24 154.85 1.26 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 75.319999999999993 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -68.86 104.54 2.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 73.329999999999998 110.856 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp 52.88 56.52 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 75.439999999999998 110.935 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.21 31.4 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.329999999999998 111.12 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.8 p -121.34 77.72 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.939 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.01 34.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.866 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.9 p -116.26 34.99 4.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 64.329999999999998 111.139 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.81 69.94 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 31.109999999999999 110.931 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -152.06 109.75 3.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.805 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.1 t -128.62 157.02 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 74.439999999999998 111.144 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.12 131.23 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 71.150000000000006 111.127 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 tp -129.45 162.3 28.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.928 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -39.62 139.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.917 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -59.58 -59.05 15.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.696 0.76 . . . . 74.019999999999996 110.904 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.1 Cg_endo -69.78 -49.16 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.735 2.29 . . . . 64.209999999999994 112.319 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -52.09 -48.53 64.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 75.329999999999998 110.932 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -66.89 -42.71 85.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.93 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -51.88 -58.11 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 72.140000000000001 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -70.03 -28.73 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 tp -63.56 -61.23 2.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.944 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.32 143.59 4.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 71.329999999999998 112.482 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -134.67 157.27 77.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.574 0.702 . . . . 65.310000000000002 110.886 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.743 2.295 . . . . 72.109999999999999 112.32 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.4 m -58.17 171.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.59 -38.13 77.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -52.3 -62.43 1.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 73.140000000000001 110.89 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.53 -35.41 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.530000000000001 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.42 -53.04 62.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 110.904 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -66.07 -42.37 89.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 71.120000000000005 110.832 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.13 -36.91 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.959 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.8 mt -74.61 -54.85 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 75.239999999999995 111.113 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.95 -24.53 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 74.030000000000001 110.855 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.15 -25.62 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 110.908 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.59 151.07 29.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 71.439999999999998 111.084 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -67.37 128.71 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 110.805 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.46 54.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.489 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -119.66 117.16 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 70.219999999999999 111.056 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 143.9 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 111.196 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.62 -24.68 40.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.129999999999995 112.491 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.2 p -73.94 -1.73 21.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 64.239999999999995 111.188 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 23.2 t -89.79 -12.6 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.854 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -106.6 139.87 40.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 73.340000000000003 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 tp -158.87 164.89 35.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 110.878 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.94 -131.67 5.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 73.239999999999995 112.485 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m -122.62 -54.5 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 65.200000000000003 110.915 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -52.11 139.26 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 74.019999999999996 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.6 tp -176.64 140.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.030000000000001 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -141.94 154.07 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.848 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.7 124.97 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 72.239999999999995 111.131 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.67 168.15 20.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 74.049999999999997 110.88 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -57.22 -39.35 75.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.510000000000005 110.909 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 m -64.02 -20.46 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 70.340000000000003 110.895 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.75 7.67 29.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.851 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -59.14 125.19 22.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.839 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 60.0 22.19 11.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 54.210000000000001 110.897 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.38 136.63 57.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 111.061 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.0 t -98.76 117.08 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 75.049999999999997 111.134 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -109.39 94.82 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.926 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 34.2 m -89.42 130.92 35.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.172 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -104.44 133.29 20.27 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 72.129999999999995 111.086 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 -41.25 4.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 74.120000000000005 112.308 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.29 138.75 29.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.854 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.76 -51.66 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 63.43 111.063 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 p -51.94 126.57 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 74.450000000000003 111.158 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -52.88 -60.61 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 110.939 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.29 -173.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.329999999999998 110.86 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 3.5 ptm -51.79 115.4 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 74.510000000000005 110.952 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.91 167.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.092 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.1 134.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 74.319999999999993 111.172 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.36 44.22 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 71.030000000000001 110.832 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.98 144.28 16.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -53.94 105.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 74.310000000000002 110.851 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -115.21 72.97 3.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.588 0.709 . . . . 71.430000000000007 110.916 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -177.09 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.677 2.252 . . . . 73.120000000000005 112.312 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.52 71.28 13.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.598 0.713 . . . . 73.329999999999998 110.951 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.695 2.263 . . . . 73.030000000000001 112.363 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 110.927 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.406 0.448 . . . . 71.299999999999997 112.466 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 129.04 16.93 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.68 2.253 . . . . 71.040000000000006 112.407 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.07 -169.56 33.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 54.340000000000003 112.472 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -103.05 138.5 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.878 0.371 . . . . 74.140000000000001 110.887 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.0 ttm -175.07 134.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.58 -175.39 4.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 74.010000000000005 110.917 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.3 tpt -86.2 118.17 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.881 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -155.23 160.69 41.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 72.129999999999995 110.905 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -89.77 -174.06 4.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.808 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 160.46 66.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.541 0.686 . . . . 71.430000000000007 111.081 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -170.76 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 112.362 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.61 25.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.843 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -134.88 119.43 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.209999999999994 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.7 mp -94.53 133.14 27.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.675 0.75 . . . . 72.400000000000006 111.104 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -170.34 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.746 2.297 . . . . 71.329999999999998 112.358 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -51.46 156.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 74.219999999999999 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -73.84 156.45 37.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 64.120000000000005 110.9 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.03 176.97 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 111.132 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -118.1 135.83 53.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.836 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.36 171.83 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 111.142 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.19 126.72 52.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.895 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.93 103.18 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.856 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -85.66 106.67 17.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 110.887 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -101.9 178.61 4.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 70.430000000000007 111.168 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 ttm -75.7 -8.05 55.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -106.05 -38.62 6.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.933 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 178.34 176.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 65.340000000000003 110.846 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.45 123.11 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.010000000000005 111.068 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.85 150.54 45.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.169 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 153.22 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 73.0 112.349 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -143.51 135.56 26.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 111.131 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -97.64 118.68 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.911 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -111.64 116.52 30.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.105 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.16 148.05 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 75.430000000000007 111.11 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.8 p -51.32 110.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 53.420000000000002 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.48 14.42 30.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 51.299999999999997 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -97.64 -170.61 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 73.340000000000003 110.878 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.91 140.92 32.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 111.15 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.1 t -52.41 -59.51 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 111.081 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.4 mt -53.72 -35.57 61.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 72.549999999999997 110.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -72.7 -26.75 61.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 72.530000000000001 110.883 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.4 t -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 73.200000000000003 111.136 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.83 -29.71 20.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.072 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -70.23 -36.77 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 75.200000000000003 110.871 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -82.82 -34.9 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.879 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -72.35 -28.25 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.935 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.0 -12.25 34.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.743 . . . . 74.549999999999997 112.537 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.94 141.06 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 55.409999999999997 111.161 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -78.79 80.7 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.31 108.51 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.911 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -52.88 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.86 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.13 22.31 16.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 73.239999999999995 112.529 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.46 105.12 16.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 55.299999999999997 111.073 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -27.84 61.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 110.859 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -119.09 128.26 54.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 71.510000000000005 110.89 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.94 -73.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.757 -0.735 . . . . 75.319999999999993 112.482 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.79 31.76 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 73.329999999999998 110.802 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.44 33.02 21.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.439999999999998 110.911 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.98 128.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 64.329999999999998 111.055 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.91 75.81 5.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 74.540000000000006 110.865 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -102.38 27.14 7.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 73.129999999999995 110.865 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -110.62 -25.88 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 64.329999999999998 111.12 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.3 m -55.3 -29.75 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 31.109999999999999 110.849 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -68.81 100.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 65.439999999999998 110.841 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.7 t -128.63 159.04 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 74.439999999999998 111.15 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.9 mt -89.86 130.46 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 71.150000000000006 111.165 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLU . 16.8 tp -119.29 166.4 13.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 72.319999999999993 110.882 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HB2' ' CB ' ' A' ' 71' ' ' LEU . 5.9 mp0 -36.8 135.87 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 71.019999999999996 110.913 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tt0 -65.26 -56.73 18.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.595 0.712 . . . . 74.019999999999996 110.867 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.69 -51.82 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 64.209999999999994 112.387 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.459 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -51.93 -48.35 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.329999999999998 110.893 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -64.94 -53.57 44.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 110.918 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.6 -47.96 63.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.816 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.31 -36.62 83.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 75.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -62.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.85 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 160.35 20.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 71.329999999999998 112.429 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 157.55 77.44 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.658 0.742 . . . . 65.310000000000002 110.928 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 166.82 26.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 72.109999999999999 112.309 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 t -57.95 171.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.97 -37.48 79.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 72.409999999999997 110.898 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.35 -62.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.912 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.59 -35.54 79.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.34 -53.19 60.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.914 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.97 -42.79 89.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 71.120000000000005 110.858 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.48 -37.14 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 64.219999999999999 110.919 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mt -74.74 -52.68 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 75.239999999999995 111.152 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -59.3 -21.08 59.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.875 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -75.94 -23.27 55.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.924 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.48 164.18 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.439999999999998 111.144 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -74.4 118.99 17.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 75.519999999999996 110.847 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.66 43.73 53.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.678 -0.772 . . . . 73.129999999999995 112.52 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.98 143.5 34.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.083 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.85 145.72 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 111.125 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.97 -28.59 53.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 75.129999999999995 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.0 p -73.53 -3.31 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.333 . . . . 64.239999999999995 111.149 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 48.1 t -85.44 -13.77 48.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.857 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.74 143.26 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 73.340000000000003 110.87 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.23 142.38 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 74.420000000000002 110.96 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.76 158.14 3.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.788 -0.72 . . . . 73.239999999999995 112.467 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.6 t -55.62 -26.97 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 65.200000000000003 110.885 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.58 114.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 74.019999999999996 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mt -141.78 95.34 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 73.030000000000001 110.945 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.99 147.47 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.936 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 90.6 t -96.02 128.31 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 72.239999999999995 111.169 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -136.56 167.77 20.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 74.049999999999997 110.899 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -55.49 -42.01 73.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.904 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -18.97 58.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 70.340000000000003 110.863 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -93.34 17.14 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 73.439999999999998 110.813 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.68 126.97 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 75.409999999999997 110.977 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 m120 58.85 24.23 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 54.210000000000001 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -58.61 126.14 26.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 111.144 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.4 t -84.98 118.76 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 75.049999999999997 111.117 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -113.01 102.74 10.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.430000000000007 110.88 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.9 m -88.55 130.14 35.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 111.205 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.6 t -101.06 133.24 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 72.129999999999995 111.065 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.649 2.233 . . . . 74.120000000000005 112.328 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -70.35 103.71 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.89 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.58 -175.83 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 63.43 111.124 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p 49.96 40.28 20.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 111.182 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -146.48 -176.19 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 75.349999999999994 110.924 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.17 -170.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 73.329999999999998 110.863 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.6 ptm -59.87 -174.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 74.510000000000005 110.919 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 113.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.122 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.44 148.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 74.319999999999993 111.117 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.45 171.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.030000000000001 110.873 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.01 -113.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 73.430000000000007 112.479 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -163.36 103.22 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 74.310000000000002 110.855 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -174.75 73.63 0.31 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.522 0.677 . . . . 71.430000000000007 110.93 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 125.36 12.03 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.594 2.196 . . . . 73.120000000000005 112.335 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -167.94 73.08 0.91 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.54 0.686 . . . . 73.329999999999998 110.92 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 -21.77 32.83 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.692 2.261 . . . . 73.030000000000001 112.302 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 110.837 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.77 0.319 . . . . 74.209999999999994 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.463 HD13 ' N ' ' A' ' 36' ' ' GLY . 3.4 mt -90.96 132.95 33.04 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.178 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -169.84 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.718 2.279 . . . . 71.329999999999998 112.375 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.26 157.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 160.12 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 43.299999999999997 110.934 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.7 pp -141.9 176.74 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.439999999999998 111.115 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -117.1 135.55 53.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 75.340000000000003 110.831 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.2 pt -116.92 173.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.147 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -128.53 132.73 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.2 m-85 -102.94 104.84 15.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.819 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.4 129.39 44.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.937 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 p -122.15 -177.71 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.510000000000005 111.141 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.3 mmt -75.76 -17.37 59.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 110.895 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -96.33 -37.89 10.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 61.119999999999997 110.858 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 179.71 176.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 54.409999999999997 110.884 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 131.44 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 111.16 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.552 HG21 HG22 ' A' ' 48' ' ' VAL . 1.8 m -121.62 150.89 56.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.546 0.689 . . . . 73.409999999999997 111.126 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 153.02 69.78 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.655 2.237 . . . . 73.0 112.325 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.14 140.48 28.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 53.340000000000003 111.119 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -104.88 126.87 52.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.43 110.894 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -107.18 116.34 31.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 111.081 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.04 142.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 111.173 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 p -54.19 120.25 6.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 106.54 -4.55 37.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.817 -0.706 . . . . 33.130000000000003 112.481 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.76 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 110.897 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.2 p -138.04 155.06 49.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.183 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.57 -59.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 70.420000000000002 111.15 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -35.45 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.896 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -72.66 -26.6 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.450000000000003 110.904 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 38' ' ' THR . 95.4 t -76.18 -47.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 111.081 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.79 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 62.219999999999999 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -69.89 -36.72 75.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.864 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -76.35 -42.66 44.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.845 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -72.27 -27.08 62.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.87 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.14 -12.07 34.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 71.540000000000006 112.457 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 29' ' ' VAL . 22.6 t -57.86 127.55 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 41.020000000000003 111.151 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -81.04 80.83 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.847 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.707 HD22 HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 110.834 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.832 0.349 . . . . 25.530000000000001 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -150.08 112.83 4.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.86 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.3 t -128.6 158.03 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.151 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 83.6 mt -89.99 131.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 111.143 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 112' ' ' VAL . 17.4 tp -123.02 160.88 25.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 64.040000000000006 110.918 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.77 143.96 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 71.019999999999996 110.916 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.1 mt-10 -57.4 -59.14 13.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.76 -46.73 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 54.219999999999999 112.306 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 6.8 tp -51.67 -45.69 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.924 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 95' ' ' THR . 49.0 t80 -72.28 -41.01 67.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 74.450000000000003 110.908 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -53.85 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 65.439999999999998 110.898 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -33.23 67.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 75' ' ' LEU . 10.8 mt -62.87 -25.0 68.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.843 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.87 142.5 4.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 71.329999999999998 112.507 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -110.71 156.84 39.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 65.310000000000002 110.854 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.81 13.76 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 62.009999999999998 112.362 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -99.29 -170.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -56.61 -47.77 78.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -53.74 -59.74 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 63.240000000000002 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 86' ' ' ILE . 16.3 mm-40 -61.2 -28.58 69.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 71.530000000000001 110.858 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -55.64 27.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.893 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.41 -37.37 82.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 110.844 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.32 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.94 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.571 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.5 mt -74.97 -34.38 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 111.116 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -58.99 -21.43 58.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 110.858 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -75.95 -25.67 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.883 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -74.71 163.97 27.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.065 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -84.2 113.63 21.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.89 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.82 52.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.535 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -95.14 129.41 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.42 146.36 27.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 111.083 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.571 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.4 -23.46 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 75.129999999999995 112.487 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.638 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.5 p -73.82 -1.84 21.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.16 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 9.4 t -88.9 -12.8 40.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 71.409999999999997 110.884 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -117.39 132.62 56.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 70.200000000000003 110.816 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.27 179.88 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.944 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.77 -155.67 15.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 71.010000000000005 112.491 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -140.44 53.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 61.43 110.856 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.1 pt20 -179.07 98.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 64.439999999999998 110.912 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 101' ' ' GLN . 10.6 mp -130.25 160.73 33.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.25 110.906 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -115.9 170.26 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.209999999999994 110.825 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 90.5 t -97.76 118.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 111.129 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -137.05 177.1 8.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 72.040000000000006 110.906 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -60.63 -31.5 70.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -65.04 -19.54 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.510000000000005 110.92 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.603 ' HZ ' HD23 ' A' ' 102' ' ' LEU . 3.1 m-85 -85.7 4.41 36.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 71.209999999999994 110.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -57.03 123.39 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 59.55 26.03 14.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.879 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -68.51 136.72 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 33.329999999999998 111.116 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.5 t -109.74 123.03 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.010000000000005 111.15 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.47 103.9 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.897 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 23' ' ' LYS . 49.9 m -93.79 118.72 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 73.439999999999998 111.168 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG21 HD22 ' A' ' 50' ' ' LEU . 23.1 t -108.57 89.29 5.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.719 . . . . 72.129999999999995 111.133 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -39.06 6.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.615 2.21 . . . . 65.439999999999998 112.343 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 110.848 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' ' 103' ' ' ARG . 41.0 mm -60.2 133.04 90.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.111 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.4 Cg_endo -69.72 -170.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 71.329999999999998 112.38 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.8 156.82 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.871 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.81 159.56 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 43.299999999999997 110.919 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.523 HD13 ' C ' ' A' ' 108' ' ' PHE . 1.1 pt -141.83 176.76 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 64.439999999999998 111.102 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.76 129.19 47.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.855 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.623 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -114.59 172.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.167 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.9 131.5 52.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.912 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.745 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -99.63 103.07 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 71.329999999999998 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -94.24 135.34 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.340000000000003 110.865 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -133.39 177.69 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 65.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.9 tpt -75.36 -8.33 56.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.884 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -104.18 -37.91 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 179.21 176.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 54.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.9 124.69 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.010000000000005 111.132 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -119.84 151.01 51.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.714 . . . . 73.409999999999997 111.17 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 156.03 64.26 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 73.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.623 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -150.93 104.29 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.077 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -79.34 132.04 36.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.91 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.552 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -121.35 116.53 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.133 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 150.8 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.05 116.26 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.861 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 2.01 37.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.733 . . . . 33.130000000000003 112.487 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -99.17 -176.15 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 73.200000000000003 110.818 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -138.93 146.01 40.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 111.147 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.48 -62.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 111.111 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 ' CD1' HD12 ' A' ' 50' ' ' LEU . 4.3 mm? -53.81 -33.54 56.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 65.400000000000006 110.946 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -72.68 -27.27 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.883 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 38' ' ' THR . 94.4 t -76.87 -45.44 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 61.210000000000001 111.119 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.51 -29.93 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.121 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -71.4 -37.99 71.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.894 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -44.24 63.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.08 -25.2 61.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.2 -12.26 44.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 71.540000000000006 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 29' ' ' VAL . 35.8 t -53.36 129.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 41.020000000000003 111.119 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -77.3 80.67 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.209999999999994 110.915 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.631 HD12 ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.176 -0.466 . . . . 70.430000000000007 110.926 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.94 0.4 . . . . 25.530000000000001 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -135.94 77.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 65.439999999999998 110.851 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.0 t -128.73 157.64 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.135 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 85.4 mt -90.02 131.24 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 111.151 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 112' ' ' VAL . 22.2 tp -127.0 160.65 30.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 64.040000000000006 110.927 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -45.79 143.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -58.11 -60.23 10.76 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.64 0.733 . . . . 73.040000000000006 110.908 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.78 -48.32 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.699 2.266 . . . . 54.219999999999999 112.348 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.578 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.81 -45.26 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 73.209999999999994 110.929 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 89.6 t80 -70.79 -49.61 44.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.904 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -54.09 -41.62 68.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -71.36 -46.27 60.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.578 HD23 HD13 ' A' ' 71' ' ' LEU . 2.4 mm? -63.35 -24.43 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.06 130.98 2.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.733 . . . . 71.329999999999998 112.505 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -115.78 157.66 44.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 65.310000000000002 110.871 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.3 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.699 2.266 . . . . 62.009999999999998 112.356 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -104.12 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.885 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -57.87 -44.12 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.877 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -53.58 -59.71 4.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 63.240000000000002 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' OE2' HD23 ' A' ' 98' ' ' LEU . 25.9 tt0 -62.73 -28.21 69.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.530000000000001 110.86 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -52.88 62.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.898 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.02 -39.2 75.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 71.120000000000005 110.891 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.2 -50.81 70.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.219999999999999 110.931 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.2 mt -74.96 -34.3 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 63.409999999999997 111.161 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.76 -20.0 53.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 110.898 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.84 -26.0 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.897 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.95 145.01 36.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.107 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -65.92 121.81 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.18 45.17 57.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.504 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -111.37 125.37 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 70.219999999999999 111.075 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.06 147.66 38.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.119 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.49 -23.4 35.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 75.129999999999995 112.519 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 25.2 p -73.93 -1.81 21.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 64.239999999999995 111.15 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.1 t -88.95 -13.49 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 71.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -141.39 167.85 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 70.200000000000003 110.839 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.404 HD23 ' OE2' ' A' ' 82' ' ' GLU . 4.2 mm? 57.38 44.9 20.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 73.450000000000003 110.899 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.54 111.75 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 71.010000000000005 112.47 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.0 t -163.02 156.85 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 61.43 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.671 ' O ' HD23 ' A' ' 102' ' ' LEU . 1.2 tp-100 -170.05 -179.53 3.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.439999999999998 110.913 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.717 ' C ' HG22 ' A' ' 38' ' ' THR . 7.2 mt -139.5 -61.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 65.25 110.931 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HD2' HD11 ' A' ' 14' ' ' ILE . 1.5 mtm180 -59.65 158.7 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.867 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.552 HG21 ' HB1' ' A' ' 33' ' ' ALA . 94.4 t -109.16 134.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 111.099 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.57 170.06 16.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.891 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -59.22 -34.16 71.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.903 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.495 ' O ' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -64.25 -20.2 65.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.510000000000005 110.878 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.1 m-85 -87.38 6.59 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.834 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.32 124.48 19.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.219999999999999 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.95 24.32 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 53.450000000000003 110.915 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.1 126.76 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 33.329999999999998 111.139 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HD12 ' A' ' 67' ' ' LEU . 41.1 t -99.91 121.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.161 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -111.98 103.17 11.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.885 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.7 m -96.08 119.41 34.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 111.124 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 50' ' ' LEU . 19.1 t -108.65 89.11 5.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -34.23 14.99 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 65.439999999999998 112.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.833 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.761 0.315 . . . . 74.209999999999994 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.9 mt -115.17 133.22 22.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 72.400000000000006 111.122 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.6 Cg_endo -69.81 178.85 4.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.723 2.282 . . . . 71.329999999999998 112.288 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.83 157.51 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 73.310000000000002 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -73.45 145.59 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 43.299999999999997 110.922 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 108' ' ' PHE . 2.0 pp -118.18 171.2 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 130.11 56.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.8 pt -117.17 173.74 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 111.157 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.6 131.78 49.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 75.219999999999999 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -103.22 102.95 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.329999999999998 110.915 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HD3' HG23 ' A' ' 114' ' ' THR . 4.5 tttp -94.82 140.02 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.898 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -140.48 175.79 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.418 . . . . 65.510000000000005 111.188 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.9 ttm -75.65 -11.67 60.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.877 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.25 -37.78 9.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 61.119999999999997 110.91 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 179.86 176.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 54.409999999999997 110.936 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 ' CG ' ' A' ' 23' ' ' LYS . 15.4 t -119.16 121.68 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 111.107 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -121.7 150.31 55.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 111.163 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 166.72 26.66 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.765 2.31 . . . . 73.0 112.343 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -154.86 145.06 21.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 53.340000000000003 111.078 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -111.78 121.95 46.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 53.43 110.9 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -95.11 116.63 28.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.38 153.8 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 111.097 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -62.94 121.61 13.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.506 . . . . 52.539999999999999 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 86.38 0.64 86.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 33.130000000000003 112.473 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.93 -169.81 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 73.200000000000003 110.847 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -142.23 154.46 44.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.19 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.8 -59.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 70.420000000000002 111.103 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.32 -34.26 60.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 65.400000000000006 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.68 -26.86 61.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 110.91 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' THR . 97.7 t -76.5 -45.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.105 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.77 -33.34 34.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 62.219999999999999 111.101 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -66.96 -35.14 79.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 110.893 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -66.88 -49.37 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.895 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -72.01 -24.56 61.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.94 -12.05 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 71.540000000000006 112.484 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 29' ' ' VAL . 25.5 t -55.86 129.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 41.020000000000003 111.136 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -86.23 80.85 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 70.430000000000007 110.898 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.892 0.377 . . . . 25.530000000000001 110.9 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -164.53 109.43 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 65.439999999999998 110.847 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 115' ' ' VAL . 11.9 t -128.48 155.0 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 72.25 111.119 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.4 mt -90.76 129.44 41.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 64.430000000000007 111.139 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 112' ' ' VAL . 21.6 tp -124.5 161.8 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 64.040000000000006 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.95 143.7 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 71.019999999999996 110.846 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -58.31 -59.52 13.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.702 . . . . 73.040000000000006 110.808 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -47.92 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.661 2.241 . . . . 54.219999999999999 112.303 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -53.0 -42.59 65.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.915 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.658 ' CD1' HG22 ' A' ' 95' ' ' THR . 58.4 t80 -71.85 -54.11 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.34 -34.81 58.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 65.439999999999998 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -78.03 -41.8 34.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.8 mm? -63.15 -25.76 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.992 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.36 140.08 5.33 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 71.329999999999998 112.508 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.74 160.3 28.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.66 0.743 . . . . 65.310000000000002 110.9 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 166.62 27.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.661 2.241 . . . . 62.009999999999998 112.326 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.0 t -58.09 171.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.817 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -59.96 -37.32 79.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.858 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -62.57 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 110.92 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -67.54 -35.63 79.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.837 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.27 -53.49 56.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.897 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.73 -42.58 90.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.936 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.52 -37.44 67.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.857 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.606 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.0 mt -74.52 -52.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 63.409999999999997 111.172 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.68 -21.59 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.819 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -76.18 -24.16 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 110.908 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -74.15 164.28 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 111.132 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -74.47 113.69 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.907 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.22 40.56 52.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.506 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -107.58 114.87 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 70.219999999999999 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.67 142.82 27.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.178 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.36 -23.68 34.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.812 -0.709 . . . . 75.129999999999995 112.471 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.658 HG22 ' CD1' ' A' ' 72' ' ' TYR . 17.8 p -74.22 -0.93 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 64.239999999999995 111.105 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 45.3 t -90.63 -12.21 37.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.837 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.98 133.67 55.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.888 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 pp -179.06 -178.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.26 -133.12 4.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 71.010000000000005 112.501 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -144.78 -42.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 61.43 110.936 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.728 ' O ' HD22 ' A' ' 102' ' ' LEU . 44.9 mt-30 -60.33 101.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.913 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 101' ' ' GLN . 4.0 mm? -134.99 127.08 29.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.25 110.948 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -84.41 168.95 15.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 70.209999999999994 110.86 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 57.5 t -102.45 119.24 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.239999999999995 111.111 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.05 172.98 12.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.866 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -29.7 68.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.834 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.8 m -65.65 -22.65 66.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.510000000000005 110.86 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 102' ' ' LEU . 3.1 m-85 -81.77 -0.15 41.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.857 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.65 123.77 16.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 62.219999999999999 110.92 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.75 27.18 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 53.450000000000003 110.915 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -68.19 151.07 47.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 33.329999999999998 111.024 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.2 t -116.28 120.99 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.010000000000005 111.146 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -114.19 98.96 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.908 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.573 HG23 ' HD3' ' A' ' 23' ' ' LYS . 43.3 m -91.41 116.65 29.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.133 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.551 HG21 ' CD2' ' A' ' 50' ' ' LEU . 22.0 t -108.64 89.19 5.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.597 0.713 . . . . 72.129999999999995 111.132 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -35.53 12.65 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.726 2.284 . . . . 65.439999999999998 112.354 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.794 0.33 . . . . 74.209999999999994 110.877 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 64.72 148.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 72.400000000000006 111.139 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.27 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.385 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.66 157.41 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 73.310000000000002 110.875 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.21 133.25 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 43.299999999999997 110.872 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.757 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.6 pp -124.12 176.96 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 64.439999999999998 111.098 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -113.79 140.9 47.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.861 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.69 175.09 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.15 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -133.03 126.77 32.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.625 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 26.6 m-85 -108.77 103.16 12.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 110.882 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -88.69 132.15 34.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.9 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -115.32 176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 65.510000000000005 111.136 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.0 tpt -75.64 -8.29 56.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 73.099999999999994 110.918 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -103.44 -37.95 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.826 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 179.39 176.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 54.409999999999997 110.966 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 23' ' ' LYS . 23.1 t -79.62 147.63 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 111.148 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.752 ' CG1' HG22 ' A' ' 48' ' ' VAL . 67.6 t -141.38 87.79 10.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 73.409999999999997 111.169 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 152.59 69.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.612 2.208 . . . . 73.0 112.396 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.63 144.28 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.428 . . . . 53.340000000000003 111.079 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.88 147.87 29.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 53.43 110.857 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.681 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -116.75 143.58 45.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 111.078 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.45 151.4 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.200000000000003 111.117 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 p -53.38 116.29 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 52.539999999999999 110.841 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' H ' HD13 ' A' ' 14' ' ' ILE . . . 74.15 25.31 71.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 33.130000000000003 112.483 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.7 p -77.83 -169.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.839 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.734 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -136.87 143.1 42.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.149 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 96.2 t -53.11 -63.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 70.420000000000002 111.116 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.85 -32.84 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 65.400000000000006 110.927 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.72 -27.52 62.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 72.450000000000003 110.815 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 38' ' ' THR . 76.1 t -77.22 -44.93 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.121 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.16 -28.33 52.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 111.121 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.55 -26.39 61.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.78 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.31 -53.78 6.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.872 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 3.42 37.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 15.82 59.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 71.540000000000006 112.459 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.752 HG22 ' CG1' ' A' ' 29' ' ' VAL . 82.0 t -52.26 127.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 41.020000000000003 111.135 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.37 80.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.86 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.430000000000007 110.938 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HB3' HD13 ' A' ' 98' ' ' LEU . 7.7 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.91 0.386 . . . . 25.530000000000001 110.894 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.43 94.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.2 t -128.67 156.41 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.25 111.111 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.1 mt -89.98 131.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 111.15 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 112' ' ' VAL . 37.6 tp -127.77 159.74 33.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.937 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.54 141.23 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 110.891 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.1 mt-10 -57.48 -59.52 12.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 73.040000000000006 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.79 -48.63 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.601 2.201 . . . . 54.219999999999999 112.38 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -51.83 -41.17 61.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 110.965 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 95' ' ' THR . 93.2 t80 -73.37 -51.38 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.834 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -34.32 63.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -78.29 -44.65 24.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.7 mm? -63.23 -21.35 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.851 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.12 131.74 2.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.813 -0.708 . . . . 71.329999999999998 112.47 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -112.6 157.31 40.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 110.885 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -177.98 2.15 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.637 2.225 . . . . 62.009999999999998 112.332 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.1 m -101.09 -176.23 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 75.409999999999997 110.872 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -55.71 -44.03 77.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 72.409999999999997 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -53.93 -59.56 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 63.240000000000002 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -30.78 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 71.530000000000001 110.92 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -56.09 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.936 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.57 -39.44 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.36 -52.32 63.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.536 HD11 ' CD ' ' A' ' 97' ' ' ARG . 63.5 mt -74.61 -34.42 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 63.409999999999997 111.149 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.54 -17.86 56.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.877 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -75.77 -26.06 57.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -69.29 164.03 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 111.065 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -82.87 113.66 20.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.94 41.15 51.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.129999999999995 112.478 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -105.66 126.48 52.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 70.219999999999999 111.069 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 148.34 24.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.059 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.63 -25.6 43.56 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 75.129999999999995 112.526 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.77 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -74.06 -1.38 19.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 64.239999999999995 111.192 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.7 t -90.61 -11.87 38.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.838 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' CD ' HD11 ' A' ' 86' ' ' ILE . 20.6 ttt-85 -91.96 168.88 11.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.846 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 63' ' ' CYS . 23.3 tp -49.56 146.71 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.450000000000003 110.943 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 98' ' ' LEU . . . 177.89 33.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 71.010000000000005 112.519 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.5 p -110.98 138.81 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 61.43 110.818 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -114.43 7.86 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 64.439999999999998 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 51.91 55.64 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -152.39 126.53 9.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.91 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.681 HG11 ' HB1' ' A' ' 33' ' ' ALA . 47.3 t -97.39 120.07 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 72.239999999999995 111.085 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -176.78 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 72.040000000000006 110.878 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -56.9 -36.0 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.510000000000005 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 m -64.85 -24.05 67.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.804 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.2 0.72 39.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 71.209999999999994 110.915 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 18' ' ' ILE . 38.4 tt0 -55.01 119.2 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 62.219999999999999 110.86 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.61 22.01 12.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 71' ' ' LEU . . . -56.58 145.11 29.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 33.329999999999998 111.116 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.696 ' O ' HD12 ' A' ' 67' ' ' LEU . 18.4 t -116.27 115.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 73.010000000000005 111.15 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -111.08 98.15 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 31.0 m -87.47 119.22 27.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 111.128 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.455 ' HA ' HG13 ' A' ' 65' ' ' VAL . 21.0 t -108.73 88.25 5.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.058 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -42.65 3.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 65.439999999999998 112.4 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.852 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' O ' HD13 ' A' ' 14' ' ' ILE . 93.2 mtt180 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.745 0.307 . . . . 74.209999999999994 110.836 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.636 HD11 ' NH1' ' A' ' 103' ' ' ARG . 42.4 mm -137.96 133.11 17.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.661 0.743 . . . . 72.400000000000006 111.087 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.6 Cg_endo -69.72 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.219 . . . . 71.329999999999998 112.378 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.91 156.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 73.310000000000002 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -73.89 158.14 35.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.911 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.2 177.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -124.61 132.21 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.921 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.7 pt -114.36 169.51 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.129 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.88 129.0 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.901 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -99.49 103.38 15.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 71.329999999999998 110.866 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' CA ' HG23 ' A' ' 28' ' ' VAL . 5.5 ttmt -95.44 143.52 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.839 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 p -138.09 179.58 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 65.510000000000005 111.137 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -8.15 55.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.099999999999994 110.905 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -107.15 -38.03 6.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.436 . . . . 61.119999999999997 110.853 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 179.36 176.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 54.409999999999997 110.925 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG23 ' CA ' ' A' ' 23' ' ' LYS . 10.5 p -118.04 134.86 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.010000000000005 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG21 HG22 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -125.92 150.73 69.9 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.565 0.697 . . . . 73.409999999999997 111.179 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 153.21 68.96 Favored 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.642 2.228 . . . . 73.0 112.292 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -149.55 105.74 3.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.079 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -70.13 125.16 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 53.43 110.911 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.066 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -99.91 123.2 43.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.113 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.21 147.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 75.200000000000003 111.19 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.8 p -52.89 114.76 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 19.79 52.57 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.815 -0.707 . . . . 33.130000000000003 112.465 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 p -93.18 -175.63 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.785 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 4.2 m -143.66 152.0 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 73.140000000000001 111.12 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.924 HG23 HD12 ' A' ' 40' ' ' LEU . 14.3 m -57.99 -45.79 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.153 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.924 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -63.87 -37.63 88.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 65.400000000000006 110.925 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.7 -27.99 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.874 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 72.1 t -77.39 -36.77 24.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 61.210000000000001 111.118 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.09 55.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.027 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -73.7 -27.69 61.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -51.76 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.530000000000001 110.855 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' HG12 ' A' ' 42' ' ' VAL . 5.6 p30 -71.89 -25.73 62.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.41 52.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.655 -0.783 . . . . 71.540000000000006 112.495 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 29' ' ' VAL . 86.9 t -51.5 135.15 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.775 0.321 . . . . 41.020000000000003 111.154 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.88 82.78 6.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.883 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.824 HD11 HG11 ' A' ' 115' ' ' VAL . 11.7 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.430000000000007 110.931 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.9 m . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.832 0.348 . . . . 25.530000000000001 110.822 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -102.38 96.76 7.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 65.439999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.7 t -128.69 157.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.25 111.129 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 89.9 mt -90.51 129.68 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 64.430000000000007 111.166 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.6 tp -125.33 163.02 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 64.040000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.81 147.2 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.877 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -61.33 -59.71 12.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.605 0.716 . . . . 73.040000000000006 110.9 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.76 -42.44 3.4 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.638 2.225 . . . . 54.219999999999999 112.349 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -58.3 -44.52 88.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 110.929 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 95' ' ' THR . 63.2 t80 -70.88 -52.34 20.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.883 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -36.45 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.439999999999998 110.862 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -73.86 -44.32 55.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 75.0 110.927 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.25 -52.66 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 75.209999999999994 110.89 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.42 142.96 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 71.329999999999998 112.524 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.83 157.56 42.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.659 0.743 . . . . 65.310000000000002 110.874 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 173.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.64 2.227 . . . . 62.009999999999998 112.323 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -102.49 -169.84 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.409999999999997 110.855 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.71 -46.81 81.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.843 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.99 -59.55 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.09 -27.75 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.862 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -53.75 48.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.918 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -69.74 -37.14 76.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 71.120000000000005 110.871 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 mt -62.49 -48.47 79.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' HA2' ' A' ' 94' ' ' GLY . 56.6 mt -73.91 -35.41 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 63.409999999999997 111.087 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.97 -20.68 64.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 74.030000000000001 110.904 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.15 -25.78 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.914 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.47 146.09 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.129999999999995 111.069 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.2 121.63 18.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.847 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 44.63 60.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.581 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -103.29 129.38 50.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 70.219999999999999 111.143 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 144.5 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.095 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.602 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.44 -22.74 32.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 75.129999999999995 112.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.619 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.7 p -73.89 -2.25 23.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.086 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.9 t -88.43 -13.35 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 110.786 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD3' HD11 ' A' ' 86' ' ' ILE . 13.6 mtp85 -123.33 167.45 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 70.200000000000003 110.908 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 58.71 46.64 14.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.854 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.34 40.71 2.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 71.010000000000005 112.462 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 2.9 t -92.02 66.98 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 61.43 110.855 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.13 138.29 46.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.54 35.37 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.25 110.896 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.636 ' NH1' HD11 ' A' ' 14' ' ' ILE . 17.2 mmt180 -132.96 135.95 45.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 70.209999999999994 110.907 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.066 HG11 ' HB1' ' A' ' 33' ' ' ALA . 26.3 t -109.61 119.58 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.117 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -136.46 178.73 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 72.040000000000006 110.891 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -58.31 -37.21 74.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 110.948 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -63.64 -19.44 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.510000000000005 110.862 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -89.62 9.92 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 71.209999999999994 110.851 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.87 125.76 24.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.219999999999999 110.889 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 60.52 21.9 11.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 53.450000000000003 110.872 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -59.71 136.33 57.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 33.329999999999998 111.088 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 67' ' ' LEU . 45.8 t -104.44 119.42 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.1 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.2 98.44 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.430000000000007 110.895 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 65' ' ' VAL . 46.4 m -93.8 119.82 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 111.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.824 HG11 HD11 ' A' ' 50' ' ' LEU . 20.2 t -108.87 88.57 5.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.165 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -36.26 11.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.274 . . . . 65.439999999999998 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.873 -179.886 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.807 0.336 . . . . 74.209999999999994 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 36' ' ' GLY . 59.0 mt -98.53 132.99 23.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 72.400000000000006 111.177 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.77 -174.4 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.334 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -53.05 156.67 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 155.0 39.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 43.299999999999997 110.84 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 pt -132.85 176.82 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 111.103 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -122.8 138.63 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.3 pt -120.82 172.56 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 75.129999999999995 111.126 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -127.53 133.28 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.887 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.748 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.1 m-85 -104.52 106.03 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.819 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -97.25 144.26 27.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.975 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -139.1 178.72 6.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.113 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -8.1 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.88 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -106.31 -37.66 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 61.119999999999997 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 179.82 175.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 110.949 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.77 127.67 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.010000000000005 111.155 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HG22 ' A' ' 48' ' ' VAL . 1.4 m -117.91 150.84 47.96 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.107 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 156.17 63.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 73.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.97 138.2 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.089 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -100.54 130.67 46.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 53.43 110.902 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.89 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -110.73 117.04 32.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 111.115 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.4 t -104.61 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.200000000000003 111.122 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -51.74 116.2 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.849 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.539 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 100.92 7.38 50.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 33.130000000000003 112.486 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -100.95 -169.97 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.995 0.426 . . . . 73.200000000000003 110.852 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.733 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -144.58 142.65 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 73.140000000000001 111.153 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 83.4 t -52.45 -63.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 70.420000000000002 111.1 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.49 -33.16 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.895 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.73 -27.4 62.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.845 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 38' ' ' THR . 92.2 t -76.82 -43.06 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 61.210000000000001 111.151 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.06 -30.13 14.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -73.62 -37.8 65.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 110.855 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -40.22 50.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 74.530000000000001 110.848 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.11 -21.78 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 74.420000000000002 110.87 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.0 -12.26 55.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 71.540000000000006 112.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 29' ' ' VAL . 46.7 t -57.8 113.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.337 . . . . 41.020000000000003 111.135 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.47 80.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.929 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 115' ' ' VAL . 11.3 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 25.530000000000001 110.857 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -100.8 118.35 36.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 65.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.23 155.53 39.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 72.25 111.17 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.589 HD12 ' HD3' ' A' ' 116' ' ' PRO . 5.1 mp -90.38 132.98 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 64.430000000000007 111.195 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.7 tp -127.37 159.31 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.040000000000006 110.929 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.15 146.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.915 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -59.38 -60.25 11.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 73.040000000000006 110.914 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.86 -46.22 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.28 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -54.13 -48.32 70.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.909 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.582 ' CD1' HG22 ' A' ' 95' ' ' THR . 42.1 t80 -68.23 -47.43 67.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.450000000000003 110.881 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -55.62 -43.7 76.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.917 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.16 -26.95 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.0 tp -72.83 -62.56 1.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.937 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.17 3.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 71.329999999999998 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -132.34 157.31 78.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.683 0.754 . . . . 65.310000000000002 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 166.28 28.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 62.009999999999998 112.318 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.19 170.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.874 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -58.78 -37.19 75.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.879 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -52.51 -62.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.7 -35.11 78.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 71.530000000000001 110.845 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -56.89 -53.34 59.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.945 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.95 -42.16 90.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.838 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tp -55.8 -37.55 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 110.954 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.3 mt -74.57 -52.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.13 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -59.04 -21.67 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.854 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -76.04 -24.99 55.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.933 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -76.05 162.96 27.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.053 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -70.23 117.34 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.07 42.84 55.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 73.129999999999995 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -113.61 121.86 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.086 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.7 144.1 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.135 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.59 -23.47 36.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.488 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.582 HG22 ' CD1' ' A' ' 72' ' ' TYR . 22.6 p -73.92 -2.24 23.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 64.239999999999995 111.136 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 36.6 t -90.24 -13.97 34.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.841 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.55 158.31 34.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 70.200000000000003 110.854 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 56.45 67.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 110.954 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.21 61.68 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 71.010000000000005 112.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.1 t -133.96 -74.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 61.43 110.91 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.27 93.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 110.844 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 38' ' ' THR . 15.6 mt -146.18 165.52 28.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.858 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -112.03 170.61 8.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 70.209999999999994 110.868 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.89 HG11 ' HB1' ' A' ' 33' ' ' ALA . 24.3 t -94.42 115.3 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.127 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.93 176.01 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 72.040000000000006 110.794 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -57.2 -36.25 70.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.510000000000005 110.873 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -22.35 66.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 110.885 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.428 ' CE2' HD22 ' A' ' 75' ' ' LEU . 3.7 m-85 -85.76 5.27 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.922 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.456 ' N ' HD13 ' A' ' 18' ' ' ILE . 85.5 tt0 -58.8 123.0 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 62.219999999999999 110.898 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.37 22.58 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 53.450000000000003 110.939 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 133.64 52.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 33.329999999999998 111.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.625 ' O ' HD12 ' A' ' 67' ' ' LEU . 36.7 t -106.17 118.86 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.128 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 42.5 m-85 -109.4 102.97 11.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 71.430000000000007 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -95.2 125.77 40.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.182 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 50' ' ' LEU . 59.5 t -100.59 133.33 21.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.602 0.715 . . . . 72.129999999999995 111.154 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.9 Cg_endo -69.75 -45.28 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.699 2.266 . . . . 65.439999999999998 112.304 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 72.140000000000001 110.841 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.72 0.295 . . . . 74.209999999999994 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.449 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -136.33 133.18 19.25 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.63 0.729 . . . . 72.400000000000006 111.148 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.77 178.1 4.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.696 2.264 . . . . 71.329999999999998 112.353 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.68 156.25 1.42 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.856 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 149.52 41.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 43.299999999999997 110.939 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.604 HG21 ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -129.07 175.84 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 64.439999999999998 111.186 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -124.98 139.17 54.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 31' ' ' ALA . 30.1 pt -125.83 164.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.12 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -121.37 138.93 54.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 75.219999999999999 110.892 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 9.9 m-85 -117.0 102.76 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.917 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -84.44 144.48 28.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.937 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 p -114.4 -157.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.510000000000005 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.4 ttp -50.52 -50.35 53.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.904 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -138.09 -33.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 61.119999999999997 110.842 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.12 151.93 21.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 54.409999999999997 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 28' ' ' VAL . 6.7 p -122.9 120.62 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 72.010000000000005 111.095 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 48' ' ' VAL . 3.7 m -109.09 136.99 20.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 73.409999999999997 111.216 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 169.57 18.67 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.638 2.225 . . . . 73.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -159.38 108.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 53.340000000000003 111.075 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -74.1 138.0 43.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 53.43 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.787 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -113.59 116.59 29.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.086 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.1 t -102.57 141.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.200000000000003 111.132 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.83 114.85 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 52.539999999999999 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.55 50.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 33.130000000000003 112.488 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.553 ' OG ' HG21 ' A' ' 104' ' ' VAL . 92.2 p -94.08 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.979 0.419 . . . . 73.200000000000003 110.806 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 42' ' ' VAL . 17.2 p -142.65 154.78 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 73.140000000000001 111.149 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 50' ' ' LEU . 47.5 t -52.4 -59.62 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.420000000000002 111.15 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.943 HD23 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -53.93 -34.94 61.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.903 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.81 -26.94 61.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 72.450000000000003 110.862 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 38' ' ' THR . 91.1 t -76.31 -47.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.210000000000001 111.104 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -55.61 -28.48 55.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.059 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -69.49 -32.93 72.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 75.200000000000003 110.824 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -53.76 21.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.918 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -72.38 -26.6 61.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.869 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.44 -4.26 40.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.813 -0.708 . . . . 71.540000000000006 112.483 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.569 HG22 HG21 ' A' ' 29' ' ' VAL . 38.8 t -51.79 141.41 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 41.020000000000003 111.127 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -88.3 80.79 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.832 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' HG12 ' A' ' 39' ' ' VAL . 10.6 tp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.876 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 25.530000000000001 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -117.39 101.66 8.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 98' ' ' LEU . 10.7 m -129.54 164.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 72.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.84 133.2 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 64.430000000000007 111.148 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 112' ' ' VAL . 35.6 tp -126.55 153.93 44.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 64.040000000000006 110.907 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.8 146.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.852 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -54.86 -60.46 7.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.674 0.749 . . . . 73.040000000000006 110.829 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.69 -44.75 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.7 2.267 . . . . 54.219999999999999 112.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -52.48 -45.31 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 73.209999999999994 110.951 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.618 ' HD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -72.79 -49.91 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.0 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -53.14 -37.85 62.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.509 . . . . 65.439999999999998 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -76.07 -46.21 30.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 71' ' ' LEU . 2.1 mm? -63.2 -22.81 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.869 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.7 136.17 3.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 71.329999999999998 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -112.2 157.41 39.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.634 0.73 . . . . 65.310000000000002 110.931 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.258 . . . . 62.009999999999998 112.379 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.5 t -120.94 -170.67 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.854 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.27 -46.4 76.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.898 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -54.43 -58.84 5.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 63.240000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -28.18 69.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.874 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -55.48 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 74.329999999999998 110.902 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.95 -40.91 87.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 110.861 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.07 -50.86 69.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 64.219999999999999 110.923 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.784 HD13 ' HA2' ' A' ' 94' ' ' GLY . 22.5 mt -74.08 -35.04 40.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.128 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.48 -17.65 60.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.915 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.18 -24.42 54.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.909 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.612 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.2 164.37 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.129999999999995 111.069 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.85 113.84 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.866 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.83 52.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 73.129999999999995 112.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -96.53 125.17 40.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 70.219999999999999 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.8 30.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.203 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.35 -23.98 36.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.798 -0.715 . . . . 75.129999999999995 112.481 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.618 HG22 ' HD1' ' A' ' 72' ' ' TYR . 20.3 p -73.42 -3.27 26.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.146 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -86.83 -16.02 37.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.821 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.62 157.91 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 70.200000000000003 110.855 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 99' ' ' GLY . 4.1 pp -166.34 -179.46 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.546 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -76.82 -130.51 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 71.010000000000005 112.489 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.78 84.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 61.43 110.853 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.569 ' C ' HD22 ' A' ' 102' ' ' LEU . 37.9 mt-30 -122.45 132.77 54.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 64.439999999999998 110.968 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.943 HD12 HD23 ' A' ' 40' ' ' LEU . 4.6 mm? -126.84 67.25 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 65.25 110.885 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -152.26 160.25 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 70.209999999999994 110.819 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 33' ' ' ALA . 99.4 t -105.5 129.89 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 111.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.39 167.94 20.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 72.040000000000006 110.883 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -57.05 -31.06 64.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 72.510000000000005 110.866 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -28.24 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 110.851 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.626 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.0 m-85 -75.98 -6.12 49.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.209999999999994 110.936 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.604 ' HB2' HG21 ' A' ' 18' ' ' ILE . 84.5 tt0 -58.72 124.15 18.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 62.219999999999999 110.893 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 61.01 22.85 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 53.450000000000003 110.915 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.15 138.32 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 33.329999999999998 111.091 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.706 ' O ' HD12 ' A' ' 67' ' ' LEU . 8.0 t -107.32 111.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 73.010000000000005 111.145 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 67' ' ' LEU . 77.9 m-85 -105.89 104.62 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 23' ' ' LYS . 72.8 m -93.35 125.52 38.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 73.439999999999998 111.134 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.44 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.1 t -85.01 133.45 43.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 111.137 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.9 Cg_endo -69.75 -165.63 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.716 2.278 . . . . 65.439999999999998 112.374 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.926 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 110.909 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.704 HD11 ' HD2' ' A' ' 103' ' ' ARG . 43.5 mm -57.98 124.65 70.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.629 0.728 . . . . 72.400000000000006 111.131 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -169.64 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.659 2.239 . . . . 71.329999999999998 112.399 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -51.02 157.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.93 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 136.37 38.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 43.299999999999997 110.987 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.5 pp -124.58 176.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 64.439999999999998 111.142 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -120.42 136.78 54.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.819 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -115.97 169.21 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 75.129999999999995 111.186 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HD1' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -118.6 126.72 52.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.83 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 2.4 m-85 -96.56 103.12 15.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.855 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -91.4 122.84 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 75.340000000000003 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 -178.12 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.124 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.8 ttm -75.8 -8.18 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.871 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -108.21 -37.89 5.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 61.119999999999997 110.893 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 179.79 176.18 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.932 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' HD1' ' A' ' 21' ' ' PHE . 13.7 p -108.46 132.76 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 111.086 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.638 HG21 HG22 ' A' ' 48' ' ' VAL . 1.7 m -122.48 151.03 59.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 73.409999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.26 62.48 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.687 2.258 . . . . 73.0 112.302 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -146.83 104.2 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 53.340000000000003 111.129 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -76.46 132.22 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 53.43 110.953 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -109.64 133.65 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.052 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.08 152.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.079 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -52.4 111.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 52.539999999999999 110.932 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.16 17.15 35.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.49 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 104' ' ' VAL . 54.0 p -107.52 163.56 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.922 0.392 . . . . 73.200000000000003 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -123.4 154.07 39.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 73.140000000000001 111.126 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 20' ' ' ILE . 15.9 m -55.83 -44.72 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.420000000000002 111.111 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' N ' HG23 ' A' ' 39' ' ' VAL . 15.5 mt -56.76 -44.17 81.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 65.400000000000006 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' CG ' HG23 ' A' ' 38' ' ' THR . 35.2 m-20 -72.72 -26.83 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.450000000000003 110.929 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 38' ' ' THR . 77.2 t -75.23 -31.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 61.210000000000001 111.164 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.28 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 111.118 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -73.43 -35.83 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.839 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -64.72 -46.96 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.832 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.31 -24.62 59.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.938 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.85 40.37 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.471 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 29' ' ' VAL . 39.0 t -51.48 136.24 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 41.020000000000003 111.177 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.84 80.96 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.834 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 110.93 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.918 0.39 . . . . 25.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -69.36 90.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.806 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 114' ' ' THR . 6.5 t -128.59 157.4 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 72.25 111.193 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.8 mp -89.63 134.72 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 64.430000000000007 111.137 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.3 tp -129.03 158.52 38.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 64.040000000000006 110.876 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.45 142.74 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.4 mt-10 -56.91 -60.16 10.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.708 0.766 . . . . 73.040000000000006 110.879 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.82 -48.95 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.721 2.28 . . . . 54.219999999999999 112.288 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.58 -41.9 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 95' ' ' THR . 68.7 t80 -72.51 -52.72 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.26 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 65.439999999999998 110.83 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -77.94 -44.54 26.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.951 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 107' ' ' SER . 1.5 mm? -63.24 -24.3 67.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.874 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.24 156.31 6.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.811 -0.709 . . . . 71.329999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -119.99 157.62 52.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 65.310000000000002 110.865 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 156.6 62.79 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 62.009999999999998 112.296 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.9 t -90.36 -169.66 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.867 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.62 -47.51 76.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -54.02 -59.75 4.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.869 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.3 mp0 -61.11 -27.94 68.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.909 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -56.35 17.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.924 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.98 -40.34 91.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 71.120000000000005 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 mt -56.93 -51.38 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 64.219999999999999 110.904 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.617 HD13 ' HA2' ' A' ' 94' ' ' GLY . 13.7 mt -73.59 -35.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 63.409999999999997 111.171 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -61.84 -18.07 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.863 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -76.01 -24.13 55.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.886 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -84.5 146.71 27.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 71.129999999999995 111.158 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.2 122.23 19.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 110.859 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.98 45.08 56.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 73.129999999999995 112.479 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -100.8 124.86 47.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 111.111 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 144.02 25.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.139 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.617 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.77 -24.82 42.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 75.129999999999995 112.423 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.756 HG22 ' CD1' ' A' ' 72' ' ' TYR . 28.2 p -74.09 -2.18 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 64.239999999999995 111.071 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 1.3 t -90.72 -13.03 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.933 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -144.05 136.67 26.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 70.200000000000003 110.947 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD13 ' NE2' ' A' ' 101' ' ' GLN . 4.3 tt -134.36 -61.25 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 73.450000000000003 110.889 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.17 -90.46 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.668 -0.777 . . . . 71.010000000000005 112.446 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.92 110.42 2.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 61.43 110.916 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD13 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -131.17 118.79 20.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 64.439999999999998 110.894 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.2 37.18 3.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.25 110.904 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.704 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 mmt85 -137.22 147.81 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 70.209999999999994 110.908 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 33' ' ' ALA . 88.3 t -104.18 129.94 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.128 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -136.74 164.16 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.894 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -54.84 -26.4 35.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 72.510000000000005 110.873 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.652 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -62.43 -29.2 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.510000000000005 110.825 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 21.3 m-85 -91.21 12.52 19.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.922 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 18' ' ' ILE . 69.3 tt0 -59.65 111.89 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 62.219999999999999 110.89 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 63.76 20.61 12.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.883 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 113' ' ' PHE . . . -67.99 151.07 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 33.329999999999998 111.128 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 22.2 t -105.73 115.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 111.178 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' HE1' ' HB3' ' A' ' 111' ' ' ALA . 34.6 m-85 -108.87 104.36 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.825 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 65' ' ' VAL . 88.2 m -95.08 130.86 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.187 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 116' ' ' PRO . 59.3 t -97.48 133.21 23.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.195 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD3' HD12 ' A' ' 66' ' ' ILE . 54.4 Cg_endo -69.6 -47.79 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.695 2.263 . . . . 65.439999999999998 112.423 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.862 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.759 0.314 . . . . 74.209999999999994 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' A' ' 103' ' ' ARG . 39.7 mm -70.59 132.92 87.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.659 0.742 . . . . 72.400000000000006 111.133 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.3 Cg_endo -69.78 -170.34 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 71.329999999999998 112.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.86 156.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 110.865 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.74 132.93 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 43.299999999999997 110.875 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.6 pp -120.12 177.27 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.137 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -112.18 151.78 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.872 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.629 HD12 ' HE1' ' A' ' 113' ' ' PHE . 2.2 pt -135.34 165.45 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.064 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HB3' HG13 ' A' ' 112' ' ' VAL . 2.9 m-85 -112.2 125.17 53.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.949 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -91.29 103.14 15.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 71.329999999999998 110.899 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' CD ' HG22 ' A' ' 28' ' ' VAL . 32.0 tptt -101.35 118.3 36.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.843 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -124.6 171.2 10.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 65.510000000000005 111.158 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mmm -75.83 -7.96 55.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 73.099999999999994 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.7 -38.04 9.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 61.119999999999997 110.93 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 179.45 176.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 54.409999999999997 110.933 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG22 ' CD ' ' A' ' 23' ' ' LYS . 17.9 t -111.74 124.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.010000000000005 111.113 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.62 150.49 76.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.111 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 155.38 65.92 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.65 2.233 . . . . 73.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 42' ' ' VAL . . . -143.45 141.46 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 111.099 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -106.15 131.65 53.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 53.43 110.929 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.78 116.54 32.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 111.059 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.36 151.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 75.200000000000003 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -52.93 109.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.925 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.02 31.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.485 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.3 p -100.8 163.32 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.415 . . . . 73.200000000000003 110.877 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 p -130.99 152.92 49.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 73.140000000000001 111.146 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.02 -60.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.131 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.12 -34.25 59.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 65.400000000000006 110.922 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -72.46 -26.77 61.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 72.450000000000003 110.789 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 38' ' ' THR . 63.8 t -76.94 -45.06 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 61.210000000000001 111.142 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -51.64 -29.95 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 111.037 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -71.66 -36.77 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 110.943 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -79.38 -45.23 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.886 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -72.19 -25.4 61.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.66 -12.19 56.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 71.540000000000006 112.462 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.646 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 87.2 t -52.66 105.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 41.020000000000003 111.136 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.644 ' O ' HD22 ' A' ' 50' ' ' LEU . 31.1 t0 -81.77 81.11 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 49' ' ' ASP . 2.0 mm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.430000000000007 110.907 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.883 0.373 . . . . 25.530000000000001 110.91 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.88 113.77 21.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 65.439999999999998 110.875 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.38 157.16 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.073 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -89.81 137.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.058 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.46 158.36 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 64.040000000000006 110.865 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.52 142.4 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.863 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -58.64 -59.23 14.3 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.53 0.681 . . . . 73.040000000000006 110.876 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.81 -47.97 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 54.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -52.47 -48.78 65.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.957 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.425 ' CD1' HG22 ' A' ' 95' ' ' THR . 28.9 t80 -65.11 -51.7 59.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.924 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.11 44.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 65.439999999999998 110.843 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -75.49 -52.34 10.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.07 -23.19 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.12 151.7 5.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 71.329999999999998 112.525 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.13 157.63 77.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 65.310000000000002 110.872 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.667 2.245 . . . . 62.009999999999998 112.334 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 p -111.24 -176.92 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.851 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -55.77 -44.84 78.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -53.79 -59.7 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 63.240000000000002 110.854 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -62.33 -28.07 69.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.878 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -55.16 31.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.949 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.94 -41.03 83.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 110.821 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.62 -52.24 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 110.917 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.768 HD13 ' HA2' ' A' ' 94' ' ' GLY . 10.9 mt -73.7 -35.02 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.409999999999997 111.101 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.79 -19.17 58.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 110.856 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -76.07 -24.0 55.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.924 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.96 151.44 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.129999999999995 111.061 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -69.73 120.26 15.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.519999999999996 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.67 44.09 54.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.726 -0.75 . . . . 73.129999999999995 112.537 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -112.11 132.64 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 70.219999999999999 111.082 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.93 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 111.145 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.86 -26.77 48.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 75.129999999999995 112.453 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.5 p -74.09 -0.99 18.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.133 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 25.5 t -90.89 -14.0 32.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 71.409999999999997 110.858 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -102.93 160.81 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 70.200000000000003 110.887 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -176.6 125.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.895 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' HD13 ' A' ' 98' ' ' LEU . . . -61.13 -166.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.467 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 21.8 m -89.07 49.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 61.43 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -128.92 41.89 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.439999999999998 110.919 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 98' ' ' LEU . 4.4 mm? -76.88 65.05 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.25 110.911 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 14' ' ' ILE . 5.1 tpp85 -109.46 158.43 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 70.209999999999994 110.913 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.7 t -80.93 127.23 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.157 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 161.14 36.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.040000000000006 110.838 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.5 -36.82 67.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.885 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -21.44 66.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 64.510000000000005 110.849 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.73 1.82 40.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 71.209999999999994 110.845 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.88 124.14 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.914 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 59.11 26.26 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 53.450000000000003 110.895 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.07 130.42 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 33.329999999999998 111.03 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 21' ' ' PHE . 15.3 t -97.91 126.78 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.010000000000005 111.099 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.629 ' HE1' HD12 ' A' ' 20' ' ' ILE . 31.9 p90 -120.74 132.61 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 71.430000000000007 110.867 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 23' ' ' LYS . 89.8 m -104.72 130.9 52.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 111.16 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.6 t -93.31 133.3 28.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 72.129999999999995 111.105 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.8 Cg_endo -69.82 -165.45 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.28 . . . . 65.439999999999998 112.355 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 72.140000000000001 110.794 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.746 0.308 . . . . 74.209999999999994 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -81.61 133.0 53.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.591 0.71 . . . . 72.400000000000006 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.271 . . . . 71.329999999999998 112.308 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -52.3 156.76 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.244 -0.435 . . . . 73.310000000000002 110.883 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.04 159.27 32.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 43.299999999999997 110.859 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.7 pt -139.66 176.78 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 111.134 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -124.08 130.59 52.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.836 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 108' ' ' PHE . 2.7 pt -114.5 162.66 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 75.129999999999995 111.103 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.5 136.18 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 5.1 m-85 -106.18 108.31 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.329999999999998 110.896 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 134.56 38.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 75.340000000000003 110.923 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -125.18 -178.95 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 111.175 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.1 ttp -75.78 -8.03 55.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.918 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -37.97 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 61.119999999999997 110.911 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 179.26 176.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 54.409999999999997 110.93 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.42 135.78 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.010000000000005 111.113 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -126.87 150.18 70.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.687 . . . . 73.409999999999997 111.183 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 150.75 68.66 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 73.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -148.5 116.22 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 53.340000000000003 111.054 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -74.22 131.52 41.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.898 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.011 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.1 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.102 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.93 147.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -52.41 113.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 52.539999999999999 110.884 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.44 25.19 51.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 33.130000000000003 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.9 t -97.27 163.28 12.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 73.200000000000003 110.891 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.1 p -121.14 165.28 15.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.087 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.571 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 88.3 t -52.02 -56.26 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 111.137 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.4 mp -56.77 -35.6 68.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 65.400000000000006 110.789 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.62 -26.76 61.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 72.450000000000003 110.893 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 88.4 t -76.67 -41.39 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 61.210000000000001 111.126 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -54.96 -30.2 58.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 62.219999999999999 111.115 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -74.13 -24.84 59.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.834 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -76.62 -54.2 6.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 110.896 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.473 HD22 ' HB2' ' A' ' 31' ' ' ALA . 43.8 p30 -77.82 -14.22 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.883 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.76 -12.42 69.42 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.463 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 93.9 t -57.33 143.15 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 41.020000000000003 111.124 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.88 81.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.84 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 115' ' ' VAL . 7.2 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.869 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.871 0.367 . . . . 25.530000000000001 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -77.13 78.69 3.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.439999999999998 110.791 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 114' ' ' THR . 5.7 t -128.46 157.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 72.25 111.17 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.484 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.2 mp -90.18 130.91 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 111.134 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' VAL . 15.7 tp -126.03 163.9 22.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 64.040000000000006 110.91 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -40.65 138.45 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.019999999999996 110.91 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -60.77 -58.64 17.85 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 73.040000000000006 110.945 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.4 Cg_endo -69.71 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.749 2.299 . . . . 54.219999999999999 112.327 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.537 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -52.25 -49.05 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.918 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.639 ' CD1' HG22 ' A' ' 95' ' ' THR . 52.6 t80 -64.9 -51.33 62.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.88 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -27.24 62.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 65.439999999999998 110.862 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -75.9 -54.66 6.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.5 mt -63.04 -21.48 66.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.965 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.02 142.77 3.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.742 -0.742 . . . . 71.329999999999998 112.508 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 157.57 77.05 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 65.310000000000002 110.872 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 157.27 60.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 62.009999999999998 112.316 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.2 m -58.14 157.34 8.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -51.73 -35.78 44.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.896 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -62.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 110.909 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.71 -35.82 81.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 110.923 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.61 -56.6 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.9 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -62.15 -41.29 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.908 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.21 -38.26 73.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.219999999999999 110.936 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.479 HD13 ' HA2' ' A' ' 94' ' ' GLY . 12.5 mt -75.04 -36.75 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 111.078 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.18 -22.26 27.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.857 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.43 -29.7 59.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.891 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -75.67 131.09 39.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.041 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -54.44 130.08 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.48 48.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.718 . . . . 73.129999999999995 112.458 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 70.219999999999999 111.162 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.74 153.01 22.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.174 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -27.39 48.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.453 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.9 p -73.94 -1.43 19.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 111.174 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.0 t -87.61 -13.88 41.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 131.92 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.814 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tt -135.07 -64.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.94 -176.68 41.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.511 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.12 109.27 20.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 61.43 110.866 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.576 ' C ' HD22 ' A' ' 102' ' ' LEU . 7.7 mt-30 -163.81 134.68 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 64.439999999999998 110.891 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.576 HD22 ' C ' ' A' ' 101' ' ' GLN . 4.5 mm? -126.78 83.79 2.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 65.25 110.924 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -152.0 146.63 25.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.884 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.011 HG11 ' HB1' ' A' ' 33' ' ' ALA . 71.0 t -109.88 131.68 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.203 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.42 167.47 21.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.040000000000006 110.835 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.59 -22.05 54.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.926 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -29.46 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 110.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.453 ' O ' HG22 ' A' ' 20' ' ' ILE . 20.0 m-85 -90.78 7.54 39.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 71.209999999999994 110.868 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' HG21 ' A' ' 18' ' ' ILE . 61.4 tt0 -57.63 123.15 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 110.878 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.4 25.36 14.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 53.450000000000003 110.907 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -86.23 162.52 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 33.329999999999998 111.078 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.567 ' O ' HD12 ' A' ' 67' ' ' LEU . 13.5 t -112.72 125.29 69.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 111.175 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -111.76 94.72 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.904 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 65' ' ' VAL . 56.1 m -89.32 130.97 35.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.158 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.566 HG21 HD22 ' A' ' 50' ' ' LEU . 59.6 t -104.4 133.35 20.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.6 0.715 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.3 Cg_endo -69.76 -41.15 4.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 65.439999999999998 112.303 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.831 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.772 0.32 . . . . 74.209999999999994 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 15' ' ' PRO . 56.3 mt -60.62 133.07 91.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.604 0.716 . . . . 72.400000000000006 111.088 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.69 -170.57 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.383 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.24 156.89 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 73.310000000000002 110.89 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -74.03 144.01 45.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 43.299999999999997 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.5 pp -129.93 176.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -114.68 138.71 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.896 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.639 HD12 ' CE1' ' A' ' 113' ' ' PHE . 23.9 pt -114.22 167.81 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 111.189 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -113.08 125.3 54.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.865 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.37 101.87 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.51 128.56 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 p -127.23 175.85 7.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 65.510000000000005 111.171 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 6.1 tpt -74.42 -8.06 55.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 73.099999999999994 110.893 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.08 -38.35 6.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 61.119999999999997 110.824 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 178.81 176.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.881 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.78 146.44 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.129 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.3 t -142.51 129.78 11.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.112 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.64 7.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.633 2.222 . . . . 73.0 112.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -121.21 115.94 23.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 111.064 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -73.91 137.22 43.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 53.43 110.898 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.22 145.87 37.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.138 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.01 152.36 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 111.117 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.51 109.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 52.539999999999999 110.833 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.47 23.49 33.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 33.130000000000003 112.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -97.19 177.52 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 73.200000000000003 110.86 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.0 p -134.69 152.21 51.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.140000000000001 111.168 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -47.85 -61.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 70.420000000000002 111.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.01 -34.05 58.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 65.400000000000006 110.921 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.4 -27.07 62.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 72.450000000000003 110.805 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 56.4 t -77.0 -43.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.125 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.98 -28.13 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 62.219999999999999 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -73.1 -27.43 61.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.806 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -53.4 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.884 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.486 ' HB3' HG23 ' A' ' 48' ' ' VAL . 13.7 t-20 -72.59 -24.73 61.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.420000000000002 110.908 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.02 15.75 43.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.783 -0.722 . . . . 71.540000000000006 112.452 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 46' ' ' ASN . 24.8 t -66.31 147.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.338 . . . . 41.020000000000003 111.135 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -88.83 80.8 7.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.904 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 70.430000000000007 110.935 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.862 0.363 . . . . 25.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -146.68 112.99 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 65.439999999999998 110.832 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 9.3 t -128.32 156.66 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 72.25 111.133 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.3 mp -89.31 137.72 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 111.159 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.77 157.88 39.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 64.040000000000006 110.952 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.48 141.45 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.879 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -57.27 -59.63 12.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 73.040000000000006 110.906 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.79 -48.86 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.744 2.296 . . . . 54.219999999999999 112.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.654 HD21 ' HB1' ' A' ' 111' ' ' ALA . 1.6 tp -51.83 -42.82 62.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.996 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.9 t80 -72.51 -51.64 19.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.87 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -36.23 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 65.439999999999998 110.852 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -78.18 -43.06 29.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.3 mm? -63.26 -28.1 69.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.944 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.07 160.55 8.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.737 -0.744 . . . . 71.329999999999998 112.457 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.55 157.37 77.48 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 65.310000000000002 110.876 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 62.009999999999998 112.425 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -102.57 -175.7 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 110.871 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -56.45 -45.2 80.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -59.65 4.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.868 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.43 -28.55 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.530000000000001 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -56.96 13.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.901 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -42.09 89.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.822 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.08 -51.93 62.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 110.963 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' HA2' ' A' ' 94' ' ' GLY . 58.0 mt -73.74 -35.26 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 111.105 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.55 -17.04 62.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.83 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -76.28 -25.38 54.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.869 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -82.46 143.84 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 71.129999999999995 111.087 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -64.03 123.17 18.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 75.519999999999996 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.93 43.92 55.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.711 -0.756 . . . . 73.129999999999995 112.551 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.615 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.9 118.02 35.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 70.219999999999999 111.179 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 148.71 26.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 111.122 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.68 -24.82 41.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 75.129999999999995 112.45 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -73.96 -1.99 22.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 64.239999999999995 111.171 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.7 t -91.05 -12.94 34.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 71.409999999999997 110.9 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -118.24 132.73 56.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 70.200000000000003 110.906 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.17 -69.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.450000000000003 110.874 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.36 -142.04 7.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 71.010000000000005 112.456 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -129.87 33.44 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 61.43 110.884 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.584 ' C ' HD22 ' A' ' 102' ' ' LEU . 33.8 mt-30 -139.41 133.95 31.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 64.439999999999998 110.968 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 101' ' ' GLN . 4.6 mm? -128.82 109.15 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 65.25 110.918 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -137.4 145.35 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 70.209999999999994 110.863 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG21 ' HB1' ' A' ' 33' ' ' ALA . 22.1 t -92.94 130.18 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.106 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.48 167.53 21.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.932 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -41.76 79.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 72.510000000000005 110.874 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.64 -17.09 59.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.510000000000005 110.898 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 m-85 -90.26 11.26 21.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.931 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.5 123.27 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.219999999999999 110.897 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 59.6 25.88 14.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 53.450000000000003 110.84 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -73.85 127.92 34.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 33.329999999999998 111.097 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 21' ' ' PHE . 21.6 t -102.12 120.52 51.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.117 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 20' ' ' ILE . 30.3 p90 -120.46 126.41 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.876 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -101.4 131.35 47.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.192 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.0 t -88.18 133.34 37.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.681 0.753 . . . . 72.129999999999995 111.089 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.0 Cg_endo -69.78 -43.56 2.58 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.709 2.273 . . . . 65.439999999999998 112.312 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.948 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.734 0.302 . . . . 74.209999999999994 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 15' ' ' PRO . 47.6 mm -62.52 133.06 94.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.658 0.742 . . . . 72.400000000000006 111.105 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.77 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.742 2.295 . . . . 71.329999999999998 112.293 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -51.74 156.75 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.310000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -73.94 144.41 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 43.299999999999997 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HG13 ' A' ' 104' ' ' VAL . 2.5 pp -138.7 176.88 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 64.439999999999998 111.143 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -121.43 141.65 50.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.877 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 pt -114.39 164.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.05 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -120.77 130.36 53.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 110.877 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.35 102.95 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 71.329999999999998 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.33 30.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 75.340000000000003 110.934 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 p -113.8 -176.45 2.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 65.510000000000005 111.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -8.6 57.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 110.924 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -110.6 -38.32 5.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 61.119999999999997 110.885 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 178.67 176.49 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 54.409999999999997 110.902 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.05 148.14 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.158 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 30' ' ' PRO . 84.0 t -129.44 132.52 24.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.117 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 29' ' ' VAL . 54.7 Cg_endo -69.68 129.37 17.56 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 73.0 112.382 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.67 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -138.01 107.51 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 53.340000000000003 111.105 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.94 149.06 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 53.43 110.91 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -130.68 121.67 25.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.069 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.3 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.200000000000003 111.145 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 p -51.21 111.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 52.539999999999999 110.852 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.84 14.16 35.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.703 . . . . 33.130000000000003 112.429 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.1 p -95.01 -178.92 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.009 0.433 . . . . 73.200000000000003 110.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -145.9 159.86 42.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 73.140000000000001 111.124 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.909 HG23 HD12 ' A' ' 40' ' ' LEU . 15.7 m -58.73 -45.3 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 111.069 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 39' ' ' VAL . 6.5 mp -66.75 -36.07 81.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 65.400000000000006 110.937 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.66 -27.44 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.450000000000003 110.892 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -77.08 -49.9 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.092 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 111.082 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -69.74 -34.19 73.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 110.854 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -87.12 -37.41 17.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.973 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' HB3' HG23 ' A' ' 48' ' ' VAL . 2.2 m-80 -72.26 -24.92 61.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.912 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.9 -12.13 70.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.542 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 46' ' ' ASN . 46.9 t -51.54 130.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 41.020000000000003 111.206 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.59 81.29 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.854 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.887 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.854 0.359 . . . . 25.530000000000001 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -161.95 112.09 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.864 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 114' ' ' THR . 9.7 p -128.92 157.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 72.25 111.133 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 3.1 mt -89.79 132.37 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 111.099 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 112' ' ' VAL . 25.0 tp -127.28 159.87 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.946 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.79 142.06 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.864 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -57.5 -59.83 11.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 73.040000000000006 110.867 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.61 2.206 . . . . 54.219999999999999 112.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 0.6 OUTLIER -51.47 -43.33 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 73.209999999999994 110.892 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 95' ' ' THR . 56.1 t80 -71.44 -51.63 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.945 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -35.39 61.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.873 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -78.1 -40.84 37.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -63.28 -26.33 68.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.877 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.7 167.57 11.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.23 157.82 77.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 65.310000000000002 110.91 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -178.1 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.702 2.268 . . . . 62.009999999999998 112.334 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -98.32 -173.3 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.879 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -58.5 -43.8 89.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.858 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -53.93 -59.65 4.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 63.240000000000002 110.899 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -28.16 69.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.530000000000001 110.958 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -52.36 64.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -41.83 70.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 71.120000000000005 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -50.01 69.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.954 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.574 HD13 ' HA2' ' A' ' 94' ' ' GLY . 64.2 mt -73.29 -42.58 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.51 -23.11 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.13 -24.17 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -83.56 142.17 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 111.049 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 130.99 43.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.904 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 40.36 59.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 73.129999999999995 112.56 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.64 123.61 49.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.127 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.32 144.2 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 75.109999999999999 111.1 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.574 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.91 -26.11 47.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 75.129999999999995 112.445 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.654 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.3 p -74.07 -1.23 19.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 64.239999999999995 111.155 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 5.9 t -90.76 -12.71 35.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.869 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -112.59 143.57 43.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 70.200000000000003 110.879 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 130.63 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.948 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.59 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 71.010000000000005 112.515 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.6 m -101.44 27.69 6.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 61.43 110.911 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.21 59.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.889 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -98.4 112.56 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.25 110.889 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -119.21 136.36 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.95 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' A' ' 33' ' ' ALA . 39.3 t -80.06 115.43 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.137 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 178.54 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 72.040000000000006 110.819 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -54.88 -40.28 69.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.510000000000005 110.889 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 t -64.44 -25.09 67.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.914 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 75' ' ' LEU . 12.8 m-85 -79.85 -2.21 42.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 18' ' ' ILE . 18.8 tt0 -58.15 124.94 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.935 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.3 m120 58.72 23.81 11.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 53.450000000000003 110.902 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -65.63 151.24 46.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 33.329999999999998 111.147 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.701 ' O ' HD12 ' A' ' 67' ' ' LEU . 23.6 t -107.07 113.02 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.010000000000005 111.184 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -108.95 95.06 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.804 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' VAL . 51.6 m -87.82 130.91 34.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 111.169 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.441 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.3 t -95.53 133.4 25.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.631 0.729 . . . . 72.129999999999995 111.165 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.73 -41.89 3.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.76 2.306 . . . . 65.439999999999998 112.321 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.843 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.735 0.302 . . . . 74.209999999999994 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.429 HG23 ' HD2' ' A' ' 15' ' ' PRO . 5.2 mp -109.61 132.96 21.04 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.758 . . . . 72.400000000000006 111.071 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.71 -168.09 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 71.329999999999998 112.412 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -50.25 157.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.86 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.44 147.0 44.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.493 . . . . 43.299999999999997 110.95 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 177.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 111.205 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -122.75 136.79 54.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.946 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.734 HG13 ' HB3' ' A' ' 31' ' ' ALA . 46.8 pt -117.44 172.02 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 111.13 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -118.74 128.74 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.894 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 4.1 m-85 -105.31 104.18 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 71.329999999999998 110.922 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -93.64 122.25 35.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -113.36 -177.83 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 65.510000000000005 111.074 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -75.95 -9.36 58.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -106.09 -37.74 6.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 61.119999999999997 110.944 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.13 176.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.911 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.36 134.58 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.102 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -129.41 150.66 76.21 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.63 0.729 . . . . 73.409999999999997 111.101 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 155.06 66.96 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 73.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.734 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.92 136.18 25.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 53.340000000000003 111.141 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -96.78 134.56 39.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 53.43 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -115.35 125.66 53.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.123 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 35' ' ' CYS . 8.1 t -95.23 156.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 75.200000000000003 111.114 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' HG12 ' A' ' 34' ' ' VAL . 58.5 m -55.55 99.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 52.539999999999999 110.802 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.95 24.6 11.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 33.130000000000003 112.476 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 104' ' ' VAL . 2.4 m -94.83 174.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 73.200000000000003 110.844 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -131.73 146.71 52.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 111.133 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.52 -62.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 111.158 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.45 -32.98 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 65.400000000000006 110.876 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.25 -27.02 62.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.863 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 38' ' ' THR . 60.8 t -77.55 -43.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.108 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 48' ' ' VAL . . . -52.82 -27.8 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 62.219999999999999 111.131 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -73.36 -34.66 65.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 75.200000000000003 110.822 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -83.28 -40.73 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.898 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -72.02 -26.95 62.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.812 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.69 83.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 71.540000000000006 112.438 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.577 HG12 ' HB1' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -53.66 156.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 41.020000000000003 111.135 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.6 t70 -72.1 80.02 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.859 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 70.430000000000007 110.829 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.865 0.364 . . . . 25.530000000000001 110.893 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -94.55 112.21 23.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 65.439999999999998 110.87 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 114' ' ' THR . 6.4 t -128.66 157.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.074 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 63.9 mt -90.08 132.79 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 64.430000000000007 111.134 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 112' ' ' VAL . 36.0 tp -125.63 159.63 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 64.040000000000006 110.902 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.78 142.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.019999999999996 110.815 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -60.11 -58.67 17.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.731 . . . . 73.040000000000006 110.965 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.85 -47.58 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.741 2.294 . . . . 54.219999999999999 112.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.8 tp -53.24 -51.16 63.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 110.957 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.3 t80 -63.46 -53.74 47.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -31.63 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 65.439999999999998 110.809 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.13 -53.78 13.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.3 -23.59 67.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.835 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.14 148.04 4.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.478 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.45 78.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.636 0.731 . . . . 65.310000000000002 110.842 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 165.45 30.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.648 2.232 . . . . 62.009999999999998 112.343 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -93.68 -170.92 2.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 110.842 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -56.96 -45.23 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.837 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -53.76 -59.79 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 63.240000000000002 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.57 -29.98 70.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.530000000000001 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -54.0 50.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.02 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.905 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.82 -51.95 61.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.936 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 94' ' ' GLY . 11.5 mt -74.92 -34.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 111.089 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.76 -20.02 45.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.030000000000001 110.799 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -75.52 -16.31 60.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.918 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.67 144.31 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 71.129999999999995 111.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -64.96 122.28 16.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.934 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.5 45.1 53.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 73.129999999999995 112.539 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.616 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.06 143.93 36.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.902 0.382 . . . . 70.219999999999999 111.092 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 150.56 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.149 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.76 -27.18 49.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.742 . . . . 75.129999999999995 112.479 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.581 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.9 p -73.92 -1.28 19.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.384 . . . . 64.239999999999995 111.154 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.3 t -89.34 -13.61 37.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 110.879 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.22 165.65 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.200000000000003 110.848 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.65 65.88 0.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.03 19.88 10.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.753 . . . . 71.010000000000005 112.438 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.66 165.18 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 61.43 110.897 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 56.67 42.11 27.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 64.439999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' THR . 2.5 tp -98.25 156.56 16.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.45 . . . . 65.25 110.879 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -118.55 163.47 16.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 110.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.542 HG11 ' HB1' ' A' ' 33' ' ' ALA . 88.0 t -102.03 122.71 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 111.107 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.28 173.61 11.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.927 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -59.26 -36.02 74.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 110.919 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -65.81 -19.53 65.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 64.510000000000005 110.909 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.02 -0.19 43.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.831 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -59.01 124.28 19.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 62.219999999999999 110.904 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.38 22.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 53.450000000000003 110.881 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -64.91 141.99 58.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 33.329999999999998 111.127 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.6 t -103.05 116.77 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 73.010000000000005 111.116 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 39' ' ' VAL . 79.8 m-85 -112.26 100.31 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.905 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 65' ' ' VAL . 39.5 m -88.22 124.83 34.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 111.174 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 50' ' ' LEU . 20.4 t -116.89 92.27 38.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.097 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 53.5 Cg_endo -69.77 -35.59 12.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.728 2.285 . . . . 65.439999999999998 112.336 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 115' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.843 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.767 0.318 . . . . 74.209999999999994 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.591 HD13 ' HA2' ' A' ' 36' ' ' GLY . 2.7 mp -112.76 133.06 22.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 72.400000000000006 111.062 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.78 -170.63 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 71.329999999999998 112.364 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.54 156.64 1.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.893 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.98 158.99 33.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 43.299999999999997 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.2 176.43 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 111.091 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 127.59 53.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.798 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.27 163.0 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 111.112 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -119.53 127.53 53.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' A' ' 48' ' ' VAL . 3.2 m-85 -99.26 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.882 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.751 ' HG2' HG22 ' A' ' 28' ' ' VAL . 12.3 tmtt? -86.1 115.17 23.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.340000000000003 110.926 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -103.91 -179.29 3.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 65.510000000000005 111.167 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.01 -17.14 59.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.099999999999994 110.946 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -93.98 -39.11 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 61.119999999999997 110.889 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 176.31 176.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.751 HG22 ' HG2' ' A' ' 23' ' ' LYS . 20.7 t -86.77 142.69 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 111.085 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.75 129.78 18.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.71 60.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.246 . . . . 73.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.84 113.31 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.340000000000003 111.118 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -79.44 122.97 27.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.848 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -100.27 116.42 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.029 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 m -87.8 144.38 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 75.200000000000003 111.109 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 p -54.78 121.35 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.539999999999999 110.889 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 106.0 -7.74 41.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 33.130000000000003 112.494 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -99.42 -178.06 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.993 0.425 . . . . 73.200000000000003 110.85 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -133.93 154.77 50.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 111.135 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.954 HG23 HD12 ' A' ' 40' ' ' LEU . 14.9 m -57.91 -45.55 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.420000000000002 111.118 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -64.33 -37.35 87.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.931 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.73 -27.3 61.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 72.450000000000003 110.886 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 73.0 t -76.42 -43.59 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 61.210000000000001 111.077 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 50' ' ' LEU . . . -51.36 -29.96 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 62.219999999999999 111.108 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -73.42 -36.84 66.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 110.848 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -40.84 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.530000000000001 110.909 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -72.1 -25.45 61.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.903 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.88 76.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.449 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 46' ' ' ASN . 48.2 t -51.5 137.99 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 41.020000000000003 111.052 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.13 80.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 50' ' ' LEU . 8.9 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.884 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 p . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.928 0.394 . . . . 25.530000000000001 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -60.81 117.27 5.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 65.439999999999998 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.8 t -128.2 155.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.105 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 70.3 mt -91.07 133.77 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 64.430000000000007 111.096 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 112' ' ' VAL . 20.3 tp -125.67 162.54 24.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.933 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -41.0 139.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -60.1 -59.38 14.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.638 0.732 . . . . 73.040000000000006 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.75 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.723 2.282 . . . . 54.219999999999999 112.318 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.76 -48.83 63.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.941 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD1' HG22 ' A' ' 95' ' ' THR . 30.3 t80 -66.99 -51.08 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.929 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -51.52 -51.66 53.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 65.439999999999998 110.881 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -61.62 -48.55 80.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 71' ' ' LEU . 3.3 mm? -62.94 -18.68 63.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.209999999999994 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.03 130.35 2.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 71.329999999999998 112.507 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 157.75 60.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 65.310000000000002 110.866 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.94 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.392 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.9 m -104.79 -174.89 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.852 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.9 -49.16 78.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.896 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -47.69 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 63.240000000000002 110.914 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.83 -28.38 64.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 71.530000000000001 110.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -53.3 55.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.851 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -43.28 68.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.22 -49.07 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.219999999999999 110.88 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.595 HD13 ' HA2' ' A' ' 94' ' ' GLY . 57.8 mt -75.06 -34.4 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 111.089 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.42 -15.64 58.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.85 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.33 -22.86 57.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.858 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.63 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.1 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 71.129999999999995 111.133 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -56.97 126.6 27.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.13 41.33 53.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.484 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.63 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -110.48 139.03 46.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 70.219999999999999 111.068 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 155.0 44.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.135 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.87 -27.08 49.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 75.129999999999995 112.427 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.558 HG22 ' CD1' ' A' ' 72' ' ' TYR . 14.9 p -73.79 -1.92 21.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.293 . . . . 64.239999999999995 111.158 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 39.1 t -87.88 -14.9 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.884 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.8 168.27 9.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 70.200000000000003 110.857 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 62.06 97.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.947 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.95 32.01 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 71.010000000000005 112.504 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.24 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.329 . . . . 61.43 110.871 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -88.26 51.7 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 64.439999999999998 110.911 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.513 HD11 ' CZ ' ' A' ' 108' ' ' PHE . 7.1 tt -91.37 114.51 27.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.93 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -85.33 134.93 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 110.934 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' A' ' 33' ' ' ALA . 83.8 t -59.76 122.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 72.239999999999995 111.091 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -137.07 160.2 39.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 72.040000000000006 110.884 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -53.95 -27.24 29.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.489 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -62.66 -29.29 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.866 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.513 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 22.0 m-85 -89.99 12.07 18.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 71.209999999999994 110.898 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.22 120.74 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.873 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.71 21.26 12.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 53.450000000000003 110.887 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.2 153.39 36.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 33.329999999999998 111.104 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.584 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.1 t -105.51 127.16 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.091 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 39' ' ' VAL . 12.1 m-85 -113.16 98.48 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.887 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.0 m -85.21 124.86 32.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.145 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.32 92.48 8.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.687 0.756 . . . . 72.129999999999995 111.124 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -34.2 14.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.663 2.242 . . . . 65.439999999999998 112.273 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 110.842 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA2' ' A' ' 36' ' ' GLY . 4.1 mt -51.65 133.2 36.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.635 0.731 . . . . 72.400000000000006 111.136 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.77 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.346 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.02 157.45 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.902 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -73.41 143.58 46.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 43.299999999999997 110.864 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.7 pp -127.92 176.88 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 64.439999999999998 111.062 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -114.2 136.83 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.872 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 31' ' ' ALA . 14.6 pt -120.23 169.4 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 111.111 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.17 137.91 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.4 m-85 -108.81 103.12 12.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.852 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -90.19 130.0 36.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.887 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 p -119.08 -177.51 3.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 65.510000000000005 111.156 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 ptm -75.9 -8.13 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.871 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -38.51 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 110.913 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -178.56 176.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 54.409999999999997 110.947 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.94 135.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 111.163 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.09 150.9 60.7 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 73.409999999999997 111.099 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.67 60.98 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 73.0 112.377 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -147.8 108.46 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 53.340000000000003 111.111 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -74.83 128.0 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 53.43 110.986 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.061 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -106.31 119.97 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.4 154.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 75.200000000000003 111.161 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.8 t -56.21 109.8 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.577 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 100.47 -17.35 56.85 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 33.130000000000003 112.489 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -66.25 142.11 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 73.200000000000003 110.818 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 42' ' ' VAL . 72.8 p -96.82 158.38 15.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.07 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.86 -58.27 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.420000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.18 -33.63 58.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 65.400000000000006 110.856 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -73.06 -27.59 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 72.450000000000003 110.796 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 38' ' ' THR . 25.7 t -76.13 -45.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.082 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.2 25.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.042 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -71.74 -38.93 70.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 75.200000000000003 110.916 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -66.46 -50.69 62.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.17 -32.86 67.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.862 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.7 44.01 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.791 . . . . 71.540000000000006 112.51 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.0 t -51.82 142.44 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 41.020000000000003 111.222 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.43 81.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.851 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.430000000000007 110.924 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.36 . . . . 25.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -145.56 125.14 13.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 65.439999999999998 110.853 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.754 HG12 HD22 ' A' ' 98' ' ' LEU . 14.0 p -127.94 149.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.25 111.166 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 17.3 mt -91.2 133.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.106 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 112' ' ' VAL . 13.9 tp -120.11 158.97 25.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 64.040000000000006 110.878 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.09 137.46 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.816 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.575 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.8 mt-10 -59.72 -55.81 42.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.67 0.748 . . . . 73.040000000000006 110.921 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.9 Cg_endo -69.81 -32.71 17.83 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.63 2.22 . . . . 54.219999999999999 112.326 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 tp -63.01 -46.64 86.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 73.209999999999994 110.882 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.32 -48.62 40.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.942 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -36.65 68.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 110.905 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -76.37 -45.19 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 107' ' ' SER . 1.9 mm? -63.04 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.965 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.05 158.29 21.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 71.329999999999998 112.522 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -130.75 157.63 77.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.649 0.738 . . . . 65.310000000000002 110.904 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.62 2.4 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.249 . . . . 62.009999999999998 112.352 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -95.93 -176.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.94 -44.39 82.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.803 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -53.49 -60.12 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 63.240000000000002 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.02 -28.43 69.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 110.902 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -55.68 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.944 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.61 -43.59 84.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 71.120000000000005 110.857 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.66 -46.9 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.895 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.651 HD13 ' HA2' ' A' ' 94' ' ' GLY . 70.1 mt -74.84 -34.63 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.409999999999997 111.103 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.53 -15.41 60.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.885 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.89 -6.05 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.981 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.65 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -105.59 135.6 46.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.129 -0.487 . . . . 71.129999999999995 111.059 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -55.14 124.89 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 75.519999999999996 110.891 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.41 42.49 50.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.47 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.65 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -101.06 147.44 26.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 70.219999999999999 111.166 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.7 153.56 43.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 111.155 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.2 -38.37 67.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.468 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -73.98 -0.85 17.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 64.239999999999995 111.153 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 8.7 t -88.24 -16.52 32.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.409999999999997 110.873 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -118.31 148.62 42.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 70.200000000000003 110.845 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.754 HD22 HG12 ' A' ' 65' ' ' VAL . 1.1 pt? -121.4 -175.09 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 73.450000000000003 110.888 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.0 7.57 5.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 71.010000000000005 112.542 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 98' ' ' LEU . 17.2 m 61.5 167.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 61.43 110.931 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 54.59 43.55 30.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 110.888 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.34 92.33 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.25 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' NH1' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -59.49 168.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.845 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 1.061 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.4 t -90.77 143.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.123 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.44 171.24 14.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 72.040000000000006 110.808 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -38.42 77.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.85 -17.71 63.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 64.510000000000005 110.898 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.5 9.68 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.209999999999994 110.842 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.541 ' HA ' HD13 ' A' ' 18' ' ' ILE . 59.2 tt0 -59.33 124.88 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 62.219999999999999 110.906 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 60.81 21.25 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 53.450000000000003 110.895 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -62.9 129.74 41.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 33.329999999999998 111.157 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 67' ' ' LEU . 12.9 t -93.1 118.73 39.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.010000000000005 111.187 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -106.29 99.87 9.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.929 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.6 m -87.06 131.2 34.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.169 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.4 132.64 21.71 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.125 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -41.35 4.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.371 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.84 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.843 0.354 . . . . 74.209999999999994 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 15' ' ' PRO . 49.1 mm -54.26 132.95 61.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.647 0.737 . . . . 72.400000000000006 111.179 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.711 2.274 . . . . 71.329999999999998 112.435 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -52.28 157.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.310000000000002 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -73.82 148.78 42.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 43.299999999999997 110.887 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.9 pp -130.38 177.11 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 64.439999999999998 111.07 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -123.35 144.62 49.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.797 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 113' ' ' PHE . 1.9 pt -125.75 170.59 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 111.087 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HB2' HG22 ' A' ' 112' ' ' VAL . 10.1 m-85 -114.5 125.32 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.887 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -92.48 103.37 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.329999999999998 110.877 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.78 127.28 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 p -114.36 -167.45 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.510000000000005 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.7 mmm -54.34 -54.85 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -141.03 27.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.963 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.3 128.45 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.409999999999997 110.915 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 23' ' ' LYS . 94.7 t -119.34 109.86 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 72.010000000000005 111.138 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG21 HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -123.11 150.27 59.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 111.175 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 159.55 53.02 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.703 2.269 . . . . 73.0 112.389 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.79 136.51 25.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 111.119 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.21 133.5 43.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 53.43 110.924 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB1' ' CG2' ' A' ' 104' ' ' VAL . . . -110.37 117.48 33.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.155 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.49 149.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 75.200000000000003 111.168 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.04 117.99 3.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 52.539999999999999 110.805 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.91 19.7 64.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 33.130000000000003 112.457 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -94.57 -169.42 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.931 0.396 . . . . 73.200000000000003 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -148.02 142.92 26.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.083 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.38 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 70.420000000000002 111.147 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HG ' HD13 ' A' ' 102' ' ' LEU . 6.2 mt -53.5 -36.27 61.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.400000000000006 110.859 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -72.67 -26.81 61.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 72.450000000000003 110.87 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 38' ' ' THR . 98.4 t -76.44 -39.9 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 61.210000000000001 111.086 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.35 -32.18 24.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.15 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -73.66 -35.94 65.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.863 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -40.31 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.530000000000001 110.942 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -72.08 -24.95 61.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 74.420000000000002 110.937 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.8 -11.67 38.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.737 . . . . 71.540000000000006 112.514 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 29' ' ' VAL . 99.9 t -61.59 110.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.347 . . . . 41.020000000000003 111.169 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.79 80.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.88 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 70.430000000000007 110.896 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.859 0.361 . . . . 25.530000000000001 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -177.0 114.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 65.439999999999998 110.835 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 155.91 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.146 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -90.45 137.46 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.430000000000007 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 113' ' ' PHE . 9.0 tp -128.51 161.54 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 64.040000000000006 110.917 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.26 141.7 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 110.924 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 mt-10 -58.47 -59.51 13.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.609 0.718 . . . . 73.040000000000006 110.894 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -48.73 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.269 . . . . 54.219999999999999 112.279 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -51.73 -46.77 64.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.944 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.699 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.5 t80 -68.41 -50.43 52.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.866 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.82 -43.98 66.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 65.439999999999998 110.875 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -77.83 -28.01 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 tp -70.88 -61.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.41 132.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.329999999999998 112.482 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -91.91 160.31 36.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.701 0.762 . . . . 65.310000000000002 110.859 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.93 62.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.719 2.28 . . . . 62.009999999999998 112.333 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -86.45 -169.85 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.898 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -56.96 -48.57 78.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.833 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -53.52 -59.44 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.924 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.46 -27.61 68.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.887 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -55.74 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.99 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.7 -37.88 82.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 110.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.97 -47.24 86.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 64.219999999999999 110.909 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.732 HD13 ' HA2' ' A' ' 94' ' ' GLY . 43.6 mt -73.0 -35.17 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 111.159 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -20.89 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 74.030000000000001 110.857 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -76.25 -24.37 54.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.926 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -81.36 148.79 29.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -76.65 120.39 21.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 75.519999999999996 110.872 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.5 44.15 59.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.695 -0.765 . . . . 73.129999999999995 112.443 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -99.37 130.56 45.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 111.064 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 146.22 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.136 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.732 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.8 -24.97 43.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.686 -0.769 . . . . 75.129999999999995 112.539 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.699 HG22 ' CD1' ' A' ' 72' ' ' TYR . 18.9 p -74.01 -2.26 23.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 64.239999999999995 111.189 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.4 t -91.35 -13.42 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 71.409999999999997 110.903 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.583 ' CB ' HD11 ' A' ' 86' ' ' ILE . 7.0 tpt85 -108.53 161.79 14.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.863 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt 64.9 110.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.69 25.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.010000000000005 112.462 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 59.4 m -78.25 -171.28 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 61.43 110.894 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 63.09 61.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.546 HD13 ' HG ' ' A' ' 40' ' ' LEU . 72.6 mt -65.87 89.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.91 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -152.02 149.7 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 70.209999999999994 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.588 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 94.2 t -83.5 133.57 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 111.139 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -136.55 155.92 49.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 72.040000000000006 110.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -57.07 -37.49 71.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 72.510000000000005 110.904 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.1 m -65.08 -18.54 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 64.510000000000005 110.778 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.413 ' C ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.59 1.21 50.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.88 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -58.0 124.41 19.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 62.219999999999999 110.844 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 59.34 24.66 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 53.450000000000003 110.907 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 165.43 24.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 33.329999999999998 111.121 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 21' ' ' PHE . 13.3 t -138.25 124.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.010000000000005 111.105 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 20' ' ' ILE . 12.8 p90 -125.06 129.23 49.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.879 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.5 m -100.97 131.83 46.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 111.16 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 50' ' ' LEU . 29.1 t -91.95 132.7 32.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.63 0.729 . . . . 72.129999999999995 111.107 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -39.89 5.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 65.439999999999998 112.382 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.83 -179.943 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.767 0.318 . . . . 74.209999999999994 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -71.45 132.72 85.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 72.400000000000006 111.097 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.734 2.29 . . . . 71.329999999999998 112.307 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -50.96 157.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 73.310000000000002 110.875 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.55 ' CD ' HG23 ' A' ' 34' ' ' VAL . 37.9 mt-30 -73.6 155.35 39.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.892 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.89 176.88 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.178 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -130.48 137.19 49.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.869 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.3 pt -114.57 173.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 111.118 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.471 ' HD2' HG12 ' A' ' 28' ' ' VAL . 2.0 m-85 -122.55 130.36 52.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.926 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.2 m-85 -97.86 109.0 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.837 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' CD ' HG22 ' A' ' 28' ' ' VAL . 36.7 tptt -92.5 107.28 19.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 75.340000000000003 110.894 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -103.63 176.93 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 65.510000000000005 111.182 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.2 ttt -75.76 -8.08 55.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 73.099999999999994 110.831 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -38.28 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 61.119999999999997 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.44 176.4 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 54.409999999999997 110.977 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 ' CD ' ' A' ' 23' ' ' LYS . 20.0 t -105.15 121.92 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 72.010000000000005 111.129 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.03 150.39 45.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 73.409999999999997 111.162 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 153.97 67.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 73.0 112.299 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -150.2 103.74 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -75.58 137.44 40.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 53.43 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -126.33 116.47 21.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.064 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.55 HG23 ' CD ' ' A' ' 17' ' ' GLN . 14.4 p -94.42 149.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 75.200000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 p -49.13 112.78 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 52.539999999999999 110.927 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.83 7.56 33.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 33.130000000000003 112.465 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 m -96.08 -178.38 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.397 . . . . 73.200000000000003 110.883 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -139.16 147.82 42.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.198 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 113' ' ' PHE . 44.6 t -52.23 -62.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 70.420000000000002 111.102 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.77 HD11 HD12 ' A' ' 50' ' ' LEU . 4.4 mm? -54.04 -33.65 57.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 65.400000000000006 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.67 -27.16 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.829 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 95.3 t -76.94 -43.3 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 111.118 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -54.73 -28.28 47.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.106 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -73.75 -27.91 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.87 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -52.19 12.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.868 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.21 -25.22 61.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 110.916 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -6.96 43.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.688 -0.768 . . . . 71.540000000000006 112.52 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.642 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.1 t -51.4 144.47 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 41.020000000000003 111.09 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.17 83.93 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.891 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.77 HD12 HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 110.844 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.878 0.37 . . . . 25.530000000000001 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -124.49 113.55 18.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 115' ' ' VAL . 8.4 t -128.62 157.01 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 72.25 111.087 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mt -90.17 130.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 111.157 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.0 tp -125.07 164.7 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 64.040000000000006 110.901 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -39.12 137.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.891 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -60.89 -58.7 17.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.684 0.754 . . . . 73.040000000000006 110.922 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.72 -49.6 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.75 2.3 . . . . 54.219999999999999 112.284 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.752 HD11 ' O ' ' A' ' 107' ' ' SER . 5.4 tp -51.96 -51.9 53.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 73.209999999999994 111.002 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.7 t80 -63.58 -41.97 98.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.925 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -52.03 -62.0 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 65.439999999999998 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -63.9 -26.82 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -62.15 -57.25 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.918 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.13 142.12 3.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.826 -0.702 . . . . 71.329999999999998 112.508 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -107.33 160.34 26.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.678 0.751 . . . . 65.310000000000002 110.862 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 172.16 13.06 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.249 . . . . 62.009999999999998 112.364 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -58.0 167.81 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.899 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -56.81 -39.74 74.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.819 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.487 ' O ' HD13 ' A' ' 85' ' ' LEU . 38.1 mttm -52.33 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 63.240000000000002 110.869 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.04 -35.2 79.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.59 -53.63 55.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.863 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.56 -41.72 92.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.859 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 81' ' ' LYS . 4.4 mp -56.45 -37.35 70.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.908 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.522 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.1 mt -74.61 -51.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.087 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.24 -23.13 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.834 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 -32.49 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.899 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -61.78 163.89 6.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 71.129999999999995 111.066 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.65 114.81 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 75.519999999999996 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.55 41.56 56.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.129999999999995 112.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -106.69 117.36 33.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 70.219999999999999 111.085 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 142.4 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 111.068 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -24.95 41.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 75.129999999999995 112.488 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.0 p -73.91 -2.03 22.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 111.209 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 t -89.12 -12.45 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.867 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 9.8 ttm-85 -94.06 154.51 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 70.200000000000003 110.785 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 tp -147.48 167.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 73.450000000000003 110.856 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.02 19.14 9.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.674 -0.774 . . . . 71.010000000000005 112.467 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.9 t 60.38 25.73 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 61.43 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.41 136.47 22.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.439999999999998 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -177.13 129.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 65.25 110.877 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.66 170.31 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 33' ' ' ALA . 39.2 t -100.62 120.44 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.103 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.71 173.61 11.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.469 . . . . 72.040000000000006 110.874 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -59.66 -33.87 72.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 110.922 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 71' ' ' LEU . 47.3 m -64.91 -19.32 65.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 64.510000000000005 110.855 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.74 5.69 38.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.907 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -59.58 124.31 19.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 62.219999999999999 110.862 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.53 20.29 12.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.848 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.59 149.23 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 33.329999999999998 111.074 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.8 t -113.51 119.86 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 73.010000000000005 111.165 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 39' ' ' VAL . 21.5 m-85 -110.61 94.81 5.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.815 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -88.26 126.37 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 111.116 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.561 HG22 HD22 ' A' ' 50' ' ' LEU . 57.9 t -96.45 133.25 25.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.136 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.75 -41.64 4.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.686 2.257 . . . . 65.439999999999998 112.36 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.865 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.82 0.343 . . . . 74.209999999999994 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.9 mp -51.87 133.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.686 0.755 . . . . 72.400000000000006 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.79 -170.05 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 71.329999999999998 112.256 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.5 157.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.89 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.29 151.52 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 43.299999999999997 110.889 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 pp -130.35 176.81 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 111.099 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -120.33 133.91 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' ' 31' ' ' ALA . 2.0 pt -114.34 172.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.087 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.46 128.39 45.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.219999999999999 110.9 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.71 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.5 m-85 -97.12 103.17 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.834 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.53 136.15 38.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 75.340000000000003 110.92 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -130.43 177.25 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 65.510000000000005 111.158 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 tpt -73.56 -8.76 57.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.898 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -104.98 -37.57 6.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 61.119999999999997 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -179.63 176.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.87 131.43 70.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.188 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.35 151.03 58.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 73.409999999999997 111.154 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.22 68.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.611 2.207 . . . . 73.0 112.304 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.0 139.49 29.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.03 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -100.68 128.9 46.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 53.43 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -106.67 116.37 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.137 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -97.33 139.16 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.200000000000003 111.149 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 p -51.7 111.1 0.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 52.539999999999999 110.881 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.43 13.81 34.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 33.130000000000003 112.493 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.443 ' OG ' HG21 ' A' ' 104' ' ' VAL . 86.6 p -101.63 -169.78 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 73.200000000000003 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.744 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -147.04 143.46 28.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 73.140000000000001 111.128 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.45 -59.41 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 111.127 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.38 -35.53 60.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.400000000000006 110.922 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.76 -27.5 62.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 110.912 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 38' ' ' THR . 91.6 t -76.56 -35.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 61.210000000000001 111.095 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.88 29.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 62.219999999999999 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -67.11 -32.61 73.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 75.200000000000003 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.05 -34.8 14.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.530000000000001 110.895 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.471 ' HB3' HG23 ' A' ' 48' ' ' VAL . 3.3 m120 -75.04 -24.4 58.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.951 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 -11.68 66.41 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 71.540000000000006 112.529 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 22' ' ' PHE . 93.9 t -51.31 138.72 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 41.020000000000003 111.202 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.48 80.81 1.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.851 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 115' ' ' VAL . 28.3 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 70.430000000000007 110.913 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.778 0.323 . . . . 25.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -71.21 111.79 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.439999999999998 110.862 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.6 t -128.62 157.28 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 72.25 111.187 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 88.5 mt -90.37 130.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.8 tp -124.65 159.37 30.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 64.040000000000006 110.908 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.56 146.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.883 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 mt-10 -59.27 -59.94 12.21 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.896 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.5 Cg_endo -69.79 -46.78 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.346 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -53.38 -49.15 67.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.209999999999994 110.927 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.634 ' CD1' HG22 ' A' ' 95' ' ' THR . 57.4 t80 -64.34 -51.01 65.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 74.450000000000003 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -25.53 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 110.809 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.31 -50.54 12.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.2 mt -62.91 -21.83 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 75.209999999999994 110.932 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.58 158.96 9.49 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 71.329999999999998 112.497 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.31 157.53 77.29 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.642 0.734 . . . . 65.310000000000002 110.877 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.03 32.34 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.725 2.284 . . . . 62.009999999999998 112.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 p -58.09 158.52 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -52.43 -36.06 53.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.409999999999997 110.926 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -52.33 -62.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 63.240000000000002 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.67 -35.79 79.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 110.922 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -56.14 -53.33 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.871 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.9 -42.97 89.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 110.878 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -55.2 -37.51 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.898 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.663 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.4 mt -74.53 -51.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 63.409999999999997 111.124 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.18 -18.59 58.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 110.869 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -76.14 -23.17 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.927 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.22 164.34 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.043 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -71.75 119.59 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.519999999999996 110.86 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.0 43.89 55.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.635 -0.793 . . . . 73.129999999999995 112.516 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -118.58 116.04 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 70.219999999999999 111.123 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.87 144.77 39.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 111.233 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.663 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.27 -23.88 35.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 75.129999999999995 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.634 HG22 ' CD1' ' A' ' 72' ' ' TYR . 37.9 p -73.96 -1.56 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 64.239999999999995 111.151 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.7 t -89.36 -12.83 39.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.91 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.658 ' HD2' HD11 ' A' ' 86' ' ' ILE . 7.1 ptm180 -112.07 144.21 41.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 70.200000000000003 110.864 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.47 164.05 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 110.989 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.06 -167.13 39.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.463 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.2 m -104.16 64.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 61.43 110.857 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.564 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.5 mt-30 -162.84 124.33 2.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 64.439999999999998 110.908 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 101' ' ' GLN . 4.8 mp -156.13 150.9 26.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 65.25 110.924 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -146.0 129.94 17.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 110.9 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.783 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.6 t -64.84 117.62 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 72.239999999999995 111.13 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -136.83 178.36 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 72.040000000000006 110.911 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -37.16 76.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.93 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' HD21 ' A' ' 71' ' ' LEU . 6.3 t -65.54 -19.73 66.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 64.510000000000005 110.903 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.505 ' O ' HD13 ' A' ' 18' ' ' ILE . 11.4 m-85 -83.41 2.23 37.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 71.209999999999994 110.848 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.402 ' HA ' HD13 ' A' ' 18' ' ' ILE . 34.5 tt0 -56.94 123.59 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 62.219999999999999 110.836 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 59.29 27.08 16.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 53.450000000000003 110.865 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 20' ' ' ILE . . . -69.95 135.36 49.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 33.329999999999998 111.128 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.565 ' O ' HD12 ' A' ' 67' ' ' LEU . 27.3 t -104.2 122.39 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.010000000000005 111.16 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -112.9 104.27 12.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.857 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.495 HG23 ' HD2' ' A' ' 23' ' ' LYS . 40.6 m -92.83 117.99 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.155 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 50' ' ' LEU . 20.0 t -108.68 88.83 5.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.525 0.679 . . . . 72.129999999999995 111.13 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -36.24 10.96 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.698 2.265 . . . . 65.439999999999998 112.296 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 72.140000000000001 110.839 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.751 0.31 . . . . 74.209999999999994 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mm 63.5 136.8 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.558 0.694 . . . . 72.400000000000006 111.143 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.78 2.52 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 71.329999999999998 112.362 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -52.07 157.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 110.878 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.75 143.7 45.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 43.299999999999997 110.956 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 109' ' ' GLU . 1.3 pt -128.75 176.8 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 64.439999999999998 111.094 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.81 136.26 52.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.878 HD11 HG11 ' A' ' 42' ' ' VAL . 1.8 pt -116.98 157.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.118 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -119.98 126.5 50.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.926 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 4.5 m-85 -105.0 102.9 12.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.927 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 117.78 26.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.95 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 p -105.33 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 65.510000000000005 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 29.8 mmt -75.72 -7.99 55.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.921 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtm -102.97 -38.39 7.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 61.119999999999997 110.889 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 178.28 176.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 54.409999999999997 110.925 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.3 t -79.1 147.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 111.058 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.93 87.84 9.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.64 0.734 . . . . 73.409999999999997 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 135.0 29.33 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 73.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.22 159.93 40.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.085 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -99.7 127.98 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.943 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -95.3 131.81 40.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.115 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.85 146.51 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.200000000000003 111.107 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.2 p -57.49 119.8 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 52.539999999999999 110.892 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.01 39.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.473 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.32 161.02 13.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.200000000000003 110.859 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.9 p -114.46 159.23 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 111.116 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.27 -58.4 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.54 -35.82 63.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.400000000000006 110.968 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.881 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG11 HD11 ' A' ' 20' ' ' ILE . 97.7 t -76.43 -44.05 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 61.210000000000001 111.167 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -55.13 -29.22 57.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.219999999999999 111.055 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -73.37 -26.6 61.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 75.200000000000003 110.869 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -69.73 -52.15 27.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.86 -25.1 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.863 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.07 -12.22 34.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 71.540000000000006 112.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.64 115.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 41.020000000000003 111.087 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.84 80.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 70.430000000000007 110.924 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.903 0.382 . . . . 25.530000000000001 110.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -152.06 109.75 3.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.805 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 8.1 t -128.62 157.02 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.6 mt -90.12 131.23 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.430000000000007 111.127 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.7 tp -129.45 162.3 28.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.928 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -39.62 139.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.917 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -59.58 -59.05 15.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.696 0.76 . . . . 73.040000000000006 110.904 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.1 Cg_endo -69.78 -49.16 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.735 2.29 . . . . 54.219999999999999 112.319 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -52.09 -48.53 64.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 110.932 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -66.89 -42.71 85.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.93 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -51.88 -58.11 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 65.439999999999998 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -70.03 -28.73 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.9 tp -63.56 -61.23 2.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.944 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.32 143.59 4.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 71.329999999999998 112.482 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -134.67 157.27 77.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.574 0.702 . . . . 65.310000000000002 110.886 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.743 2.295 . . . . 62.009999999999998 112.32 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.4 m -58.17 171.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.59 -38.13 77.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -52.3 -62.43 1.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 63.240000000000002 110.89 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.53 -35.41 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.530000000000001 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.42 -53.04 62.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 110.904 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -66.07 -42.37 89.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 71.120000000000005 110.832 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.13 -36.91 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.959 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 14.8 mt -74.61 -54.85 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 111.113 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.95 -24.53 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 74.030000000000001 110.855 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.15 -25.62 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 110.908 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.458 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -80.59 151.07 29.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 111.084 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -67.37 128.71 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 110.805 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.46 54.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.489 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -119.66 117.16 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 70.219999999999999 111.056 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 143.9 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 111.196 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.62 -24.68 40.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.129999999999995 112.491 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.476 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.2 p -73.94 -1.73 21.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 64.239999999999995 111.188 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 23.2 t -89.79 -12.6 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.854 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 14.9 mtt-85 -106.6 139.87 40.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.892 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 tp -158.87 164.89 35.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 73.450000000000003 110.878 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.94 -131.67 5.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.485 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m -122.62 -54.5 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 61.43 110.915 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -52.11 139.26 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 64.439999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.6 tp -176.64 140.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HD3' HG22 ' A' ' 38' ' ' THR . 7.8 tpp180 -141.94 154.07 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.848 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 37' ' ' SER . 92.3 t -74.7 124.97 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 72.239999999999995 111.131 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.67 168.15 20.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 72.040000000000006 110.88 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -57.22 -39.35 75.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.510000000000005 110.909 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 m -64.02 -20.46 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 110.895 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.75 7.67 29.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 71.209999999999994 110.851 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.433 ' N ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -59.14 125.19 22.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 62.219999999999999 110.839 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 60.0 22.19 11.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 53.450000000000003 110.897 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.38 136.63 57.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 33.329999999999998 111.061 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.718 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.0 t -98.76 117.08 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.134 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -109.39 94.82 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.926 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 34.2 m -89.42 130.92 35.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.172 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.6 t -104.44 133.29 20.27 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 72.129999999999995 111.086 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.423 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.84 -41.25 4.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 65.439999999999998 112.308 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.854 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.722 0.296 . . . . 74.209999999999994 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -94.53 133.14 27.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.675 0.75 . . . . 72.400000000000006 111.104 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.73 -170.34 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.746 2.297 . . . . 71.329999999999998 112.358 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -51.46 156.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -73.84 156.45 37.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 43.299999999999997 110.9 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.03 176.97 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 111.132 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -118.1 135.83 53.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.836 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.773 HG13 ' HB3' ' A' ' 31' ' ' ALA . 32.0 pt -114.36 171.83 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 111.142 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.19 126.72 52.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.895 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 1.7 m-85 -97.93 103.18 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.856 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 28' ' ' VAL . 15.8 tptm -85.66 106.67 17.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 110.887 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -101.9 178.61 4.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 65.510000000000005 111.168 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 ttm -75.7 -8.05 55.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -106.05 -38.62 6.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.119999999999997 110.933 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 178.34 176.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 54.409999999999997 110.846 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 23' ' ' LYS . 21.3 t -102.45 123.11 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.010000000000005 111.068 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.85 150.54 45.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.169 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 153.22 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 73.0 112.349 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -143.51 135.56 26.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.131 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -97.64 118.68 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 53.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.64 116.52 30.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.105 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.16 148.05 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 75.200000000000003 111.11 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.8 p -51.32 110.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.539999999999999 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.48 14.42 30.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 33.130000000000003 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -97.64 -170.61 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 73.200000000000003 110.878 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -141.91 140.92 32.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 73.140000000000001 111.15 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.1 t -52.41 -59.51 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 111.081 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 50' ' ' LEU . 6.4 mt -53.72 -35.57 61.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 65.400000000000006 110.872 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -72.7 -26.75 61.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 72.450000000000003 110.883 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 38' ' ' THR . 97.4 t -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.71 20.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.072 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -70.23 -36.77 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 75.200000000000003 110.871 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -82.82 -34.9 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.879 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.35 -28.25 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.935 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.0 -12.25 34.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.743 . . . . 71.540000000000006 112.537 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 22' ' ' PHE . 98.9 t -59.94 141.06 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 41.020000000000003 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -78.79 80.7 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 115' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 70.430000000000007 110.911 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.821 0.344 . . . . 25.530000000000001 110.849 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -68.81 100.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 65.439999999999998 110.841 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 114' ' ' THR . 4.7 t -128.63 159.04 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 72.25 111.15 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.9 mt -89.86 130.46 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 111.165 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLU . 16.8 tp -119.29 166.4 13.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.040000000000006 110.882 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 71' ' ' LEU . 5.9 mp0 -36.8 135.87 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 71.019999999999996 110.913 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.553 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tt0 -65.26 -56.73 18.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.595 0.712 . . . . 73.040000000000006 110.867 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.69 -51.82 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 54.219999999999999 112.387 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -51.93 -48.35 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.893 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.608 ' CD1' HG22 ' A' ' 95' ' ' THR . 20.2 t80 -64.94 -53.57 44.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 110.918 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.6 -47.96 63.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.816 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.31 -36.62 83.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 75.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -62.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.85 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 160.35 20.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 71.329999999999998 112.429 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 157.55 77.44 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.658 0.742 . . . . 65.310000000000002 110.928 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 166.82 26.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.309 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 t -57.95 171.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.97 -37.48 79.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 72.409999999999997 110.898 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.35 -62.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 110.912 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.59 -35.54 79.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.34 -53.19 60.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.914 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.97 -42.79 89.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 71.120000000000005 110.858 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.48 -37.14 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 64.219999999999999 110.919 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.1 mt -74.74 -52.68 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.152 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -59.3 -21.08 59.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.875 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -75.94 -23.27 55.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.924 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.48 164.18 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.144 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -74.4 118.99 17.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 75.519999999999996 110.847 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.66 43.73 53.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.678 -0.772 . . . . 73.129999999999995 112.52 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -106.98 143.5 34.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.083 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.85 145.72 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 111.125 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.97 -28.59 53.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 75.129999999999995 112.473 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.0 p -73.53 -3.31 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.333 . . . . 64.239999999999995 111.149 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 48.1 t -85.44 -13.77 48.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.857 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.74 143.26 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 70.200000000000003 110.87 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.23 142.38 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.96 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.76 158.14 3.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.788 -0.72 . . . . 71.010000000000005 112.467 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.6 t -55.62 -26.97 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 61.43 110.885 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.58 114.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 64.439999999999998 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mt -141.78 95.34 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.945 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.99 147.47 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.936 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.6 t -96.02 128.31 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 72.239999999999995 111.169 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -136.56 167.77 20.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 72.040000000000006 110.899 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -55.49 -42.01 73.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.904 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -18.97 58.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 64.510000000000005 110.863 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -93.34 17.14 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 71.209999999999994 110.813 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.68 126.97 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 62.219999999999999 110.977 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 m120 58.85 24.23 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 53.450000000000003 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -58.61 126.14 26.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 33.329999999999998 111.144 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 12.4 t -84.98 118.76 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 73.010000000000005 111.117 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 111' ' ' ALA . 74.5 m-85 -113.01 102.74 10.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.430000000000007 110.88 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.9 m -88.55 130.14 35.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 111.205 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 50' ' ' LEU . 60.6 t -101.06 133.24 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 72.129999999999995 111.065 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.4 Cg_endo -69.8 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.649 2.233 . . . . 65.439999999999998 112.328 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.89 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 121.472 0.484 . . . . 71.299999999999997 112.552 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 101.86 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.676 2.251 . . . . 64.129999999999995 112.337 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.72 165.14 22.33 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.77 -0.729 . . . . 41.340000000000003 112.513 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 p -100.45 -62.45 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.911 0.386 . . . . 73.310000000000002 110.85 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.6 mmt 54.84 30.54 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 73.430000000000007 110.9 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -79.74 -50.27 10.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.420000000000002 110.915 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.8 ttp -80.76 152.6 28.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 62.509999999999998 110.9 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.29 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 71.439999999999998 110.937 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 26.85 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.838 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.3 68.27 9.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 71.340000000000003 111.085 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.62 -13.11 34.54 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 63.229999999999997 112.405 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.5 -23.09 66.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 110.86 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -67.79 93.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.866 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.463 HD13 ' N ' ' A' ' 36' ' ' GLY . 3.4 mt -90.96 132.95 33.04 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.178 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -169.84 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.718 2.279 . . . . 71.329999999999998 112.375 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.26 157.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 160.12 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 43.299999999999997 110.934 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.7 pp -141.9 176.74 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.439999999999998 111.115 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -117.1 135.55 53.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 75.340000000000003 110.831 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.2 pt -116.92 173.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.147 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -128.53 132.73 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.2 m-85 -102.94 104.84 15.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.819 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.4 129.39 44.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.937 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 p -122.15 -177.71 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.510000000000005 111.141 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.3 mmt -75.76 -17.37 59.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 110.895 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -96.33 -37.89 10.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 61.119999999999997 110.858 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 179.71 176.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 54.409999999999997 110.884 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 131.44 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 111.16 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.552 HG21 HG22 ' A' ' 48' ' ' VAL . 1.8 m -121.62 150.89 56.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.546 0.689 . . . . 73.409999999999997 111.126 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 153.02 69.78 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.655 2.237 . . . . 73.0 112.325 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.14 140.48 28.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 53.340000000000003 111.119 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -104.88 126.87 52.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.43 110.894 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -107.18 116.34 31.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 111.081 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.04 142.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 111.173 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 p -54.19 120.25 6.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 106.54 -4.55 37.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.817 -0.706 . . . . 33.130000000000003 112.481 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.76 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 110.897 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.2 p -138.04 155.06 49.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.183 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.57 -59.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 70.420000000000002 111.15 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -35.45 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.896 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -72.66 -26.6 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.450000000000003 110.904 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 38' ' ' THR . 95.4 t -76.18 -47.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 111.081 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.79 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 62.219999999999999 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -69.89 -36.72 75.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.864 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -76.35 -42.66 44.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.845 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -72.27 -27.08 62.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.87 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.14 -12.07 34.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 71.540000000000006 112.457 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 29' ' ' VAL . 22.6 t -57.86 127.55 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 41.020000000000003 111.151 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -81.04 80.83 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.847 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.707 HD22 HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -84.49 134.74 34.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 110.834 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' N ' HD13 ' A' ' 50' ' ' LEU . 11.0 mt-10 -61.09 121.71 13.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 53.100000000000001 110.862 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.06 -113.27 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 24.25 112.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 54.87 26.43 7.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 55.299999999999997 111.082 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.9 142.84 50.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.329999999999998 110.924 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -121.42 56.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 110.933 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.72 30.8 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.811 -0.709 . . . . 75.319999999999993 112.435 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.59 179.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 73.329999999999998 110.849 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.2 mt -90.17 -25.51 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 72.140000000000001 110.923 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.06 75.16 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 51.329999999999998 111.13 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.28 110.78 3.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 74.540000000000006 110.868 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 p -95.15 -67.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 65.319999999999993 110.895 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -149.78 141.56 23.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 62.32 111.176 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.43 115.46 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 25.530000000000001 110.818 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -150.08 112.83 4.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.86 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.3 t -128.6 158.03 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.151 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 83.6 mt -89.99 131.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 111.143 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 112' ' ' VAL . 17.4 tp -123.02 160.88 25.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 64.040000000000006 110.918 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.77 143.96 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 71.019999999999996 110.916 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.1 mt-10 -57.4 -59.14 13.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.76 -46.73 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 54.219999999999999 112.306 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 6.8 tp -51.67 -45.69 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.924 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 95' ' ' THR . 49.0 t80 -72.28 -41.01 67.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 74.450000000000003 110.908 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -53.85 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 65.439999999999998 110.898 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -33.23 67.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 75' ' ' LEU . 10.8 mt -62.87 -25.0 68.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.843 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.87 142.5 4.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 71.329999999999998 112.507 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -110.71 156.84 39.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 65.310000000000002 110.854 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.81 13.76 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 62.009999999999998 112.362 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -99.29 -170.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -56.61 -47.77 78.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -53.74 -59.74 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 63.240000000000002 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 86' ' ' ILE . 16.3 mm-40 -61.2 -28.58 69.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 71.530000000000001 110.858 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -55.64 27.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.893 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.41 -37.37 82.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 110.844 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.32 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.94 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.571 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.5 mt -74.97 -34.38 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 111.116 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -58.99 -21.43 58.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 110.858 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -75.95 -25.67 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.883 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -74.71 163.97 27.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.065 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -84.2 113.63 21.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.89 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.82 52.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.535 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -95.14 129.41 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.42 146.36 27.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 111.083 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.571 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.4 -23.46 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 75.129999999999995 112.487 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.638 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.5 p -73.82 -1.84 21.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.16 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 9.4 t -88.9 -12.8 40.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 71.409999999999997 110.884 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -117.39 132.62 56.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 70.200000000000003 110.816 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.27 179.88 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.944 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.77 -155.67 15.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 71.010000000000005 112.491 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -140.44 53.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 61.43 110.856 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.1 pt20 -179.07 98.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 64.439999999999998 110.912 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 101' ' ' GLN . 10.6 mp -130.25 160.73 33.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.25 110.906 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -115.9 170.26 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.209999999999994 110.825 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 90.5 t -97.76 118.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 111.129 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -137.05 177.1 8.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 72.040000000000006 110.906 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -60.63 -31.5 70.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -65.04 -19.54 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.510000000000005 110.92 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.603 ' HZ ' HD23 ' A' ' 102' ' ' LEU . 3.1 m-85 -85.7 4.41 36.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 71.209999999999994 110.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -57.03 123.39 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 59.55 26.03 14.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.879 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -68.51 136.72 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 33.329999999999998 111.116 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.5 t -109.74 123.03 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.010000000000005 111.15 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.47 103.9 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.897 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 23' ' ' LYS . 49.9 m -93.79 118.72 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 73.439999999999998 111.168 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG21 HD22 ' A' ' 50' ' ' LEU . 23.1 t -108.57 89.29 5.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.719 . . . . 72.129999999999995 111.133 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -39.06 6.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.615 2.21 . . . . 65.439999999999998 112.343 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -65.84 159.38 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 110.848 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.9 172.11 8.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 53.109999999999999 111.087 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 m -93.15 157.77 16.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 111.129 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -68.96 142.2 54.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 110.867 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -155.94 -177.0 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ptm -52.09 117.86 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 110.858 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.08 131.72 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 62.43 111.117 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.04 151.51 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 44.350000000000001 111.117 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -150.26 156.43 41.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 71.030000000000001 110.774 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.0 -20.63 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.801 -0.714 . . . . 73.430000000000007 112.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.21 66.4 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 74.310000000000002 110.885 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -148.91 69.57 10.0 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.579 0.704 . . . . 71.430000000000007 110.867 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -43.7 2.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.378 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 72.89 16.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.589 0.709 . . . . 72.420000000000002 110.919 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.38 4.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.693 2.262 . . . . 73.030000000000001 112.342 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 72.120000000000005 110.917 179.934 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.454 0.474 . . . . 71.299999999999997 112.522 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.636 2.224 . . . . 64.129999999999995 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.39 141.08 15.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 41.340000000000003 112.481 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -100.95 146.53 27.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 73.310000000000002 110.875 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mmt -114.52 -62.72 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 73.430000000000007 110.894 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -66.21 162.85 19.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 71.420000000000002 110.867 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.2 ptm -99.71 139.51 35.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 62.509999999999998 110.898 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -146.26 166.51 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 71.439999999999998 110.873 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 t -52.16 103.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.913 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 13' ' ' ARG . . . -152.13 73.9 7.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 71.340000000000003 111.073 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -16.69 37.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 63.229999999999997 112.376 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.04 -22.98 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.873 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB2' ' HB1' ' A' ' 10' ' ' ALA . 38.5 mtt180 -104.07 103.68 13.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.209999999999994 110.851 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' ' 103' ' ' ARG . 41.0 mm -60.2 133.04 90.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.111 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.4 Cg_endo -69.72 -170.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 71.329999999999998 112.38 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.8 156.82 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.871 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.81 159.56 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 43.299999999999997 110.919 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.523 HD13 ' C ' ' A' ' 108' ' ' PHE . 1.1 pt -141.83 176.76 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 64.439999999999998 111.102 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.76 129.19 47.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.855 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.623 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -114.59 172.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.167 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.9 131.5 52.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.912 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.745 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -99.63 103.07 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 71.329999999999998 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -94.24 135.34 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.340000000000003 110.865 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -133.39 177.69 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 65.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.9 tpt -75.36 -8.33 56.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.884 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -104.18 -37.91 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 179.21 176.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 54.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.9 124.69 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.010000000000005 111.132 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -119.84 151.01 51.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.714 . . . . 73.409999999999997 111.17 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 156.03 64.26 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 73.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.623 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -150.93 104.29 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.077 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -79.34 132.04 36.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.91 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.552 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -121.35 116.53 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.133 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 150.8 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.05 116.26 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.861 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 2.01 37.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.733 . . . . 33.130000000000003 112.487 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -99.17 -176.15 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 73.200000000000003 110.818 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -138.93 146.01 40.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 111.147 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.48 -62.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 111.111 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 ' CD1' HD12 ' A' ' 50' ' ' LEU . 4.3 mm? -53.81 -33.54 56.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 65.400000000000006 110.946 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -72.68 -27.27 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.883 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 38' ' ' THR . 94.4 t -76.87 -45.44 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 61.210000000000001 111.119 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.51 -29.93 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.121 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -71.4 -37.99 71.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.894 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -44.24 63.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.08 -25.2 61.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.2 -12.26 44.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 71.540000000000006 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 29' ' ' VAL . 35.8 t -53.36 129.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 41.020000000000003 111.119 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.691 ' O ' HG21 ' A' ' 119' ' ' THR . 31.5 t0 -77.3 80.67 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.209999999999994 110.915 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.631 HD12 ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -110.59 106.71 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.176 -0.466 . . . . 70.430000000000007 110.926 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -129.0 113.93 15.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.878 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.5 110.76 0.84 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.715 -0.755 . . . . 24.25 112.505 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.959 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -51.89 103.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 55.299999999999997 111.119 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.02 -27.56 9.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 72.329999999999998 110.905 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.18 119.68 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 64.450000000000003 110.903 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.47 -177.5 18.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 75.319999999999993 112.471 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.8 -73.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 73.329999999999998 110.871 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.02 -29.33 28.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.140000000000001 110.933 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.959 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -68.3 -50.05 56.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 51.329999999999998 111.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 t -87.35 53.27 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 74.540000000000006 110.92 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -81.16 -170.49 2.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 65.319999999999993 110.92 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.83 100.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.32 111.159 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.6 m -57.28 146.31 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 25.530000000000001 110.844 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -135.94 77.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 65.439999999999998 110.851 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.0 t -128.73 157.64 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.135 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 85.4 mt -90.02 131.24 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 111.151 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 112' ' ' VAL . 22.2 tp -127.0 160.65 30.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 64.040000000000006 110.927 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -45.79 143.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -58.11 -60.23 10.76 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.64 0.733 . . . . 73.040000000000006 110.908 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.78 -48.32 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.699 2.266 . . . . 54.219999999999999 112.348 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.578 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.81 -45.26 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 73.209999999999994 110.929 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 89.6 t80 -70.79 -49.61 44.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.904 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -54.09 -41.62 68.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -71.36 -46.27 60.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.578 HD23 HD13 ' A' ' 71' ' ' LEU . 2.4 mm? -63.35 -24.43 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.06 130.98 2.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.733 . . . . 71.329999999999998 112.505 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -115.78 157.66 44.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 65.310000000000002 110.871 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.3 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.699 2.266 . . . . 62.009999999999998 112.356 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -104.12 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.885 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -57.87 -44.12 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.877 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -53.58 -59.71 4.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 63.240000000000002 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' OE2' HD23 ' A' ' 98' ' ' LEU . 25.9 tt0 -62.73 -28.21 69.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.530000000000001 110.86 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -52.88 62.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.898 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.02 -39.2 75.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 71.120000000000005 110.891 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.2 -50.81 70.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.219999999999999 110.931 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.2 mt -74.96 -34.3 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 63.409999999999997 111.161 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.76 -20.0 53.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 110.898 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.84 -26.0 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.897 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.95 145.01 36.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.107 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -65.92 121.81 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.18 45.17 57.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.504 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -111.37 125.37 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 70.219999999999999 111.075 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.06 147.66 38.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.119 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.49 -23.4 35.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 75.129999999999995 112.519 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 25.2 p -73.93 -1.81 21.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 64.239999999999995 111.15 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.1 t -88.95 -13.49 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 71.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -141.39 167.85 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 70.200000000000003 110.839 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.404 HD23 ' OE2' ' A' ' 82' ' ' GLU . 4.2 mm? 57.38 44.9 20.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 73.450000000000003 110.899 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.54 111.75 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 71.010000000000005 112.47 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.0 t -163.02 156.85 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 61.43 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.671 ' O ' HD23 ' A' ' 102' ' ' LEU . 1.2 tp-100 -170.05 -179.53 3.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.439999999999998 110.913 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.717 ' C ' HG22 ' A' ' 38' ' ' THR . 7.2 mt -139.5 -61.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 65.25 110.931 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HD2' HD11 ' A' ' 14' ' ' ILE . 1.5 mtm180 -59.65 158.7 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.867 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.552 HG21 ' HB1' ' A' ' 33' ' ' ALA . 94.4 t -109.16 134.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 111.099 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.57 170.06 16.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.891 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -59.22 -34.16 71.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.903 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.495 ' O ' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -64.25 -20.2 65.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.510000000000005 110.878 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.1 m-85 -87.38 6.59 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.834 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.32 124.48 19.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.219999999999999 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.95 24.32 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 53.450000000000003 110.915 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.1 126.76 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 33.329999999999998 111.139 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HD12 ' A' ' 67' ' ' LEU . 41.1 t -99.91 121.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.161 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -111.98 103.17 11.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.885 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.7 m -96.08 119.41 34.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 111.124 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 50' ' ' LEU . 19.1 t -108.65 89.11 5.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -34.23 14.99 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 65.439999999999998 112.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -76.38 148.45 37.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.833 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.61 -176.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.109999999999999 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 49' ' ' ASP . 1.1 p -124.72 176.92 6.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 111.13 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 53' ' ' ALA . 16.6 mtpt -112.13 -171.83 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.895 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -106.49 167.33 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.329999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.5 mtt -104.23 179.27 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 110.845 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.43 172.82 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 62.43 111.058 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.9 146.38 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 44.350000000000001 111.145 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -175.25 149.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 71.030000000000001 110.818 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.62 -38.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 73.430000000000007 112.48 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 59.08 27.21 16.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 74.310000000000002 110.891 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.1 tptt 57.35 73.63 0.75 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.592 0.711 . . . . 71.430000000000007 110.942 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 129.08 17.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.652 2.235 . . . . 73.120000000000005 112.355 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -172.09 69.19 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.594 0.712 . . . . 72.420000000000002 110.901 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -173.16 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 73.030000000000001 112.318 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.8 m170 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.859 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.449 0.472 . . . . 71.299999999999997 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -174.73 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.74 2.293 . . . . 64.129999999999995 112.284 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.77 -117.07 1.7 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 41.340000000000003 112.453 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m 56.67 39.51 29.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.854 0.359 . . . . 73.310000000000002 110.864 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.1 132.04 43.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 110.901 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -104.19 30.8 4.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 71.420000000000002 110.898 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.9 mmm -136.62 -178.99 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 62.509999999999998 110.872 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -119.72 139.27 52.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 71.439999999999998 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.5 p -175.83 147.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 72.439999999999998 110.841 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -54.52 160.39 2.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 71.340000000000003 111.118 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 53.1 Cg_endo -69.76 79.96 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.682 2.255 . . . . 63.229999999999997 112.301 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -118.46 25.11 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -130.79 116.02 17.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 110.864 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.9 mt -115.17 133.22 22.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 72.400000000000006 111.122 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.6 Cg_endo -69.81 178.85 4.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.723 2.282 . . . . 71.329999999999998 112.288 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.83 157.51 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 73.310000000000002 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -73.45 145.59 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 43.299999999999997 110.922 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 108' ' ' PHE . 2.0 pp -118.18 171.2 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 130.11 56.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.8 pt -117.17 173.74 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 111.157 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.6 131.78 49.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 75.219999999999999 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -103.22 102.95 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.329999999999998 110.915 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HD3' HG23 ' A' ' 114' ' ' THR . 4.5 tttp -94.82 140.02 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.898 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -140.48 175.79 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.418 . . . . 65.510000000000005 111.188 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.9 ttm -75.65 -11.67 60.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.877 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.25 -37.78 9.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 61.119999999999997 110.91 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 179.86 176.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 54.409999999999997 110.936 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 ' CG ' ' A' ' 23' ' ' LYS . 15.4 t -119.16 121.68 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 111.107 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -121.7 150.31 55.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 111.163 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 166.72 26.66 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.765 2.31 . . . . 73.0 112.343 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -154.86 145.06 21.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 53.340000000000003 111.078 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -111.78 121.95 46.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 53.43 110.9 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -95.11 116.63 28.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.38 153.8 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 111.097 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -62.94 121.61 13.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.506 . . . . 52.539999999999999 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 86.38 0.64 86.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 33.130000000000003 112.473 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.93 -169.81 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 73.200000000000003 110.847 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -142.23 154.46 44.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.19 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.8 -59.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 70.420000000000002 111.103 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.32 -34.26 60.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 65.400000000000006 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.68 -26.86 61.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 110.91 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' THR . 97.7 t -76.5 -45.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.105 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.77 -33.34 34.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 62.219999999999999 111.101 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -66.96 -35.14 79.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 110.893 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -66.88 -49.37 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.895 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -72.01 -24.56 61.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.94 -12.05 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 71.540000000000006 112.484 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 29' ' ' VAL . 25.5 t -55.86 129.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 41.020000000000003 111.136 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -86.23 80.85 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -79.08 121.0 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 70.430000000000007 110.898 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -59.35 140.12 56.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 53.100000000000001 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.24 -110.49 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 24.25 112.522 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 53.23 46.98 25.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 55.299999999999997 111.099 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.42 -32.5 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 110.815 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 52.45 35.06 16.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 64.450000000000003 110.873 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.58 140.9 8.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.749 -0.739 . . . . 75.319999999999993 112.536 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -82.19 -27.55 32.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 73.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 58' ' ' LEU . 4.4 mm? -55.25 169.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 72.140000000000001 110.91 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 133.67 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 51.329999999999998 111.062 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.63 179.68 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 74.540000000000006 110.865 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -170.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 65.319999999999993 110.868 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.61 99.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.158 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -98.94 116.07 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 25.530000000000001 110.9 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -164.53 109.43 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 65.439999999999998 110.847 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 115' ' ' VAL . 11.9 t -128.48 155.0 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 72.25 111.119 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.4 mt -90.76 129.44 41.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 64.430000000000007 111.139 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 112' ' ' VAL . 21.6 tp -124.5 161.8 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 64.040000000000006 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.95 143.7 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 71.019999999999996 110.846 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -58.31 -59.52 13.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.702 . . . . 73.040000000000006 110.808 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -47.92 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.661 2.241 . . . . 54.219999999999999 112.303 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -53.0 -42.59 65.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.915 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.658 ' CD1' HG22 ' A' ' 95' ' ' THR . 58.4 t80 -71.85 -54.11 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.34 -34.81 58.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 65.439999999999998 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -78.03 -41.8 34.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.8 mm? -63.15 -25.76 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.992 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.36 140.08 5.33 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 71.329999999999998 112.508 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.74 160.3 28.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.66 0.743 . . . . 65.310000000000002 110.9 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 166.62 27.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.661 2.241 . . . . 62.009999999999998 112.326 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.0 t -58.09 171.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.817 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -59.96 -37.32 79.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.858 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -62.57 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 110.92 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -67.54 -35.63 79.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.837 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.27 -53.49 56.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.897 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.73 -42.58 90.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.936 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.52 -37.44 67.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.857 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.606 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.0 mt -74.52 -52.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 63.409999999999997 111.172 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.68 -21.59 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.819 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -76.18 -24.16 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 110.908 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -74.15 164.28 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 111.132 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -74.47 113.69 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.907 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.22 40.56 52.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.506 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -107.58 114.87 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 70.219999999999999 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.67 142.82 27.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.178 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.36 -23.68 34.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.812 -0.709 . . . . 75.129999999999995 112.471 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.658 HG22 ' CD1' ' A' ' 72' ' ' TYR . 17.8 p -74.22 -0.93 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 64.239999999999995 111.105 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 45.3 t -90.63 -12.21 37.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.837 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.98 133.67 55.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.888 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 pp -179.06 -178.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.26 -133.12 4.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 71.010000000000005 112.501 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -144.78 -42.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 61.43 110.936 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.728 ' O ' HD22 ' A' ' 102' ' ' LEU . 44.9 mt-30 -60.33 101.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.913 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 101' ' ' GLN . 4.0 mm? -134.99 127.08 29.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.25 110.948 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -84.41 168.95 15.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 70.209999999999994 110.86 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 57.5 t -102.45 119.24 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.239999999999995 111.111 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.05 172.98 12.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.866 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -29.7 68.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.834 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.8 m -65.65 -22.65 66.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.510000000000005 110.86 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 102' ' ' LEU . 3.1 m-85 -81.77 -0.15 41.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.857 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.65 123.77 16.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 62.219999999999999 110.92 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.75 27.18 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 53.450000000000003 110.915 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -68.19 151.07 47.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 33.329999999999998 111.024 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.2 t -116.28 120.99 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.010000000000005 111.146 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -114.19 98.96 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.908 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.573 HG23 ' HD3' ' A' ' 23' ' ' LYS . 43.3 m -91.41 116.65 29.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.133 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.551 HG21 ' CD2' ' A' ' 50' ' ' LEU . 22.0 t -108.64 89.19 5.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.597 0.713 . . . . 72.129999999999995 111.132 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -35.53 12.65 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.726 2.284 . . . . 65.439999999999998 112.354 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.08 108.84 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.842 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -163.09 179.48 7.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 53.109999999999999 111.077 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 t -99.25 173.51 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.409999999999997 111.09 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -54.05 173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 110.863 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.5 146.61 24.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 110.892 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -144.43 105.45 4.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.895 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.81 139.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 62.43 111.069 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.1 143.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 44.350000000000001 111.12 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -172.95 130.55 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 71.030000000000001 110.912 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.39 101.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 73.430000000000007 112.47 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.89 124.3 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 74.310000000000002 110.875 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -143.33 161.29 48.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.473 0.654 . . . . 71.430000000000007 110.928 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 94.18 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.636 2.224 . . . . 73.120000000000005 112.299 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -138.37 157.88 71.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 72.420000000000002 110.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 174.67 9.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.757 2.305 . . . . 73.030000000000001 112.321 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 110.82 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 CA-C-O 121.466 0.481 . . . . 71.299999999999997 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 158.89 55.34 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.129999999999995 112.318 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.05 145.08 9.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 41.340000000000003 112.464 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.45 -179.94 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 73.310000000000002 110.832 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 tpt -120.85 -64.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 73.430000000000007 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -171.38 -179.93 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 71.420000000000002 110.872 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -131.07 168.98 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 62.509999999999998 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -155.56 161.11 40.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 71.439999999999998 110.816 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 p -73.15 166.15 23.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 110.835 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.32 74.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.569 0.699 . . . . 71.340000000000003 111.051 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 78.05 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 63.229999999999997 112.334 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -121.55 25.31 9.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.858 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 63.35 30.52 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.877 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 64.72 148.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 72.400000000000006 111.139 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.27 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.385 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.66 157.41 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 73.310000000000002 110.875 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.21 133.25 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 43.299999999999997 110.872 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.757 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.6 pp -124.12 176.96 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 64.439999999999998 111.098 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -113.79 140.9 47.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.861 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.69 175.09 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.15 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -133.03 126.77 32.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.625 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 26.6 m-85 -108.77 103.16 12.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 110.882 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -88.69 132.15 34.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.9 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -115.32 176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 65.510000000000005 111.136 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.0 tpt -75.64 -8.29 56.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 73.099999999999994 110.918 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -103.44 -37.95 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.826 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 179.39 176.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 54.409999999999997 110.966 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 23' ' ' LYS . 23.1 t -79.62 147.63 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 111.148 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.752 ' CG1' HG22 ' A' ' 48' ' ' VAL . 67.6 t -141.38 87.79 10.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 73.409999999999997 111.169 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 152.59 69.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.612 2.208 . . . . 73.0 112.396 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.63 144.28 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.428 . . . . 53.340000000000003 111.079 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.88 147.87 29.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 53.43 110.857 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.681 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -116.75 143.58 45.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 111.078 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.45 151.4 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.200000000000003 111.117 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 p -53.38 116.29 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 52.539999999999999 110.841 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' H ' HD13 ' A' ' 14' ' ' ILE . . . 74.15 25.31 71.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 33.130000000000003 112.483 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.7 p -77.83 -169.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.839 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.734 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -136.87 143.1 42.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.149 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 96.2 t -53.11 -63.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 70.420000000000002 111.116 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.85 -32.84 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 65.400000000000006 110.927 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.72 -27.52 62.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 72.450000000000003 110.815 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 38' ' ' THR . 76.1 t -77.22 -44.93 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.121 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.16 -28.33 52.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 111.121 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.55 -26.39 61.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.78 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.31 -53.78 6.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.872 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 3.42 37.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 15.82 59.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 71.540000000000006 112.459 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.752 HG22 ' CG1' ' A' ' 29' ' ' VAL . 82.0 t -52.26 127.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 41.020000000000003 111.135 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.37 80.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.86 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tt -126.63 105.13 8.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.430000000000007 110.938 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -106.41 141.17 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 53.100000000000001 110.805 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.35 66.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 24.25 112.496 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.03 120.73 5.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.362 . . . . 55.299999999999997 111.144 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -25.01 58.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.329999999999998 110.844 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -124.91 132.55 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 64.450000000000003 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.26 163.73 12.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.767 -0.73 . . . . 75.319999999999993 112.491 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -63.76 125.09 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 73.329999999999998 110.871 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.85 25.95 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 72.140000000000001 110.92 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.27 163.59 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 51.329999999999998 111.123 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t 56.24 25.8 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.866 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -70.97 -46.37 62.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 65.319999999999993 110.866 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 p -131.16 99.77 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 62.32 111.144 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HB3' HD13 ' A' ' 98' ' ' LEU . 7.7 t -96.21 30.84 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 25.530000000000001 110.894 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.43 94.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.2 t -128.67 156.41 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.25 111.111 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.1 mt -89.98 131.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 111.15 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 112' ' ' VAL . 37.6 tp -127.77 159.74 33.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.937 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.54 141.23 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 110.891 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.1 mt-10 -57.48 -59.52 12.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 73.040000000000006 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.79 -48.63 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.601 2.201 . . . . 54.219999999999999 112.38 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -51.83 -41.17 61.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 110.965 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 95' ' ' THR . 93.2 t80 -73.37 -51.38 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.834 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -34.32 63.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -78.29 -44.65 24.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.7 mm? -63.23 -21.35 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.851 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.12 131.74 2.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.813 -0.708 . . . . 71.329999999999998 112.47 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -112.6 157.31 40.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 110.885 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -177.98 2.15 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.637 2.225 . . . . 62.009999999999998 112.332 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.1 m -101.09 -176.23 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 75.409999999999997 110.872 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -55.71 -44.03 77.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 72.409999999999997 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -53.93 -59.56 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 63.240000000000002 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -30.78 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 71.530000000000001 110.92 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -56.09 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.936 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.57 -39.44 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.36 -52.32 63.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.536 HD11 ' CD ' ' A' ' 97' ' ' ARG . 63.5 mt -74.61 -34.42 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 63.409999999999997 111.149 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.54 -17.86 56.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.877 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -75.77 -26.06 57.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -69.29 164.03 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 111.065 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -82.87 113.66 20.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.94 41.15 51.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.129999999999995 112.478 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -105.66 126.48 52.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 70.219999999999999 111.069 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 148.34 24.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.059 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.63 -25.6 43.56 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 75.129999999999995 112.526 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.77 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -74.06 -1.38 19.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 64.239999999999995 111.192 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.7 t -90.61 -11.87 38.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.838 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' CD ' HD11 ' A' ' 86' ' ' ILE . 20.6 ttt-85 -91.96 168.88 11.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.846 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 63' ' ' CYS . 23.3 tp -49.56 146.71 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.450000000000003 110.943 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 98' ' ' LEU . . . 177.89 33.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 71.010000000000005 112.519 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.5 p -110.98 138.81 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 61.43 110.818 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -114.43 7.86 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 64.439999999999998 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 51.91 55.64 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -152.39 126.53 9.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.91 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.681 HG11 ' HB1' ' A' ' 33' ' ' ALA . 47.3 t -97.39 120.07 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 72.239999999999995 111.085 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -176.78 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 72.040000000000006 110.878 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -56.9 -36.0 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.510000000000005 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 m -64.85 -24.05 67.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.804 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.2 0.72 39.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 71.209999999999994 110.915 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 18' ' ' ILE . 38.4 tt0 -55.01 119.2 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 62.219999999999999 110.86 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.61 22.01 12.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 71' ' ' LEU . . . -56.58 145.11 29.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 33.329999999999998 111.116 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.696 ' O ' HD12 ' A' ' 67' ' ' LEU . 18.4 t -116.27 115.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 73.010000000000005 111.15 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -111.08 98.15 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 31.0 m -87.47 119.22 27.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 111.128 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.455 ' HA ' HG13 ' A' ' 65' ' ' VAL . 21.0 t -108.73 88.25 5.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.058 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -42.65 3.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 65.439999999999998 112.4 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -108.46 141.85 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.852 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -174.68 -177.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 53.109999999999999 111.139 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.3 m -62.17 135.42 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.409999999999997 111.129 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 60.92 31.06 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.893 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -140.84 172.16 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.881 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -170.47 173.71 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.814 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.65 176.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.074 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.99 -36.79 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 44.350000000000001 111.19 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -175.37 -179.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 110.84 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.97 95.18 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.448 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -173.33 143.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 74.310000000000002 110.899 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.82 157.89 43.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 110.878 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.699 2.266 . . . . 73.120000000000005 112.309 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.42 68.39 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.518 0.675 . . . . 72.420000000000002 110.894 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 -170.95 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 73.030000000000001 112.302 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 26.2 p80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 110.861 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 121.44 0.467 . . . . 71.299999999999997 112.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 109.89 2.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 64.129999999999995 112.37 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.42 71.05 0.43 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.791 -0.719 . . . . 41.340000000000003 112.537 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -108.92 140.65 42.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 73.310000000000002 110.822 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -157.28 178.5 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.954 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.854 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ptp -88.9 -175.39 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 62.509999999999998 110.821 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -147.08 166.39 27.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 71.439999999999998 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.3 m -77.34 -178.64 5.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.856 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -109.44 160.36 28.01 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.567 0.699 . . . . 71.340000000000003 111.125 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 54.1 Cg_endo -69.69 -14.93 37.02 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.774 2.316 . . . . 63.229999999999997 112.39 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.72 25.06 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 110.86 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' O ' HD13 ' A' ' 14' ' ' ILE . 93.2 mtt180 -137.46 63.07 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.836 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.636 HD11 ' NH1' ' A' ' 103' ' ' ARG . 42.4 mm -137.96 133.11 17.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.661 0.743 . . . . 72.400000000000006 111.087 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.6 Cg_endo -69.72 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.219 . . . . 71.329999999999998 112.378 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.91 156.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 73.310000000000002 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -73.89 158.14 35.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.911 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.2 177.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -124.61 132.21 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.921 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.7 pt -114.36 169.51 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.129 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.88 129.0 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.901 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -99.49 103.38 15.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 71.329999999999998 110.866 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' CA ' HG23 ' A' ' 28' ' ' VAL . 5.5 ttmt -95.44 143.52 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.839 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 p -138.09 179.58 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 65.510000000000005 111.137 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -8.15 55.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.099999999999994 110.905 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -107.15 -38.03 6.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.436 . . . . 61.119999999999997 110.853 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 179.36 176.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 54.409999999999997 110.925 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG23 ' CA ' ' A' ' 23' ' ' LYS . 10.5 p -118.04 134.86 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.010000000000005 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG21 HG22 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -125.92 150.73 69.9 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.565 0.697 . . . . 73.409999999999997 111.179 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 153.21 68.96 Favored 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.642 2.228 . . . . 73.0 112.292 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -149.55 105.74 3.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.079 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -70.13 125.16 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 53.43 110.911 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.066 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -99.91 123.2 43.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.113 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.21 147.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 75.200000000000003 111.19 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.8 p -52.89 114.76 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 19.79 52.57 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.815 -0.707 . . . . 33.130000000000003 112.465 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 p -93.18 -175.63 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.785 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 4.2 m -143.66 152.0 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 73.140000000000001 111.12 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.924 HG23 HD12 ' A' ' 40' ' ' LEU . 14.3 m -57.99 -45.79 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.153 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.924 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -63.87 -37.63 88.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 65.400000000000006 110.925 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.7 -27.99 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.874 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 72.1 t -77.39 -36.77 24.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 61.210000000000001 111.118 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.09 55.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.027 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -73.7 -27.69 61.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -51.76 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.530000000000001 110.855 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' HG12 ' A' ' 42' ' ' VAL . 5.6 p30 -71.89 -25.73 62.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.41 52.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.655 -0.783 . . . . 71.540000000000006 112.495 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 29' ' ' VAL . 86.9 t -51.5 135.15 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.775 0.321 . . . . 41.020000000000003 111.154 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.88 82.78 6.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.883 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.824 HD11 HG11 ' A' ' 115' ' ' VAL . 11.7 tp -139.49 123.03 17.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.430000000000007 110.931 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.17 147.86 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 53.100000000000001 110.843 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.67 35.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 24.25 112.477 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 155.04 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 55.299999999999997 111.139 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.8 m -98.12 111.99 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.939 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.89 121.16 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 64.450000000000003 110.863 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.93 -177.98 21.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 75.319999999999993 112.481 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -103.6 27.76 7.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.0 mt -141.08 178.61 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 110.911 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 102.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 51.329999999999998 111.115 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.0 p -54.27 -36.02 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.540000000000006 110.89 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.7 t -174.42 162.26 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 65.319999999999993 110.864 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -53.27 123.47 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 62.32 111.169 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.9 m -97.18 25.65 5.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 25.530000000000001 110.822 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -102.38 96.76 7.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 65.439999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.7 t -128.69 157.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.25 111.129 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 89.9 mt -90.51 129.68 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 64.430000000000007 111.166 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.6 tp -125.33 163.02 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 64.040000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.81 147.2 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.877 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -61.33 -59.71 12.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.605 0.716 . . . . 73.040000000000006 110.9 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.76 -42.44 3.4 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.638 2.225 . . . . 54.219999999999999 112.349 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -58.3 -44.52 88.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 110.929 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 95' ' ' THR . 63.2 t80 -70.88 -52.34 20.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.883 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -36.45 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.439999999999998 110.862 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -73.86 -44.32 55.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 75.0 110.927 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.25 -52.66 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 75.209999999999994 110.89 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.42 142.96 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 71.329999999999998 112.524 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.83 157.56 42.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.659 0.743 . . . . 65.310000000000002 110.874 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 173.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.64 2.227 . . . . 62.009999999999998 112.323 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -102.49 -169.84 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.409999999999997 110.855 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.71 -46.81 81.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.843 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.99 -59.55 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.09 -27.75 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.862 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -53.75 48.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.918 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -69.74 -37.14 76.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 71.120000000000005 110.871 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 mt -62.49 -48.47 79.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' HA2' ' A' ' 94' ' ' GLY . 56.6 mt -73.91 -35.41 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 63.409999999999997 111.087 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.97 -20.68 64.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 74.030000000000001 110.904 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.15 -25.78 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.914 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.47 146.09 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.129999999999995 111.069 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.2 121.63 18.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.847 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 44.63 60.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.581 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -103.29 129.38 50.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 70.219999999999999 111.143 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 144.5 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.095 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.602 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.44 -22.74 32.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 75.129999999999995 112.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.619 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.7 p -73.89 -2.25 23.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.086 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.9 t -88.43 -13.35 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 110.786 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD3' HD11 ' A' ' 86' ' ' ILE . 13.6 mtp85 -123.33 167.45 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 70.200000000000003 110.908 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 58.71 46.64 14.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.854 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.34 40.71 2.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 71.010000000000005 112.462 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 2.9 t -92.02 66.98 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 61.43 110.855 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.13 138.29 46.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.54 35.37 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.25 110.896 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.636 ' NH1' HD11 ' A' ' 14' ' ' ILE . 17.2 mmt180 -132.96 135.95 45.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 70.209999999999994 110.907 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.066 HG11 ' HB1' ' A' ' 33' ' ' ALA . 26.3 t -109.61 119.58 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.117 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -136.46 178.73 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 72.040000000000006 110.891 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -58.31 -37.21 74.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 110.948 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -63.64 -19.44 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.510000000000005 110.862 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -89.62 9.92 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 71.209999999999994 110.851 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.87 125.76 24.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.219999999999999 110.889 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 60.52 21.9 11.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 53.450000000000003 110.872 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -59.71 136.33 57.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 33.329999999999998 111.088 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 67' ' ' LEU . 45.8 t -104.44 119.42 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.1 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.2 98.44 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.430000000000007 110.895 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 65' ' ' VAL . 46.4 m -93.8 119.82 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 111.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.824 HG11 HD11 ' A' ' 50' ' ' LEU . 20.2 t -108.87 88.57 5.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.165 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -36.26 11.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.274 . . . . 65.439999999999998 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -62.18 166.1 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.873 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.52 176.87 7.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 53.109999999999999 111.083 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 t -103.63 173.01 6.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 111.152 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -115.26 -64.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.863 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -54.49 172.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 73.329999999999998 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.6 ptt? -122.21 -42.56 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.819 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 55.74 35.62 25.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 122' ' ' MET . 47.3 t -62.09 -33.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 44.350000000000001 111.074 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -54.99 -69.62 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 110.916 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 52.42 -139.39 30.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.698 -0.763 . . . . 73.430000000000007 112.545 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -158.97 172.98 17.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 74.310000000000002 110.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -122.36 68.72 29.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.604 0.716 . . . . 71.430000000000007 110.891 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -48.1 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.698 2.265 . . . . 73.120000000000005 112.288 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -157.9 137.71 8.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.552 0.691 . . . . 72.420000000000002 110.893 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.98 2.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 73.030000000000001 112.346 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 110.837 179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 CA-C-O 121.458 0.477 . . . . 71.299999999999997 112.421 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 123.63 10.28 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.651 2.234 . . . . 64.129999999999995 112.342 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.35 87.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 41.340000000000003 112.499 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 t -161.78 160.52 28.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.332 . . . . 73.310000000000002 110.885 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.7 ttt -61.93 162.61 8.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 73.430000000000007 110.857 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -120.5 120.05 34.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 71.420000000000002 110.825 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtt -95.54 164.3 12.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 62.509999999999998 110.849 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -121.7 136.34 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 71.439999999999998 110.905 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 p -178.46 174.51 1.24 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 72.439999999999998 110.815 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.09 43.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 71.340000000000003 111.126 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -171.04 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.652 2.234 . . . . 63.229999999999997 112.341 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.37 25.06 10.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 73.209999999999994 110.902 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -137.45 121.82 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.855 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 36' ' ' GLY . 59.0 mt -98.53 132.99 23.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 72.400000000000006 111.177 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.77 -174.4 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.334 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -53.05 156.67 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 155.0 39.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 43.299999999999997 110.84 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 pt -132.85 176.82 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 111.103 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -122.8 138.63 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.3 pt -120.82 172.56 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 75.129999999999995 111.126 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -127.53 133.28 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.887 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.748 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.1 m-85 -104.52 106.03 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.819 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -97.25 144.26 27.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.975 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -139.1 178.72 6.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.113 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -8.1 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.88 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -106.31 -37.66 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 61.119999999999997 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 179.82 175.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 110.949 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.77 127.67 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.010000000000005 111.155 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HG22 ' A' ' 48' ' ' VAL . 1.4 m -117.91 150.84 47.96 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.107 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 156.17 63.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 73.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.97 138.2 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.089 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -100.54 130.67 46.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 53.43 110.902 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.89 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -110.73 117.04 32.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 111.115 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.4 t -104.61 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.200000000000003 111.122 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -51.74 116.2 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.849 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.539 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 100.92 7.38 50.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 33.130000000000003 112.486 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -100.95 -169.97 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.995 0.426 . . . . 73.200000000000003 110.852 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.733 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -144.58 142.65 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 73.140000000000001 111.153 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 83.4 t -52.45 -63.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 70.420000000000002 111.1 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.49 -33.16 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.895 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.73 -27.4 62.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.845 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 38' ' ' THR . 92.2 t -76.82 -43.06 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 61.210000000000001 111.151 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.06 -30.13 14.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -73.62 -37.8 65.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 110.855 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -40.22 50.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 74.530000000000001 110.848 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.11 -21.78 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 74.420000000000002 110.87 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.0 -12.26 55.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 71.540000000000006 112.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 29' ' ' VAL . 46.7 t -57.8 113.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.337 . . . . 41.020000000000003 111.135 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.47 80.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.929 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 115' ' ' VAL . 11.3 tp -111.81 128.08 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 110.899 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.0 tt0 -52.2 113.03 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.943 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -142.99 -108.68 0.67 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.712 -0.756 . . . . 24.25 112.428 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 51.76 47.6 24.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.749 0.309 . . . . 55.299999999999997 111.095 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.93 30.61 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 72.329999999999998 110.912 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -101.44 88.21 3.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 64.450000000000003 110.864 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.06 30.56 76.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 75.319999999999993 112.536 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -78.62 159.8 27.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 73.329999999999998 110.785 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.19 -35.15 5.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 110.931 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.67 57.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 51.329999999999998 111.114 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.74 82.9 1.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.903 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.6 m -73.89 175.72 7.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.319999999999993 110.87 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -51.54 136.65 25.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 62.32 111.116 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 p -122.38 121.58 37.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 25.530000000000001 110.857 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -100.8 118.35 36.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 65.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.23 155.53 39.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 72.25 111.17 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.589 HD12 ' HD3' ' A' ' 116' ' ' PRO . 5.1 mp -90.38 132.98 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 64.430000000000007 111.195 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.7 tp -127.37 159.31 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.040000000000006 110.929 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.15 146.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.915 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -59.38 -60.25 11.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 73.040000000000006 110.914 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.86 -46.22 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.28 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -54.13 -48.32 70.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.909 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.582 ' CD1' HG22 ' A' ' 95' ' ' THR . 42.1 t80 -68.23 -47.43 67.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.450000000000003 110.881 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -55.62 -43.7 76.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.917 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.16 -26.95 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.0 tp -72.83 -62.56 1.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.937 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.17 3.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 71.329999999999998 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -132.34 157.31 78.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.683 0.754 . . . . 65.310000000000002 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 166.28 28.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 62.009999999999998 112.318 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.19 170.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.874 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -58.78 -37.19 75.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.879 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -52.51 -62.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.7 -35.11 78.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 71.530000000000001 110.845 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -56.89 -53.34 59.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.945 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.95 -42.16 90.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.838 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tp -55.8 -37.55 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 110.954 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.3 mt -74.57 -52.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.13 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -59.04 -21.67 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.854 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -76.04 -24.99 55.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.933 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -76.05 162.96 27.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.053 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -70.23 117.34 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.07 42.84 55.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 73.129999999999995 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -113.61 121.86 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.086 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.7 144.1 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.135 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.59 -23.47 36.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.488 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.582 HG22 ' CD1' ' A' ' 72' ' ' TYR . 22.6 p -73.92 -2.24 23.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 64.239999999999995 111.136 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 36.6 t -90.24 -13.97 34.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.841 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.55 158.31 34.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 70.200000000000003 110.854 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 56.45 67.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 110.954 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.21 61.68 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 71.010000000000005 112.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.1 t -133.96 -74.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 61.43 110.91 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.27 93.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 110.844 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 38' ' ' THR . 15.6 mt -146.18 165.52 28.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.858 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -112.03 170.61 8.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 70.209999999999994 110.868 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.89 HG11 ' HB1' ' A' ' 33' ' ' ALA . 24.3 t -94.42 115.3 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.127 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.93 176.01 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 72.040000000000006 110.794 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -57.2 -36.25 70.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.510000000000005 110.873 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -22.35 66.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 110.885 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.428 ' CE2' HD22 ' A' ' 75' ' ' LEU . 3.7 m-85 -85.76 5.27 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.922 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.456 ' N ' HD13 ' A' ' 18' ' ' ILE . 85.5 tt0 -58.8 123.0 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 62.219999999999999 110.898 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.37 22.58 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 53.450000000000003 110.939 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 133.64 52.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 33.329999999999998 111.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.625 ' O ' HD12 ' A' ' 67' ' ' LEU . 36.7 t -106.17 118.86 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.128 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 42.5 m-85 -109.4 102.97 11.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 71.430000000000007 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -95.2 125.77 40.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.182 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 50' ' ' LEU . 59.5 t -100.59 133.33 21.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.602 0.715 . . . . 72.129999999999995 111.154 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.9 Cg_endo -69.75 -45.28 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.699 2.266 . . . . 65.439999999999998 112.304 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -129.45 130.18 45.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 72.140000000000001 110.841 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.73 119.24 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 53.109999999999999 111.032 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.72 100.57 7.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 73.409999999999997 111.144 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.25 138.18 58.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 73.349999999999994 110.903 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -140.47 61.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.835 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -118.19 -39.6 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 74.510000000000005 110.925 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.02 120.29 6.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 62.43 111.082 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.21 -29.92 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 44.350000000000001 111.158 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.57 170.18 10.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 110.861 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.74 91.03 2.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 73.430000000000007 112.495 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.8 28.25 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 110.823 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.68 73.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.506 0.669 . . . . 71.430000000000007 110.856 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 120.79 7.51 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.668 2.245 . . . . 73.120000000000005 112.367 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -51.52 156.87 1.98 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 72.420000000000002 110.92 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -46.1 1.34 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.669 2.246 . . . . 73.030000000000001 112.305 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 72.120000000000005 110.888 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 CA-C-O 121.381 0.434 . . . . 71.299999999999997 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -170.95 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.624 2.216 . . . . 64.129999999999995 112.35 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.19 -144.49 5.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.741 -0.743 . . . . 41.340000000000003 112.544 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.1 p -156.54 179.1 9.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 73.310000000000002 110.822 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mmt -129.02 -171.6 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.824 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -127.73 29.52 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.420000000000002 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.4 mtt -144.83 -175.5 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 62.509999999999998 110.847 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -114.35 138.43 50.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.897 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.24 -179.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.954 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.43 73.98 0.47 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.545 0.688 . . . . 71.340000000000003 111.11 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.651 2.234 . . . . 63.229999999999997 112.368 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -106.29 24.74 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.865 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -103.71 2.89 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.839 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.449 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -136.33 133.18 19.25 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.63 0.729 . . . . 72.400000000000006 111.148 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.77 178.1 4.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.696 2.264 . . . . 71.329999999999998 112.353 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.68 156.25 1.42 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.856 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 149.52 41.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 43.299999999999997 110.939 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.604 HG21 ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -129.07 175.84 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 64.439999999999998 111.186 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -124.98 139.17 54.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 31' ' ' ALA . 30.1 pt -125.83 164.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.12 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -121.37 138.93 54.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 75.219999999999999 110.892 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 9.9 m-85 -117.0 102.76 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.917 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -84.44 144.48 28.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.937 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 p -114.4 -157.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.510000000000005 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.4 ttp -50.52 -50.35 53.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.904 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -138.09 -33.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 61.119999999999997 110.842 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.12 151.93 21.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 54.409999999999997 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 28' ' ' VAL . 6.7 p -122.9 120.62 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 72.010000000000005 111.095 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 48' ' ' VAL . 3.7 m -109.09 136.99 20.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 73.409999999999997 111.216 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 169.57 18.67 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.638 2.225 . . . . 73.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -159.38 108.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 53.340000000000003 111.075 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -74.1 138.0 43.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 53.43 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.787 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -113.59 116.59 29.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.086 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.1 t -102.57 141.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.200000000000003 111.132 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.83 114.85 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 52.539999999999999 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.55 50.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 33.130000000000003 112.488 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.553 ' OG ' HG21 ' A' ' 104' ' ' VAL . 92.2 p -94.08 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.979 0.419 . . . . 73.200000000000003 110.806 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 42' ' ' VAL . 17.2 p -142.65 154.78 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 73.140000000000001 111.149 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 50' ' ' LEU . 47.5 t -52.4 -59.62 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.420000000000002 111.15 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.943 HD23 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -53.93 -34.94 61.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.903 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.81 -26.94 61.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 72.450000000000003 110.862 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 38' ' ' THR . 91.1 t -76.31 -47.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.210000000000001 111.104 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -55.61 -28.48 55.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.059 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -69.49 -32.93 72.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 75.200000000000003 110.824 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -53.76 21.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.918 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -72.38 -26.6 61.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.869 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.44 -4.26 40.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.813 -0.708 . . . . 71.540000000000006 112.483 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.569 HG22 HG21 ' A' ' 29' ' ' VAL . 38.8 t -51.79 141.41 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 41.020000000000003 111.127 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -88.3 80.79 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.832 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' HG12 ' A' ' 39' ' ' VAL . 10.6 tp -93.5 114.34 26.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.876 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.579 ' HB2' HG23 ' A' ' 62' ' ' THR . 48.0 mm-40 -62.43 151.51 36.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 53.100000000000001 110.876 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -142.72 23.73 2.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 24.25 112.445 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.33 112.6 25.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.804 0.335 . . . . 55.299999999999997 111.105 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.55 -26.02 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 72.329999999999998 110.958 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -75.91 -25.98 56.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 64.450000000000003 110.915 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.22 155.29 4.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.728 . . . . 75.319999999999993 112.457 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -101.51 -61.41 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 73.329999999999998 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.19 -28.76 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 110.854 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.22 123.37 8.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 51.329999999999998 111.157 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 t -103.84 66.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.540000000000006 110.839 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m 57.73 36.11 26.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 65.319999999999993 110.924 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.579 HG23 ' HB2' ' A' ' 51' ' ' GLU . 14.5 p 49.93 43.3 25.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 62.32 111.118 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 t -58.64 -27.15 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 25.530000000000001 110.856 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -117.39 101.66 8.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 98' ' ' LEU . 10.7 m -129.54 164.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 72.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.84 133.2 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 64.430000000000007 111.148 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 112' ' ' VAL . 35.6 tp -126.55 153.93 44.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 64.040000000000006 110.907 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.8 146.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.852 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -54.86 -60.46 7.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.674 0.749 . . . . 73.040000000000006 110.829 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.69 -44.75 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.7 2.267 . . . . 54.219999999999999 112.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -52.48 -45.31 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 73.209999999999994 110.951 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.618 ' HD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -72.79 -49.91 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.0 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -53.14 -37.85 62.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.509 . . . . 65.439999999999998 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -76.07 -46.21 30.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 71' ' ' LEU . 2.1 mm? -63.2 -22.81 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.869 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.7 136.17 3.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 71.329999999999998 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -112.2 157.41 39.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.634 0.73 . . . . 65.310000000000002 110.931 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.258 . . . . 62.009999999999998 112.379 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.5 t -120.94 -170.67 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.854 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.27 -46.4 76.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.898 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -54.43 -58.84 5.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 63.240000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -28.18 69.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.874 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -55.48 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 74.329999999999998 110.902 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.95 -40.91 87.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 110.861 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.07 -50.86 69.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 64.219999999999999 110.923 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.784 HD13 ' HA2' ' A' ' 94' ' ' GLY . 22.5 mt -74.08 -35.04 40.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.128 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.48 -17.65 60.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.915 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.18 -24.42 54.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.909 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.612 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.2 164.37 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.129999999999995 111.069 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.85 113.84 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.866 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.83 52.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 73.129999999999995 112.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -96.53 125.17 40.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 70.219999999999999 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.8 30.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.203 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.35 -23.98 36.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.798 -0.715 . . . . 75.129999999999995 112.481 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.618 HG22 ' HD1' ' A' ' 72' ' ' TYR . 20.3 p -73.42 -3.27 26.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.146 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -86.83 -16.02 37.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.821 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.62 157.91 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 70.200000000000003 110.855 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 99' ' ' GLY . 4.1 pp -166.34 -179.46 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.546 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -76.82 -130.51 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 71.010000000000005 112.489 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.78 84.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 61.43 110.853 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.569 ' C ' HD22 ' A' ' 102' ' ' LEU . 37.9 mt-30 -122.45 132.77 54.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 64.439999999999998 110.968 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.943 HD12 HD23 ' A' ' 40' ' ' LEU . 4.6 mm? -126.84 67.25 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 65.25 110.885 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -152.26 160.25 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 70.209999999999994 110.819 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 33' ' ' ALA . 99.4 t -105.5 129.89 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 111.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.39 167.94 20.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 72.040000000000006 110.883 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -57.05 -31.06 64.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 72.510000000000005 110.866 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -28.24 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 110.851 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.626 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.0 m-85 -75.98 -6.12 49.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.209999999999994 110.936 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.604 ' HB2' HG21 ' A' ' 18' ' ' ILE . 84.5 tt0 -58.72 124.15 18.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 62.219999999999999 110.893 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 61.01 22.85 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 53.450000000000003 110.915 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.15 138.32 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 33.329999999999998 111.091 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.706 ' O ' HD12 ' A' ' 67' ' ' LEU . 8.0 t -107.32 111.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 73.010000000000005 111.145 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 67' ' ' LEU . 77.9 m-85 -105.89 104.62 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 23' ' ' LYS . 72.8 m -93.35 125.52 38.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 73.439999999999998 111.134 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.44 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.1 t -85.01 133.45 43.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 111.137 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.9 Cg_endo -69.75 -165.63 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.716 2.278 . . . . 65.439999999999998 112.374 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 149.84 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.926 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.02 103.2 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 53.109999999999999 111.094 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.5 t -138.19 172.61 12.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 73.409999999999997 111.128 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.18 169.12 18.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.349999999999994 110.882 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -122.22 -40.92 2.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 110.881 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.5 mtt 61.58 61.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.510000000000005 110.937 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.45 175.23 6.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.1 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.98 133.66 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 44.350000000000001 111.099 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -133.47 144.06 49.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 71.030000000000001 110.868 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -152.43 65.41 0.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 73.430000000000007 112.478 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -114.14 123.13 48.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 74.310000000000002 110.926 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.83 157.64 77.83 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 71.430000000000007 110.951 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 150.73 68.21 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.321 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -139.89 70.46 36.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.496 0.665 . . . . 72.420000000000002 110.868 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -46.24 1.3 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 73.030000000000001 112.359 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.803 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 121.48 0.489 . . . . 71.299999999999997 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -44.87 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.681 2.254 . . . . 64.129999999999995 112.35 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.73 -152.3 17.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 41.340000000000003 112.474 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -172.04 158.17 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.310000000000002 110.865 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -145.64 -177.65 5.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.855 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.02 107.04 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 tpp -145.63 119.47 9.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.509999999999998 110.891 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -149.84 166.56 29.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 71.439999999999998 110.937 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -115.07 -170.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.862 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.3 73.07 2.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.533 0.682 . . . . 71.340000000000003 111.128 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -173.46 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 63.229999999999997 112.298 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -120.78 25.09 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.876 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -156.17 131.75 9.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.909 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.704 HD11 ' HD2' ' A' ' 103' ' ' ARG . 43.5 mm -57.98 124.65 70.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.629 0.728 . . . . 72.400000000000006 111.131 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -169.64 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.659 2.239 . . . . 71.329999999999998 112.399 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -51.02 157.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.93 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 136.37 38.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 43.299999999999997 110.987 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.5 pp -124.58 176.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 64.439999999999998 111.142 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -120.42 136.78 54.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.819 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -115.97 169.21 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 75.129999999999995 111.186 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HD1' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -118.6 126.72 52.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.83 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 2.4 m-85 -96.56 103.12 15.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.855 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -91.4 122.84 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 75.340000000000003 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 -178.12 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.124 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.737 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . 2.8 ttm -75.8 -8.18 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.871 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -108.21 -37.89 5.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 61.119999999999997 110.893 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 179.79 176.18 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.932 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' HD1' ' A' ' 21' ' ' PHE . 13.7 p -108.46 132.76 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 111.086 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.638 HG21 HG22 ' A' ' 48' ' ' VAL . 1.7 m -122.48 151.03 59.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 73.409999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.26 62.48 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.687 2.258 . . . . 73.0 112.302 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -146.83 104.2 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 53.340000000000003 111.129 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -76.46 132.22 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 53.43 110.953 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -109.64 133.65 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.052 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.08 152.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.079 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -52.4 111.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 52.539999999999999 110.932 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.16 17.15 35.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.49 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 104' ' ' VAL . 54.0 p -107.52 163.56 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.922 0.392 . . . . 73.200000000000003 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -123.4 154.07 39.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 73.140000000000001 111.126 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 20' ' ' ILE . 15.9 m -55.83 -44.72 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.420000000000002 111.111 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' HA3' ' A' ' 52' ' ' GLY . 15.5 mt -56.76 -44.17 81.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 65.400000000000006 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' CG ' HG23 ' A' ' 38' ' ' THR . 35.2 m-20 -72.72 -26.83 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.450000000000003 110.929 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 38' ' ' THR . 77.2 t -75.23 -31.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 61.210000000000001 111.164 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.28 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 111.118 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -73.43 -35.83 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.839 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -64.72 -46.96 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.832 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.31 -24.62 59.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.938 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.85 40.37 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.471 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 29' ' ' VAL . 39.0 t -51.48 136.24 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 41.020000000000003 111.177 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.84 80.96 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.834 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.5 tp -144.18 109.51 5.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 110.93 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -106.47 138.84 41.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 53.100000000000001 110.888 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 40' ' ' LEU . . . -148.98 45.37 0.71 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 24.25 112.439 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.68 94.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 55.299999999999997 111.117 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.405 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -94.29 41.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.329999999999998 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -106.93 124.55 49.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 64.450000000000003 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.39 -175.76 28.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.703 -0.761 . . . . 75.319999999999993 112.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.89 -42.58 48.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 73.329999999999998 110.881 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.78 101.14 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.917 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 54' ' ' CYS . . . -171.4 174.34 4.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 51.329999999999998 111.055 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.5 p -58.62 162.58 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.540000000000006 110.839 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -131.38 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 65.319999999999993 110.838 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -85.68 125.38 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 62.32 111.129 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -93.32 60.07 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 25.530000000000001 110.88 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -69.36 90.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.806 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 114' ' ' THR . 6.5 t -128.59 157.4 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 72.25 111.193 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.8 mp -89.63 134.72 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 64.430000000000007 111.137 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.3 tp -129.03 158.52 38.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 64.040000000000006 110.876 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.45 142.74 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.4 mt-10 -56.91 -60.16 10.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.708 0.766 . . . . 73.040000000000006 110.879 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.82 -48.95 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.721 2.28 . . . . 54.219999999999999 112.288 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.58 -41.9 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 95' ' ' THR . 68.7 t80 -72.51 -52.72 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.26 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 65.439999999999998 110.83 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -77.94 -44.54 26.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.951 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 107' ' ' SER . 1.5 mm? -63.24 -24.3 67.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.874 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.24 156.31 6.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.811 -0.709 . . . . 71.329999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -119.99 157.62 52.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 65.310000000000002 110.865 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 156.6 62.79 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 62.009999999999998 112.296 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.9 t -90.36 -169.66 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.867 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.62 -47.51 76.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -54.02 -59.75 4.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.869 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.3 mp0 -61.11 -27.94 68.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.909 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -56.35 17.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.924 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.98 -40.34 91.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 71.120000000000005 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 mt -56.93 -51.38 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 64.219999999999999 110.904 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.617 HD13 ' HA2' ' A' ' 94' ' ' GLY . 13.7 mt -73.59 -35.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 63.409999999999997 111.171 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -61.84 -18.07 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.863 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -76.01 -24.13 55.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.886 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -84.5 146.71 27.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 71.129999999999995 111.158 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.2 122.23 19.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 110.859 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.98 45.08 56.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 73.129999999999995 112.479 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -100.8 124.86 47.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 111.111 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 144.02 25.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.139 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.617 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.77 -24.82 42.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 75.129999999999995 112.423 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.756 HG22 ' CD1' ' A' ' 72' ' ' TYR . 28.2 p -74.09 -2.18 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 64.239999999999995 111.071 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 1.3 t -90.72 -13.03 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.933 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -144.05 136.67 26.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 70.200000000000003 110.947 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD13 ' NE2' ' A' ' 101' ' ' GLN . 4.3 tt -134.36 -61.25 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 73.450000000000003 110.889 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.17 -90.46 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.668 -0.777 . . . . 71.010000000000005 112.446 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.92 110.42 2.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 61.43 110.916 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD13 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -131.17 118.79 20.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 64.439999999999998 110.894 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.2 37.18 3.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.25 110.904 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.704 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 mmt85 -137.22 147.81 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 70.209999999999994 110.908 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 33' ' ' ALA . 88.3 t -104.18 129.94 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.128 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -136.74 164.16 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.894 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -54.84 -26.4 35.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 72.510000000000005 110.873 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.652 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -62.43 -29.2 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.510000000000005 110.825 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 21.3 m-85 -91.21 12.52 19.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.922 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 18' ' ' ILE . 69.3 tt0 -59.65 111.89 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 62.219999999999999 110.89 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 63.76 20.61 12.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.883 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 113' ' ' PHE . . . -67.99 151.07 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 33.329999999999998 111.128 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 22.2 t -105.73 115.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 111.178 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' HE1' ' HB3' ' A' ' 111' ' ' ALA . 34.6 m-85 -108.87 104.36 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.825 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 65' ' ' VAL . 88.2 m -95.08 130.86 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.187 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 116' ' ' PRO . 59.3 t -97.48 133.21 23.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.195 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD3' HD12 ' A' ' 66' ' ' ILE . 54.4 Cg_endo -69.6 -47.79 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.695 2.263 . . . . 65.439999999999998 112.423 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -80.56 128.34 33.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.862 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 25' ' ' MET . . . -176.94 -179.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.109999999999999 111.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.55 117.5 2.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 111.155 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -110.23 109.53 20.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.349999999999994 110.926 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -108.05 54.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.879 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.0 ptm 39.62 41.56 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 110.836 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.64 79.84 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 62.43 111.076 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.11 123.08 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 44.350000000000001 111.136 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.5 115.14 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 71.030000000000001 110.894 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.79 -159.82 33.43 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.787 -0.721 . . . . 73.430000000000007 112.494 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -160.14 117.52 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 74.310000000000002 110.846 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -100.44 136.13 20.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.508 0.67 . . . . 71.430000000000007 110.876 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 177.75 5.25 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.66 2.24 . . . . 73.120000000000005 112.398 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.58 73.74 2.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.528 0.68 . . . . 72.420000000000002 110.91 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -172.71 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.696 2.264 . . . . 73.030000000000001 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 110.848 179.927 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 121.407 0.448 . . . . 71.299999999999997 112.451 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -179.29 2.77 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.701 2.267 . . . . 64.129999999999995 112.433 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.32 -161.21 28.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 41.340000000000003 112.483 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 m -146.64 111.84 5.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 73.310000000000002 110.813 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 tpp -107.79 160.68 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 73.430000000000007 110.855 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.45 99.24 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.886 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.1 mtm -140.96 151.4 44.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 62.509999999999998 110.903 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.35 136.07 37.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.439999999999998 110.851 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -170.56 -179.56 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.921 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.91 68.41 55.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.749 . . . . 71.340000000000003 111.123 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.24 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.63 2.22 . . . . 63.229999999999997 112.335 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -113.36 24.92 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 110.9 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 -165.0 136.65 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.896 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' A' ' 103' ' ' ARG . 39.7 mm -70.59 132.92 87.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.659 0.742 . . . . 72.400000000000006 111.133 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.3 Cg_endo -69.78 -170.34 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 71.329999999999998 112.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.86 156.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 110.865 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.74 132.93 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 43.299999999999997 110.875 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.6 pp -120.12 177.27 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.137 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -112.18 151.78 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.872 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.629 HD12 ' HE1' ' A' ' 113' ' ' PHE . 2.2 pt -135.34 165.45 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.064 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HB3' HG13 ' A' ' 112' ' ' VAL . 2.9 m-85 -112.2 125.17 53.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.949 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -91.29 103.14 15.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 71.329999999999998 110.899 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' CD ' HG22 ' A' ' 28' ' ' VAL . 32.0 tptt -101.35 118.3 36.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.843 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -124.6 171.2 10.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 65.510000000000005 111.158 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mmm -75.83 -7.96 55.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 73.099999999999994 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.7 -38.04 9.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 61.119999999999997 110.93 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 179.45 176.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 54.409999999999997 110.933 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG22 ' CD ' ' A' ' 23' ' ' LYS . 17.9 t -111.74 124.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.010000000000005 111.113 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.62 150.49 76.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.111 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 155.38 65.92 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.65 2.233 . . . . 73.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 42' ' ' VAL . . . -143.45 141.46 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 111.099 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -106.15 131.65 53.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 53.43 110.929 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.78 116.54 32.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 111.059 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.36 151.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 75.200000000000003 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -52.93 109.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.925 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.02 31.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.485 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.3 p -100.8 163.32 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.415 . . . . 73.200000000000003 110.877 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 p -130.99 152.92 49.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 73.140000000000001 111.146 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.02 -60.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.131 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.12 -34.25 59.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 65.400000000000006 110.922 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -72.46 -26.77 61.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 72.450000000000003 110.789 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 38' ' ' THR . 63.8 t -76.94 -45.06 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 61.210000000000001 111.142 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -51.64 -29.95 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 111.037 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -71.66 -36.77 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 110.943 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -79.38 -45.23 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.886 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -72.19 -25.4 61.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.66 -12.19 56.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 71.540000000000006 112.462 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.646 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 87.2 t -52.66 105.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 41.020000000000003 111.136 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.644 ' O ' HD22 ' A' ' 50' ' ' LEU . 31.1 t0 -81.77 81.11 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 49' ' ' ASP . 2.0 mm? -135.3 105.67 6.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.430000000000007 110.907 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.54 130.36 42.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 53.100000000000001 110.826 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.32 26.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.655 -0.783 . . . . 24.25 112.457 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.11 158.92 31.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 55.299999999999997 111.132 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 t -94.38 56.4 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.896 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -175.45 142.47 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.450000000000003 110.874 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.86 -96.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 75.319999999999993 112.518 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -60.41 -179.47 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 73.329999999999998 110.834 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 59' ' ' ALA . 3.6 pp -52.53 -29.62 26.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 72.140000000000001 110.89 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' N ' HD12 ' A' ' 58' ' ' LEU . . . -154.47 144.26 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 111.121 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.7 96.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.540000000000006 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -99.36 27.38 5.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 65.319999999999993 110.85 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -117.39 24.67 10.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 62.32 111.144 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.89 -25.62 40.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 25.530000000000001 110.91 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.88 113.77 21.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 65.439999999999998 110.875 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.38 157.16 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.073 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -89.81 137.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.058 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.46 158.36 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 64.040000000000006 110.865 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.52 142.4 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.863 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -58.64 -59.23 14.3 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.53 0.681 . . . . 73.040000000000006 110.876 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.81 -47.97 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 54.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -52.47 -48.78 65.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.957 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.425 ' CD1' HG22 ' A' ' 95' ' ' THR . 28.9 t80 -65.11 -51.7 59.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.924 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.11 44.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 65.439999999999998 110.843 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -75.49 -52.34 10.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.07 -23.19 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.12 151.7 5.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 71.329999999999998 112.525 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.13 157.63 77.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 65.310000000000002 110.872 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.667 2.245 . . . . 62.009999999999998 112.334 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 p -111.24 -176.92 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.851 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -55.77 -44.84 78.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -53.79 -59.7 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 63.240000000000002 110.854 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -62.33 -28.07 69.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.878 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -55.16 31.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.949 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.94 -41.03 83.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 110.821 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.62 -52.24 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 110.917 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.768 HD13 ' HA2' ' A' ' 94' ' ' GLY . 10.9 mt -73.7 -35.02 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.409999999999997 111.101 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.79 -19.17 58.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 110.856 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -76.07 -24.0 55.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.924 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.96 151.44 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.129999999999995 111.061 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -69.73 120.26 15.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.519999999999996 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.67 44.09 54.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.726 -0.75 . . . . 73.129999999999995 112.537 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -112.11 132.64 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 70.219999999999999 111.082 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.93 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 111.145 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.86 -26.77 48.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 75.129999999999995 112.453 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.5 p -74.09 -0.99 18.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.133 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 25.5 t -90.89 -14.0 32.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 71.409999999999997 110.858 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -102.93 160.81 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 70.200000000000003 110.887 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -176.6 125.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.895 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' HD13 ' A' ' 98' ' ' LEU . . . -61.13 -166.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.467 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 21.8 m -89.07 49.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 61.43 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -128.92 41.89 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.439999999999998 110.919 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 98' ' ' LEU . 4.4 mm? -76.88 65.05 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.25 110.911 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 14' ' ' ILE . 5.1 tpp85 -109.46 158.43 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 70.209999999999994 110.913 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.7 t -80.93 127.23 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.157 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 161.14 36.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.040000000000006 110.838 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.5 -36.82 67.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.885 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -21.44 66.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 64.510000000000005 110.849 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.73 1.82 40.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 71.209999999999994 110.845 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.88 124.14 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.914 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 59.11 26.26 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 53.450000000000003 110.895 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.07 130.42 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 33.329999999999998 111.03 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 21' ' ' PHE . 15.3 t -97.91 126.78 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.010000000000005 111.099 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.629 ' HE1' HD12 ' A' ' 20' ' ' ILE . 31.9 p90 -120.74 132.61 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 71.430000000000007 110.867 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 23' ' ' LYS . 89.8 m -104.72 130.9 52.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 111.16 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.6 t -93.31 133.3 28.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 72.129999999999995 111.105 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.8 Cg_endo -69.82 -165.45 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.28 . . . . 65.439999999999998 112.355 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 104.15 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 72.140000000000001 110.794 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.56 -75.41 0.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 53.109999999999999 111.167 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 t -174.12 173.53 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 73.409999999999997 111.095 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -62.99 -171.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 73.349999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.34 179.27 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.842 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.1 ttm -131.45 157.96 42.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 74.510000000000005 110.831 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.9 173.47 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.117 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.95 141.6 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 44.350000000000001 111.059 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.65 172.98 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 71.030000000000001 110.929 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 169.3 -70.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 73.430000000000007 112.497 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -52.4 114.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.391 . . . . 74.310000000000002 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -174.15 71.56 0.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.548 0.689 . . . . 71.430000000000007 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.66 2.24 . . . . 73.120000000000005 112.374 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -175.66 73.6 0.28 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 72.420000000000002 110.852 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 122.17 8.83 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.615 2.21 . . . . 73.030000000000001 112.332 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.120000000000005 110.873 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 CA-C-O 121.454 0.475 . . . . 71.299999999999997 112.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 172.88 11.81 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.735 2.29 . . . . 64.129999999999995 112.332 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 94.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 41.340000000000003 112.549 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -130.39 133.3 46.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 110.878 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.2 ptp -146.87 135.51 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 73.430000000000007 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.852 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 34.8 mtt -55.34 171.63 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 62.509999999999998 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -141.81 141.47 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.854 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -137.98 140.19 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.439999999999998 110.841 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -129.91 69.67 81.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.508 0.671 . . . . 71.340000000000003 111.074 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -25.11 29.01 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.719 2.279 . . . . 63.229999999999997 112.353 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.17 25.11 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.881 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 58.39 54.71 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.851 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -81.61 133.0 53.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.591 0.71 . . . . 72.400000000000006 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.271 . . . . 71.329999999999998 112.308 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -52.3 156.76 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.244 -0.435 . . . . 73.310000000000002 110.883 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.04 159.27 32.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 43.299999999999997 110.859 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.7 pt -139.66 176.78 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 111.134 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -124.08 130.59 52.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.836 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 108' ' ' PHE . 2.7 pt -114.5 162.66 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 75.129999999999995 111.103 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.5 136.18 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 5.1 m-85 -106.18 108.31 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.329999999999998 110.896 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 134.56 38.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 75.340000000000003 110.923 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -125.18 -178.95 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 111.175 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.1 ttp -75.78 -8.03 55.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.918 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -37.97 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 61.119999999999997 110.911 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.661 ' OE1' HG12 ' A' ' 124' ' ' VAL . 2.0 pt20 179.26 176.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 54.409999999999997 110.93 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.42 135.78 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.010000000000005 111.113 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG13 HE21 ' A' ' 27' ' ' GLN . 0.4 OUTLIER -126.87 150.18 70.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.687 . . . . 73.409999999999997 111.183 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 150.75 68.66 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 73.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -148.5 116.22 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 53.340000000000003 111.054 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -74.22 131.52 41.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.898 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.011 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.1 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.102 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.93 147.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -52.41 113.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 52.539999999999999 110.884 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.44 25.19 51.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 33.130000000000003 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.9 t -97.27 163.28 12.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 73.200000000000003 110.891 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.1 p -121.14 165.28 15.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.087 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.571 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 88.3 t -52.02 -56.26 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 111.137 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.4 mp -56.77 -35.6 68.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 65.400000000000006 110.789 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.62 -26.76 61.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 72.450000000000003 110.893 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 88.4 t -76.67 -41.39 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 61.210000000000001 111.126 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -54.96 -30.2 58.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 62.219999999999999 111.115 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -74.13 -24.84 59.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.834 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -76.62 -54.2 6.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 110.896 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.473 HD22 ' HB2' ' A' ' 31' ' ' ALA . 43.8 p30 -77.82 -14.22 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.883 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.76 -12.42 69.42 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.463 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 93.9 t -57.33 143.15 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 41.020000000000003 111.124 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.88 81.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.84 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 115' ' ' VAL . 7.2 mt -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.869 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -70.6 113.42 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 53.100000000000001 110.913 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.88 95.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.679 -0.772 . . . . 24.25 112.448 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.88 125.6 25.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 55.299999999999997 111.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.23 76.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.879 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.7 -27.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 64.450000000000003 110.924 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.04 -52.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 75.319999999999993 112.531 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.82 -176.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 73.329999999999998 110.881 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -51.94 166.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.943 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.5 146.27 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 51.329999999999998 111.075 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 p -85.31 -170.4 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.884 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -104.27 53.96 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.857 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.839 HG21 HD21 ' A' ' 102' ' ' LEU . 96.1 m -115.23 -35.92 4.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.145 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.2 m -82.53 -67.65 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 25.530000000000001 110.837 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -77.13 78.69 3.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.439999999999998 110.791 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 114' ' ' THR . 5.7 t -128.46 157.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 72.25 111.17 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.484 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.2 mp -90.18 130.91 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 111.134 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' VAL . 15.7 tp -126.03 163.9 22.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 64.040000000000006 110.91 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -40.65 138.45 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.019999999999996 110.91 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -60.77 -58.64 17.85 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 73.040000000000006 110.945 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.4 Cg_endo -69.71 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.749 2.299 . . . . 54.219999999999999 112.327 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.537 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -52.25 -49.05 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.918 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.639 ' CD1' HG22 ' A' ' 95' ' ' THR . 52.6 t80 -64.9 -51.33 62.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.88 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -27.24 62.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 65.439999999999998 110.862 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -75.9 -54.66 6.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.5 mt -63.04 -21.48 66.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.965 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.02 142.77 3.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.742 -0.742 . . . . 71.329999999999998 112.508 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 157.57 77.05 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 65.310000000000002 110.872 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 157.27 60.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 62.009999999999998 112.316 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.2 m -58.14 157.34 8.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -51.73 -35.78 44.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.896 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -62.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 110.909 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.71 -35.82 81.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 110.923 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.61 -56.6 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.9 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -62.15 -41.29 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.908 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.21 -38.26 73.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.219999999999999 110.936 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.479 HD13 ' HA2' ' A' ' 94' ' ' GLY . 12.5 mt -75.04 -36.75 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 111.078 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.18 -22.26 27.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.857 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.43 -29.7 59.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.891 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -75.67 131.09 39.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.041 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -54.44 130.08 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.48 48.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.718 . . . . 73.129999999999995 112.458 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 70.219999999999999 111.162 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.74 153.01 22.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.174 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -27.39 48.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.453 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.9 p -73.94 -1.43 19.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 111.174 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.0 t -87.61 -13.88 41.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 131.92 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.814 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tt -135.07 -64.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.94 -176.68 41.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.511 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.12 109.27 20.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 61.43 110.866 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.576 ' C ' HD22 ' A' ' 102' ' ' LEU . 7.7 mt-30 -163.81 134.68 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 64.439999999999998 110.891 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 62' ' ' THR . 4.5 mm? -126.78 83.79 2.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 65.25 110.924 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -152.0 146.63 25.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.884 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.011 HG11 ' HB1' ' A' ' 33' ' ' ALA . 71.0 t -109.88 131.68 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.203 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.42 167.47 21.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.040000000000006 110.835 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.59 -22.05 54.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.926 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -29.46 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 110.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.453 ' O ' HG22 ' A' ' 20' ' ' ILE . 20.0 m-85 -90.78 7.54 39.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 71.209999999999994 110.868 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' HG21 ' A' ' 18' ' ' ILE . 61.4 tt0 -57.63 123.15 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 110.878 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.4 25.36 14.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 53.450000000000003 110.907 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -86.23 162.52 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 33.329999999999998 111.078 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.567 ' O ' HD12 ' A' ' 67' ' ' LEU . 13.5 t -112.72 125.29 69.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 111.175 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -111.76 94.72 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.904 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 65' ' ' VAL . 56.1 m -89.32 130.97 35.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.158 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.566 HG21 HD22 ' A' ' 50' ' ' LEU . 59.6 t -104.4 133.35 20.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.6 0.715 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.3 Cg_endo -69.76 -41.15 4.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 65.439999999999998 112.303 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.29 124.11 28.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.831 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -162.16 -170.5 2.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 53.109999999999999 111.097 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -140.23 143.5 36.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 73.409999999999997 111.053 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -174.25 158.59 2.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 110.888 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -126.67 69.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.909 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.5 mmm -141.72 -169.96 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.862 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.12 114.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 62.43 111.078 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.661 HG12 ' OE1' ' A' ' 27' ' ' GLN . 10.6 p -174.65 150.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 44.350000000000001 111.144 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -123.95 147.37 47.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.030000000000001 110.905 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.62 130.89 1.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 73.430000000000007 112.508 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -120.55 -172.28 2.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 74.310000000000002 110.89 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -178.3 157.57 1.07 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 71.430000000000007 110.858 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.68 155.8 65.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.748 2.298 . . . . 73.120000000000005 112.353 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -173.93 70.68 0.34 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.601 0.715 . . . . 72.420000000000002 110.881 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -18.62 36.76 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.298 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.3 t60 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.817 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 121.432 0.462 . . . . 71.299999999999997 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.05 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 64.129999999999995 112.373 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.33 49.87 0.91 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 41.340000000000003 112.44 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 p -160.62 179.65 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 73.310000000000002 110.901 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 143.38 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.865 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -165.11 179.51 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.815 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 mmt -80.48 82.84 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 62.509999999999998 110.853 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -116.06 163.3 16.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 71.439999999999998 110.847 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -100.28 -65.56 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 72.439999999999998 110.847 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 59.31 73.78 0.65 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.639 0.733 . . . . 71.340000000000003 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -35.23 12.79 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.764 2.309 . . . . 63.229999999999997 112.289 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -100.8 24.56 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.876 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -157.78 121.26 4.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 110.865 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 15' ' ' PRO . 56.3 mt -60.62 133.07 91.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.604 0.716 . . . . 72.400000000000006 111.088 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.69 -170.57 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.383 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.24 156.89 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 73.310000000000002 110.89 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -74.03 144.01 45.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 43.299999999999997 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.5 pp -129.93 176.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -114.68 138.71 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.896 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.639 HD12 ' CE1' ' A' ' 113' ' ' PHE . 23.9 pt -114.22 167.81 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 111.189 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -113.08 125.3 54.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.865 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.37 101.87 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.51 128.56 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 p -127.23 175.85 7.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 65.510000000000005 111.171 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 6.1 tpt -74.42 -8.06 55.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 73.099999999999994 110.893 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HE2' HG13 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -105.08 -38.35 6.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 61.119999999999997 110.824 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 178.81 176.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.881 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.78 146.44 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.129 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.3 t -142.51 129.78 11.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.112 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.64 7.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.633 2.222 . . . . 73.0 112.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -121.21 115.94 23.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 111.064 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -73.91 137.22 43.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 53.43 110.898 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.22 145.87 37.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.138 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.01 152.36 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 111.117 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.51 109.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 52.539999999999999 110.833 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.47 23.49 33.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 33.130000000000003 112.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -97.19 177.52 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 73.200000000000003 110.86 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.0 p -134.69 152.21 51.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.140000000000001 111.168 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -47.85 -61.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 70.420000000000002 111.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.01 -34.05 58.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 65.400000000000006 110.921 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.4 -27.07 62.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 72.450000000000003 110.805 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 56.4 t -77.0 -43.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.125 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.98 -28.13 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 62.219999999999999 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -73.1 -27.43 61.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.806 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -53.4 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.884 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.486 ' HB3' HG23 ' A' ' 48' ' ' VAL . 13.7 t-20 -72.59 -24.73 61.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.420000000000002 110.908 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.02 15.75 43.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.783 -0.722 . . . . 71.540000000000006 112.452 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 46' ' ' ASN . 24.8 t -66.31 147.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.338 . . . . 41.020000000000003 111.135 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.44 ' O ' HG21 ' A' ' 119' ' ' THR . 43.8 t0 -88.83 80.8 7.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.904 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -128.7 123.12 32.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 70.430000000000007 110.935 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' N ' HD13 ' A' ' 50' ' ' LEU . 4.9 pt-20 -116.12 149.68 38.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 53.100000000000001 110.903 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.94 83.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 24.25 112.453 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -69.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 55.299999999999997 111.101 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.9 t 53.13 44.78 29.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -63.64 -34.86 78.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 64.450000000000003 110.934 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.09 71.98 0.65 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.53 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.703 ' O ' HD12 ' A' ' 58' ' ' LEU . 15.6 p-10 -122.63 -47.04 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 110.921 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 57' ' ' ASN . 8.5 mp -138.4 158.19 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 72.140000000000001 110.967 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.67 112.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 51.329999999999998 111.114 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.8 p -106.4 163.02 13.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 74.540000000000006 110.932 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -128.97 73.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 65.319999999999993 110.894 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -133.4 29.7 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 62.32 111.177 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.14 32.33 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 25.530000000000001 110.886 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -146.68 112.99 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 65.439999999999998 110.832 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 9.3 t -128.32 156.66 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 72.25 111.133 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.3 mp -89.31 137.72 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 111.159 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.77 157.88 39.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 64.040000000000006 110.952 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.48 141.45 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.879 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -57.27 -59.63 12.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 73.040000000000006 110.906 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.79 -48.86 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.744 2.296 . . . . 54.219999999999999 112.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.654 HD21 ' HB1' ' A' ' 111' ' ' ALA . 1.6 tp -51.83 -42.82 62.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.996 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.9 t80 -72.51 -51.64 19.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.87 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -36.23 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 65.439999999999998 110.852 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -78.18 -43.06 29.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.3 mm? -63.26 -28.1 69.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.944 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.07 160.55 8.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.737 -0.744 . . . . 71.329999999999998 112.457 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.55 157.37 77.48 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 65.310000000000002 110.876 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 62.009999999999998 112.425 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -102.57 -175.7 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 110.871 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -56.45 -45.2 80.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -59.65 4.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.868 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.43 -28.55 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.530000000000001 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -56.96 13.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.901 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -42.09 89.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.822 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.08 -51.93 62.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 110.963 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' HA2' ' A' ' 94' ' ' GLY . 58.0 mt -73.74 -35.26 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 111.105 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.55 -17.04 62.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.83 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -76.28 -25.38 54.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.869 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -82.46 143.84 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 71.129999999999995 111.087 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -64.03 123.17 18.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 75.519999999999996 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.93 43.92 55.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.711 -0.756 . . . . 73.129999999999995 112.551 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.615 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.9 118.02 35.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 70.219999999999999 111.179 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 148.71 26.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 111.122 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.68 -24.82 41.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 75.129999999999995 112.45 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -73.96 -1.99 22.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 64.239999999999995 111.171 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.7 t -91.05 -12.94 34.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 71.409999999999997 110.9 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -118.24 132.73 56.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 70.200000000000003 110.906 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.17 -69.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.450000000000003 110.874 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.36 -142.04 7.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 71.010000000000005 112.456 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -129.87 33.44 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 61.43 110.884 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.584 ' C ' HD22 ' A' ' 102' ' ' LEU . 33.8 mt-30 -139.41 133.95 31.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 64.439999999999998 110.968 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 101' ' ' GLN . 4.6 mm? -128.82 109.15 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 65.25 110.918 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -137.4 145.35 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 70.209999999999994 110.863 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG21 ' HB1' ' A' ' 33' ' ' ALA . 22.1 t -92.94 130.18 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.106 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.48 167.53 21.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.932 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -41.76 79.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 72.510000000000005 110.874 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.64 -17.09 59.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.510000000000005 110.898 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 m-85 -90.26 11.26 21.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.931 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.5 123.27 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.219999999999999 110.897 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 59.6 25.88 14.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 53.450000000000003 110.84 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -73.85 127.92 34.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 33.329999999999998 111.097 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 21' ' ' PHE . 21.6 t -102.12 120.52 51.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.117 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 20' ' ' ILE . 30.3 p90 -120.46 126.41 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.876 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -101.4 131.35 47.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.192 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.0 t -88.18 133.34 37.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.681 0.753 . . . . 72.129999999999995 111.089 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.0 Cg_endo -69.78 -43.56 2.58 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.709 2.273 . . . . 65.439999999999998 112.312 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -62.37 144.96 55.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.948 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.96 162.28 29.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 53.109999999999999 111.103 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 49' ' ' ASP . 10.0 m -160.51 136.25 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 111.149 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.74 136.71 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.922 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -144.03 166.36 25.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 73.329999999999998 110.885 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.2 ptp -59.47 -178.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.862 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.95 44.57 29.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.141 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 26' ' ' LYS . 65.0 t -53.11 137.49 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 44.350000000000001 111.097 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.61 161.23 37.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.030000000000001 110.915 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -52.33 138.71 31.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.783 -0.722 . . . . 73.430000000000007 112.44 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -107.73 -179.61 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.945 0.403 . . . . 74.310000000000002 110.892 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -162.44 157.65 19.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 71.430000000000007 110.884 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -170.95 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.675 2.25 . . . . 73.120000000000005 112.399 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -135.46 157.6 76.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.504 0.668 . . . . 72.420000000000002 110.929 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.37 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.713 2.276 . . . . 73.030000000000001 112.343 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.848 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 CA-C-O 121.433 0.463 . . . . 71.299999999999997 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -174.71 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 64.129999999999995 112.322 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.88 -102.47 0.19 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.461 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -114.47 148.58 37.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 73.310000000000002 110.88 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.3 mtm -153.16 135.67 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.895 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.6 179.15 7.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 110.9 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.0 ttp -145.29 128.83 17.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.509999999999998 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -137.88 165.69 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 71.439999999999998 110.896 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.1 114.97 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 110.876 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -177.57 160.4 1.36 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.535 0.683 . . . . 71.340000000000003 111.125 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 53.7 Cg_endo -69.78 -28.54 25.05 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.643 2.229 . . . . 63.229999999999997 112.362 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -107.69 25.03 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 31.1 mmm180 -148.01 128.39 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 110.899 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 15' ' ' PRO . 47.6 mm -62.52 133.06 94.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.658 0.742 . . . . 72.400000000000006 111.105 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.77 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.742 2.295 . . . . 71.329999999999998 112.293 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -51.74 156.75 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.310000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -73.94 144.41 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 43.299999999999997 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HG13 ' A' ' 104' ' ' VAL . 2.5 pp -138.7 176.88 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 64.439999999999998 111.143 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -121.43 141.65 50.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.877 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 pt -114.39 164.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.05 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -120.77 130.36 53.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 110.877 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.35 102.95 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 71.329999999999998 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.33 30.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 75.340000000000003 110.934 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 p -113.8 -176.45 2.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 65.510000000000005 111.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -8.6 57.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 110.924 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -110.6 -38.32 5.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 61.119999999999997 110.885 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 178.67 176.49 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 54.409999999999997 110.902 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.05 148.14 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.158 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 30' ' ' PRO . 84.0 t -129.44 132.52 24.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.117 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 29' ' ' VAL . 54.7 Cg_endo -69.68 129.37 17.56 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 73.0 112.382 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.67 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -138.01 107.51 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 53.340000000000003 111.105 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.94 149.06 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 53.43 110.91 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -130.68 121.67 25.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.069 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.3 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.200000000000003 111.145 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 p -51.21 111.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 52.539999999999999 110.852 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.84 14.16 35.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.703 . . . . 33.130000000000003 112.429 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.1 p -95.01 -178.92 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.009 0.433 . . . . 73.200000000000003 110.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -145.9 159.86 42.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 73.140000000000001 111.124 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.909 HG23 HD12 ' A' ' 40' ' ' LEU . 15.7 m -58.73 -45.3 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 111.069 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 39' ' ' VAL . 6.5 mp -66.75 -36.07 81.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 65.400000000000006 110.937 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.66 -27.44 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.450000000000003 110.892 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -77.08 -49.9 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.092 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 111.082 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -69.74 -34.19 73.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 110.854 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -87.12 -37.41 17.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.973 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' HB3' HG23 ' A' ' 48' ' ' VAL . 2.2 m-80 -72.26 -24.92 61.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.912 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.9 -12.13 70.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.542 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 46' ' ' ASN . 46.9 t -51.54 130.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 41.020000000000003 111.206 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' CG ' HG23 ' A' ' 119' ' ' THR . 20.0 t70 -71.59 81.29 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -76.08 131.26 39.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.887 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -51.99 112.1 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 53.100000000000001 110.901 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.29 134.32 0.4 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 24.25 112.455 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.09 -26.67 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 55.299999999999997 111.095 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 63.38 44.21 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.899 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.02 -35.14 5.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 64.450000000000003 110.904 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.85 19.66 2.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 75.319999999999993 112.535 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.0 t30 53.43 63.32 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 73.329999999999998 110.849 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mt -123.55 -41.18 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.917 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.37 -29.66 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 51.329999999999998 111.14 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.9 t -82.63 59.96 4.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 110.949 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 p -100.1 28.05 5.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.319999999999993 110.849 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.02 140.19 18.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 62.32 111.133 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.2 m -126.78 79.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 25.530000000000001 110.917 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -161.95 112.09 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.864 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 114' ' ' THR . 9.7 p -128.92 157.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 72.25 111.133 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 3.1 mt -89.79 132.37 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 111.099 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 112' ' ' VAL . 25.0 tp -127.28 159.87 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.946 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.79 142.06 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.864 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -57.5 -59.83 11.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 73.040000000000006 110.867 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.61 2.206 . . . . 54.219999999999999 112.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 0.6 OUTLIER -51.47 -43.33 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 73.209999999999994 110.892 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 95' ' ' THR . 56.1 t80 -71.44 -51.63 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.945 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -35.39 61.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.873 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -78.1 -40.84 37.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -63.28 -26.33 68.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.877 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.7 167.57 11.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.23 157.82 77.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 65.310000000000002 110.91 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -178.1 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.702 2.268 . . . . 62.009999999999998 112.334 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -98.32 -173.3 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.879 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -58.5 -43.8 89.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.858 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -53.93 -59.65 4.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 63.240000000000002 110.899 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -28.16 69.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.530000000000001 110.958 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -52.36 64.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -41.83 70.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 71.120000000000005 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -50.01 69.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.954 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.574 HD13 ' HA2' ' A' ' 94' ' ' GLY . 64.2 mt -73.29 -42.58 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.51 -23.11 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.13 -24.17 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -83.56 142.17 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 111.049 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 130.99 43.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.904 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 40.36 59.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 73.129999999999995 112.56 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.64 123.61 49.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.127 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.32 144.2 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 75.109999999999999 111.1 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.574 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.91 -26.11 47.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 75.129999999999995 112.445 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.654 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.3 p -74.07 -1.23 19.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 64.239999999999995 111.155 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 5.9 t -90.76 -12.71 35.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.869 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -112.59 143.57 43.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 70.200000000000003 110.879 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 130.63 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.948 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.59 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 71.010000000000005 112.515 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.6 m -101.44 27.69 6.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 61.43 110.911 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.21 59.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.889 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -98.4 112.56 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.25 110.889 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -119.21 136.36 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.95 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' A' ' 33' ' ' ALA . 39.3 t -80.06 115.43 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.137 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 178.54 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 72.040000000000006 110.819 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -54.88 -40.28 69.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.510000000000005 110.889 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 t -64.44 -25.09 67.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.914 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 75' ' ' LEU . 12.8 m-85 -79.85 -2.21 42.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 18' ' ' ILE . 18.8 tt0 -58.15 124.94 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.935 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.3 m120 58.72 23.81 11.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 53.450000000000003 110.902 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -65.63 151.24 46.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 33.329999999999998 111.147 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.701 ' O ' HD12 ' A' ' 67' ' ' LEU . 23.6 t -107.07 113.02 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.010000000000005 111.184 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -108.95 95.06 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.804 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' VAL . 51.6 m -87.82 130.91 34.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 111.169 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.441 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.3 t -95.53 133.4 25.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.631 0.729 . . . . 72.129999999999995 111.165 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.73 -41.89 3.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.76 2.306 . . . . 65.439999999999998 112.321 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -132.79 120.25 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.843 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.85 -176.14 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 53.109999999999999 111.122 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.446 HG23 ' CG ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.55 112.18 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 111.144 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -173.96 139.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.349999999999994 110.88 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -80.19 -26.81 39.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.88 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.2 mtt -117.41 -171.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.57 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 62.43 111.138 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 m -82.4 -177.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 44.350000000000001 111.09 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -98.94 -174.71 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.924 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.77 86.51 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 73.430000000000007 112.504 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -123.44 126.26 46.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.310000000000002 110.925 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -115.4 73.76 4.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 71.430000000000007 110.923 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 82.93 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.673 2.249 . . . . 73.120000000000005 112.317 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 131' ' ' PRO . 2.9 mtpp -67.75 -60.39 5.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.585 0.707 . . . . 72.420000000000002 110.888 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 53.5 Cg_endo -69.75 170.34 16.8 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.745 2.297 . . . . 73.030000000000001 112.307 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.877 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.516 0.509 . . . . 71.299999999999997 112.458 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 179.71 3.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.724 2.283 . . . . 64.129999999999995 112.345 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.38 170.84 12.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 41.340000000000003 112.506 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.59 -174.87 3.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.868 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.7 tpp -126.46 138.64 53.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 73.430000000000007 110.859 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -158.29 -178.47 7.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.420000000000002 110.883 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.13 173.12 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 62.509999999999998 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -116.01 166.11 12.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.881 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -100.82 -175.05 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.838 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.8 71.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.594 0.711 . . . . 71.340000000000003 111.189 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 177.88 5.16 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.229999999999997 112.341 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.1 24.7 10.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.839 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -108.76 102.4 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.209999999999994 110.859 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.429 HG23 ' HD2' ' A' ' 15' ' ' PRO . 5.2 mp -109.61 132.96 21.04 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.758 . . . . 72.400000000000006 111.071 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.71 -168.09 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 71.329999999999998 112.412 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -50.25 157.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.86 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.44 147.0 44.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.493 . . . . 43.299999999999997 110.95 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 177.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 111.205 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -122.75 136.79 54.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.946 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.734 HG13 ' HB3' ' A' ' 31' ' ' ALA . 46.8 pt -117.44 172.02 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 111.13 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -118.74 128.74 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.894 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 4.1 m-85 -105.31 104.18 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 71.329999999999998 110.922 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -93.64 122.25 35.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -113.36 -177.83 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 65.510000000000005 111.074 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -75.95 -9.36 58.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -106.09 -37.74 6.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 61.119999999999997 110.944 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.13 176.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.911 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.36 134.58 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.102 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -129.41 150.66 76.21 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.63 0.729 . . . . 73.409999999999997 111.101 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 155.06 66.96 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 73.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.734 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.92 136.18 25.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 53.340000000000003 111.141 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -96.78 134.56 39.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 53.43 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -115.35 125.66 53.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.123 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 35' ' ' CYS . 8.1 t -95.23 156.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 75.200000000000003 111.114 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' HG12 ' A' ' 34' ' ' VAL . 58.5 m -55.55 99.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 52.539999999999999 110.802 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.95 24.6 11.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 33.130000000000003 112.476 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 104' ' ' VAL . 2.4 m -94.83 174.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 73.200000000000003 110.844 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -131.73 146.71 52.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 111.133 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.52 -62.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 111.158 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.45 -32.98 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 65.400000000000006 110.876 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.25 -27.02 62.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.863 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 38' ' ' THR . 60.8 t -77.55 -43.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.108 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 48' ' ' VAL . . . -52.82 -27.8 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 62.219999999999999 111.131 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -73.36 -34.66 65.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 75.200000000000003 110.822 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -83.28 -40.73 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.898 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -72.02 -26.95 62.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.812 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.69 83.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 71.540000000000006 112.438 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.577 HG12 ' HB1' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -53.66 156.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 41.020000000000003 111.135 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.6 t70 -72.1 80.02 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.859 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -159.95 146.81 16.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 70.430000000000007 110.829 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.9 141.0 50.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 53.100000000000001 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.29 155.51 21.54 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 24.25 112.519 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.99 23.8 11.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 55.299999999999997 111.068 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 t 51.93 50.53 18.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 72.329999999999998 110.853 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -51.8 129.21 25.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 64.450000000000003 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.99 99.76 0.15 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 75.319999999999993 112.478 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -54.5 -28.41 44.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 73.329999999999998 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mt -125.16 -71.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 72.140000000000001 110.923 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.71 -176.9 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 51.329999999999998 111.08 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.5 m -122.67 114.92 21.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.540000000000006 110.924 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.83 -62.46 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.886 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -171.1 157.05 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 62.32 111.135 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.23 98.7 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 25.530000000000001 110.893 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -94.55 112.21 23.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 65.439999999999998 110.87 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 114' ' ' THR . 6.4 t -128.66 157.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.074 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 63.9 mt -90.08 132.79 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 64.430000000000007 111.134 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 112' ' ' VAL . 36.0 tp -125.63 159.63 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 64.040000000000006 110.902 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.78 142.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.019999999999996 110.815 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -60.11 -58.67 17.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.731 . . . . 73.040000000000006 110.965 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.85 -47.58 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.741 2.294 . . . . 54.219999999999999 112.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.8 tp -53.24 -51.16 63.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 110.957 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.3 t80 -63.46 -53.74 47.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -31.63 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 65.439999999999998 110.809 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.13 -53.78 13.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.3 -23.59 67.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.835 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.14 148.04 4.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.478 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.45 78.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.636 0.731 . . . . 65.310000000000002 110.842 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 165.45 30.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.648 2.232 . . . . 62.009999999999998 112.343 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -93.68 -170.92 2.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 110.842 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -56.96 -45.23 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.837 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -53.76 -59.79 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 63.240000000000002 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.57 -29.98 70.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.530000000000001 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -54.0 50.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.02 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.905 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.82 -51.95 61.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.936 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 94' ' ' GLY . 11.5 mt -74.92 -34.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 111.089 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.76 -20.02 45.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.030000000000001 110.799 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -75.52 -16.31 60.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.918 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.67 144.31 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 71.129999999999995 111.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -64.96 122.28 16.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.934 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.5 45.1 53.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 73.129999999999995 112.539 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.616 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.06 143.93 36.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.902 0.382 . . . . 70.219999999999999 111.092 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 150.56 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.149 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.76 -27.18 49.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.742 . . . . 75.129999999999995 112.479 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.581 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.9 p -73.92 -1.28 19.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.384 . . . . 64.239999999999995 111.154 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.3 t -89.34 -13.61 37.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 110.879 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.22 165.65 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.200000000000003 110.848 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.65 65.88 0.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.03 19.88 10.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.753 . . . . 71.010000000000005 112.438 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.66 165.18 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 61.43 110.897 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 56.67 42.11 27.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 64.439999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' THR . 2.5 tp -98.25 156.56 16.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.45 . . . . 65.25 110.879 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -118.55 163.47 16.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 110.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.542 HG11 ' HB1' ' A' ' 33' ' ' ALA . 88.0 t -102.03 122.71 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 111.107 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.28 173.61 11.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.927 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -59.26 -36.02 74.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 110.919 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -65.81 -19.53 65.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 64.510000000000005 110.909 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.02 -0.19 43.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.831 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -59.01 124.28 19.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 62.219999999999999 110.904 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.38 22.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 53.450000000000003 110.881 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -64.91 141.99 58.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 33.329999999999998 111.127 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.6 t -103.05 116.77 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 73.010000000000005 111.116 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 39' ' ' VAL . 79.8 m-85 -112.26 100.31 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.905 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 65' ' ' VAL . 39.5 m -88.22 124.83 34.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 111.174 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 50' ' ' LEU . 20.4 t -116.89 92.27 38.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.097 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 53.5 Cg_endo -69.77 -35.59 12.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.728 2.285 . . . . 65.439999999999998 112.336 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -87.47 150.38 23.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.843 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.07 175.56 6.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 53.109999999999999 111.113 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.54 -19.99 62.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 73.409999999999997 111.126 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -51.26 113.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 73.349999999999994 110.853 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.39 174.11 11.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.935 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.496 ' HB3' HG13 ' A' ' 124' ' ' VAL . 14.6 mmt -117.75 -32.15 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 110.887 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 57.79 49.61 11.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 62.43 111.147 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 122' ' ' MET . 26.6 m -89.64 175.05 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 44.350000000000001 111.118 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 58.26 41.53 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 71.030000000000001 110.956 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -123.22 -10.47 5.6 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 73.430000000000007 112.428 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -53.18 123.13 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -83.22 159.21 62.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 110.921 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -21.98 32.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.120000000000005 112.354 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -154.35 162.66 26.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.713 . . . . 72.420000000000002 110.881 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -172.09 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.682 2.255 . . . . 73.030000000000001 112.378 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 110.926 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.496 0.498 . . . . 71.299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.77 2.313 . . . . 64.129999999999995 112.329 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.03 -19.69 0.65 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 41.340000000000003 112.506 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.55 66.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 73.310000000000002 110.832 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -175.36 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 73.430000000000007 110.922 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.97 179.45 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 71.420000000000002 110.871 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -115.95 -176.08 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 110.817 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -142.94 161.36 38.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 71.439999999999998 110.923 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.9 t -99.36 -171.43 2.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.842 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -137.27 160.36 65.99 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.569 0.7 . . . . 71.340000000000003 111.058 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 53.2 Cg_endo -69.83 -11.26 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.229999999999997 112.344 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.93 -23.11 66.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 110.848 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -169.16 140.37 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 74.209999999999994 110.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.591 HD13 ' HA2' ' A' ' 36' ' ' GLY . 2.7 mp -112.76 133.06 22.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 72.400000000000006 111.062 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.78 -170.63 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 71.329999999999998 112.364 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.54 156.64 1.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.893 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.98 158.99 33.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 43.299999999999997 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.2 176.43 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 111.091 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 127.59 53.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.798 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.27 163.0 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 111.112 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -119.53 127.53 53.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' A' ' 48' ' ' VAL . 3.2 m-85 -99.26 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.882 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.751 ' HG2' HG22 ' A' ' 28' ' ' VAL . 12.3 tmtt? -86.1 115.17 23.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.340000000000003 110.926 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -103.91 -179.29 3.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 65.510000000000005 111.167 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.01 -17.14 59.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.099999999999994 110.946 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -93.98 -39.11 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 61.119999999999997 110.889 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 176.31 176.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.751 HG22 ' HG2' ' A' ' 23' ' ' LYS . 20.7 t -86.77 142.69 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 111.085 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.75 129.78 18.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.71 60.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.246 . . . . 73.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.84 113.31 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.340000000000003 111.118 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -79.44 122.97 27.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.848 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -100.27 116.42 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.029 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 m -87.8 144.38 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 75.200000000000003 111.109 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 p -54.78 121.35 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.539999999999999 110.889 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 106.0 -7.74 41.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 33.130000000000003 112.494 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -99.42 -178.06 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.993 0.425 . . . . 73.200000000000003 110.85 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -133.93 154.77 50.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 111.135 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.954 HG23 HD12 ' A' ' 40' ' ' LEU . 14.9 m -57.91 -45.55 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.420000000000002 111.118 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -64.33 -37.35 87.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.931 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.73 -27.3 61.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 72.450000000000003 110.886 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 73.0 t -76.42 -43.59 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 61.210000000000001 111.077 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 50' ' ' LEU . . . -51.36 -29.96 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 62.219999999999999 111.108 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -73.42 -36.84 66.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 110.848 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -40.84 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.530000000000001 110.909 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -72.1 -25.45 61.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.903 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.88 76.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.449 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 46' ' ' ASN . 48.2 t -51.5 137.99 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 41.020000000000003 111.052 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.13 80.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 50' ' ' LEU . 8.9 tt -107.92 107.67 18.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.884 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.36 112.49 8.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 53.100000000000001 110.862 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.99 38.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 24.25 112.474 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.22 73.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 55.299999999999997 111.08 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 56.79 26.53 11.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.945 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -127.82 163.09 25.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.450000000000003 110.863 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.24 -162.19 53.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.729 -0.748 . . . . 75.319999999999993 112.531 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.28 163.04 25.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 110.931 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.79 62.88 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.87 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.73 143.01 33.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 51.329999999999998 111.12 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.7 p -102.35 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.947 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -92.21 -28.13 17.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 65.319999999999993 110.818 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 t -140.95 150.41 43.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 62.32 111.111 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 p -130.67 81.73 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 25.530000000000001 110.855 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -60.81 117.27 5.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 65.439999999999998 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.8 t -128.2 155.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.105 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 70.3 mt -91.07 133.77 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 64.430000000000007 111.096 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 112' ' ' VAL . 20.3 tp -125.67 162.54 24.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.933 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -41.0 139.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -60.1 -59.38 14.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.638 0.732 . . . . 73.040000000000006 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.75 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.723 2.282 . . . . 54.219999999999999 112.318 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.76 -48.83 63.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.941 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD1' HG22 ' A' ' 95' ' ' THR . 30.3 t80 -66.99 -51.08 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.929 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -51.52 -51.66 53.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 65.439999999999998 110.881 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -61.62 -48.55 80.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 71' ' ' LEU . 3.3 mm? -62.94 -18.68 63.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.209999999999994 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.03 130.35 2.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 71.329999999999998 112.507 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 157.75 60.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 65.310000000000002 110.866 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.94 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.392 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.9 m -104.79 -174.89 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.852 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.9 -49.16 78.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.896 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -47.69 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 63.240000000000002 110.914 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.83 -28.38 64.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 71.530000000000001 110.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -53.3 55.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.851 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -43.28 68.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.22 -49.07 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.219999999999999 110.88 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.595 HD13 ' HA2' ' A' ' 94' ' ' GLY . 57.8 mt -75.06 -34.4 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 111.089 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.42 -15.64 58.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.85 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.33 -22.86 57.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.858 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.63 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.1 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 71.129999999999995 111.133 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -56.97 126.6 27.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.13 41.33 53.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.484 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.63 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -110.48 139.03 46.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 70.219999999999999 111.068 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 155.0 44.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.135 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.87 -27.08 49.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 75.129999999999995 112.427 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.558 HG22 ' CD1' ' A' ' 72' ' ' TYR . 14.9 p -73.79 -1.92 21.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.293 . . . . 64.239999999999995 111.158 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 39.1 t -87.88 -14.9 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.884 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.8 168.27 9.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 70.200000000000003 110.857 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 62.06 97.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.947 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.95 32.01 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 71.010000000000005 112.504 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.24 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.329 . . . . 61.43 110.871 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -88.26 51.7 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 64.439999999999998 110.911 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.513 HD11 ' CZ ' ' A' ' 108' ' ' PHE . 7.1 tt -91.37 114.51 27.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.93 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -85.33 134.93 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 110.934 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' A' ' 33' ' ' ALA . 83.8 t -59.76 122.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 72.239999999999995 111.091 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -137.07 160.2 39.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 72.040000000000006 110.884 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -53.95 -27.24 29.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.489 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -62.66 -29.29 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.866 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.513 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 22.0 m-85 -89.99 12.07 18.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 71.209999999999994 110.898 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.22 120.74 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.873 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.71 21.26 12.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 53.450000000000003 110.887 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.2 153.39 36.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 33.329999999999998 111.104 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.584 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.1 t -105.51 127.16 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.091 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 39' ' ' VAL . 12.1 m-85 -113.16 98.48 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.887 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.0 m -85.21 124.86 32.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.145 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.32 92.48 8.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.687 0.756 . . . . 72.129999999999995 111.124 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -34.2 14.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.663 2.242 . . . . 65.439999999999998 112.273 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 144.08 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 110.842 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.89 166.73 20.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 53.109999999999999 111.125 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.8 t -69.9 131.93 45.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 73.409999999999997 111.182 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -175.33 171.59 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 110.887 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -93.77 -29.14 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 73.329999999999998 110.9 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 151.03 41.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 74.510000000000005 110.809 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.97 140.11 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.096 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.2 t -144.22 149.67 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 44.350000000000001 111.139 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -55.15 172.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.52 -150.43 25.31 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 73.430000000000007 112.463 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -150.2 -174.11 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 74.310000000000002 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 pttp 37.55 67.89 1.81 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.587 0.708 . . . . 71.430000000000007 110.861 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 138.82 38.78 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.696 2.264 . . . . 73.120000000000005 112.402 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -132.57 160.77 66.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.568 0.699 . . . . 72.420000000000002 110.914 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -44.01 2.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.312 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 72.120000000000005 110.879 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 121.383 0.435 . . . . 71.299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -175.95 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 64.129999999999995 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -146.7 -177.92 21.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 41.340000000000003 112.439 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -129.56 -179.16 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.310000000000002 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.9 mtm -143.57 165.71 26.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.866 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.24 178.46 8.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.826 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.1 mtp -106.2 176.6 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 62.509999999999998 110.855 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -152.02 156.56 40.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 71.439999999999998 110.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -91.09 -172.35 3.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.836 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.94 73.76 0.46 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 71.340000000000003 111.15 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 81.9 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.611 2.207 . . . . 63.229999999999997 112.361 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -117.61 25.29 10.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 73.209999999999994 110.85 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -124.15 -166.93 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 74.209999999999994 110.858 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA2' ' A' ' 36' ' ' GLY . 4.1 mt -51.65 133.2 36.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.635 0.731 . . . . 72.400000000000006 111.136 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.77 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.346 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.02 157.45 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.902 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -73.41 143.58 46.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 43.299999999999997 110.864 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.7 pp -127.92 176.88 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 64.439999999999998 111.062 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -114.2 136.83 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.872 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 31' ' ' ALA . 14.6 pt -120.23 169.4 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 111.111 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.17 137.91 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.4 m-85 -108.81 103.12 12.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.852 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -90.19 130.0 36.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.887 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 118' ' ' ALA . 11.1 p -119.08 -177.51 3.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 65.510000000000005 111.156 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 ptm -75.9 -8.13 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.871 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -38.51 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 110.913 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.725 ' OE1' ' HB3' ' A' ' 123' ' ' ALA . 5.0 pt20 -178.56 176.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 54.409999999999997 110.947 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.94 135.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 111.163 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.09 150.9 60.7 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 73.409999999999997 111.099 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.67 60.98 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 73.0 112.377 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -147.8 108.46 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 53.340000000000003 111.111 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -74.83 128.0 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 53.43 110.986 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.061 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -106.31 119.97 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.4 154.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 75.200000000000003 111.161 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.8 t -56.21 109.8 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.577 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 100.47 -17.35 56.85 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 33.130000000000003 112.489 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -66.25 142.11 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 73.200000000000003 110.818 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 42' ' ' VAL . 72.8 p -96.82 158.38 15.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.07 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.86 -58.27 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.420000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.18 -33.63 58.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 65.400000000000006 110.856 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -73.06 -27.59 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 72.450000000000003 110.796 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 38' ' ' THR . 25.7 t -76.13 -45.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.082 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.2 25.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.042 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -71.74 -38.93 70.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 75.200000000000003 110.916 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -66.46 -50.69 62.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.17 -32.86 67.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.862 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.7 44.01 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.791 . . . . 71.540000000000006 112.51 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.0 t -51.82 142.44 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 41.020000000000003 111.222 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.43 81.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.851 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.98 112.28 17.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.430000000000007 110.924 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -52.04 145.36 10.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 53.100000000000001 110.847 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.66 32.83 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.78 -0.724 . . . . 24.25 112.517 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.8 86.45 2.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.321 . . . . 55.299999999999997 111.172 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 m -90.01 -40.58 12.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.852 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.41 138.41 46.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 110.925 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.46 -103.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 75.319999999999993 112.493 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.31 -171.87 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 73.329999999999998 110.913 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.44 68.93 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 72.140000000000001 110.899 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.54 -45.32 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 51.329999999999998 111.079 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 45.1 t -76.96 72.56 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.903 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -54.81 -65.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 65.319999999999993 110.856 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -159.88 146.68 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 62.32 111.145 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.3 p -116.75 155.31 29.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 25.530000000000001 110.88 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -145.56 125.14 13.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 65.439999999999998 110.853 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.754 HG12 HD22 ' A' ' 98' ' ' LEU . 14.0 p -127.94 149.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.25 111.166 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 17.3 mt -91.2 133.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.106 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 112' ' ' VAL . 13.9 tp -120.11 158.97 25.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 64.040000000000006 110.878 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.09 137.46 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.816 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.575 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.8 mt-10 -59.72 -55.81 42.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.67 0.748 . . . . 73.040000000000006 110.921 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.9 Cg_endo -69.81 -32.71 17.83 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.63 2.22 . . . . 54.219999999999999 112.326 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 tp -63.01 -46.64 86.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 73.209999999999994 110.882 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.32 -48.62 40.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.942 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -36.65 68.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 110.905 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -76.37 -45.19 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 107' ' ' SER . 1.9 mm? -63.04 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.965 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.05 158.29 21.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 71.329999999999998 112.522 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -130.75 157.63 77.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.649 0.738 . . . . 65.310000000000002 110.904 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.62 2.4 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.249 . . . . 62.009999999999998 112.352 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -95.93 -176.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.94 -44.39 82.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.803 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -53.49 -60.12 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 63.240000000000002 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.02 -28.43 69.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 110.902 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -55.68 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.944 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.61 -43.59 84.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 71.120000000000005 110.857 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.66 -46.9 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.895 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.651 HD13 ' HA2' ' A' ' 94' ' ' GLY . 70.1 mt -74.84 -34.63 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.409999999999997 111.103 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.53 -15.41 60.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.885 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.89 -6.05 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.981 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.65 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -105.59 135.6 46.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.129 -0.487 . . . . 71.129999999999995 111.059 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -55.14 124.89 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 75.519999999999996 110.891 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.41 42.49 50.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.47 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.65 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -101.06 147.44 26.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 70.219999999999999 111.166 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.7 153.56 43.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 111.155 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.2 -38.37 67.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.468 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -73.98 -0.85 17.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 64.239999999999995 111.153 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 8.7 t -88.24 -16.52 32.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.409999999999997 110.873 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -118.31 148.62 42.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 70.200000000000003 110.845 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.754 HD22 HG12 ' A' ' 65' ' ' VAL . 1.1 pt? -121.4 -175.09 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 73.450000000000003 110.888 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.0 7.57 5.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 71.010000000000005 112.542 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 98' ' ' LEU . 17.2 m 61.5 167.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 61.43 110.931 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 54.59 43.55 30.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 110.888 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.34 92.33 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.25 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' NH1' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -59.49 168.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.845 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 1.061 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.4 t -90.77 143.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.123 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.44 171.24 14.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 72.040000000000006 110.808 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -38.42 77.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.85 -17.71 63.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 64.510000000000005 110.898 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.5 9.68 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.209999999999994 110.842 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.541 ' HA ' HD13 ' A' ' 18' ' ' ILE . 59.2 tt0 -59.33 124.88 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 62.219999999999999 110.906 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 60.81 21.25 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 53.450000000000003 110.895 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -62.9 129.74 41.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 33.329999999999998 111.157 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 67' ' ' LEU . 12.9 t -93.1 118.73 39.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.010000000000005 111.187 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -106.29 99.87 9.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.929 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.6 m -87.06 131.2 34.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.169 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.4 132.64 21.71 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.125 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -41.35 4.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.371 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -125.22 103.53 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.84 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 24' ' ' THR . . . -139.03 -175.32 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 53.109999999999999 111.078 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 p -111.02 -173.83 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 111.173 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -81.98 -173.48 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.906 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -168.33 179.24 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.882 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.3 tpt -84.87 109.2 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.877 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.725 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . . . -176.38 168.99 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 62.43 111.128 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.6 151.73 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 44.350000000000001 111.134 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -175.54 176.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.922 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.66 155.15 25.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.693 -0.765 . . . . 73.430000000000007 112.468 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -160.19 179.71 8.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 74.310000000000002 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -91.06 160.59 37.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 71.430000000000007 110.87 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.15 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.253 . . . . 73.120000000000005 112.407 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.48 73.47 0.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 72.420000000000002 110.893 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 142.87 49.39 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.64 2.227 . . . . 73.030000000000001 112.406 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 72.120000000000005 110.834 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 CA-C-O 121.395 0.442 . . . . 71.299999999999997 112.443 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 169.38 19.08 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.678 2.252 . . . . 64.129999999999995 112.373 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.04 120.49 0.65 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 41.340000000000003 112.503 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 m -130.55 159.18 37.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 73.310000000000002 110.903 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mtt -125.94 161.5 27.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.917 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.21 119.97 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 71.420000000000002 110.901 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -134.03 168.93 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 62.509999999999998 110.885 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -129.97 136.48 49.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 71.439999999999998 110.862 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.8 p -134.14 175.8 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 72.439999999999998 110.855 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.13 69.82 2.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.512 0.672 . . . . 71.340000000000003 111.098 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 111.36 2.78 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.754 2.303 . . . . 63.229999999999997 112.315 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.18 24.93 10.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.821 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.4 42.73 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.88 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 15' ' ' PRO . 49.1 mm -54.26 132.95 61.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.647 0.737 . . . . 72.400000000000006 111.179 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.711 2.274 . . . . 71.329999999999998 112.435 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -52.28 157.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.310000000000002 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -73.82 148.78 42.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 43.299999999999997 110.887 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.9 pp -130.38 177.11 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 64.439999999999998 111.07 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -123.35 144.62 49.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.797 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 113' ' ' PHE . 1.9 pt -125.75 170.59 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 111.087 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HB2' HG22 ' A' ' 112' ' ' VAL . 10.1 m-85 -114.5 125.32 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.887 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -92.48 103.37 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.329999999999998 110.877 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.78 127.28 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 p -114.36 -167.45 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.510000000000005 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.7 mmm -54.34 -54.85 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -141.03 27.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.963 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.3 128.45 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.409999999999997 110.915 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 23' ' ' LYS . 94.7 t -119.34 109.86 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 72.010000000000005 111.138 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG21 HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -123.11 150.27 59.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 111.175 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 159.55 53.02 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.703 2.269 . . . . 73.0 112.389 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.79 136.51 25.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 111.119 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.21 133.5 43.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 53.43 110.924 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB1' ' CG2' ' A' ' 104' ' ' VAL . . . -110.37 117.48 33.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.155 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.49 149.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 75.200000000000003 111.168 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.04 117.99 3.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 52.539999999999999 110.805 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.91 19.7 64.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 33.130000000000003 112.457 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -94.57 -169.42 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.931 0.396 . . . . 73.200000000000003 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -148.02 142.92 26.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.083 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.38 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 70.420000000000002 111.147 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HG ' HD13 ' A' ' 102' ' ' LEU . 6.2 mt -53.5 -36.27 61.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.400000000000006 110.859 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -72.67 -26.81 61.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 72.450000000000003 110.87 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 38' ' ' THR . 98.4 t -76.44 -39.9 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 61.210000000000001 111.086 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.35 -32.18 24.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.15 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -73.66 -35.94 65.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.863 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -40.31 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.530000000000001 110.942 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -72.08 -24.95 61.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 74.420000000000002 110.937 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.8 -11.67 38.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.737 . . . . 71.540000000000006 112.514 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 29' ' ' VAL . 99.9 t -61.59 110.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.347 . . . . 41.020000000000003 111.169 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.79 80.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.88 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -123.76 146.43 48.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 70.430000000000007 110.896 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -93.98 152.06 19.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 53.100000000000001 110.845 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' HD13 ' A' ' 40' ' ' LEU . . . -94.52 147.25 18.52 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.726 . . . . 24.25 112.516 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.78 -75.43 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 55.299999999999997 111.098 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.6 m -57.74 142.72 44.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.887 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 58' ' ' LEU . 3.4 tp10 -100.37 -66.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 64.450000000000003 110.953 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.18 -94.05 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 112.422 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -87.29 -58.21 2.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 73.329999999999998 110.84 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 55' ' ' GLU . 2.2 pt? -55.07 135.31 49.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.140000000000001 110.841 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.53 164.27 2.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 51.329999999999998 111.122 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.0 p -121.99 -176.97 3.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 110.868 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 m -76.61 -175.84 3.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 65.319999999999993 110.843 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 t -52.32 140.52 21.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.117 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 p -122.67 146.32 47.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 25.530000000000001 110.912 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -177.0 114.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 65.439999999999998 110.835 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 155.91 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.146 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -90.45 137.46 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.430000000000007 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 113' ' ' PHE . 9.0 tp -128.51 161.54 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 64.040000000000006 110.917 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.26 141.7 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 110.924 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 mt-10 -58.47 -59.51 13.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.609 0.718 . . . . 73.040000000000006 110.894 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -48.73 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.269 . . . . 54.219999999999999 112.279 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -51.73 -46.77 64.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.944 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.699 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.5 t80 -68.41 -50.43 52.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.866 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.82 -43.98 66.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 65.439999999999998 110.875 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -77.83 -28.01 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 tp -70.88 -61.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.41 132.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.329999999999998 112.482 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -91.91 160.31 36.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.701 0.762 . . . . 65.310000000000002 110.859 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.93 62.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.719 2.28 . . . . 62.009999999999998 112.333 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -86.45 -169.85 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.898 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -56.96 -48.57 78.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.833 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -53.52 -59.44 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.924 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.46 -27.61 68.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.887 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -55.74 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.99 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.7 -37.88 82.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 110.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.97 -47.24 86.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 64.219999999999999 110.909 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.732 HD13 ' HA2' ' A' ' 94' ' ' GLY . 43.6 mt -73.0 -35.17 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 111.159 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -20.89 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 74.030000000000001 110.857 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -76.25 -24.37 54.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.926 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -81.36 148.79 29.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -76.65 120.39 21.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 75.519999999999996 110.872 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.5 44.15 59.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.695 -0.765 . . . . 73.129999999999995 112.443 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -99.37 130.56 45.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 111.064 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 146.22 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.136 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.732 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.8 -24.97 43.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.686 -0.769 . . . . 75.129999999999995 112.539 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.699 HG22 ' CD1' ' A' ' 72' ' ' TYR . 18.9 p -74.01 -2.26 23.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 64.239999999999995 111.189 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.4 t -91.35 -13.42 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 71.409999999999997 110.903 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.583 ' CB ' HD11 ' A' ' 86' ' ' ILE . 7.0 tpt85 -108.53 161.79 14.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.863 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt 64.9 110.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.69 25.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.010000000000005 112.462 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 59.4 m -78.25 -171.28 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 61.43 110.894 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 63.09 61.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.546 HD13 ' HG ' ' A' ' 40' ' ' LEU . 72.6 mt -65.87 89.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.91 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -152.02 149.7 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 70.209999999999994 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.588 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 94.2 t -83.5 133.57 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 111.139 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -136.55 155.92 49.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 72.040000000000006 110.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -57.07 -37.49 71.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 72.510000000000005 110.904 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.1 m -65.08 -18.54 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 64.510000000000005 110.778 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.413 ' C ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.59 1.21 50.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.88 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -58.0 124.41 19.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 62.219999999999999 110.844 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 59.34 24.66 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 53.450000000000003 110.907 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 165.43 24.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 33.329999999999998 111.121 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 21' ' ' PHE . 13.3 t -138.25 124.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.010000000000005 111.105 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 20' ' ' ILE . 12.8 p90 -125.06 129.23 49.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.879 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.5 m -100.97 131.83 46.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 111.16 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 50' ' ' LEU . 29.1 t -91.95 132.7 32.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.63 0.729 . . . . 72.129999999999995 111.107 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -39.89 5.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 65.439999999999998 112.382 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -86.52 166.37 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.83 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -167.57 173.99 8.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 53.109999999999999 111.112 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -102.42 144.54 30.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 73.409999999999997 111.122 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 88.68 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.877 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -88.64 62.57 6.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 73.329999999999998 110.895 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 58.5 mtt 57.92 49.65 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.510000000000005 110.944 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 -178.91 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.43 111.125 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.3 141.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 44.350000000000001 111.132 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -123.22 101.08 7.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.030000000000001 110.88 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -101.93 163.21 17.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 73.430000000000007 112.489 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.07 118.69 9.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 110.977 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.15 69.21 1.74 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.609 0.719 . . . . 71.430000000000007 110.937 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.21 33.87 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.385 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -123.44 160.69 49.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.53 0.681 . . . . 72.420000000000002 110.901 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.82 8.65 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 73.030000000000001 112.333 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.5 t60 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.861 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 121.391 0.439 . . . . 71.299999999999997 112.55 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 173.43 10.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.618 2.212 . . . . 64.129999999999995 112.382 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.3 158.09 22.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.742 . . . . 41.340000000000003 112.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 t -142.9 164.36 30.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.881 0.372 . . . . 73.310000000000002 110.837 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 74.7 mtp -117.44 -175.9 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 110.884 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -133.04 141.96 48.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 71.420000000000002 110.887 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.79 177.31 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 62.509999999999998 110.865 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -151.0 138.72 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.949 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.7 t -99.36 -28.63 13.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 72.439999999999998 110.84 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -105.87 160.58 25.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.7 . . . . 71.340000000000003 111.088 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 54.0 Cg_endo -69.73 80.75 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.719 2.279 . . . . 63.229999999999997 112.371 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.3 24.94 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.835 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -136.52 121.26 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.89 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -71.45 132.72 85.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 72.400000000000006 111.097 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.734 2.29 . . . . 71.329999999999998 112.307 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -50.96 157.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 73.310000000000002 110.875 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.55 ' CD ' HG23 ' A' ' 34' ' ' VAL . 37.9 mt-30 -73.6 155.35 39.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.892 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.89 176.88 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.178 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -130.48 137.19 49.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.869 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.3 pt -114.57 173.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 111.118 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' HD2' HG12 ' A' ' 28' ' ' VAL . 2.0 m-85 -122.55 130.36 52.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.926 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.2 m-85 -97.86 109.0 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.837 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' CD ' HG22 ' A' ' 28' ' ' VAL . 36.7 tptt -92.5 107.28 19.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 75.340000000000003 110.894 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -103.63 176.93 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 65.510000000000005 111.182 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.2 ttt -75.76 -8.08 55.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 73.099999999999994 110.831 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -38.28 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 61.119999999999997 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.44 176.4 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 54.409999999999997 110.977 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 ' CD ' ' A' ' 23' ' ' LYS . 20.0 t -105.15 121.92 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 72.010000000000005 111.129 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.03 150.39 45.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 73.409999999999997 111.162 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 153.97 67.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 73.0 112.299 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -150.2 103.74 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -75.58 137.44 40.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 53.43 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -126.33 116.47 21.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.064 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.55 HG23 ' CD ' ' A' ' 17' ' ' GLN . 14.4 p -94.42 149.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 75.200000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 p -49.13 112.78 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 52.539999999999999 110.927 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.83 7.56 33.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 33.130000000000003 112.465 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 m -96.08 -178.38 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.397 . . . . 73.200000000000003 110.883 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -139.16 147.82 42.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.198 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 113' ' ' PHE . 44.6 t -52.23 -62.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 70.420000000000002 111.102 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.77 HD11 HD12 ' A' ' 50' ' ' LEU . 4.4 mm? -54.04 -33.65 57.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 65.400000000000006 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.67 -27.16 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.829 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 95.3 t -76.94 -43.3 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 111.118 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -54.73 -28.28 47.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.106 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -73.75 -27.91 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.87 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -52.19 12.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.868 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.21 -25.22 61.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 110.916 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -6.96 43.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.688 -0.768 . . . . 71.540000000000006 112.52 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.642 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.1 t -51.4 144.47 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 41.020000000000003 111.09 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.17 83.93 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.891 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.77 HD12 HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -89.7 129.08 36.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 110.844 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' N ' HD13 ' A' ' 50' ' ' LEU . 10.8 tm-20 -53.41 112.63 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 53.100000000000001 110.878 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.42 36.7 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 24.25 112.426 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.87 71.22 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.328 . . . . 55.299999999999997 111.072 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.8 m -55.91 -26.4 47.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.329999999999998 110.887 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -84.01 -176.19 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 64.450000000000003 110.937 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.01 -172.88 29.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 75.319999999999993 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -99.4 26.91 5.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.329999999999998 110.888 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.0 mt -149.69 115.6 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.18 129.39 31.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 51.329999999999998 111.127 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.7 p -55.43 120.8 7.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 110.877 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.1 p -65.86 -172.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 65.319999999999993 110.871 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -51.89 139.54 21.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 62.32 111.086 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.5 m -91.77 86.17 5.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 25.530000000000001 110.897 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -124.49 113.55 18.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 115' ' ' VAL . 8.4 t -128.62 157.01 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 72.25 111.087 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mt -90.17 130.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 111.157 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.0 tp -125.07 164.7 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 64.040000000000006 110.901 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -39.12 137.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.891 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -60.89 -58.7 17.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.684 0.754 . . . . 73.040000000000006 110.922 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.72 -49.6 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.75 2.3 . . . . 54.219999999999999 112.284 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.752 HD11 ' O ' ' A' ' 107' ' ' SER . 5.4 tp -51.96 -51.9 53.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 73.209999999999994 111.002 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.7 t80 -63.58 -41.97 98.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.925 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -52.03 -62.0 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 65.439999999999998 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -63.9 -26.82 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -62.15 -57.25 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.918 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.13 142.12 3.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.826 -0.702 . . . . 71.329999999999998 112.508 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -107.33 160.34 26.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.678 0.751 . . . . 65.310000000000002 110.862 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 172.16 13.06 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.249 . . . . 62.009999999999998 112.364 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -58.0 167.81 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.899 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -56.81 -39.74 74.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.819 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.487 ' O ' HD13 ' A' ' 85' ' ' LEU . 38.1 mttm -52.33 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 63.240000000000002 110.869 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.04 -35.2 79.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.59 -53.63 55.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.863 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.56 -41.72 92.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.859 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 81' ' ' LYS . 4.4 mp -56.45 -37.35 70.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.908 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.522 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.1 mt -74.61 -51.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.087 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.24 -23.13 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.834 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 -32.49 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.899 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -61.78 163.89 6.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 71.129999999999995 111.066 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.65 114.81 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 75.519999999999996 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.55 41.56 56.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.129999999999995 112.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -106.69 117.36 33.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 70.219999999999999 111.085 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 142.4 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 111.068 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -24.95 41.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 75.129999999999995 112.488 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.0 p -73.91 -2.03 22.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 111.209 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 t -89.12 -12.45 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.867 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 9.8 ttm-85 -94.06 154.51 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 70.200000000000003 110.785 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 tp -147.48 167.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 73.450000000000003 110.856 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.02 19.14 9.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.674 -0.774 . . . . 71.010000000000005 112.467 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.9 t 60.38 25.73 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 61.43 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.41 136.47 22.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.439999999999998 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -177.13 129.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 65.25 110.877 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.66 170.31 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 33' ' ' ALA . 39.2 t -100.62 120.44 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.103 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.71 173.61 11.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.469 . . . . 72.040000000000006 110.874 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -59.66 -33.87 72.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 110.922 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 71' ' ' LEU . 47.3 m -64.91 -19.32 65.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 64.510000000000005 110.855 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.74 5.69 38.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.907 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -59.58 124.31 19.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 62.219999999999999 110.862 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.53 20.29 12.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.848 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.59 149.23 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 33.329999999999998 111.074 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.8 t -113.51 119.86 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 73.010000000000005 111.165 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 39' ' ' VAL . 21.5 m-85 -110.61 94.81 5.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.815 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -88.26 126.37 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 111.116 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.561 HG22 HD22 ' A' ' 50' ' ' LEU . 57.9 t -96.45 133.25 25.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.136 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.75 -41.64 4.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.686 2.257 . . . . 65.439999999999998 112.36 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -80.93 167.69 19.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.865 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.39 -170.59 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 53.109999999999999 111.116 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.8 p -87.48 177.75 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.174 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 175.27 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 73.349999999999994 110.908 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -68.72 103.89 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.853 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 2.6 ttp -76.05 175.29 9.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.889 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.2 103.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.082 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 127' ' ' PHE . 33.8 m -65.99 -176.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 44.350000000000001 111.17 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.07 -43.22 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.030000000000001 110.913 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -157.78 35.7 0.54 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 73.430000000000007 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.527 ' O ' HG11 ' A' ' 124' ' ' VAL . 32.3 p90 -158.13 119.61 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 74.310000000000002 110.851 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -147.07 73.34 12.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.55 0.69 . . . . 71.430000000000007 110.995 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 92.24 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.732 2.288 . . . . 73.120000000000005 112.299 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -123.21 137.7 28.73 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.574 0.702 . . . . 72.420000000000002 110.919 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 151.62 68.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 73.030000000000001 112.348 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.8 t60 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 110.837 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 CA-C-O 121.453 0.474 . . . . 71.299999999999997 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 179.13 3.93 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.686 2.258 . . . . 64.129999999999995 112.326 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.12 170.16 32.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 41.340000000000003 112.479 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.0 m -147.26 148.59 31.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 73.310000000000002 110.847 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.6 mtm -152.05 -175.64 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.887 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -169.88 162.13 9.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 71.420000000000002 110.873 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -129.97 109.07 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 62.509999999999998 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.89 164.16 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 71.439999999999998 110.922 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.2 t -52.59 131.48 34.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.843 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 13' ' ' ARG . . . -159.05 71.57 3.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 71.340000000000003 111.103 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 -16.63 37.6 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 63.229999999999997 112.394 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -114.09 24.92 11.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.864 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HB2' ' HB1' ' A' ' 10' ' ' ALA . 21.0 mtp85 -158.04 134.28 9.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.209999999999994 110.9 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.9 mp -51.87 133.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.686 0.755 . . . . 72.400000000000006 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.79 -170.05 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 71.329999999999998 112.256 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.5 157.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.89 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.29 151.52 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 43.299999999999997 110.889 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 pp -130.35 176.81 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 111.099 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -120.33 133.91 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' ' 31' ' ' ALA . 2.0 pt -114.34 172.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.087 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.46 128.39 45.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.219999999999999 110.9 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.71 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.5 m-85 -97.12 103.17 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.834 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.53 136.15 38.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 75.340000000000003 110.92 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -130.43 177.25 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 65.510000000000005 111.158 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 tpt -73.56 -8.76 57.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.898 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -104.98 -37.57 6.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 61.119999999999997 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -179.63 176.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.87 131.43 70.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.188 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.35 151.03 58.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 73.409999999999997 111.154 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.22 68.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.611 2.207 . . . . 73.0 112.304 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.0 139.49 29.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.03 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -100.68 128.9 46.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 53.43 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -106.67 116.37 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.137 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -97.33 139.16 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.200000000000003 111.149 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 p -51.7 111.1 0.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 52.539999999999999 110.881 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.43 13.81 34.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 33.130000000000003 112.493 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.443 ' OG ' HG21 ' A' ' 104' ' ' VAL . 86.6 p -101.63 -169.78 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 73.200000000000003 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.744 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -147.04 143.46 28.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 73.140000000000001 111.128 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.45 -59.41 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 111.127 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.38 -35.53 60.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.400000000000006 110.922 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.76 -27.5 62.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 110.912 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 38' ' ' THR . 91.6 t -76.56 -35.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 61.210000000000001 111.095 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.88 29.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 62.219999999999999 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -67.11 -32.61 73.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 75.200000000000003 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.05 -34.8 14.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.530000000000001 110.895 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.471 ' HB3' HG23 ' A' ' 48' ' ' VAL . 3.3 m120 -75.04 -24.4 58.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.951 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 -11.68 66.41 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 71.540000000000006 112.529 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 22' ' ' PHE . 93.9 t -51.31 138.72 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 41.020000000000003 111.202 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.48 80.81 1.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.851 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 115' ' ' VAL . 28.3 tp -127.05 144.35 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 70.430000000000007 110.913 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HB3' HG21 ' A' ' 62' ' ' THR . 4.8 pt-20 -54.3 143.68 22.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 53.100000000000001 110.856 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.94 -42.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 24.25 112.499 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.05 122.62 47.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 55.299999999999997 111.121 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.8 t -54.62 -58.74 6.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 72.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.33 131.5 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 64.450000000000003 110.85 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.4 -135.82 2.54 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.715 -0.755 . . . . 75.319999999999993 112.472 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.69 -47.51 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 73.329999999999998 110.849 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.2 177.74 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.881 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.69 161.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 51.329999999999998 111.086 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.8 m -67.72 105.82 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.911 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -115.72 -26.7 7.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 65.319999999999993 110.834 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.594 HG23 ' HA ' ' A' ' 118' ' ' ALA . 6.6 m -82.5 73.09 9.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 62.32 111.176 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.5 m -131.15 -46.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 25.530000000000001 110.88 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -71.21 111.79 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.439999999999998 110.862 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.6 t -128.62 157.28 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 72.25 111.187 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 88.5 mt -90.37 130.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.8 tp -124.65 159.37 30.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 64.040000000000006 110.908 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.56 146.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.883 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 mt-10 -59.27 -59.94 12.21 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.896 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.5 Cg_endo -69.79 -46.78 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.346 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -53.38 -49.15 67.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.209999999999994 110.927 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.634 ' CD1' HG22 ' A' ' 95' ' ' THR . 57.4 t80 -64.34 -51.01 65.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 74.450000000000003 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -25.53 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 110.809 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.31 -50.54 12.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.2 mt -62.91 -21.83 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 75.209999999999994 110.932 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.58 158.96 9.49 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 71.329999999999998 112.497 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.31 157.53 77.29 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.642 0.734 . . . . 65.310000000000002 110.877 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.03 32.34 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.725 2.284 . . . . 62.009999999999998 112.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 p -58.09 158.52 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -52.43 -36.06 53.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.409999999999997 110.926 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -52.33 -62.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 63.240000000000002 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.67 -35.79 79.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 110.922 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -56.14 -53.33 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.871 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.9 -42.97 89.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 110.878 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -55.2 -37.51 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.898 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.663 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.4 mt -74.53 -51.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 63.409999999999997 111.124 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.18 -18.59 58.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 110.869 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -76.14 -23.17 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.927 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.22 164.34 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.043 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -71.75 119.59 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.519999999999996 110.86 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.0 43.89 55.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.635 -0.793 . . . . 73.129999999999995 112.516 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -118.58 116.04 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 70.219999999999999 111.123 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.87 144.77 39.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 111.233 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.663 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.27 -23.88 35.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 75.129999999999995 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.634 HG22 ' CD1' ' A' ' 72' ' ' TYR . 37.9 p -73.96 -1.56 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 64.239999999999995 111.151 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.7 t -89.36 -12.83 39.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.91 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.658 ' HD2' HD11 ' A' ' 86' ' ' ILE . 7.1 ptm180 -112.07 144.21 41.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 70.200000000000003 110.864 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.47 164.05 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 110.989 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.06 -167.13 39.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.463 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.2 m -104.16 64.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 61.43 110.857 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.564 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.5 mt-30 -162.84 124.33 2.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 64.439999999999998 110.908 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 101' ' ' GLN . 4.8 mp -156.13 150.9 26.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 65.25 110.924 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -146.0 129.94 17.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 110.9 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.783 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.6 t -64.84 117.62 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 72.239999999999995 111.13 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -136.83 178.36 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 72.040000000000006 110.911 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -37.16 76.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.93 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' HD21 ' A' ' 71' ' ' LEU . 6.3 t -65.54 -19.73 66.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 64.510000000000005 110.903 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.505 ' O ' HD13 ' A' ' 18' ' ' ILE . 11.4 m-85 -83.41 2.23 37.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 71.209999999999994 110.848 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.402 ' HA ' HD13 ' A' ' 18' ' ' ILE . 34.5 tt0 -56.94 123.59 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 62.219999999999999 110.836 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 59.29 27.08 16.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 53.450000000000003 110.865 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 20' ' ' ILE . . . -69.95 135.36 49.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 33.329999999999998 111.128 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.565 ' O ' HD12 ' A' ' 67' ' ' LEU . 27.3 t -104.2 122.39 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.010000000000005 111.16 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -112.9 104.27 12.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.857 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.495 HG23 ' HD2' ' A' ' 23' ' ' LYS . 40.6 m -92.83 117.99 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.155 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 50' ' ' LEU . 20.0 t -108.68 88.83 5.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.525 0.679 . . . . 72.129999999999995 111.13 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -36.24 10.96 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.698 2.265 . . . . 65.439999999999998 112.296 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -139.51 125.45 19.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 72.140000000000001 110.839 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.594 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -171.73 179.97 2.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 53.109999999999999 111.157 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.8 p -134.0 -174.17 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 111.091 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -105.81 154.83 19.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.888 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -97.8 -173.94 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.886 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.1 tpt -80.27 -44.63 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.510000000000005 110.91 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.71 111.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 62.43 111.066 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.9 p -165.56 151.63 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 44.350000000000001 111.093 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 61.64 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.439 . . . . 71.030000000000001 110.919 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.95 -107.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.509 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -151.92 134.05 15.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.927 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -140.42 159.28 63.97 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.708 . . . . 71.430000000000007 110.85 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 130' ' ' LYS . 53.0 Cg_endo -69.74 150.06 67.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.675 2.25 . . . . 73.120000000000005 112.318 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 129' ' ' PRO . 10.0 ptmt 37.51 67.86 1.81 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 110.911 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.71 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.673 2.249 . . . . 73.030000000000001 112.338 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.5 t60 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.803 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 121.408 0.449 . . . . 71.299999999999997 112.508 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 79.58 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.653 2.235 . . . . 64.129999999999995 112.393 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.9 -96.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 41.340000000000003 112.497 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -110.37 82.98 1.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.889 0.376 . . . . 73.310000000000002 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mmt -142.46 123.81 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.934 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -76.32 85.46 3.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 71.420000000000002 110.872 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.4 ptm -145.02 164.83 29.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 62.509999999999998 110.919 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -124.58 166.54 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.439999999999998 110.909 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -149.22 176.25 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.822 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.78 69.93 0.89 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.718 . . . . 71.340000000000003 111.161 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -171.12 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 63.229999999999997 112.3 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.23 25.2 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.887 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -136.4 -167.18 2.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mm 63.5 136.8 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.558 0.694 . . . . 72.400000000000006 111.143 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.78 2.52 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 71.329999999999998 112.362 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -52.07 157.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 110.878 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.75 143.7 45.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 43.299999999999997 110.956 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 109' ' ' GLU . 1.3 pt -128.75 176.8 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 64.439999999999998 111.094 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.81 136.26 52.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.878 HD11 HG11 ' A' ' 42' ' ' VAL . 1.8 pt -116.98 157.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.118 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -119.98 126.5 50.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.926 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 4.5 m-85 -105.0 102.9 12.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.927 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 117.78 26.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.95 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 p -105.33 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 65.510000000000005 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 29.8 mmt -75.72 -7.99 55.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.921 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtm -102.97 -38.39 7.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 61.119999999999997 110.889 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 178.28 176.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 54.409999999999997 110.925 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.3 t -79.1 147.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 111.058 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.93 87.84 9.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.64 0.734 . . . . 73.409999999999997 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 135.0 29.33 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 73.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.22 159.93 40.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.085 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -99.7 127.98 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.943 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -95.3 131.81 40.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.115 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.85 146.51 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.200000000000003 111.107 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.2 p -57.49 119.8 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 52.539999999999999 110.892 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.01 39.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.473 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.32 161.02 13.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.200000000000003 110.859 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.9 p -114.46 159.23 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 111.116 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.27 -58.4 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.54 -35.82 63.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.400000000000006 110.968 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.881 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG11 HD11 ' A' ' 20' ' ' ILE . 97.7 t -76.43 -44.05 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 61.210000000000001 111.167 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -55.13 -29.22 57.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.219999999999999 111.055 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -73.37 -26.6 61.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 75.200000000000003 110.869 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -69.73 -52.15 27.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.86 -25.1 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.863 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.07 -12.22 34.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 71.540000000000006 112.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.64 115.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 41.020000000000003 111.087 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.84 80.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.1 119.71 20.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 70.430000000000007 110.924 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.93 118.03 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 53.100000000000001 110.861 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.37 112.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.689 -0.767 . . . . 24.25 112.456 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 55.299999999999997 111.127 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.64 97.38 6.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 72.329999999999998 110.966 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -138.3 153.48 49.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 64.450000000000003 110.863 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.24 154.85 1.26 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 75.319999999999993 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -68.86 104.54 2.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 73.329999999999998 110.856 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp 52.88 56.52 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 72.140000000000001 110.935 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.21 31.4 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 51.329999999999998 111.12 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.8 p -121.34 77.72 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.939 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.01 34.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 110.866 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.9 p -116.26 34.99 4.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 62.32 111.139 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.81 69.94 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 25.530000000000001 110.931 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -152.06 109.75 3.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.805 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 8.1 t -128.62 157.02 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.6 mt -90.12 131.23 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.430000000000007 111.127 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.7 tp -129.45 162.3 28.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.928 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -39.62 139.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.917 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -59.58 -59.05 15.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.696 0.76 . . . . 73.040000000000006 110.904 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.1 Cg_endo -69.78 -49.16 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.735 2.29 . . . . 54.219999999999999 112.319 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -52.09 -48.53 64.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 110.932 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -66.89 -42.71 85.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.93 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -51.88 -58.11 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 65.439999999999998 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -70.03 -28.73 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.9 tp -63.56 -61.23 2.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.944 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.32 143.59 4.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 71.329999999999998 112.482 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -134.67 157.27 77.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.574 0.702 . . . . 65.310000000000002 110.886 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.743 2.295 . . . . 62.009999999999998 112.32 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.4 m -58.17 171.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.59 -38.13 77.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -52.3 -62.43 1.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 63.240000000000002 110.89 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.53 -35.41 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.530000000000001 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.42 -53.04 62.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 110.904 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -66.07 -42.37 89.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 71.120000000000005 110.832 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.13 -36.91 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.959 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 14.8 mt -74.61 -54.85 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 111.113 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.95 -24.53 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 74.030000000000001 110.855 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.15 -25.62 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 110.908 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.458 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -80.59 151.07 29.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 111.084 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -67.37 128.71 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 110.805 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.46 54.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.489 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -119.66 117.16 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 70.219999999999999 111.056 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 143.9 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 111.196 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.62 -24.68 40.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.129999999999995 112.491 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.476 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.2 p -73.94 -1.73 21.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 64.239999999999995 111.188 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 23.2 t -89.79 -12.6 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.854 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 14.9 mtt-85 -106.6 139.87 40.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.892 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 tp -158.87 164.89 35.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 73.450000000000003 110.878 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.94 -131.67 5.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.485 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m -122.62 -54.5 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 61.43 110.915 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -52.11 139.26 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 64.439999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.6 tp -176.64 140.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HD3' HG22 ' A' ' 38' ' ' THR . 7.8 tpp180 -141.94 154.07 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.848 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 37' ' ' SER . 92.3 t -74.7 124.97 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 72.239999999999995 111.131 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.67 168.15 20.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 72.040000000000006 110.88 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -57.22 -39.35 75.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.510000000000005 110.909 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 m -64.02 -20.46 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 110.895 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.75 7.67 29.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 71.209999999999994 110.851 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.433 ' N ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -59.14 125.19 22.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 62.219999999999999 110.839 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 60.0 22.19 11.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 53.450000000000003 110.897 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.38 136.63 57.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 33.329999999999998 111.061 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.718 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.0 t -98.76 117.08 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.134 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -109.39 94.82 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.926 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 34.2 m -89.42 130.92 35.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.172 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.6 t -104.44 133.29 20.27 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 72.129999999999995 111.086 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.423 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.84 -41.25 4.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 65.439999999999998 112.308 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -143.29 138.75 29.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.854 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.76 -51.66 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 53.109999999999999 111.063 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 p -51.94 126.57 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 111.158 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -52.88 -60.61 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 73.349999999999994 110.939 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.29 -173.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.329999999999998 110.86 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 3.5 ptm -51.79 115.4 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 74.510000000000005 110.952 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . . . -52.91 167.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.092 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.1 134.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 44.350000000000001 111.172 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.36 44.22 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 71.030000000000001 110.832 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.98 144.28 16.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -53.94 105.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 74.310000000000002 110.851 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -115.21 72.97 3.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.588 0.709 . . . . 71.430000000000007 110.916 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -177.09 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.677 2.252 . . . . 73.120000000000005 112.312 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.52 71.28 13.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.598 0.713 . . . . 72.420000000000002 110.951 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.695 2.263 . . . . 73.030000000000001 112.363 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.927 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.406 0.448 . . . . 71.299999999999997 112.466 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 129.04 16.93 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.68 2.253 . . . . 64.129999999999995 112.407 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.07 -169.56 33.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.472 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -103.05 138.5 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.878 0.371 . . . . 73.310000000000002 110.887 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.0 ttm -175.07 134.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.58 -175.39 4.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 71.420000000000002 110.917 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.3 tpt -86.2 118.17 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 62.509999999999998 110.881 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -155.23 160.69 41.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 71.439999999999998 110.905 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -89.77 -174.06 4.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.808 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -136.2 160.46 66.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.541 0.686 . . . . 71.340000000000003 111.081 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 54.1 Cg_endo -69.8 -170.76 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 112.362 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.61 25.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.843 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -134.88 119.43 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.209999999999994 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -94.53 133.14 27.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.675 0.75 . . . . 72.400000000000006 111.104 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.73 -170.34 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.746 2.297 . . . . 71.329999999999998 112.358 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -51.46 156.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -73.84 156.45 37.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 43.299999999999997 110.9 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.03 176.97 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 111.132 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -118.1 135.83 53.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.836 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.773 HG13 ' HB3' ' A' ' 31' ' ' ALA . 32.0 pt -114.36 171.83 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 111.142 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.19 126.72 52.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.895 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 1.7 m-85 -97.93 103.18 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.856 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 28' ' ' VAL . 15.8 tptm -85.66 106.67 17.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 110.887 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -101.9 178.61 4.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 65.510000000000005 111.168 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 ttm -75.7 -8.05 55.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -106.05 -38.62 6.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.119999999999997 110.933 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 178.34 176.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 54.409999999999997 110.846 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 23' ' ' LYS . 21.3 t -102.45 123.11 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.010000000000005 111.068 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.85 150.54 45.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.169 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 153.22 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 73.0 112.349 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -143.51 135.56 26.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.131 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -97.64 118.68 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 53.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.64 116.52 30.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.105 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.16 148.05 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 75.200000000000003 111.11 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.8 p -51.32 110.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.539999999999999 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.48 14.42 30.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 33.130000000000003 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -97.64 -170.61 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 73.200000000000003 110.878 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -141.91 140.92 32.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 73.140000000000001 111.15 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.1 t -52.41 -59.51 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 111.081 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 50' ' ' LEU . 6.4 mt -53.72 -35.57 61.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 65.400000000000006 110.872 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -72.7 -26.75 61.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 72.450000000000003 110.883 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 38' ' ' THR . 97.4 t -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.71 20.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.072 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -70.23 -36.77 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 75.200000000000003 110.871 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -82.82 -34.9 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.879 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -72.35 -28.25 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.935 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.0 -12.25 34.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.743 . . . . 71.540000000000006 112.537 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 22' ' ' PHE . 98.9 t -59.94 141.06 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 41.020000000000003 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -78.79 80.7 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -118.31 108.51 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 70.430000000000007 110.911 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -52.88 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 53.100000000000001 110.86 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.13 22.31 16.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 24.25 112.529 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.46 105.12 16.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 55.299999999999997 111.073 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -27.84 61.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 110.859 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -119.09 128.26 54.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 64.450000000000003 110.89 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.94 -73.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.757 -0.735 . . . . 75.319999999999993 112.482 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.79 31.76 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 73.329999999999998 110.802 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.44 33.02 21.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.911 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.98 128.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 51.329999999999998 111.055 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.91 75.81 5.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 74.540000000000006 110.865 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -102.38 27.14 7.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 65.319999999999993 110.865 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -110.62 -25.88 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.32 111.12 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 m -55.3 -29.75 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 25.530000000000001 110.849 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -68.81 100.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 65.439999999999998 110.841 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 114' ' ' THR . 4.7 t -128.63 159.04 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 72.25 111.15 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.9 mt -89.86 130.46 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 111.165 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLU . 16.8 tp -119.29 166.4 13.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.040000000000006 110.882 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 71' ' ' LEU . 5.9 mp0 -36.8 135.87 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 71.019999999999996 110.913 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.553 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tt0 -65.26 -56.73 18.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.595 0.712 . . . . 73.040000000000006 110.867 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.69 -51.82 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 54.219999999999999 112.387 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -51.93 -48.35 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.893 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.608 ' CD1' HG22 ' A' ' 95' ' ' THR . 20.2 t80 -64.94 -53.57 44.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 110.918 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.6 -47.96 63.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.816 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.31 -36.62 83.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 75.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -62.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.85 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 160.35 20.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 71.329999999999998 112.429 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 157.55 77.44 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.658 0.742 . . . . 65.310000000000002 110.928 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 166.82 26.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.309 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 t -57.95 171.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.97 -37.48 79.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 72.409999999999997 110.898 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.35 -62.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 110.912 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.59 -35.54 79.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.34 -53.19 60.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.914 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.97 -42.79 89.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 71.120000000000005 110.858 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.48 -37.14 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 64.219999999999999 110.919 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.1 mt -74.74 -52.68 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.152 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -59.3 -21.08 59.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.875 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -75.94 -23.27 55.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.924 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.48 164.18 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.144 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -74.4 118.99 17.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 75.519999999999996 110.847 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.66 43.73 53.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.678 -0.772 . . . . 73.129999999999995 112.52 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -106.98 143.5 34.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.083 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -133.85 145.72 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 111.125 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.97 -28.59 53.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 75.129999999999995 112.473 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.0 p -73.53 -3.31 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.333 . . . . 64.239999999999995 111.149 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 48.1 t -85.44 -13.77 48.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.857 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.74 143.26 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 70.200000000000003 110.87 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.23 142.38 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.96 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.76 158.14 3.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.788 -0.72 . . . . 71.010000000000005 112.467 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.6 t -55.62 -26.97 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 61.43 110.885 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.58 114.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 64.439999999999998 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mt -141.78 95.34 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.945 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.99 147.47 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.936 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.6 t -96.02 128.31 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 72.239999999999995 111.169 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -136.56 167.77 20.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 72.040000000000006 110.899 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -55.49 -42.01 73.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.904 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -18.97 58.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 64.510000000000005 110.863 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -93.34 17.14 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 71.209999999999994 110.813 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.68 126.97 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 62.219999999999999 110.977 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 m120 58.85 24.23 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 53.450000000000003 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -58.61 126.14 26.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 33.329999999999998 111.144 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 12.4 t -84.98 118.76 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 73.010000000000005 111.117 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 111' ' ' ALA . 74.5 m-85 -113.01 102.74 10.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.430000000000007 110.88 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.9 m -88.55 130.14 35.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 111.205 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 50' ' ' LEU . 60.6 t -101.06 133.24 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 72.129999999999995 111.065 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.4 Cg_endo -69.8 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.649 2.233 . . . . 65.439999999999998 112.328 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -70.35 103.71 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.89 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.58 -175.83 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 53.109999999999999 111.124 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p 49.96 40.28 20.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 73.409999999999997 111.182 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -146.48 -176.19 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 110.924 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.17 -170.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 73.329999999999998 110.863 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.6 ptm -59.87 -174.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 74.510000000000005 110.919 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 113.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.122 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.44 148.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 44.350000000000001 111.117 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.45 171.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.030000000000001 110.873 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.01 -113.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 73.430000000000007 112.479 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -163.36 103.22 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 74.310000000000002 110.855 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -174.75 73.63 0.31 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.522 0.677 . . . . 71.430000000000007 110.93 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 125.36 12.03 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.594 2.196 . . . . 73.120000000000005 112.335 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 93' ' ' THR . 12.9 ttmm -167.94 73.08 0.91 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 110.92 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 -21.77 32.83 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.692 2.261 . . . . 73.030000000000001 112.302 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 72.120000000000005 110.837 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.77 0.319 . . . . 74.209999999999994 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.463 HD13 ' N ' ' A' ' 36' ' ' GLY . 3.4 mt -90.96 132.95 33.04 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.178 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -169.84 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.718 2.279 . . . . 71.329999999999998 112.375 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.26 157.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 160.12 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 43.299999999999997 110.934 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.7 pp -141.9 176.74 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.439999999999998 111.115 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -117.1 135.55 53.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 75.340000000000003 110.831 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.2 pt -116.92 173.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.147 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -128.53 132.73 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.2 m-85 -102.94 104.84 15.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.819 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.4 129.39 44.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.937 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 p -122.15 -177.71 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.510000000000005 111.141 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.3 mmt -75.76 -17.37 59.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 110.895 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -96.33 -37.89 10.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 61.119999999999997 110.858 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 179.71 176.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 54.409999999999997 110.884 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 131.44 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 111.16 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.552 HG21 HG22 ' A' ' 48' ' ' VAL . 1.8 m -121.62 150.89 56.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.546 0.689 . . . . 73.409999999999997 111.126 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 153.02 69.78 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.655 2.237 . . . . 73.0 112.325 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.14 140.48 28.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 53.340000000000003 111.119 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -104.88 126.87 52.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.43 110.894 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -107.18 116.34 31.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 111.081 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.04 142.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 111.173 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 p -54.19 120.25 6.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 106.54 -4.55 37.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.817 -0.706 . . . . 33.130000000000003 112.481 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.76 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 110.897 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.2 p -138.04 155.06 49.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.183 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.57 -59.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 70.420000000000002 111.15 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -35.45 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.896 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -72.66 -26.6 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.450000000000003 110.904 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 38' ' ' THR . 95.4 t -76.18 -47.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 111.081 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.79 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 62.219999999999999 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -69.89 -36.72 75.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.864 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -76.35 -42.66 44.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.845 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -72.27 -27.08 62.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.87 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.14 -12.07 34.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 71.540000000000006 112.457 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 29' ' ' VAL . 22.6 t -57.86 127.55 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 41.020000000000003 111.151 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -81.04 80.83 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.847 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.707 HD22 HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 110.834 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.832 0.349 . . . . 25.530000000000001 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -150.08 112.83 4.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.86 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.3 t -128.6 158.03 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.151 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 83.6 mt -89.99 131.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 111.143 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 112' ' ' VAL . 17.4 tp -123.02 160.88 25.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 64.040000000000006 110.918 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.77 143.96 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 71.019999999999996 110.916 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.1 mt-10 -57.4 -59.14 13.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.76 -46.73 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 54.219999999999999 112.306 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 6.8 tp -51.67 -45.69 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.924 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 95' ' ' THR . 49.0 t80 -72.28 -41.01 67.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 74.450000000000003 110.908 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -53.85 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 65.439999999999998 110.898 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -33.23 67.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 75' ' ' LEU . 10.8 mt -62.87 -25.0 68.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.843 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.87 142.5 4.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 71.329999999999998 112.507 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -110.71 156.84 39.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 65.310000000000002 110.854 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.81 13.76 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 62.009999999999998 112.362 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -99.29 -170.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -56.61 -47.77 78.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -53.74 -59.74 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 63.240000000000002 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 86' ' ' ILE . 16.3 mm-40 -61.2 -28.58 69.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 71.530000000000001 110.858 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -55.64 27.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.893 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.41 -37.37 82.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 110.844 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.32 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.94 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.571 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.5 mt -74.97 -34.38 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 111.116 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -58.99 -21.43 58.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 110.858 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -75.95 -25.67 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.883 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -74.71 163.97 27.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.065 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -84.2 113.63 21.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.89 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.82 52.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.535 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -95.14 129.41 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.42 146.36 27.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 111.083 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.571 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.4 -23.46 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 75.129999999999995 112.487 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.638 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.5 p -73.82 -1.84 21.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.16 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 9.4 t -88.9 -12.8 40.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 71.409999999999997 110.884 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -117.39 132.62 56.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 70.200000000000003 110.816 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.27 179.88 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.944 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.77 -155.67 15.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 71.010000000000005 112.491 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -140.44 53.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 61.43 110.856 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.1 pt20 -179.07 98.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 64.439999999999998 110.912 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 101' ' ' GLN . 10.6 mp -130.25 160.73 33.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.25 110.906 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -115.9 170.26 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.209999999999994 110.825 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.69 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 90.5 t -97.76 118.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 111.129 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -137.05 177.1 8.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 72.040000000000006 110.906 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -60.63 -31.5 70.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -65.04 -19.54 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.510000000000005 110.92 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.603 ' HZ ' HD23 ' A' ' 102' ' ' LEU . 3.1 m-85 -85.7 4.41 36.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 71.209999999999994 110.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -57.03 123.39 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 59.55 26.03 14.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.879 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -68.51 136.72 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 33.329999999999998 111.116 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.5 t -109.74 123.03 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.010000000000005 111.15 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.47 103.9 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.897 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 23' ' ' LYS . 49.9 m -93.79 118.72 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 73.439999999999998 111.168 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG21 HD22 ' A' ' 50' ' ' LEU . 23.1 t -108.57 89.29 5.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.719 . . . . 72.129999999999995 111.133 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -39.06 6.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.615 2.21 . . . . 65.439999999999998 112.343 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 110.848 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' ' 103' ' ' ARG . 41.0 mm -60.2 133.04 90.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.111 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.4 Cg_endo -69.72 -170.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 71.329999999999998 112.38 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.8 156.82 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.871 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.81 159.56 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 43.299999999999997 110.919 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.523 HD13 ' C ' ' A' ' 108' ' ' PHE . 1.1 pt -141.83 176.76 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 64.439999999999998 111.102 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.76 129.19 47.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.855 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.623 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -114.59 172.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.167 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.9 131.5 52.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.912 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.745 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -99.63 103.07 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 71.329999999999998 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -94.24 135.34 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.340000000000003 110.865 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -133.39 177.69 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 65.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.9 tpt -75.36 -8.33 56.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.884 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -104.18 -37.91 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 179.21 176.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 54.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.9 124.69 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.010000000000005 111.132 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -119.84 151.01 51.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.714 . . . . 73.409999999999997 111.17 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 156.03 64.26 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 73.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.623 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -150.93 104.29 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.077 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -79.34 132.04 36.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.91 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.552 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -121.35 116.53 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.133 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 150.8 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.05 116.26 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.861 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 2.01 37.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.733 . . . . 33.130000000000003 112.487 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -99.17 -176.15 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 73.200000000000003 110.818 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -138.93 146.01 40.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 111.147 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.48 -62.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 111.111 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 ' CD1' HD12 ' A' ' 50' ' ' LEU . 4.3 mm? -53.81 -33.54 56.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 65.400000000000006 110.946 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -72.68 -27.27 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.883 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 38' ' ' THR . 94.4 t -76.87 -45.44 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 61.210000000000001 111.119 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.51 -29.93 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.121 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -71.4 -37.99 71.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.894 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -44.24 63.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.08 -25.2 61.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.2 -12.26 44.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 71.540000000000006 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 29' ' ' VAL . 35.8 t -53.36 129.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 41.020000000000003 111.119 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -77.3 80.67 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.209999999999994 110.915 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.631 HD12 ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.176 -0.466 . . . . 70.430000000000007 110.926 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.6 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.94 0.4 . . . . 25.530000000000001 110.844 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -135.94 77.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 65.439999999999998 110.851 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.0 t -128.73 157.64 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.135 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 85.4 mt -90.02 131.24 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 111.151 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 112' ' ' VAL . 22.2 tp -127.0 160.65 30.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 64.040000000000006 110.927 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -45.79 143.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -58.11 -60.23 10.76 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.64 0.733 . . . . 73.040000000000006 110.908 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.78 -48.32 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.699 2.266 . . . . 54.219999999999999 112.348 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.578 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.81 -45.26 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 73.209999999999994 110.929 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 89.6 t80 -70.79 -49.61 44.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.904 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -54.09 -41.62 68.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -71.36 -46.27 60.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.578 HD23 HD13 ' A' ' 71' ' ' LEU . 2.4 mm? -63.35 -24.43 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.06 130.98 2.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.733 . . . . 71.329999999999998 112.505 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -115.78 157.66 44.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 65.310000000000002 110.871 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.3 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.699 2.266 . . . . 62.009999999999998 112.356 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -104.12 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.885 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -57.87 -44.12 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.877 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -53.58 -59.71 4.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 63.240000000000002 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' OE2' HD23 ' A' ' 98' ' ' LEU . 25.9 tt0 -62.73 -28.21 69.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.530000000000001 110.86 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -52.88 62.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.898 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.02 -39.2 75.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 71.120000000000005 110.891 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.2 -50.81 70.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.219999999999999 110.931 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.2 mt -74.96 -34.3 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 63.409999999999997 111.161 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.76 -20.0 53.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 110.898 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.84 -26.0 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.897 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.95 145.01 36.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.107 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -65.92 121.81 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.18 45.17 57.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.504 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -111.37 125.37 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 70.219999999999999 111.075 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.06 147.66 38.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.119 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.49 -23.4 35.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 75.129999999999995 112.519 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 25.2 p -73.93 -1.81 21.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 64.239999999999995 111.15 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.1 t -88.95 -13.49 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 71.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -141.39 167.85 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 70.200000000000003 110.839 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.404 HD23 ' OE2' ' A' ' 82' ' ' GLU . 4.2 mm? 57.38 44.9 20.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 73.450000000000003 110.899 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.54 111.75 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 71.010000000000005 112.47 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.0 t -163.02 156.85 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 61.43 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.671 ' O ' HD23 ' A' ' 102' ' ' LEU . 1.2 tp-100 -170.05 -179.53 3.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.439999999999998 110.913 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.717 ' C ' HG22 ' A' ' 38' ' ' THR . 7.2 mt -139.5 -61.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 65.25 110.931 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HD2' HD11 ' A' ' 14' ' ' ILE . 1.5 mtm180 -59.65 158.7 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.867 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.552 HG21 ' HB1' ' A' ' 33' ' ' ALA . 94.4 t -109.16 134.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 111.099 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.57 170.06 16.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.891 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -59.22 -34.16 71.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.903 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.495 ' O ' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -64.25 -20.2 65.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.510000000000005 110.878 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.1 m-85 -87.38 6.59 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.834 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.32 124.48 19.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.219999999999999 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.95 24.32 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 53.450000000000003 110.915 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.1 126.76 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 33.329999999999998 111.139 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HD12 ' A' ' 67' ' ' LEU . 41.1 t -99.91 121.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.161 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -111.98 103.17 11.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.885 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.7 m -96.08 119.41 34.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 111.124 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 50' ' ' LEU . 19.1 t -108.65 89.11 5.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -34.23 14.99 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 65.439999999999998 112.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.833 -179.908 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.761 0.315 . . . . 74.209999999999994 110.864 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.9 mt -115.17 133.22 22.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 72.400000000000006 111.122 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.6 Cg_endo -69.81 178.85 4.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.723 2.282 . . . . 71.329999999999998 112.288 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.83 157.51 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 73.310000000000002 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.45 145.59 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 43.299999999999997 110.922 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 108' ' ' PHE . 2.0 pp -118.18 171.2 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 130.11 56.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.8 pt -117.17 173.74 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 111.157 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.6 131.78 49.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 75.219999999999999 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -103.22 102.95 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.329999999999998 110.915 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HD3' HG23 ' A' ' 114' ' ' THR . 4.5 tttp -94.82 140.02 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.898 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -140.48 175.79 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.418 . . . . 65.510000000000005 111.188 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.9 ttm -75.65 -11.67 60.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.877 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.25 -37.78 9.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 61.119999999999997 110.91 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 179.86 176.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 54.409999999999997 110.936 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 ' CG ' ' A' ' 23' ' ' LYS . 15.4 t -119.16 121.68 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 111.107 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -121.7 150.31 55.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 111.163 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 166.72 26.66 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.765 2.31 . . . . 73.0 112.343 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -154.86 145.06 21.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 53.340000000000003 111.078 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -111.78 121.95 46.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 53.43 110.9 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -95.11 116.63 28.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.38 153.8 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 111.097 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -62.94 121.61 13.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.506 . . . . 52.539999999999999 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 86.38 0.64 86.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 33.130000000000003 112.473 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.93 -169.81 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 73.200000000000003 110.847 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -142.23 154.46 44.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.19 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.8 -59.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 70.420000000000002 111.103 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.32 -34.26 60.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 65.400000000000006 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.68 -26.86 61.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 110.91 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' THR . 97.7 t -76.5 -45.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.105 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.77 -33.34 34.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 62.219999999999999 111.101 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -66.96 -35.14 79.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 110.893 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -66.88 -49.37 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.895 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -72.01 -24.56 61.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.94 -12.05 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 71.540000000000006 112.484 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 29' ' ' VAL . 25.5 t -55.86 129.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 41.020000000000003 111.136 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -86.23 80.85 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 70.430000000000007 110.898 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.892 0.377 . . . . 25.530000000000001 110.9 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -164.53 109.43 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 65.439999999999998 110.847 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 115' ' ' VAL . 11.9 t -128.48 155.0 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 72.25 111.119 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.4 mt -90.76 129.44 41.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 64.430000000000007 111.139 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 112' ' ' VAL . 21.6 tp -124.5 161.8 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 64.040000000000006 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.95 143.7 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 71.019999999999996 110.846 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -58.31 -59.52 13.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.702 . . . . 73.040000000000006 110.808 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -47.92 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.661 2.241 . . . . 54.219999999999999 112.303 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -53.0 -42.59 65.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.915 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.658 ' CD1' HG22 ' A' ' 95' ' ' THR . 58.4 t80 -71.85 -54.11 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.34 -34.81 58.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 65.439999999999998 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -78.03 -41.8 34.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.8 mm? -63.15 -25.76 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.992 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.36 140.08 5.33 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 71.329999999999998 112.508 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.74 160.3 28.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.66 0.743 . . . . 65.310000000000002 110.9 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 166.62 27.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.661 2.241 . . . . 62.009999999999998 112.326 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.0 t -58.09 171.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.817 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -59.96 -37.32 79.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.858 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -62.57 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 110.92 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -67.54 -35.63 79.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.837 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.27 -53.49 56.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.897 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.73 -42.58 90.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.936 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.52 -37.44 67.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.857 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.606 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.0 mt -74.52 -52.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 63.409999999999997 111.172 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.68 -21.59 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.819 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -76.18 -24.16 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 110.908 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -74.15 164.28 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 111.132 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -74.47 113.69 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.907 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.22 40.56 52.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.506 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -107.58 114.87 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 70.219999999999999 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.67 142.82 27.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.178 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.36 -23.68 34.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.812 -0.709 . . . . 75.129999999999995 112.471 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.658 HG22 ' CD1' ' A' ' 72' ' ' TYR . 17.8 p -74.22 -0.93 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 64.239999999999995 111.105 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 45.3 t -90.63 -12.21 37.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.837 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.98 133.67 55.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.888 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 pp -179.06 -178.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.26 -133.12 4.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 71.010000000000005 112.501 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -144.78 -42.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 61.43 110.936 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.728 ' O ' HD22 ' A' ' 102' ' ' LEU . 44.9 mt-30 -60.33 101.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.913 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 101' ' ' GLN . 4.0 mm? -134.99 127.08 29.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.25 110.948 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -84.41 168.95 15.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 70.209999999999994 110.86 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.525 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 57.5 t -102.45 119.24 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.239999999999995 111.111 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.05 172.98 12.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.866 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -29.7 68.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.834 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.8 m -65.65 -22.65 66.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.510000000000005 110.86 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 102' ' ' LEU . 3.1 m-85 -81.77 -0.15 41.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.857 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.65 123.77 16.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 62.219999999999999 110.92 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.75 27.18 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 53.450000000000003 110.915 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -68.19 151.07 47.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 33.329999999999998 111.024 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.2 t -116.28 120.99 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.010000000000005 111.146 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -114.19 98.96 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.908 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.573 HG23 ' HD3' ' A' ' 23' ' ' LYS . 43.3 m -91.41 116.65 29.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.133 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.551 HG21 ' CD2' ' A' ' 50' ' ' LEU . 22.0 t -108.64 89.19 5.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.597 0.713 . . . . 72.129999999999995 111.132 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -35.53 12.65 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.726 2.284 . . . . 65.439999999999998 112.354 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.842 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.794 0.33 . . . . 74.209999999999994 110.877 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 64.72 148.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 72.400000000000006 111.139 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.27 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.385 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.66 157.41 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 73.310000000000002 110.875 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.21 133.25 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 43.299999999999997 110.872 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.757 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.6 pp -124.12 176.96 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 64.439999999999998 111.098 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -113.79 140.9 47.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.861 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.69 175.09 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.15 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -133.03 126.77 32.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.625 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 26.6 m-85 -108.77 103.16 12.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 110.882 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -88.69 132.15 34.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.9 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -115.32 176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 65.510000000000005 111.136 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.0 tpt -75.64 -8.29 56.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 73.099999999999994 110.918 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -103.44 -37.95 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.826 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 179.39 176.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 54.409999999999997 110.966 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 23' ' ' LYS . 23.1 t -79.62 147.63 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 111.148 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.752 ' CG1' HG22 ' A' ' 48' ' ' VAL . 67.6 t -141.38 87.79 10.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 73.409999999999997 111.169 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 152.59 69.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.612 2.208 . . . . 73.0 112.396 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.63 144.28 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.428 . . . . 53.340000000000003 111.079 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.88 147.87 29.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 53.43 110.857 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.681 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -116.75 143.58 45.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 111.078 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.45 151.4 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.200000000000003 111.117 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 p -53.38 116.29 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 52.539999999999999 110.841 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' H ' HD13 ' A' ' 14' ' ' ILE . . . 74.15 25.31 71.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 33.130000000000003 112.483 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.7 p -77.83 -169.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.839 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.734 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -136.87 143.1 42.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.149 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 96.2 t -53.11 -63.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 70.420000000000002 111.116 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.85 -32.84 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 65.400000000000006 110.927 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.72 -27.52 62.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 72.450000000000003 110.815 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 38' ' ' THR . 76.1 t -77.22 -44.93 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.121 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.16 -28.33 52.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 111.121 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.55 -26.39 61.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.78 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.31 -53.78 6.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.872 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 3.42 37.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 15.82 59.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 71.540000000000006 112.459 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.752 HG22 ' CG1' ' A' ' 29' ' ' VAL . 82.0 t -52.26 127.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 41.020000000000003 111.135 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.37 80.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.86 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.430000000000007 110.938 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HB3' HD13 ' A' ' 98' ' ' LEU . 7.7 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.91 0.386 . . . . 25.530000000000001 110.894 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.43 94.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.2 t -128.67 156.41 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.25 111.111 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.1 mt -89.98 131.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 111.15 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 112' ' ' VAL . 37.6 tp -127.77 159.74 33.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.937 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.54 141.23 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 110.891 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.1 mt-10 -57.48 -59.52 12.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 73.040000000000006 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.79 -48.63 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.601 2.201 . . . . 54.219999999999999 112.38 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -51.83 -41.17 61.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 110.965 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 95' ' ' THR . 93.2 t80 -73.37 -51.38 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.834 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -34.32 63.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -78.29 -44.65 24.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.7 mm? -63.23 -21.35 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.851 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.12 131.74 2.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.813 -0.708 . . . . 71.329999999999998 112.47 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -112.6 157.31 40.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 110.885 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -177.98 2.15 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.637 2.225 . . . . 62.009999999999998 112.332 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.1 m -101.09 -176.23 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 75.409999999999997 110.872 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -55.71 -44.03 77.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 72.409999999999997 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -53.93 -59.56 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 63.240000000000002 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -30.78 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 71.530000000000001 110.92 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -56.09 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.936 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.57 -39.44 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.36 -52.32 63.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.536 HD11 ' CD ' ' A' ' 97' ' ' ARG . 63.5 mt -74.61 -34.42 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 63.409999999999997 111.149 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.54 -17.86 56.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.877 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -75.77 -26.06 57.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -69.29 164.03 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 111.065 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -82.87 113.66 20.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.94 41.15 51.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.129999999999995 112.478 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -105.66 126.48 52.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 70.219999999999999 111.069 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 148.34 24.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.059 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.63 -25.6 43.56 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 75.129999999999995 112.526 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.77 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -74.06 -1.38 19.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 64.239999999999995 111.192 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.7 t -90.61 -11.87 38.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.838 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.536 ' CD ' HD11 ' A' ' 86' ' ' ILE . 20.6 ttt-85 -91.96 168.88 11.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.846 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 63' ' ' CYS . 23.3 tp -49.56 146.71 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.450000000000003 110.943 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 98' ' ' LEU . . . 177.89 33.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 71.010000000000005 112.519 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.5 p -110.98 138.81 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 61.43 110.818 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -114.43 7.86 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 64.439999999999998 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 51.91 55.64 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -152.39 126.53 9.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.91 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.681 HG11 ' HB1' ' A' ' 33' ' ' ALA . 47.3 t -97.39 120.07 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 72.239999999999995 111.085 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -176.78 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 72.040000000000006 110.878 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -56.9 -36.0 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.510000000000005 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 m -64.85 -24.05 67.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.804 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.2 0.72 39.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 71.209999999999994 110.915 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 18' ' ' ILE . 38.4 tt0 -55.01 119.2 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 62.219999999999999 110.86 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.61 22.01 12.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 71' ' ' LEU . . . -56.58 145.11 29.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 33.329999999999998 111.116 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.696 ' O ' HD12 ' A' ' 67' ' ' LEU . 18.4 t -116.27 115.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 73.010000000000005 111.15 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -111.08 98.15 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 31.0 m -87.47 119.22 27.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 111.128 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.455 ' HA ' HG13 ' A' ' 65' ' ' VAL . 21.0 t -108.73 88.25 5.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.058 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -42.65 3.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 65.439999999999998 112.4 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.852 -179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' O ' HD13 ' A' ' 14' ' ' ILE . 93.2 mtt180 . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.745 0.307 . . . . 74.209999999999994 110.836 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.636 HD11 ' NH1' ' A' ' 103' ' ' ARG . 42.4 mm -137.96 133.11 17.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.661 0.743 . . . . 72.400000000000006 111.087 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.6 Cg_endo -69.72 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.219 . . . . 71.329999999999998 112.378 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.91 156.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 73.310000000000002 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -73.89 158.14 35.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.911 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.2 177.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -124.61 132.21 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.921 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.7 pt -114.36 169.51 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.129 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.88 129.0 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.901 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -99.49 103.38 15.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 71.329999999999998 110.866 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' CA ' HG23 ' A' ' 28' ' ' VAL . 5.5 ttmt -95.44 143.52 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.839 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 p -138.09 179.58 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 65.510000000000005 111.137 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -8.15 55.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.099999999999994 110.905 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -107.15 -38.03 6.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.436 . . . . 61.119999999999997 110.853 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 179.36 176.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 54.409999999999997 110.925 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG23 ' CA ' ' A' ' 23' ' ' LYS . 10.5 p -118.04 134.86 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.010000000000005 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG21 HG22 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -125.92 150.73 69.9 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.565 0.697 . . . . 73.409999999999997 111.179 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 153.21 68.96 Favored 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.642 2.228 . . . . 73.0 112.292 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -149.55 105.74 3.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.079 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -70.13 125.16 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 53.43 110.911 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.066 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -99.91 123.2 43.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.113 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.21 147.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 75.200000000000003 111.19 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.8 p -52.89 114.76 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 19.79 52.57 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.815 -0.707 . . . . 33.130000000000003 112.465 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 p -93.18 -175.63 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.785 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 4.2 m -143.66 152.0 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 73.140000000000001 111.12 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.924 HG23 HD12 ' A' ' 40' ' ' LEU . 14.3 m -57.99 -45.79 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.153 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.924 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -63.87 -37.63 88.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 65.400000000000006 110.925 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.7 -27.99 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.874 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 72.1 t -77.39 -36.77 24.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 61.210000000000001 111.118 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.09 55.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.027 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -73.7 -27.69 61.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -51.76 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.530000000000001 110.855 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' HG12 ' A' ' 42' ' ' VAL . 5.6 p30 -71.89 -25.73 62.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.41 52.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.655 -0.783 . . . . 71.540000000000006 112.495 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 29' ' ' VAL . 86.9 t -51.5 135.15 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.775 0.321 . . . . 41.020000000000003 111.154 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.88 82.78 6.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.883 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.824 HD11 HG11 ' A' ' 115' ' ' VAL . 11.7 tp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.430000000000007 110.931 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.9 m . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.832 0.348 . . . . 25.530000000000001 110.822 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -102.38 96.76 7.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 65.439999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.7 t -128.69 157.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.25 111.129 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 89.9 mt -90.51 129.68 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 64.430000000000007 111.166 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.6 tp -125.33 163.02 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 64.040000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.81 147.2 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.877 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -61.33 -59.71 12.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.605 0.716 . . . . 73.040000000000006 110.9 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.76 -42.44 3.4 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.638 2.225 . . . . 54.219999999999999 112.349 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -58.3 -44.52 88.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 110.929 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 95' ' ' THR . 63.2 t80 -70.88 -52.34 20.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.883 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -36.45 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.439999999999998 110.862 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -73.86 -44.32 55.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 75.0 110.927 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.25 -52.66 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 75.209999999999994 110.89 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.42 142.96 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 71.329999999999998 112.524 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.83 157.56 42.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.659 0.743 . . . . 65.310000000000002 110.874 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 173.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.64 2.227 . . . . 62.009999999999998 112.323 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -102.49 -169.84 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.409999999999997 110.855 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.71 -46.81 81.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.843 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.99 -59.55 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.09 -27.75 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.862 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -53.75 48.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.918 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -69.74 -37.14 76.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 71.120000000000005 110.871 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 mt -62.49 -48.47 79.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' HA2' ' A' ' 94' ' ' GLY . 56.6 mt -73.91 -35.41 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 63.409999999999997 111.087 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.97 -20.68 64.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 74.030000000000001 110.904 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.15 -25.78 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.914 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.47 146.09 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.129999999999995 111.069 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.2 121.63 18.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.847 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 44.63 60.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.581 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -103.29 129.38 50.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 70.219999999999999 111.143 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 144.5 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.095 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.602 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.44 -22.74 32.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 75.129999999999995 112.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.619 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.7 p -73.89 -2.25 23.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.086 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.9 t -88.43 -13.35 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 110.786 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD3' HD11 ' A' ' 86' ' ' ILE . 13.6 mtp85 -123.33 167.45 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 70.200000000000003 110.908 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 58.71 46.64 14.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.854 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.34 40.71 2.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 71.010000000000005 112.462 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 2.9 t -92.02 66.98 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 61.43 110.855 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.13 138.29 46.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.54 35.37 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.25 110.896 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.636 ' NH1' HD11 ' A' ' 14' ' ' ILE . 17.2 mmt180 -132.96 135.95 45.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 70.209999999999994 110.907 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.066 HG11 ' HB1' ' A' ' 33' ' ' ALA . 26.3 t -109.61 119.58 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.117 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -136.46 178.73 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 72.040000000000006 110.891 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -58.31 -37.21 74.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 110.948 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -63.64 -19.44 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.510000000000005 110.862 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -89.62 9.92 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 71.209999999999994 110.851 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.87 125.76 24.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.219999999999999 110.889 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 60.52 21.9 11.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 53.450000000000003 110.872 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -59.71 136.33 57.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 33.329999999999998 111.088 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 67' ' ' LEU . 45.8 t -104.44 119.42 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.1 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.2 98.44 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.430000000000007 110.895 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 65' ' ' VAL . 46.4 m -93.8 119.82 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 111.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.824 HG11 HD11 ' A' ' 50' ' ' LEU . 20.2 t -108.87 88.57 5.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.165 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -36.26 11.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.274 . . . . 65.439999999999998 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.873 -179.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.807 0.336 . . . . 74.209999999999994 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 36' ' ' GLY . 59.0 mt -98.53 132.99 23.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 72.400000000000006 111.177 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.77 -174.4 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.334 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -53.05 156.67 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 155.0 39.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 43.299999999999997 110.84 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 pt -132.85 176.82 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 111.103 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -122.8 138.63 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.3 pt -120.82 172.56 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 75.129999999999995 111.126 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -127.53 133.28 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.887 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.748 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.1 m-85 -104.52 106.03 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.819 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -97.25 144.26 27.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.975 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -139.1 178.72 6.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.113 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -8.1 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.88 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -106.31 -37.66 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 61.119999999999997 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 179.82 175.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 110.949 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.77 127.67 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.010000000000005 111.155 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HG22 ' A' ' 48' ' ' VAL . 1.4 m -117.91 150.84 47.96 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.107 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 156.17 63.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 73.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.97 138.2 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.089 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -100.54 130.67 46.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 53.43 110.902 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.89 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -110.73 117.04 32.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 111.115 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.4 t -104.61 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.200000000000003 111.122 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -51.74 116.2 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.849 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.539 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 100.92 7.38 50.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 33.130000000000003 112.486 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -100.95 -169.97 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.995 0.426 . . . . 73.200000000000003 110.852 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.733 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -144.58 142.65 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 73.140000000000001 111.153 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 83.4 t -52.45 -63.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 70.420000000000002 111.1 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.49 -33.16 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.895 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.73 -27.4 62.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.845 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 38' ' ' THR . 92.2 t -76.82 -43.06 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 61.210000000000001 111.151 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.06 -30.13 14.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -73.62 -37.8 65.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 110.855 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -40.22 50.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 74.530000000000001 110.848 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.11 -21.78 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 74.420000000000002 110.87 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.0 -12.26 55.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 71.540000000000006 112.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 29' ' ' VAL . 46.7 t -57.8 113.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.337 . . . . 41.020000000000003 111.135 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.47 80.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.929 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 115' ' ' VAL . 11.3 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 110.899 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.921 0.391 . . . . 25.530000000000001 110.857 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -100.8 118.35 36.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 65.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.23 155.53 39.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 72.25 111.17 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.589 HD12 ' HD3' ' A' ' 116' ' ' PRO . 5.1 mp -90.38 132.98 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 64.430000000000007 111.195 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.7 tp -127.37 159.31 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.040000000000006 110.929 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.15 146.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.915 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -59.38 -60.25 11.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 73.040000000000006 110.914 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.86 -46.22 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.28 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -54.13 -48.32 70.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.909 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.582 ' CD1' HG22 ' A' ' 95' ' ' THR . 42.1 t80 -68.23 -47.43 67.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.450000000000003 110.881 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -55.62 -43.7 76.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.917 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.16 -26.95 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.0 tp -72.83 -62.56 1.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.937 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.17 3.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 71.329999999999998 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -132.34 157.31 78.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.683 0.754 . . . . 65.310000000000002 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 166.28 28.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 62.009999999999998 112.318 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.19 170.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.874 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -58.78 -37.19 75.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.879 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -52.51 -62.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.7 -35.11 78.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 71.530000000000001 110.845 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -56.89 -53.34 59.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.945 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.95 -42.16 90.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.838 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tp -55.8 -37.55 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 110.954 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.3 mt -74.57 -52.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.13 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -59.04 -21.67 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.854 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -76.04 -24.99 55.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.933 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -76.05 162.96 27.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.053 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -70.23 117.34 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.07 42.84 55.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 73.129999999999995 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -113.61 121.86 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.086 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.7 144.1 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.135 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.59 -23.47 36.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.488 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.582 HG22 ' CD1' ' A' ' 72' ' ' TYR . 22.6 p -73.92 -2.24 23.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 64.239999999999995 111.136 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 36.6 t -90.24 -13.97 34.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.841 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.55 158.31 34.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 70.200000000000003 110.854 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 56.45 67.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 110.954 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.21 61.68 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 71.010000000000005 112.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.1 t -133.96 -74.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 61.43 110.91 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.27 93.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 110.844 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 38' ' ' THR . 15.6 mt -146.18 165.52 28.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.858 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -112.03 170.61 8.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 70.209999999999994 110.868 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.89 HG11 ' HB1' ' A' ' 33' ' ' ALA . 24.3 t -94.42 115.3 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.127 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.93 176.01 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 72.040000000000006 110.794 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -57.2 -36.25 70.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.510000000000005 110.873 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -22.35 66.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 110.885 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.428 ' CE2' HD22 ' A' ' 75' ' ' LEU . 3.7 m-85 -85.76 5.27 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.922 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.456 ' N ' HD13 ' A' ' 18' ' ' ILE . 85.5 tt0 -58.8 123.0 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 62.219999999999999 110.898 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.37 22.58 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 53.450000000000003 110.939 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 133.64 52.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 33.329999999999998 111.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.625 ' O ' HD12 ' A' ' 67' ' ' LEU . 36.7 t -106.17 118.86 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.128 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 42.5 m-85 -109.4 102.97 11.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 71.430000000000007 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -95.2 125.77 40.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.182 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 50' ' ' LEU . 59.5 t -100.59 133.33 21.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.602 0.715 . . . . 72.129999999999995 111.154 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.9 Cg_endo -69.75 -45.28 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.699 2.266 . . . . 65.439999999999998 112.304 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 72.140000000000001 110.841 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.72 0.295 . . . . 74.209999999999994 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.449 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -136.33 133.18 19.25 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.63 0.729 . . . . 72.400000000000006 111.148 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.77 178.1 4.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.696 2.264 . . . . 71.329999999999998 112.353 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.68 156.25 1.42 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.856 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 149.52 41.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 43.299999999999997 110.939 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.604 HG21 ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -129.07 175.84 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 64.439999999999998 111.186 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -124.98 139.17 54.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 31' ' ' ALA . 30.1 pt -125.83 164.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.12 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -121.37 138.93 54.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 75.219999999999999 110.892 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 9.9 m-85 -117.0 102.76 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.917 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -84.44 144.48 28.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.937 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 p -114.4 -157.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.510000000000005 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.4 ttp -50.52 -50.35 53.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.904 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -138.09 -33.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 61.119999999999997 110.842 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.12 151.93 21.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 54.409999999999997 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 28' ' ' VAL . 6.7 p -122.9 120.62 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 72.010000000000005 111.095 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 48' ' ' VAL . 3.7 m -109.09 136.99 20.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 73.409999999999997 111.216 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 169.57 18.67 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.638 2.225 . . . . 73.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -159.38 108.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 53.340000000000003 111.075 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -74.1 138.0 43.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 53.43 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.787 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -113.59 116.59 29.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.086 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.1 t -102.57 141.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.200000000000003 111.132 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.83 114.85 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 52.539999999999999 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.55 50.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 33.130000000000003 112.488 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.553 ' OG ' HG21 ' A' ' 104' ' ' VAL . 92.2 p -94.08 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.979 0.419 . . . . 73.200000000000003 110.806 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 42' ' ' VAL . 17.2 p -142.65 154.78 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 73.140000000000001 111.149 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 50' ' ' LEU . 47.5 t -52.4 -59.62 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.420000000000002 111.15 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.943 HD23 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -53.93 -34.94 61.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.903 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.81 -26.94 61.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 72.450000000000003 110.862 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 38' ' ' THR . 91.1 t -76.31 -47.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.210000000000001 111.104 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -55.61 -28.48 55.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.059 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -69.49 -32.93 72.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 75.200000000000003 110.824 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -53.76 21.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.918 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -72.38 -26.6 61.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.869 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.44 -4.26 40.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.813 -0.708 . . . . 71.540000000000006 112.483 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.569 HG22 HG21 ' A' ' 29' ' ' VAL . 38.8 t -51.79 141.41 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 41.020000000000003 111.127 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -88.3 80.79 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.832 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' HG12 ' A' ' 39' ' ' VAL . 10.6 tp . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.876 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 25.530000000000001 110.856 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -117.39 101.66 8.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 98' ' ' LEU . 10.7 m -129.54 164.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 72.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.84 133.2 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 64.430000000000007 111.148 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 112' ' ' VAL . 35.6 tp -126.55 153.93 44.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 64.040000000000006 110.907 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.8 146.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.852 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -54.86 -60.46 7.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.674 0.749 . . . . 73.040000000000006 110.829 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.69 -44.75 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.7 2.267 . . . . 54.219999999999999 112.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -52.48 -45.31 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 73.209999999999994 110.951 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.618 ' HD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -72.79 -49.91 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.0 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -53.14 -37.85 62.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.509 . . . . 65.439999999999998 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -76.07 -46.21 30.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 71' ' ' LEU . 2.1 mm? -63.2 -22.81 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.869 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.7 136.17 3.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 71.329999999999998 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -112.2 157.41 39.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.634 0.73 . . . . 65.310000000000002 110.931 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.258 . . . . 62.009999999999998 112.379 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.5 t -120.94 -170.67 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.854 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.27 -46.4 76.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.898 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -54.43 -58.84 5.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 63.240000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -28.18 69.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.874 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -55.48 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 74.329999999999998 110.902 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.95 -40.91 87.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 110.861 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.07 -50.86 69.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 64.219999999999999 110.923 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.784 HD13 ' HA2' ' A' ' 94' ' ' GLY . 22.5 mt -74.08 -35.04 40.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.128 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.48 -17.65 60.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.915 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.18 -24.42 54.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.909 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.612 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.2 164.37 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.129999999999995 111.069 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.85 113.84 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.866 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.83 52.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 73.129999999999995 112.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -96.53 125.17 40.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 70.219999999999999 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.8 30.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.203 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.35 -23.98 36.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.798 -0.715 . . . . 75.129999999999995 112.481 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.618 HG22 ' HD1' ' A' ' 72' ' ' TYR . 20.3 p -73.42 -3.27 26.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.146 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -86.83 -16.02 37.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.821 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.62 157.91 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 70.200000000000003 110.855 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 99' ' ' GLY . 4.1 pp -166.34 -179.46 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.546 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -76.82 -130.51 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 71.010000000000005 112.489 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.78 84.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 61.43 110.853 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.569 ' C ' HD22 ' A' ' 102' ' ' LEU . 37.9 mt-30 -122.45 132.77 54.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 64.439999999999998 110.968 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.943 HD12 HD23 ' A' ' 40' ' ' LEU . 4.6 mm? -126.84 67.25 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 65.25 110.885 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -152.26 160.25 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 70.209999999999994 110.819 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 33' ' ' ALA . 99.4 t -105.5 129.89 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 111.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.39 167.94 20.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 72.040000000000006 110.883 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -57.05 -31.06 64.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 72.510000000000005 110.866 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -28.24 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 110.851 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.626 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.0 m-85 -75.98 -6.12 49.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.209999999999994 110.936 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.604 ' HB2' HG21 ' A' ' 18' ' ' ILE . 84.5 tt0 -58.72 124.15 18.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 62.219999999999999 110.893 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 61.01 22.85 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 53.450000000000003 110.915 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.15 138.32 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 33.329999999999998 111.091 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.706 ' O ' HD12 ' A' ' 67' ' ' LEU . 8.0 t -107.32 111.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 73.010000000000005 111.145 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 67' ' ' LEU . 77.9 m-85 -105.89 104.62 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 23' ' ' LYS . 72.8 m -93.35 125.52 38.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 73.439999999999998 111.134 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.44 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.1 t -85.01 133.45 43.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 111.137 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.9 Cg_endo -69.75 -165.63 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.716 2.278 . . . . 65.439999999999998 112.374 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.926 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.808 0.337 . . . . 74.209999999999994 110.909 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.704 HD11 ' HD2' ' A' ' 103' ' ' ARG . 43.5 mm -57.98 124.65 70.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.629 0.728 . . . . 72.400000000000006 111.131 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -169.64 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.659 2.239 . . . . 71.329999999999998 112.399 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -51.02 157.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.93 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 136.37 38.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 43.299999999999997 110.987 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.5 pp -124.58 176.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 64.439999999999998 111.142 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -120.42 136.78 54.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.819 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -115.97 169.21 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 75.129999999999995 111.186 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HD1' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -118.6 126.72 52.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.83 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 2.4 m-85 -96.56 103.12 15.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.855 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -91.4 122.84 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 75.340000000000003 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 -178.12 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.124 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.8 ttm -75.8 -8.18 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.871 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -108.21 -37.89 5.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 61.119999999999997 110.893 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 179.79 176.18 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.932 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' HD1' ' A' ' 21' ' ' PHE . 13.7 p -108.46 132.76 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 111.086 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.638 HG21 HG22 ' A' ' 48' ' ' VAL . 1.7 m -122.48 151.03 59.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 73.409999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.26 62.48 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.687 2.258 . . . . 73.0 112.302 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -146.83 104.2 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 53.340000000000003 111.129 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -76.46 132.22 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 53.43 110.953 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -109.64 133.65 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.052 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.08 152.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.079 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -52.4 111.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 52.539999999999999 110.932 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.16 17.15 35.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.49 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 104' ' ' VAL . 54.0 p -107.52 163.56 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.922 0.392 . . . . 73.200000000000003 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -123.4 154.07 39.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 73.140000000000001 111.126 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 20' ' ' ILE . 15.9 m -55.83 -44.72 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.420000000000002 111.111 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' N ' HG23 ' A' ' 39' ' ' VAL . 15.5 mt -56.76 -44.17 81.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 65.400000000000006 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' CG ' HG23 ' A' ' 38' ' ' THR . 35.2 m-20 -72.72 -26.83 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.450000000000003 110.929 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 38' ' ' THR . 77.2 t -75.23 -31.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 61.210000000000001 111.164 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.28 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 111.118 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -73.43 -35.83 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.839 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -64.72 -46.96 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.832 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.31 -24.62 59.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.938 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.85 40.37 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.471 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 29' ' ' VAL . 39.0 t -51.48 136.24 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 41.020000000000003 111.177 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.84 80.96 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.834 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 110.93 -179.997 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.918 0.39 . . . . 25.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -69.36 90.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.806 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 114' ' ' THR . 6.5 t -128.59 157.4 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 72.25 111.193 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.8 mp -89.63 134.72 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 64.430000000000007 111.137 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.3 tp -129.03 158.52 38.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 64.040000000000006 110.876 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.45 142.74 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.4 mt-10 -56.91 -60.16 10.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.708 0.766 . . . . 73.040000000000006 110.879 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.82 -48.95 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.721 2.28 . . . . 54.219999999999999 112.288 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.58 -41.9 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 95' ' ' THR . 68.7 t80 -72.51 -52.72 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.26 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 65.439999999999998 110.83 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -77.94 -44.54 26.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.951 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 107' ' ' SER . 1.5 mm? -63.24 -24.3 67.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.874 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.24 156.31 6.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.811 -0.709 . . . . 71.329999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -119.99 157.62 52.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 65.310000000000002 110.865 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 156.6 62.79 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 62.009999999999998 112.296 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.9 t -90.36 -169.66 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.867 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.62 -47.51 76.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -54.02 -59.75 4.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.869 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.3 mp0 -61.11 -27.94 68.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.909 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -56.35 17.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.924 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.98 -40.34 91.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 71.120000000000005 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 mt -56.93 -51.38 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 64.219999999999999 110.904 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.617 HD13 ' HA2' ' A' ' 94' ' ' GLY . 13.7 mt -73.59 -35.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 63.409999999999997 111.171 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -61.84 -18.07 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.863 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -76.01 -24.13 55.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.886 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -84.5 146.71 27.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 71.129999999999995 111.158 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.2 122.23 19.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 110.859 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.98 45.08 56.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 73.129999999999995 112.479 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -100.8 124.86 47.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 111.111 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 144.02 25.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.139 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.617 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.77 -24.82 42.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 75.129999999999995 112.423 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.756 HG22 ' CD1' ' A' ' 72' ' ' TYR . 28.2 p -74.09 -2.18 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 64.239999999999995 111.071 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 1.3 t -90.72 -13.03 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.933 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -144.05 136.67 26.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 70.200000000000003 110.947 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD13 ' NE2' ' A' ' 101' ' ' GLN . 4.3 tt -134.36 -61.25 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 73.450000000000003 110.889 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.17 -90.46 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.668 -0.777 . . . . 71.010000000000005 112.446 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.92 110.42 2.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 61.43 110.916 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD13 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -131.17 118.79 20.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 64.439999999999998 110.894 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.2 37.18 3.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.25 110.904 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.704 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 mmt85 -137.22 147.81 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 70.209999999999994 110.908 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 33' ' ' ALA . 88.3 t -104.18 129.94 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.128 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -136.74 164.16 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.894 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -54.84 -26.4 35.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 72.510000000000005 110.873 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.652 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -62.43 -29.2 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.510000000000005 110.825 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 21.3 m-85 -91.21 12.52 19.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.922 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 18' ' ' ILE . 69.3 tt0 -59.65 111.89 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 62.219999999999999 110.89 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 63.76 20.61 12.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.883 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 113' ' ' PHE . . . -67.99 151.07 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 33.329999999999998 111.128 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 22.2 t -105.73 115.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 111.178 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' HE1' ' HB3' ' A' ' 111' ' ' ALA . 34.6 m-85 -108.87 104.36 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.825 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 65' ' ' VAL . 88.2 m -95.08 130.86 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.187 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 116' ' ' PRO . 59.3 t -97.48 133.21 23.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.195 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD3' HD12 ' A' ' 66' ' ' ILE . 54.4 Cg_endo -69.6 -47.79 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.695 2.263 . . . . 65.439999999999998 112.423 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.862 179.999 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.759 0.314 . . . . 74.209999999999994 110.896 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' A' ' 103' ' ' ARG . 39.7 mm -70.59 132.92 87.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.659 0.742 . . . . 72.400000000000006 111.133 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.3 Cg_endo -69.78 -170.34 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 71.329999999999998 112.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.86 156.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 110.865 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.74 132.93 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 43.299999999999997 110.875 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.6 pp -120.12 177.27 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.137 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -112.18 151.78 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.872 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.629 HD12 ' HE1' ' A' ' 113' ' ' PHE . 2.2 pt -135.34 165.45 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.064 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HB3' HG13 ' A' ' 112' ' ' VAL . 2.9 m-85 -112.2 125.17 53.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.949 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -91.29 103.14 15.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 71.329999999999998 110.899 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' CD ' HG22 ' A' ' 28' ' ' VAL . 32.0 tptt -101.35 118.3 36.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.843 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -124.6 171.2 10.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 65.510000000000005 111.158 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mmm -75.83 -7.96 55.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 73.099999999999994 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.7 -38.04 9.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 61.119999999999997 110.93 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 179.45 176.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 54.409999999999997 110.933 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.674 HG22 ' CD ' ' A' ' 23' ' ' LYS . 17.9 t -111.74 124.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.010000000000005 111.113 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.62 150.49 76.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.111 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 155.38 65.92 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.65 2.233 . . . . 73.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 42' ' ' VAL . . . -143.45 141.46 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 111.099 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -106.15 131.65 53.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 53.43 110.929 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.78 116.54 32.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 111.059 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.36 151.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 75.200000000000003 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -52.93 109.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.925 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.02 31.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.485 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.3 p -100.8 163.32 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.415 . . . . 73.200000000000003 110.877 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 p -130.99 152.92 49.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 73.140000000000001 111.146 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.02 -60.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.131 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.12 -34.25 59.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 65.400000000000006 110.922 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -72.46 -26.77 61.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 72.450000000000003 110.789 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 38' ' ' THR . 63.8 t -76.94 -45.06 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 61.210000000000001 111.142 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -51.64 -29.95 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 111.037 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -71.66 -36.77 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 110.943 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -79.38 -45.23 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.886 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -72.19 -25.4 61.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.66 -12.19 56.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 71.540000000000006 112.462 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.646 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 87.2 t -52.66 105.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 41.020000000000003 111.136 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.644 ' O ' HD22 ' A' ' 50' ' ' LEU . 31.1 t0 -81.77 81.11 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 49' ' ' ASP . 2.0 mm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.430000000000007 110.907 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.883 0.373 . . . . 25.530000000000001 110.91 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.88 113.77 21.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 65.439999999999998 110.875 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.38 157.16 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.073 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -89.81 137.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.058 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.46 158.36 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 64.040000000000006 110.865 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.52 142.4 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.863 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -58.64 -59.23 14.3 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.53 0.681 . . . . 73.040000000000006 110.876 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.81 -47.97 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 54.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -52.47 -48.78 65.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.957 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.425 ' CD1' HG22 ' A' ' 95' ' ' THR . 28.9 t80 -65.11 -51.7 59.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.924 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.11 44.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 65.439999999999998 110.843 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -75.49 -52.34 10.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.07 -23.19 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.12 151.7 5.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 71.329999999999998 112.525 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.13 157.63 77.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 65.310000000000002 110.872 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.667 2.245 . . . . 62.009999999999998 112.334 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 p -111.24 -176.92 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.851 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -55.77 -44.84 78.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -53.79 -59.7 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 63.240000000000002 110.854 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -62.33 -28.07 69.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.878 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -55.16 31.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.949 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.94 -41.03 83.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 110.821 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.62 -52.24 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 110.917 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.768 HD13 ' HA2' ' A' ' 94' ' ' GLY . 10.9 mt -73.7 -35.02 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.409999999999997 111.101 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.79 -19.17 58.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 110.856 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -76.07 -24.0 55.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.924 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.96 151.44 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.129999999999995 111.061 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -69.73 120.26 15.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.519999999999996 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.67 44.09 54.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.726 -0.75 . . . . 73.129999999999995 112.537 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -112.11 132.64 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 70.219999999999999 111.082 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.93 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 111.145 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.86 -26.77 48.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 75.129999999999995 112.453 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.5 p -74.09 -0.99 18.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.133 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 25.5 t -90.89 -14.0 32.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 71.409999999999997 110.858 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -102.93 160.81 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 70.200000000000003 110.887 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -176.6 125.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.895 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' HD13 ' A' ' 98' ' ' LEU . . . -61.13 -166.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.467 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 21.8 m -89.07 49.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 61.43 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -128.92 41.89 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.439999999999998 110.919 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 98' ' ' LEU . 4.4 mm? -76.88 65.05 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.25 110.911 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 14' ' ' ILE . 5.1 tpp85 -109.46 158.43 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 70.209999999999994 110.913 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.7 t -80.93 127.23 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.157 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 161.14 36.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.040000000000006 110.838 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.5 -36.82 67.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.885 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -21.44 66.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 64.510000000000005 110.849 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.73 1.82 40.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 71.209999999999994 110.845 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.88 124.14 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.914 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 59.11 26.26 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 53.450000000000003 110.895 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.07 130.42 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 33.329999999999998 111.03 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 21' ' ' PHE . 15.3 t -97.91 126.78 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.010000000000005 111.099 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.629 ' HE1' HD12 ' A' ' 20' ' ' ILE . 31.9 p90 -120.74 132.61 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 71.430000000000007 110.867 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 23' ' ' LYS . 89.8 m -104.72 130.9 52.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 111.16 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.6 t -93.31 133.3 28.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 72.129999999999995 111.105 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.8 Cg_endo -69.82 -165.45 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.28 . . . . 65.439999999999998 112.355 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 72.140000000000001 110.794 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.746 0.308 . . . . 74.209999999999994 110.851 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -81.61 133.0 53.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.591 0.71 . . . . 72.400000000000006 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.271 . . . . 71.329999999999998 112.308 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -52.3 156.76 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.244 -0.435 . . . . 73.310000000000002 110.883 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.04 159.27 32.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 43.299999999999997 110.859 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.7 pt -139.66 176.78 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 111.134 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -124.08 130.59 52.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.836 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 108' ' ' PHE . 2.7 pt -114.5 162.66 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 75.129999999999995 111.103 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.5 136.18 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 5.1 m-85 -106.18 108.31 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.329999999999998 110.896 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 134.56 38.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 75.340000000000003 110.923 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -125.18 -178.95 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 111.175 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.1 ttp -75.78 -8.03 55.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.918 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -37.97 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 61.119999999999997 110.911 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.4 HE21 HG13 ' A' ' 29' ' ' VAL . 2.0 pt20 179.26 176.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 54.409999999999997 110.93 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.42 135.78 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.010000000000005 111.113 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG13 HE21 ' A' ' 27' ' ' GLN . 0.4 OUTLIER -126.87 150.18 70.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.687 . . . . 73.409999999999997 111.183 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 150.75 68.66 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 73.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -148.5 116.22 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 53.340000000000003 111.054 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -74.22 131.52 41.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.898 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.011 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.1 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.102 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.93 147.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -52.41 113.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 52.539999999999999 110.884 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.44 25.19 51.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 33.130000000000003 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.9 t -97.27 163.28 12.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 73.200000000000003 110.891 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.1 p -121.14 165.28 15.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.087 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.571 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 88.3 t -52.02 -56.26 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 111.137 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.4 mp -56.77 -35.6 68.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 65.400000000000006 110.789 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.62 -26.76 61.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 72.450000000000003 110.893 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 88.4 t -76.67 -41.39 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 61.210000000000001 111.126 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -54.96 -30.2 58.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 62.219999999999999 111.115 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -74.13 -24.84 59.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.834 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -76.62 -54.2 6.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 110.896 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.473 HD22 ' HB2' ' A' ' 31' ' ' ALA . 43.8 p30 -77.82 -14.22 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.883 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.76 -12.42 69.42 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.463 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 93.9 t -57.33 143.15 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 41.020000000000003 111.124 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.88 81.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.84 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 115' ' ' VAL . 7.2 mt . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.869 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.871 0.367 . . . . 25.530000000000001 110.837 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -77.13 78.69 3.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.439999999999998 110.791 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 114' ' ' THR . 5.7 t -128.46 157.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 72.25 111.17 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.484 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.2 mp -90.18 130.91 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 111.134 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' VAL . 15.7 tp -126.03 163.9 22.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 64.040000000000006 110.91 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -40.65 138.45 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.019999999999996 110.91 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -60.77 -58.64 17.85 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 73.040000000000006 110.945 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.4 Cg_endo -69.71 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.749 2.299 . . . . 54.219999999999999 112.327 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.537 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -52.25 -49.05 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.918 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.639 ' CD1' HG22 ' A' ' 95' ' ' THR . 52.6 t80 -64.9 -51.33 62.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.88 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -27.24 62.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 65.439999999999998 110.862 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -75.9 -54.66 6.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.5 mt -63.04 -21.48 66.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.965 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.02 142.77 3.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.742 -0.742 . . . . 71.329999999999998 112.508 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 157.57 77.05 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 65.310000000000002 110.872 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 157.27 60.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 62.009999999999998 112.316 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.2 m -58.14 157.34 8.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -51.73 -35.78 44.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.896 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -62.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 110.909 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.71 -35.82 81.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 110.923 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.61 -56.6 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.9 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -62.15 -41.29 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.908 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.21 -38.26 73.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.219999999999999 110.936 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.479 HD13 ' HA2' ' A' ' 94' ' ' GLY . 12.5 mt -75.04 -36.75 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 111.078 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.18 -22.26 27.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.857 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -29.7 59.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.891 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -75.67 131.09 39.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.041 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -54.44 130.08 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.48 48.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.718 . . . . 73.129999999999995 112.458 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.584 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 70.219999999999999 111.162 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.74 153.01 22.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.174 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -27.39 48.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.453 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.9 p -73.94 -1.43 19.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 111.174 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.0 t -87.61 -13.88 41.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 131.92 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.814 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tt -135.07 -64.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.94 -176.68 41.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.511 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.12 109.27 20.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 61.43 110.866 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.576 ' C ' HD22 ' A' ' 102' ' ' LEU . 7.7 mt-30 -163.81 134.68 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 64.439999999999998 110.891 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.576 HD22 ' C ' ' A' ' 101' ' ' GLN . 4.5 mm? -126.78 83.79 2.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 65.25 110.924 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -152.0 146.63 25.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.884 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.011 HG11 ' HB1' ' A' ' 33' ' ' ALA . 71.0 t -109.88 131.68 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.203 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.42 167.47 21.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.040000000000006 110.835 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.59 -22.05 54.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.926 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -29.46 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 110.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.453 ' O ' HG22 ' A' ' 20' ' ' ILE . 20.0 m-85 -90.78 7.54 39.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 71.209999999999994 110.868 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' HG21 ' A' ' 18' ' ' ILE . 61.4 tt0 -57.63 123.15 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 110.878 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.4 25.36 14.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 53.450000000000003 110.907 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -86.23 162.52 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 33.329999999999998 111.078 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.567 ' O ' HD12 ' A' ' 67' ' ' LEU . 13.5 t -112.72 125.29 69.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 111.175 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -111.76 94.72 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.904 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 65' ' ' VAL . 56.1 m -89.32 130.97 35.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.158 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.566 HG21 HD22 ' A' ' 50' ' ' LEU . 59.6 t -104.4 133.35 20.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.6 0.715 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.3 Cg_endo -69.76 -41.15 4.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 65.439999999999998 112.303 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.831 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.772 0.32 . . . . 74.209999999999994 110.865 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 15' ' ' PRO . 56.3 mt -60.62 133.07 91.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.604 0.716 . . . . 72.400000000000006 111.088 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.69 -170.57 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.383 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.24 156.89 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 73.310000000000002 110.89 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -74.03 144.01 45.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 43.299999999999997 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.5 pp -129.93 176.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -114.68 138.71 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.896 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.639 HD12 ' CE1' ' A' ' 113' ' ' PHE . 23.9 pt -114.22 167.81 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 111.189 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -113.08 125.3 54.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.865 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.37 101.87 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.51 128.56 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 p -127.23 175.85 7.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 65.510000000000005 111.171 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 6.1 tpt -74.42 -8.06 55.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 73.099999999999994 110.893 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.08 -38.35 6.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 61.119999999999997 110.824 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 178.81 176.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.881 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.78 146.44 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.129 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.3 t -142.51 129.78 11.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.112 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.64 7.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.633 2.222 . . . . 73.0 112.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -121.21 115.94 23.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 111.064 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -73.91 137.22 43.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 53.43 110.898 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.22 145.87 37.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.138 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.01 152.36 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 111.117 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.51 109.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 52.539999999999999 110.833 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.47 23.49 33.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 33.130000000000003 112.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -97.19 177.52 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 73.200000000000003 110.86 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.0 p -134.69 152.21 51.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.140000000000001 111.168 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -47.85 -61.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 70.420000000000002 111.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.01 -34.05 58.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 65.400000000000006 110.921 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.4 -27.07 62.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 72.450000000000003 110.805 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 56.4 t -77.0 -43.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.125 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.98 -28.13 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 62.219999999999999 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -73.1 -27.43 61.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.806 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -53.4 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.884 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.486 ' HB3' HG23 ' A' ' 48' ' ' VAL . 13.7 t-20 -72.59 -24.73 61.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.420000000000002 110.908 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.02 15.75 43.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.783 -0.722 . . . . 71.540000000000006 112.452 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 46' ' ' ASN . 24.8 t -66.31 147.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.338 . . . . 41.020000000000003 111.135 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -88.83 80.8 7.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.904 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 70.430000000000007 110.935 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.862 0.363 . . . . 25.530000000000001 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -146.68 112.99 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 65.439999999999998 110.832 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 9.3 t -128.32 156.66 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 72.25 111.133 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.3 mp -89.31 137.72 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 111.159 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.77 157.88 39.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 64.040000000000006 110.952 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.48 141.45 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.879 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -57.27 -59.63 12.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 73.040000000000006 110.906 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.79 -48.86 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.744 2.296 . . . . 54.219999999999999 112.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.654 HD21 ' HB1' ' A' ' 111' ' ' ALA . 1.6 tp -51.83 -42.82 62.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.996 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.9 t80 -72.51 -51.64 19.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.87 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -36.23 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 65.439999999999998 110.852 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -78.18 -43.06 29.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.3 mm? -63.26 -28.1 69.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.944 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.07 160.55 8.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.737 -0.744 . . . . 71.329999999999998 112.457 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.55 157.37 77.48 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 65.310000000000002 110.876 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 62.009999999999998 112.425 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -102.57 -175.7 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 110.871 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -56.45 -45.2 80.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -59.65 4.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.868 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.43 -28.55 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.530000000000001 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -56.96 13.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.901 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -42.09 89.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.822 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.08 -51.93 62.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 110.963 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' HA2' ' A' ' 94' ' ' GLY . 58.0 mt -73.74 -35.26 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 111.105 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.55 -17.04 62.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.83 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -76.28 -25.38 54.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.869 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -82.46 143.84 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 71.129999999999995 111.087 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -64.03 123.17 18.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 75.519999999999996 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.93 43.92 55.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.711 -0.756 . . . . 73.129999999999995 112.551 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.615 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.9 118.02 35.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 70.219999999999999 111.179 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 148.71 26.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 111.122 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.68 -24.82 41.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 75.129999999999995 112.45 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -73.96 -1.99 22.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 64.239999999999995 111.171 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.7 t -91.05 -12.94 34.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 71.409999999999997 110.9 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -118.24 132.73 56.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 70.200000000000003 110.906 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.17 -69.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.450000000000003 110.874 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.36 -142.04 7.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 71.010000000000005 112.456 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -129.87 33.44 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 61.43 110.884 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.584 ' C ' HD22 ' A' ' 102' ' ' LEU . 33.8 mt-30 -139.41 133.95 31.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 64.439999999999998 110.968 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 101' ' ' GLN . 4.6 mm? -128.82 109.15 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 65.25 110.918 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -137.4 145.35 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 70.209999999999994 110.863 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG21 ' HB1' ' A' ' 33' ' ' ALA . 22.1 t -92.94 130.18 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.106 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.48 167.53 21.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.932 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -41.76 79.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 72.510000000000005 110.874 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.64 -17.09 59.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.510000000000005 110.898 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 m-85 -90.26 11.26 21.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.931 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.5 123.27 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.219999999999999 110.897 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 59.6 25.88 14.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 53.450000000000003 110.84 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -73.85 127.92 34.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 33.329999999999998 111.097 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 21' ' ' PHE . 21.6 t -102.12 120.52 51.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.117 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 20' ' ' ILE . 30.3 p90 -120.46 126.41 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.876 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -101.4 131.35 47.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.192 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.0 t -88.18 133.34 37.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.681 0.753 . . . . 72.129999999999995 111.089 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.0 Cg_endo -69.78 -43.56 2.58 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.709 2.273 . . . . 65.439999999999998 112.312 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.948 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.734 0.302 . . . . 74.209999999999994 110.899 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 15' ' ' PRO . 47.6 mm -62.52 133.06 94.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.658 0.742 . . . . 72.400000000000006 111.105 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.77 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.742 2.295 . . . . 71.329999999999998 112.293 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -51.74 156.75 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.310000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -73.94 144.41 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 43.299999999999997 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HG13 ' A' ' 104' ' ' VAL . 2.5 pp -138.7 176.88 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 64.439999999999998 111.143 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -121.43 141.65 50.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.877 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 pt -114.39 164.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.05 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -120.77 130.36 53.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 110.877 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.35 102.95 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 71.329999999999998 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.33 30.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 75.340000000000003 110.934 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 p -113.8 -176.45 2.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 65.510000000000005 111.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -8.6 57.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 110.924 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -110.6 -38.32 5.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 61.119999999999997 110.885 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 178.67 176.49 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 54.409999999999997 110.902 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.05 148.14 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.158 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 30' ' ' PRO . 84.0 t -129.44 132.52 24.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.117 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 29' ' ' VAL . 54.7 Cg_endo -69.68 129.37 17.56 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 73.0 112.382 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.67 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -138.01 107.51 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 53.340000000000003 111.105 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.94 149.06 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 53.43 110.91 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -130.68 121.67 25.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.069 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.3 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.200000000000003 111.145 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 p -51.21 111.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 52.539999999999999 110.852 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.84 14.16 35.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.703 . . . . 33.130000000000003 112.429 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.1 p -95.01 -178.92 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.009 0.433 . . . . 73.200000000000003 110.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -145.9 159.86 42.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 73.140000000000001 111.124 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.909 HG23 HD12 ' A' ' 40' ' ' LEU . 15.7 m -58.73 -45.3 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 111.069 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 39' ' ' VAL . 6.5 mp -66.75 -36.07 81.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 65.400000000000006 110.937 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.66 -27.44 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.450000000000003 110.892 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -77.08 -49.9 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.092 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 111.082 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -69.74 -34.19 73.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 110.854 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -87.12 -37.41 17.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.973 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' HB3' HG23 ' A' ' 48' ' ' VAL . 2.2 m-80 -72.26 -24.92 61.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.912 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.9 -12.13 70.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.542 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 46' ' ' ASN . 46.9 t -51.54 130.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 41.020000000000003 111.206 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.59 81.29 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.854 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.887 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.854 0.359 . . . . 25.530000000000001 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -161.95 112.09 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.864 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 114' ' ' THR . 9.7 p -128.92 157.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 72.25 111.133 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 3.1 mt -89.79 132.37 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 111.099 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 112' ' ' VAL . 25.0 tp -127.28 159.87 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.946 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.79 142.06 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.864 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -57.5 -59.83 11.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 73.040000000000006 110.867 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.61 2.206 . . . . 54.219999999999999 112.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 0.6 OUTLIER -51.47 -43.33 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 73.209999999999994 110.892 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 95' ' ' THR . 56.1 t80 -71.44 -51.63 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.945 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -35.39 61.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.873 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -78.1 -40.84 37.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -63.28 -26.33 68.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.877 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.7 167.57 11.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.23 157.82 77.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 65.310000000000002 110.91 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -178.1 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.702 2.268 . . . . 62.009999999999998 112.334 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -98.32 -173.3 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.879 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -58.5 -43.8 89.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.858 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -53.93 -59.65 4.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 63.240000000000002 110.899 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -28.16 69.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.530000000000001 110.958 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -52.36 64.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -41.83 70.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 71.120000000000005 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -50.01 69.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.954 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.574 HD13 ' HA2' ' A' ' 94' ' ' GLY . 64.2 mt -73.29 -42.58 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.51 -23.11 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.13 -24.17 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -83.56 142.17 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 111.049 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 130.99 43.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.904 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 40.36 59.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 73.129999999999995 112.56 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.64 123.61 49.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.127 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.32 144.2 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 75.109999999999999 111.1 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.574 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.91 -26.11 47.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 75.129999999999995 112.445 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.654 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.3 p -74.07 -1.23 19.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 64.239999999999995 111.155 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 5.9 t -90.76 -12.71 35.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.869 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -112.59 143.57 43.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 70.200000000000003 110.879 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 130.63 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.948 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.59 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 71.010000000000005 112.515 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.6 m -101.44 27.69 6.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 61.43 110.911 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.21 59.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.889 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -98.4 112.56 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.25 110.889 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -119.21 136.36 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.95 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' A' ' 33' ' ' ALA . 39.3 t -80.06 115.43 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.137 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 178.54 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 72.040000000000006 110.819 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -54.88 -40.28 69.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.510000000000005 110.889 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 t -64.44 -25.09 67.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.914 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 75' ' ' LEU . 12.8 m-85 -79.85 -2.21 42.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 18' ' ' ILE . 18.8 tt0 -58.15 124.94 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.935 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.3 m120 58.72 23.81 11.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 53.450000000000003 110.902 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -65.63 151.24 46.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 33.329999999999998 111.147 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.701 ' O ' HD12 ' A' ' 67' ' ' LEU . 23.6 t -107.07 113.02 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.010000000000005 111.184 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -108.95 95.06 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.804 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' VAL . 51.6 m -87.82 130.91 34.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 111.169 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.441 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.3 t -95.53 133.4 25.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.631 0.729 . . . . 72.129999999999995 111.165 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.73 -41.89 3.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.76 2.306 . . . . 65.439999999999998 112.321 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.843 -179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.735 0.302 . . . . 74.209999999999994 110.859 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.429 HG23 ' HD2' ' A' ' 15' ' ' PRO . 5.2 mp -109.61 132.96 21.04 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.758 . . . . 72.400000000000006 111.071 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.71 -168.09 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 71.329999999999998 112.412 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -50.25 157.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.86 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.44 147.0 44.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.493 . . . . 43.299999999999997 110.95 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 177.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 111.205 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -122.75 136.79 54.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.946 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.734 HG13 ' HB3' ' A' ' 31' ' ' ALA . 46.8 pt -117.44 172.02 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 111.13 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -118.74 128.74 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.894 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 4.1 m-85 -105.31 104.18 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 71.329999999999998 110.922 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -93.64 122.25 35.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -113.36 -177.83 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 65.510000000000005 111.074 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -75.95 -9.36 58.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -106.09 -37.74 6.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 61.119999999999997 110.944 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.13 176.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.911 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.36 134.58 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.102 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -129.41 150.66 76.21 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.63 0.729 . . . . 73.409999999999997 111.101 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 155.06 66.96 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 73.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.734 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.92 136.18 25.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 53.340000000000003 111.141 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -96.78 134.56 39.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 53.43 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -115.35 125.66 53.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.123 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 35' ' ' CYS . 8.1 t -95.23 156.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 75.200000000000003 111.114 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' HG12 ' A' ' 34' ' ' VAL . 58.5 m -55.55 99.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 52.539999999999999 110.802 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.95 24.6 11.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 33.130000000000003 112.476 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 104' ' ' VAL . 2.4 m -94.83 174.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 73.200000000000003 110.844 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -131.73 146.71 52.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 111.133 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.52 -62.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 111.158 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.45 -32.98 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 65.400000000000006 110.876 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.25 -27.02 62.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.863 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 38' ' ' THR . 60.8 t -77.55 -43.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.108 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 48' ' ' VAL . . . -52.82 -27.8 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 62.219999999999999 111.131 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -73.36 -34.66 65.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 75.200000000000003 110.822 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -83.28 -40.73 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.898 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -72.02 -26.95 62.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.812 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.69 83.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 71.540000000000006 112.438 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.577 HG12 ' HB1' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -53.66 156.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 41.020000000000003 111.135 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.6 t70 -72.1 80.02 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.859 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 70.430000000000007 110.829 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.865 0.364 . . . . 25.530000000000001 110.893 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -94.55 112.21 23.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 65.439999999999998 110.87 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 114' ' ' THR . 6.4 t -128.66 157.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.074 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 63.9 mt -90.08 132.79 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 64.430000000000007 111.134 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 112' ' ' VAL . 36.0 tp -125.63 159.63 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 64.040000000000006 110.902 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.78 142.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.019999999999996 110.815 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -60.11 -58.67 17.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.731 . . . . 73.040000000000006 110.965 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.85 -47.58 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.741 2.294 . . . . 54.219999999999999 112.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.8 tp -53.24 -51.16 63.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 110.957 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.3 t80 -63.46 -53.74 47.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -31.63 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 65.439999999999998 110.809 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.13 -53.78 13.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.3 -23.59 67.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.835 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.14 148.04 4.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.478 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.45 78.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.636 0.731 . . . . 65.310000000000002 110.842 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 165.45 30.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.648 2.232 . . . . 62.009999999999998 112.343 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -93.68 -170.92 2.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 110.842 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -56.96 -45.23 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.837 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -53.76 -59.79 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 63.240000000000002 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.57 -29.98 70.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.530000000000001 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -54.0 50.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.02 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.905 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.82 -51.95 61.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.936 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 94' ' ' GLY . 11.5 mt -74.92 -34.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 111.089 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.76 -20.02 45.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.030000000000001 110.799 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -75.52 -16.31 60.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.918 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.67 144.31 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 71.129999999999995 111.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -64.96 122.28 16.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.934 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.5 45.1 53.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 73.129999999999995 112.539 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.616 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.06 143.93 36.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.902 0.382 . . . . 70.219999999999999 111.092 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 150.56 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.149 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.76 -27.18 49.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.742 . . . . 75.129999999999995 112.479 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.581 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.9 p -73.92 -1.28 19.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.384 . . . . 64.239999999999995 111.154 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.3 t -89.34 -13.61 37.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 110.879 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.22 165.65 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.200000000000003 110.848 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.65 65.88 0.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.03 19.88 10.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.753 . . . . 71.010000000000005 112.438 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.66 165.18 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 61.43 110.897 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 56.67 42.11 27.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 64.439999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' THR . 2.5 tp -98.25 156.56 16.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.45 . . . . 65.25 110.879 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -118.55 163.47 16.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 110.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.542 HG11 ' HB1' ' A' ' 33' ' ' ALA . 88.0 t -102.03 122.71 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 111.107 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.28 173.61 11.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.927 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -59.26 -36.02 74.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 110.919 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -65.81 -19.53 65.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 64.510000000000005 110.909 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.02 -0.19 43.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.831 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -59.01 124.28 19.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 62.219999999999999 110.904 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.38 22.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 53.450000000000003 110.881 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -64.91 141.99 58.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 33.329999999999998 111.127 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.6 t -103.05 116.77 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 73.010000000000005 111.116 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 39' ' ' VAL . 79.8 m-85 -112.26 100.31 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.905 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 65' ' ' VAL . 39.5 m -88.22 124.83 34.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 111.174 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 50' ' ' LEU . 20.4 t -116.89 92.27 38.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.097 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 53.5 Cg_endo -69.77 -35.59 12.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.728 2.285 . . . . 65.439999999999998 112.336 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 115' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.843 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.767 0.318 . . . . 74.209999999999994 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.591 HD13 ' HA2' ' A' ' 36' ' ' GLY . 2.7 mp -112.76 133.06 22.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 72.400000000000006 111.062 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.78 -170.63 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 71.329999999999998 112.364 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.54 156.64 1.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.893 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.98 158.99 33.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 43.299999999999997 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.2 176.43 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 111.091 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 127.59 53.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.798 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.27 163.0 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 111.112 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -119.53 127.53 53.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' A' ' 48' ' ' VAL . 3.2 m-85 -99.26 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.882 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.751 ' HG2' HG22 ' A' ' 28' ' ' VAL . 12.3 tmtt? -86.1 115.17 23.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.340000000000003 110.926 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -103.91 -179.29 3.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 65.510000000000005 111.167 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.01 -17.14 59.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.099999999999994 110.946 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -93.98 -39.11 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 61.119999999999997 110.889 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 176.31 176.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.751 HG22 ' HG2' ' A' ' 23' ' ' LYS . 20.7 t -86.77 142.69 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 111.085 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.75 129.78 18.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.71 60.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.246 . . . . 73.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.84 113.31 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.340000000000003 111.118 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -79.44 122.97 27.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.848 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -100.27 116.42 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.029 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 m -87.8 144.38 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 75.200000000000003 111.109 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 p -54.78 121.35 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.539999999999999 110.889 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 106.0 -7.74 41.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 33.130000000000003 112.494 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -99.42 -178.06 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.993 0.425 . . . . 73.200000000000003 110.85 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -133.93 154.77 50.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 111.135 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.954 HG23 HD12 ' A' ' 40' ' ' LEU . 14.9 m -57.91 -45.55 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.420000000000002 111.118 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -64.33 -37.35 87.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.931 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.73 -27.3 61.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 72.450000000000003 110.886 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 73.0 t -76.42 -43.59 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 61.210000000000001 111.077 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 50' ' ' LEU . . . -51.36 -29.96 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 62.219999999999999 111.108 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -73.42 -36.84 66.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 110.848 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -40.84 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.530000000000001 110.909 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -72.1 -25.45 61.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.903 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.88 76.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.449 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 46' ' ' ASN . 48.2 t -51.5 137.99 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 41.020000000000003 111.052 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.13 80.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 50' ' ' LEU . 8.9 tt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.884 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 p . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.928 0.394 . . . . 25.530000000000001 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -60.81 117.27 5.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 65.439999999999998 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.8 t -128.2 155.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.105 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 70.3 mt -91.07 133.77 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 64.430000000000007 111.096 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 112' ' ' VAL . 20.3 tp -125.67 162.54 24.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.933 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -41.0 139.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.517 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -60.1 -59.38 14.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.638 0.732 . . . . 73.040000000000006 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.75 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.723 2.282 . . . . 54.219999999999999 112.318 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.76 -48.83 63.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.941 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD1' HG22 ' A' ' 95' ' ' THR . 30.3 t80 -66.99 -51.08 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.929 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -51.52 -51.66 53.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 65.439999999999998 110.881 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -61.62 -48.55 80.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 71' ' ' LEU . 3.3 mm? -62.94 -18.68 63.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.209999999999994 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.03 130.35 2.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 71.329999999999998 112.507 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 157.75 60.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 65.310000000000002 110.866 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.94 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.392 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.9 m -104.79 -174.89 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.852 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.9 -49.16 78.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.896 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -47.69 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 63.240000000000002 110.914 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.83 -28.38 64.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 71.530000000000001 110.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -53.3 55.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.851 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -43.28 68.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.22 -49.07 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.219999999999999 110.88 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.595 HD13 ' HA2' ' A' ' 94' ' ' GLY . 57.8 mt -75.06 -34.4 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 111.089 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.42 -15.64 58.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.85 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.33 -22.86 57.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.858 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.63 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.1 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 71.129999999999995 111.133 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -56.97 126.6 27.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.13 41.33 53.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.484 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.63 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -110.48 139.03 46.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 70.219999999999999 111.068 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 155.0 44.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.135 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.87 -27.08 49.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 75.129999999999995 112.427 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.558 HG22 ' CD1' ' A' ' 72' ' ' TYR . 14.9 p -73.79 -1.92 21.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.293 . . . . 64.239999999999995 111.158 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 39.1 t -87.88 -14.9 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.884 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.8 168.27 9.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 70.200000000000003 110.857 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 62.06 97.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.947 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.95 32.01 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 71.010000000000005 112.504 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.24 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.329 . . . . 61.43 110.871 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -88.26 51.7 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 64.439999999999998 110.911 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.513 HD11 ' CZ ' ' A' ' 108' ' ' PHE . 7.1 tt -91.37 114.51 27.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.93 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -85.33 134.93 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 110.934 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' A' ' 33' ' ' ALA . 83.8 t -59.76 122.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 72.239999999999995 111.091 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -137.07 160.2 39.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 72.040000000000006 110.884 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -53.95 -27.24 29.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.489 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -62.66 -29.29 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.866 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.513 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 22.0 m-85 -89.99 12.07 18.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 71.209999999999994 110.898 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.22 120.74 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.873 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.71 21.26 12.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 53.450000000000003 110.887 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.2 153.39 36.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 33.329999999999998 111.104 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.584 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.1 t -105.51 127.16 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.091 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 39' ' ' VAL . 12.1 m-85 -113.16 98.48 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.887 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.0 m -85.21 124.86 32.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.145 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.32 92.48 8.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.687 0.756 . . . . 72.129999999999995 111.124 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -34.2 14.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.663 2.242 . . . . 65.439999999999998 112.273 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 110.842 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.888 0.375 . . . . 74.209999999999994 110.858 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA2' ' A' ' 36' ' ' GLY . 4.1 mt -51.65 133.2 36.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.635 0.731 . . . . 72.400000000000006 111.136 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.77 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.346 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.02 157.45 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.902 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -73.41 143.58 46.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 43.299999999999997 110.864 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.7 pp -127.92 176.88 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 64.439999999999998 111.062 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -114.2 136.83 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.872 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 31' ' ' ALA . 14.6 pt -120.23 169.4 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 111.111 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.17 137.91 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.4 m-85 -108.81 103.12 12.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.852 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -90.19 130.0 36.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.887 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.1 p -119.08 -177.51 3.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 65.510000000000005 111.156 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 ptm -75.9 -8.13 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.871 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -38.51 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 110.913 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -178.56 176.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 54.409999999999997 110.947 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.94 135.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 111.163 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.09 150.9 60.7 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 73.409999999999997 111.099 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.67 60.98 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 73.0 112.377 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -147.8 108.46 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 53.340000000000003 111.111 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -74.83 128.0 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 53.43 110.986 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.061 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -106.31 119.97 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.4 154.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 75.200000000000003 111.161 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.8 t -56.21 109.8 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.577 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 100.47 -17.35 56.85 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 33.130000000000003 112.489 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -66.25 142.11 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 73.200000000000003 110.818 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 42' ' ' VAL . 72.8 p -96.82 158.38 15.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.07 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.86 -58.27 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.420000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.18 -33.63 58.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 65.400000000000006 110.856 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -73.06 -27.59 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 72.450000000000003 110.796 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 38' ' ' THR . 25.7 t -76.13 -45.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.082 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.2 25.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.042 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -71.74 -38.93 70.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 75.200000000000003 110.916 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -66.46 -50.69 62.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.17 -32.86 67.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.862 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.7 44.01 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.791 . . . . 71.540000000000006 112.51 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.0 t -51.82 142.44 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 41.020000000000003 111.222 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.43 81.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.851 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.430000000000007 110.924 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.36 . . . . 25.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -145.56 125.14 13.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 65.439999999999998 110.853 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.754 HG12 HD22 ' A' ' 98' ' ' LEU . 14.0 p -127.94 149.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.25 111.166 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 17.3 mt -91.2 133.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.106 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 112' ' ' VAL . 13.9 tp -120.11 158.97 25.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 64.040000000000006 110.878 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.09 137.46 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.816 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.575 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.8 mt-10 -59.72 -55.81 42.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.67 0.748 . . . . 73.040000000000006 110.921 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.9 Cg_endo -69.81 -32.71 17.83 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.63 2.22 . . . . 54.219999999999999 112.326 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 tp -63.01 -46.64 86.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 73.209999999999994 110.882 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.32 -48.62 40.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.942 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -36.65 68.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 110.905 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -76.37 -45.19 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 107' ' ' SER . 1.9 mm? -63.04 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.965 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.05 158.29 21.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 71.329999999999998 112.522 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -130.75 157.63 77.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.649 0.738 . . . . 65.310000000000002 110.904 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.62 2.4 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.249 . . . . 62.009999999999998 112.352 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -95.93 -176.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.94 -44.39 82.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.803 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -53.49 -60.12 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 63.240000000000002 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.02 -28.43 69.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 110.902 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -55.68 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.944 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.61 -43.59 84.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 71.120000000000005 110.857 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.66 -46.9 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.895 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.651 HD13 ' HA2' ' A' ' 94' ' ' GLY . 70.1 mt -74.84 -34.63 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.409999999999997 111.103 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.53 -15.41 60.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.885 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.89 -6.05 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.981 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.65 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -105.59 135.6 46.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.129 -0.487 . . . . 71.129999999999995 111.059 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -55.14 124.89 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 75.519999999999996 110.891 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.41 42.49 50.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.47 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.65 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -101.06 147.44 26.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 70.219999999999999 111.166 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.7 153.56 43.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 111.155 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.2 -38.37 67.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.468 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -73.98 -0.85 17.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 64.239999999999995 111.153 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 8.7 t -88.24 -16.52 32.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.409999999999997 110.873 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -118.31 148.62 42.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 70.200000000000003 110.845 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.754 HD22 HG12 ' A' ' 65' ' ' VAL . 1.1 pt? -121.4 -175.09 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 73.450000000000003 110.888 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.0 7.57 5.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 71.010000000000005 112.542 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 98' ' ' LEU . 17.2 m 61.5 167.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 61.43 110.931 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 54.59 43.55 30.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 110.888 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.34 92.33 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.25 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' NH1' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -59.49 168.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.845 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 1.061 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.4 t -90.77 143.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.123 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.44 171.24 14.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 72.040000000000006 110.808 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -38.42 77.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.85 -17.71 63.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 64.510000000000005 110.898 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.5 9.68 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.209999999999994 110.842 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.541 ' HA ' HD13 ' A' ' 18' ' ' ILE . 59.2 tt0 -59.33 124.88 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 62.219999999999999 110.906 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 60.81 21.25 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 53.450000000000003 110.895 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.511 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -62.9 129.74 41.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 33.329999999999998 111.157 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 67' ' ' LEU . 12.9 t -93.1 118.73 39.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.010000000000005 111.187 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -106.29 99.87 9.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.929 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.6 m -87.06 131.2 34.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.169 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.4 132.64 21.71 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.125 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -41.35 4.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.371 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.84 -179.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.843 0.354 . . . . 74.209999999999994 110.88 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 15' ' ' PRO . 49.1 mm -54.26 132.95 61.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.647 0.737 . . . . 72.400000000000006 111.179 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.711 2.274 . . . . 71.329999999999998 112.435 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -52.28 157.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.310000000000002 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -73.82 148.78 42.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 43.299999999999997 110.887 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.9 pp -130.38 177.11 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 64.439999999999998 111.07 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -123.35 144.62 49.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.797 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 113' ' ' PHE . 1.9 pt -125.75 170.59 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 111.087 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HB2' HG22 ' A' ' 112' ' ' VAL . 10.1 m-85 -114.5 125.32 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.887 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -92.48 103.37 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.329999999999998 110.877 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.78 127.28 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 p -114.36 -167.45 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.510000000000005 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.7 mmm -54.34 -54.85 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -141.03 27.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.963 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.3 128.45 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.409999999999997 110.915 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 23' ' ' LYS . 94.7 t -119.34 109.86 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 72.010000000000005 111.138 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG21 HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -123.11 150.27 59.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 111.175 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 159.55 53.02 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.703 2.269 . . . . 73.0 112.389 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.79 136.51 25.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 111.119 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.21 133.5 43.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 53.43 110.924 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB1' ' CG2' ' A' ' 104' ' ' VAL . . . -110.37 117.48 33.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.155 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.49 149.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 75.200000000000003 111.168 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.04 117.99 3.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 52.539999999999999 110.805 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.91 19.7 64.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 33.130000000000003 112.457 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -94.57 -169.42 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.931 0.396 . . . . 73.200000000000003 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -148.02 142.92 26.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.083 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.38 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 70.420000000000002 111.147 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HG ' HD13 ' A' ' 102' ' ' LEU . 6.2 mt -53.5 -36.27 61.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.400000000000006 110.859 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -72.67 -26.81 61.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 72.450000000000003 110.87 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 38' ' ' THR . 98.4 t -76.44 -39.9 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 61.210000000000001 111.086 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.35 -32.18 24.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.15 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -73.66 -35.94 65.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.863 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -40.31 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.530000000000001 110.942 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -72.08 -24.95 61.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 74.420000000000002 110.937 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.8 -11.67 38.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.737 . . . . 71.540000000000006 112.514 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 29' ' ' VAL . 99.9 t -61.59 110.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.347 . . . . 41.020000000000003 111.169 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.79 80.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.88 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 70.430000000000007 110.896 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.859 0.361 . . . . 25.530000000000001 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -177.0 114.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 65.439999999999998 110.835 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 155.91 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.146 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -90.45 137.46 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.430000000000007 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 113' ' ' PHE . 9.0 tp -128.51 161.54 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 64.040000000000006 110.917 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.26 141.7 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 110.924 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 mt-10 -58.47 -59.51 13.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.609 0.718 . . . . 73.040000000000006 110.894 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -48.73 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.269 . . . . 54.219999999999999 112.279 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -51.73 -46.77 64.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.944 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.699 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.5 t80 -68.41 -50.43 52.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.866 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.82 -43.98 66.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 65.439999999999998 110.875 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -77.83 -28.01 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 tp -70.88 -61.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.41 132.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.329999999999998 112.482 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -91.91 160.31 36.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.701 0.762 . . . . 65.310000000000002 110.859 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.93 62.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.719 2.28 . . . . 62.009999999999998 112.333 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -86.45 -169.85 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.898 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -56.96 -48.57 78.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.833 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -53.52 -59.44 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.924 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.46 -27.61 68.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.887 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -55.74 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.99 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.7 -37.88 82.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 110.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.97 -47.24 86.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 64.219999999999999 110.909 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.732 HD13 ' HA2' ' A' ' 94' ' ' GLY . 43.6 mt -73.0 -35.17 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 111.159 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -20.89 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 74.030000000000001 110.857 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -76.25 -24.37 54.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.926 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -81.36 148.79 29.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -76.65 120.39 21.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 75.519999999999996 110.872 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.5 44.15 59.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.695 -0.765 . . . . 73.129999999999995 112.443 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -99.37 130.56 45.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 111.064 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 146.22 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.136 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.732 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.8 -24.97 43.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.686 -0.769 . . . . 75.129999999999995 112.539 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.699 HG22 ' CD1' ' A' ' 72' ' ' TYR . 18.9 p -74.01 -2.26 23.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 64.239999999999995 111.189 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.4 t -91.35 -13.42 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 71.409999999999997 110.903 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.583 ' CB ' HD11 ' A' ' 86' ' ' ILE . 7.0 tpt85 -108.53 161.79 14.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.863 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt 64.9 110.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.69 25.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.010000000000005 112.462 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 59.4 m -78.25 -171.28 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 61.43 110.894 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 63.09 61.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.546 HD13 ' HG ' ' A' ' 40' ' ' LEU . 72.6 mt -65.87 89.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.91 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -152.02 149.7 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 70.209999999999994 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.588 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 94.2 t -83.5 133.57 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 111.139 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -136.55 155.92 49.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 72.040000000000006 110.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -57.07 -37.49 71.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 72.510000000000005 110.904 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.1 m -65.08 -18.54 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 64.510000000000005 110.778 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.413 ' C ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.59 1.21 50.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.88 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -58.0 124.41 19.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 62.219999999999999 110.844 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 59.34 24.66 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 53.450000000000003 110.907 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 165.43 24.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 33.329999999999998 111.121 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 21' ' ' PHE . 13.3 t -138.25 124.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.010000000000005 111.105 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 20' ' ' ILE . 12.8 p90 -125.06 129.23 49.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.879 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.5 m -100.97 131.83 46.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 111.16 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 50' ' ' LEU . 29.1 t -91.95 132.7 32.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.63 0.729 . . . . 72.129999999999995 111.107 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -39.89 5.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 65.439999999999998 112.382 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.83 -179.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.767 0.318 . . . . 74.209999999999994 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -71.45 132.72 85.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 72.400000000000006 111.097 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.734 2.29 . . . . 71.329999999999998 112.307 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -50.96 157.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 73.310000000000002 110.875 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.55 ' CD ' HG23 ' A' ' 34' ' ' VAL . 37.9 mt-30 -73.6 155.35 39.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.892 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.89 176.88 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.178 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -130.48 137.19 49.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.869 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.647 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.3 pt -114.57 173.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 111.118 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.471 ' HD2' HG12 ' A' ' 28' ' ' VAL . 2.0 m-85 -122.55 130.36 52.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.926 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.2 m-85 -97.86 109.0 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.837 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' CD ' HG22 ' A' ' 28' ' ' VAL . 36.7 tptt -92.5 107.28 19.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 75.340000000000003 110.894 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -103.63 176.93 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 65.510000000000005 111.182 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.2 ttt -75.76 -8.08 55.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 73.099999999999994 110.831 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -38.28 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 61.119999999999997 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.44 176.4 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 54.409999999999997 110.977 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 ' CD ' ' A' ' 23' ' ' LYS . 20.0 t -105.15 121.92 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 72.010000000000005 111.129 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.03 150.39 45.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 73.409999999999997 111.162 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 153.97 67.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 73.0 112.299 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -150.2 103.74 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -75.58 137.44 40.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 53.43 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -126.33 116.47 21.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.064 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.55 HG23 ' CD ' ' A' ' 17' ' ' GLN . 14.4 p -94.42 149.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 75.200000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 p -49.13 112.78 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 52.539999999999999 110.927 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.83 7.56 33.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 33.130000000000003 112.465 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 m -96.08 -178.38 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.397 . . . . 73.200000000000003 110.883 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -139.16 147.82 42.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.198 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 113' ' ' PHE . 44.6 t -52.23 -62.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 70.420000000000002 111.102 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.77 HD11 HD12 ' A' ' 50' ' ' LEU . 4.4 mm? -54.04 -33.65 57.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 65.400000000000006 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.67 -27.16 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.829 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 95.3 t -76.94 -43.3 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 111.118 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -54.73 -28.28 47.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.106 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -73.75 -27.91 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.87 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -52.19 12.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.868 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.21 -25.22 61.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 110.916 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -6.96 43.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.688 -0.768 . . . . 71.540000000000006 112.52 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.642 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.1 t -51.4 144.47 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 41.020000000000003 111.09 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.17 83.93 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.891 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.77 HD12 HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 110.844 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.5 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.878 0.37 . . . . 25.530000000000001 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -124.49 113.55 18.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 115' ' ' VAL . 8.4 t -128.62 157.01 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 72.25 111.087 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mt -90.17 130.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 111.157 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.0 tp -125.07 164.7 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 64.040000000000006 110.901 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -39.12 137.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.891 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -60.89 -58.7 17.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.684 0.754 . . . . 73.040000000000006 110.922 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.72 -49.6 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.75 2.3 . . . . 54.219999999999999 112.284 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.752 HD11 ' O ' ' A' ' 107' ' ' SER . 5.4 tp -51.96 -51.9 53.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 73.209999999999994 111.002 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.7 t80 -63.58 -41.97 98.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.925 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -52.03 -62.0 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 65.439999999999998 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -63.9 -26.82 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -62.15 -57.25 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.918 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.13 142.12 3.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.826 -0.702 . . . . 71.329999999999998 112.508 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -107.33 160.34 26.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.678 0.751 . . . . 65.310000000000002 110.862 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 172.16 13.06 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.249 . . . . 62.009999999999998 112.364 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -58.0 167.81 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.899 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -56.81 -39.74 74.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.819 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.487 ' O ' HD13 ' A' ' 85' ' ' LEU . 38.1 mttm -52.33 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 63.240000000000002 110.869 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.04 -35.2 79.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.59 -53.63 55.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.863 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.56 -41.72 92.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.859 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 81' ' ' LYS . 4.4 mp -56.45 -37.35 70.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.908 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.522 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.1 mt -74.61 -51.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.087 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.24 -23.13 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.834 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 -32.49 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.899 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -61.78 163.89 6.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 71.129999999999995 111.066 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.65 114.81 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 75.519999999999996 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.55 41.56 56.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.129999999999995 112.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -106.69 117.36 33.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 70.219999999999999 111.085 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 142.4 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 111.068 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -24.95 41.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 75.129999999999995 112.488 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.0 p -73.91 -2.03 22.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 111.209 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 t -89.12 -12.45 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.867 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 9.8 ttm-85 -94.06 154.51 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 70.200000000000003 110.785 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 tp -147.48 167.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 73.450000000000003 110.856 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.02 19.14 9.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.674 -0.774 . . . . 71.010000000000005 112.467 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.9 t 60.38 25.73 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 61.43 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.41 136.47 22.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.439999999999998 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -177.13 129.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 65.25 110.877 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.66 170.31 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 33' ' ' ALA . 39.2 t -100.62 120.44 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.103 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.71 173.61 11.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.469 . . . . 72.040000000000006 110.874 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -59.66 -33.87 72.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 110.922 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 71' ' ' LEU . 47.3 m -64.91 -19.32 65.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 64.510000000000005 110.855 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.74 5.69 38.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.907 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -59.58 124.31 19.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 62.219999999999999 110.862 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.53 20.29 12.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.848 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.59 149.23 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 33.329999999999998 111.074 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.8 t -113.51 119.86 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 73.010000000000005 111.165 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 39' ' ' VAL . 21.5 m-85 -110.61 94.81 5.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.815 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -88.26 126.37 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 111.116 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.561 HG22 HD22 ' A' ' 50' ' ' LEU . 57.9 t -96.45 133.25 25.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.136 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.75 -41.64 4.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.686 2.257 . . . . 65.439999999999998 112.36 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.865 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtp85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.82 0.343 . . . . 74.209999999999994 110.9 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.9 mp -51.87 133.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.686 0.755 . . . . 72.400000000000006 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.79 -170.05 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 71.329999999999998 112.256 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.5 157.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.89 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.29 151.52 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 43.299999999999997 110.889 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 pp -130.35 176.81 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 111.099 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -120.33 133.91 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' ' 31' ' ' ALA . 2.0 pt -114.34 172.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.087 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.46 128.39 45.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.219999999999999 110.9 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.71 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.5 m-85 -97.12 103.17 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.834 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.53 136.15 38.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 75.340000000000003 110.92 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -130.43 177.25 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 65.510000000000005 111.158 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 tpt -73.56 -8.76 57.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.898 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -104.98 -37.57 6.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 61.119999999999997 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -179.63 176.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.87 131.43 70.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.188 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.35 151.03 58.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 73.409999999999997 111.154 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.22 68.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.611 2.207 . . . . 73.0 112.304 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.0 139.49 29.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.03 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -100.68 128.9 46.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 53.43 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -106.67 116.37 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.137 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -97.33 139.16 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.200000000000003 111.149 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 p -51.7 111.1 0.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 52.539999999999999 110.881 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.43 13.81 34.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 33.130000000000003 112.493 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.443 ' OG ' HG21 ' A' ' 104' ' ' VAL . 86.6 p -101.63 -169.78 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 73.200000000000003 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.744 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -147.04 143.46 28.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 73.140000000000001 111.128 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.45 -59.41 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 111.127 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.38 -35.53 60.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.400000000000006 110.922 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.76 -27.5 62.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 110.912 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 38' ' ' THR . 91.6 t -76.56 -35.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 61.210000000000001 111.095 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.88 29.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 62.219999999999999 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -67.11 -32.61 73.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 75.200000000000003 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.05 -34.8 14.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.530000000000001 110.895 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.471 ' HB3' HG23 ' A' ' 48' ' ' VAL . 3.3 m120 -75.04 -24.4 58.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.951 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 -11.68 66.41 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 71.540000000000006 112.529 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 22' ' ' PHE . 93.9 t -51.31 138.72 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 41.020000000000003 111.202 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.48 80.81 1.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.851 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 115' ' ' VAL . 28.3 tp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 70.430000000000007 110.913 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.5 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.778 0.323 . . . . 25.530000000000001 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -71.21 111.79 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.439999999999998 110.862 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.6 t -128.62 157.28 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 72.25 111.187 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 88.5 mt -90.37 130.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.8 tp -124.65 159.37 30.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 64.040000000000006 110.908 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.56 146.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.883 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 mt-10 -59.27 -59.94 12.21 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.896 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.5 Cg_endo -69.79 -46.78 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.346 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -53.38 -49.15 67.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.209999999999994 110.927 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.634 ' CD1' HG22 ' A' ' 95' ' ' THR . 57.4 t80 -64.34 -51.01 65.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 74.450000000000003 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -25.53 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 110.809 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.31 -50.54 12.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.2 mt -62.91 -21.83 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 75.209999999999994 110.932 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.58 158.96 9.49 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 71.329999999999998 112.497 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.31 157.53 77.29 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.642 0.734 . . . . 65.310000000000002 110.877 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.03 32.34 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.725 2.284 . . . . 62.009999999999998 112.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 p -58.09 158.52 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -52.43 -36.06 53.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.409999999999997 110.926 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -52.33 -62.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 63.240000000000002 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.67 -35.79 79.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 110.922 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -56.14 -53.33 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.871 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.9 -42.97 89.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 110.878 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -55.2 -37.51 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.898 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.663 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.4 mt -74.53 -51.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 63.409999999999997 111.124 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.18 -18.59 58.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 110.869 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -76.14 -23.17 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.927 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.22 164.34 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.043 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -71.75 119.59 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.519999999999996 110.86 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.0 43.89 55.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.635 -0.793 . . . . 73.129999999999995 112.516 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -118.58 116.04 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 70.219999999999999 111.123 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.87 144.77 39.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 111.233 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.663 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.27 -23.88 35.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 75.129999999999995 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.634 HG22 ' CD1' ' A' ' 72' ' ' TYR . 37.9 p -73.96 -1.56 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 64.239999999999995 111.151 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.7 t -89.36 -12.83 39.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.91 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.658 ' HD2' HD11 ' A' ' 86' ' ' ILE . 7.1 ptm180 -112.07 144.21 41.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 70.200000000000003 110.864 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.47 164.05 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 110.989 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.06 -167.13 39.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.463 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.2 m -104.16 64.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 61.43 110.857 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.564 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.5 mt-30 -162.84 124.33 2.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 64.439999999999998 110.908 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 101' ' ' GLN . 4.8 mp -156.13 150.9 26.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 65.25 110.924 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -146.0 129.94 17.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 110.9 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.783 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.6 t -64.84 117.62 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 72.239999999999995 111.13 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -136.83 178.36 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 72.040000000000006 110.911 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -37.16 76.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.93 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' HD21 ' A' ' 71' ' ' LEU . 6.3 t -65.54 -19.73 66.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 64.510000000000005 110.903 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.505 ' O ' HD13 ' A' ' 18' ' ' ILE . 11.4 m-85 -83.41 2.23 37.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 71.209999999999994 110.848 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.402 ' HA ' HD13 ' A' ' 18' ' ' ILE . 34.5 tt0 -56.94 123.59 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 62.219999999999999 110.836 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 59.29 27.08 16.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 53.450000000000003 110.865 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 20' ' ' ILE . . . -69.95 135.36 49.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 33.329999999999998 111.128 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.565 ' O ' HD12 ' A' ' 67' ' ' LEU . 27.3 t -104.2 122.39 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.010000000000005 111.16 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -112.9 104.27 12.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.857 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.495 HG23 ' HD2' ' A' ' 23' ' ' LYS . 40.6 m -92.83 117.99 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.155 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 50' ' ' LEU . 20.0 t -108.68 88.83 5.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.525 0.679 . . . . 72.129999999999995 111.13 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -36.24 10.96 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.698 2.265 . . . . 65.439999999999998 112.296 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 72.140000000000001 110.839 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.751 0.31 . . . . 74.209999999999994 110.918 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mm 63.5 136.8 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.558 0.694 . . . . 72.400000000000006 111.143 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.78 2.52 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 71.329999999999998 112.362 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -52.07 157.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 110.878 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.75 143.7 45.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 43.299999999999997 110.956 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 109' ' ' GLU . 1.3 pt -128.75 176.8 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 64.439999999999998 111.094 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.81 136.26 52.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.878 HD11 HG11 ' A' ' 42' ' ' VAL . 1.8 pt -116.98 157.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.118 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -119.98 126.5 50.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.926 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 4.5 m-85 -105.0 102.9 12.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.927 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 117.78 26.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.95 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 p -105.33 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 65.510000000000005 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 29.8 mmt -75.72 -7.99 55.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.921 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtm -102.97 -38.39 7.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 61.119999999999997 110.889 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 178.28 176.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 54.409999999999997 110.925 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.3 t -79.1 147.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 111.058 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.93 87.84 9.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.64 0.734 . . . . 73.409999999999997 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 135.0 29.33 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 73.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.22 159.93 40.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.085 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -99.7 127.98 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.943 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -95.3 131.81 40.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.115 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.85 146.51 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.200000000000003 111.107 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.2 p -57.49 119.8 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 52.539999999999999 110.892 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.01 39.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.473 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.32 161.02 13.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.200000000000003 110.859 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.9 p -114.46 159.23 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 111.116 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.27 -58.4 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.54 -35.82 63.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.400000000000006 110.968 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.881 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG11 HD11 ' A' ' 20' ' ' ILE . 97.7 t -76.43 -44.05 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 61.210000000000001 111.167 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -55.13 -29.22 57.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.219999999999999 111.055 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -73.37 -26.6 61.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 75.200000000000003 110.869 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -69.73 -52.15 27.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.86 -25.1 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.863 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.07 -12.22 34.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 71.540000000000006 112.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.64 115.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 41.020000000000003 111.087 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.84 80.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 70.430000000000007 110.924 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.0 m . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.903 0.382 . . . . 25.530000000000001 110.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -152.06 109.75 3.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.805 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 8.1 t -128.62 157.02 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.6 mt -90.12 131.23 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.430000000000007 111.127 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.7 tp -129.45 162.3 28.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.928 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -39.62 139.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.917 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -59.58 -59.05 15.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.696 0.76 . . . . 73.040000000000006 110.904 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.1 Cg_endo -69.78 -49.16 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.735 2.29 . . . . 54.219999999999999 112.319 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -52.09 -48.53 64.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 110.932 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -66.89 -42.71 85.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.93 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -51.88 -58.11 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 65.439999999999998 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -70.03 -28.73 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.9 tp -63.56 -61.23 2.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.944 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.32 143.59 4.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 71.329999999999998 112.482 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -134.67 157.27 77.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.574 0.702 . . . . 65.310000000000002 110.886 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.743 2.295 . . . . 62.009999999999998 112.32 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.4 m -58.17 171.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.59 -38.13 77.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -52.3 -62.43 1.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 63.240000000000002 110.89 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.53 -35.41 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.530000000000001 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.42 -53.04 62.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 110.904 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -66.07 -42.37 89.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 71.120000000000005 110.832 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.13 -36.91 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.959 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 14.8 mt -74.61 -54.85 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 111.113 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.95 -24.53 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 74.030000000000001 110.855 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.15 -25.62 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 110.908 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.458 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -80.59 151.07 29.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 111.084 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -67.37 128.71 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 110.805 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.46 54.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.489 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -119.66 117.16 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 70.219999999999999 111.056 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 143.9 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 111.196 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.62 -24.68 40.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.129999999999995 112.491 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.476 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.2 p -73.94 -1.73 21.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 64.239999999999995 111.188 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 23.2 t -89.79 -12.6 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.854 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 14.9 mtt-85 -106.6 139.87 40.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.892 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 tp -158.87 164.89 35.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 73.450000000000003 110.878 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.94 -131.67 5.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.485 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m -122.62 -54.5 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 61.43 110.915 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -52.11 139.26 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 64.439999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.6 tp -176.64 140.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HD3' HG22 ' A' ' 38' ' ' THR . 7.8 tpp180 -141.94 154.07 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.848 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 37' ' ' SER . 92.3 t -74.7 124.97 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 72.239999999999995 111.131 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.67 168.15 20.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 72.040000000000006 110.88 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -57.22 -39.35 75.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.510000000000005 110.909 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 m -64.02 -20.46 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 110.895 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.75 7.67 29.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 71.209999999999994 110.851 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.433 ' N ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -59.14 125.19 22.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 62.219999999999999 110.839 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 60.0 22.19 11.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 53.450000000000003 110.897 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.38 136.63 57.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 33.329999999999998 111.061 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.718 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.0 t -98.76 117.08 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.134 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -109.39 94.82 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.926 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 34.2 m -89.42 130.92 35.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.172 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.6 t -104.44 133.29 20.27 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 72.129999999999995 111.086 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.423 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.84 -41.25 4.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 65.439999999999998 112.308 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.854 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.722 0.296 . . . . 74.209999999999994 110.913 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -94.53 133.14 27.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.675 0.75 . . . . 72.400000000000006 111.104 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.73 -170.34 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.746 2.297 . . . . 71.329999999999998 112.358 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -51.46 156.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -73.84 156.45 37.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 43.299999999999997 110.9 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.03 176.97 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 111.132 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -118.1 135.83 53.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.836 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.773 HG13 ' HB3' ' A' ' 31' ' ' ALA . 32.0 pt -114.36 171.83 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 111.142 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.19 126.72 52.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.895 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 1.7 m-85 -97.93 103.18 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.856 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 28' ' ' VAL . 15.8 tptm -85.66 106.67 17.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 110.887 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -101.9 178.61 4.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 65.510000000000005 111.168 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 ttm -75.7 -8.05 55.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -106.05 -38.62 6.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.119999999999997 110.933 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 178.34 176.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 54.409999999999997 110.846 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 23' ' ' LYS . 21.3 t -102.45 123.11 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.010000000000005 111.068 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.85 150.54 45.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.169 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 153.22 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 73.0 112.349 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -143.51 135.56 26.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.131 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -97.64 118.68 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 53.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.64 116.52 30.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.105 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.16 148.05 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 75.200000000000003 111.11 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.8 p -51.32 110.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.539999999999999 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.48 14.42 30.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 33.130000000000003 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -97.64 -170.61 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 73.200000000000003 110.878 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -141.91 140.92 32.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 73.140000000000001 111.15 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.1 t -52.41 -59.51 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 111.081 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 50' ' ' LEU . 6.4 mt -53.72 -35.57 61.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 65.400000000000006 110.872 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -72.7 -26.75 61.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 72.450000000000003 110.883 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 38' ' ' THR . 97.4 t -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.71 20.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.072 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -70.23 -36.77 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 75.200000000000003 110.871 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -82.82 -34.9 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.879 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.404 ' ND2' HG23 ' A' ' 48' ' ' VAL . 43.4 t30 -72.35 -28.25 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.935 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.0 -12.25 34.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.743 . . . . 71.540000000000006 112.537 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 22' ' ' PHE . 98.9 t -59.94 141.06 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 41.020000000000003 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -78.79 80.7 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 115' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 70.430000000000007 110.911 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 m . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.821 0.344 . . . . 25.530000000000001 110.849 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -68.81 100.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 65.439999999999998 110.841 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 114' ' ' THR . 4.7 t -128.63 159.04 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 72.25 111.15 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.9 mt -89.86 130.46 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 111.165 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLU . 16.8 tp -119.29 166.4 13.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.040000000000006 110.882 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 71' ' ' LEU . 5.9 mp0 -36.8 135.87 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 71.019999999999996 110.913 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.553 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tt0 -65.26 -56.73 18.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.595 0.712 . . . . 73.040000000000006 110.867 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.69 -51.82 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 54.219999999999999 112.387 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -51.93 -48.35 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.893 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.608 ' CD1' HG22 ' A' ' 95' ' ' THR . 20.2 t80 -64.94 -53.57 44.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 110.918 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.6 -47.96 63.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.816 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.31 -36.62 83.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 75.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -62.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.85 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 160.35 20.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 71.329999999999998 112.429 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 157.55 77.44 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.658 0.742 . . . . 65.310000000000002 110.928 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 166.82 26.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.309 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 t -57.95 171.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.97 -37.48 79.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 72.409999999999997 110.898 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.35 -62.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 110.912 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.59 -35.54 79.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.34 -53.19 60.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.914 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.97 -42.79 89.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 71.120000000000005 110.858 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.48 -37.14 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 64.219999999999999 110.919 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.1 mt -74.74 -52.68 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.152 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -59.3 -21.08 59.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.875 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -75.94 -23.27 55.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.924 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.48 164.18 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.144 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -74.4 118.99 17.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 75.519999999999996 110.847 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.66 43.73 53.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.678 -0.772 . . . . 73.129999999999995 112.52 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -106.98 143.5 34.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.083 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.85 145.72 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 111.125 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.97 -28.59 53.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 75.129999999999995 112.473 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.0 p -73.53 -3.31 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.333 . . . . 64.239999999999995 111.149 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 48.1 t -85.44 -13.77 48.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.857 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.74 143.26 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 70.200000000000003 110.87 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.23 142.38 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.96 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.76 158.14 3.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.788 -0.72 . . . . 71.010000000000005 112.467 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.6 t -55.62 -26.97 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 61.43 110.885 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.58 114.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 64.439999999999998 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mt -141.78 95.34 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.945 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.99 147.47 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.936 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.6 t -96.02 128.31 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 72.239999999999995 111.169 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -136.56 167.77 20.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 72.040000000000006 110.899 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -55.49 -42.01 73.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.904 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -18.97 58.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 64.510000000000005 110.863 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -93.34 17.14 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 71.209999999999994 110.813 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.68 126.97 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 62.219999999999999 110.977 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 m120 58.85 24.23 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 53.450000000000003 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -58.61 126.14 26.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 33.329999999999998 111.144 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 12.4 t -84.98 118.76 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 73.010000000000005 111.117 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 111' ' ' ALA . 74.5 m-85 -113.01 102.74 10.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.430000000000007 110.88 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.9 m -88.55 130.14 35.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 111.205 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 50' ' ' LEU . 60.6 t -101.06 133.24 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 72.129999999999995 111.065 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.4 Cg_endo -69.8 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.649 2.233 . . . . 65.439999999999998 112.328 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.89 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.364 0 CA-C-O 121.472 0.484 . . . . 71.299999999999997 112.552 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 101.86 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.676 2.251 . . . . 64.129999999999995 112.337 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.72 165.14 22.33 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.77 -0.729 . . . . 41.340000000000003 112.513 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.3 p -100.45 -62.45 1.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.911 0.386 . . . . 73.310000000000002 110.85 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 23.6 mmt 54.84 30.54 13.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 73.430000000000007 110.9 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -79.74 -50.27 10.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.420000000000002 110.915 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 38.8 ttp -80.76 152.6 28.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 62.509999999999998 110.9 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -146.11 158.29 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.421 . . . . 71.439999999999998 110.937 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 t -104.12 26.85 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.838 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.3 68.27 9.93 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.578 0.704 . . . . 71.340000000000003 111.085 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.62 -13.11 34.54 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.7 2.266 . . . . 63.229999999999997 112.405 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -62.5 -23.09 66.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 73.209999999999994 110.86 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -67.79 93.06 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 74.209999999999994 110.866 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.463 HD13 ' N ' ' A' ' 36' ' ' GLY . 3.4 mt -90.96 132.95 33.04 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.178 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -169.84 0.35 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.718 2.279 . . . . 71.329999999999998 112.375 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -51.26 157.08 1.01 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.84 160.12 22.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 43.299999999999997 110.934 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.7 pp -141.9 176.74 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 64.439999999999998 111.115 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -117.1 135.55 53.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.479 . . . . 75.340000000000003 110.831 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.455 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.2 pt -116.92 173.57 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.147 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -128.53 132.73 48.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.887 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.685 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.2 m-85 -102.94 104.84 15.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.819 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.4 129.39 44.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.937 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.2 p -122.15 -177.71 3.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.510000000000005 111.141 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.3 mmt -75.76 -17.37 59.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 110.895 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -96.33 -37.89 10.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 61.119999999999997 110.858 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 179.71 176.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 54.409999999999997 110.884 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 131.44 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 111.16 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.552 HG21 HG22 ' A' ' 48' ' ' VAL . 1.8 m -121.62 150.89 56.11 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.546 0.689 . . . . 73.409999999999997 111.126 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 153.02 69.78 Favored 'Trans proline' 0 C--O 1.231 0.148 0 C-N-CA 122.655 2.237 . . . . 73.0 112.325 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.14 140.48 28.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.178 -0.465 . . . . 53.340000000000003 111.119 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -104.88 126.87 52.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 53.43 110.894 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.69 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -107.18 116.34 31.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 111.081 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.04 142.35 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 111.173 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.5 p -54.19 120.25 6.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.463 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 106.54 -4.55 37.28 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.817 -0.706 . . . . 33.130000000000003 112.481 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.76 -177.03 3.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.854 0.359 . . . . 73.200000000000003 110.897 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.73 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.2 p -138.04 155.06 49.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.183 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.57 -59.59 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 70.420000000000002 111.15 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.74 -35.45 61.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.896 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -72.66 -26.6 61.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.450000000000003 110.904 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 38' ' ' THR . 95.4 t -76.18 -47.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 61.210000000000001 111.081 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.685 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.79 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 62.219999999999999 111.082 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -69.89 -36.72 75.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 110.864 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -76.35 -42.66 44.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 74.530000000000001 110.845 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -72.27 -27.08 62.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.87 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.14 -12.07 34.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.726 -0.749 . . . . 71.540000000000006 112.457 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 29' ' ' VAL . 22.6 t -57.86 127.55 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.766 0.317 . . . . 41.020000000000003 111.151 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -81.04 80.83 7.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 75.209999999999994 110.847 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.707 HD22 HG21 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -84.49 134.74 34.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 110.834 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' N ' HD13 ' A' ' 50' ' ' LEU . 11.0 mt-10 -61.09 121.71 13.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 53.100000000000001 110.862 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 157.06 -113.27 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 24.25 112.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 54.87 26.43 7.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 55.299999999999997 111.082 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 29.8 p -122.9 142.84 50.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 72.329999999999998 110.924 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -121.42 56.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 110.933 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.6 21.72 30.8 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.811 -0.709 . . . . 75.319999999999993 112.435 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -66.59 179.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.922 0.391 . . . . 73.329999999999998 110.849 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 37.2 mt -90.17 -25.51 20.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 72.140000000000001 110.923 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.06 75.16 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 51.329999999999998 111.13 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.28 110.78 3.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 74.540000000000006 110.868 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 p -95.15 -67.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 65.319999999999993 110.895 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 p -149.78 141.56 23.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 62.32 111.176 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 3.1 m -105.43 115.46 30.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 25.530000000000001 110.818 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -150.08 112.83 4.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 65.439999999999998 110.86 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.3 t -128.6 158.03 41.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.25 111.151 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 83.6 mt -89.99 131.44 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 111.143 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 112' ' ' VAL . 17.4 tp -123.02 160.88 25.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 64.040000000000006 110.918 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.77 143.96 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 71.019999999999996 110.916 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.1 mt-10 -57.4 -59.14 13.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.76 -46.73 1.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.729 2.286 . . . . 54.219999999999999 112.306 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 6.8 tp -51.67 -45.69 63.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.924 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 95' ' ' THR . 49.0 t80 -72.28 -41.01 67.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 74.450000000000003 110.908 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -53.85 42.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 65.439999999999998 110.898 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -33.23 67.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 75.0 110.921 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 75' ' ' LEU . 10.8 mt -62.87 -25.0 68.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.843 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.87 142.5 4.61 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 71.329999999999998 112.507 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -110.71 156.84 39.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.644 0.735 . . . . 65.310000000000002 110.854 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 171.81 13.76 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.676 2.25 . . . . 62.009999999999998 112.362 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.1 m -99.29 -170.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 75.409999999999997 110.885 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -56.61 -47.77 78.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.138 -0.483 . . . . 72.409999999999997 110.878 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -53.74 -59.74 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 63.240000000000002 110.881 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' O ' HD12 ' A' ' 86' ' ' ILE . 16.3 mm-40 -61.2 -28.58 69.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 71.530000000000001 110.858 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -55.64 27.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 110.893 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.41 -37.37 82.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.063 -0.517 . . . . 71.120000000000005 110.844 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -57.32 -52.14 66.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.94 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.571 HD13 ' HA2' ' A' ' 94' ' ' GLY . 7.5 mt -74.97 -34.38 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 63.409999999999997 111.116 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -58.99 -21.43 58.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.030000000000001 110.858 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -75.95 -25.67 56.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 74.109999999999999 110.883 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -74.71 163.97 27.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.065 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -84.2 113.63 21.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.89 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.82 52.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.535 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -95.14 129.41 42.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 70.219999999999999 111.121 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.42 146.36 27.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 75.109999999999999 111.083 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.571 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.4 -23.46 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.747 -0.74 . . . . 75.129999999999995 112.487 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.638 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.5 p -73.82 -1.84 21.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.16 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 9.4 t -88.9 -12.8 40.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 71.409999999999997 110.884 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -117.39 132.62 56.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 70.200000000000003 110.816 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.27 179.88 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.944 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.77 -155.67 15.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 71.010000000000005 112.491 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.7 t -140.44 53.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.309 . . . . 61.43 110.856 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.658 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.1 pt20 -179.07 98.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 64.439999999999998 110.912 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.658 HD12 ' C ' ' A' ' 101' ' ' GLN . 10.6 mp -130.25 160.73 33.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.25 110.906 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -115.9 170.26 8.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.209999999999994 110.825 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.69 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 90.5 t -97.76 118.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 111.129 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -137.05 177.1 8.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 72.040000000000006 110.906 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -60.63 -31.5 70.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.88 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.7 m -65.04 -19.54 66.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.510000000000005 110.92 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.603 ' HZ ' HD23 ' A' ' 102' ' ' LEU . 3.1 m-85 -85.7 4.41 36.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 71.209999999999994 110.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -57.03 123.39 15.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.857 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 59.55 26.03 14.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.879 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -68.51 136.72 53.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 33.329999999999998 111.116 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.5 t -109.74 123.03 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 73.010000000000005 111.15 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.47 103.9 12.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.430000000000007 110.897 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.546 HG23 ' HD2' ' A' ' 23' ' ' LYS . 49.9 m -93.79 118.72 31.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 73.439999999999998 111.168 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG21 HD22 ' A' ' 50' ' ' LEU . 23.1 t -108.57 89.29 5.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.611 0.719 . . . . 72.129999999999995 111.133 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 -39.06 6.77 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.615 2.21 . . . . 65.439999999999998 112.343 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -65.84 159.38 25.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 110.848 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.9 172.11 8.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 53.109999999999999 111.087 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 m -93.15 157.77 16.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 111.129 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -68.96 142.2 54.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 110.867 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -155.94 -177.0 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ptm -52.09 117.86 3.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 74.510000000000005 110.858 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.08 131.72 6.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 62.43 111.117 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.5 m -69.04 151.51 10.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 44.350000000000001 111.117 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -150.26 156.43 41.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 71.030000000000001 110.774 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 136.0 -20.63 3.59 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.801 -0.714 . . . . 73.430000000000007 112.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -78.21 66.4 3.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 74.310000000000002 110.885 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -148.91 69.57 10.0 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.579 0.704 . . . . 71.430000000000007 110.867 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.8 -43.7 2.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 73.120000000000005 112.378 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.92 72.89 16.78 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.589 0.709 . . . . 72.420000000000002 110.919 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 115.38 4.06 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.693 2.262 . . . . 73.030000000000001 112.342 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 72.120000000000005 110.917 179.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 121.454 0.474 . . . . 71.299999999999997 112.522 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.636 2.224 . . . . 64.129999999999995 112.34 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.39 141.08 15.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 41.340000000000003 112.481 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -100.95 146.53 27.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 73.310000000000002 110.875 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mmt -114.52 -62.72 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 73.430000000000007 110.894 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -66.21 162.85 19.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 71.420000000000002 110.867 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.2 ptm -99.71 139.51 35.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 62.509999999999998 110.898 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -146.26 166.51 26.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 71.439999999999998 110.873 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.1 t -52.16 103.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 72.439999999999998 110.913 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 13' ' ' ARG . . . -152.13 73.9 7.65 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 71.340000000000003 111.073 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -16.69 37.85 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.683 2.255 . . . . 63.229999999999997 112.376 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -92.04 -22.98 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 110.873 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB2' ' HB1' ' A' ' 10' ' ' ALA . 38.5 mtt180 -104.07 103.68 13.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 74.209999999999994 110.851 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.484 HD11 ' HD2' ' A' ' 103' ' ' ARG . 41.0 mm -60.2 133.04 90.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.62 0.724 . . . . 72.400000000000006 111.111 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.4 Cg_endo -69.72 -170.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.706 2.27 . . . . 71.329999999999998 112.38 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -51.8 156.82 1.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.871 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -73.81 159.56 32.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 43.299999999999997 110.919 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.523 HD13 ' C ' ' A' ' 108' ' ' PHE . 1.1 pt -141.83 176.76 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 64.439999999999998 111.102 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.76 129.19 47.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.855 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.623 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -114.59 172.63 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.167 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.9 131.5 52.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 75.219999999999999 110.912 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.745 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -99.63 103.07 14.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 71.329999999999998 110.886 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -94.24 135.34 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 75.340000000000003 110.865 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.4 p -133.39 177.69 7.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 65.510000000000005 111.149 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.9 tpt -75.36 -8.33 56.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.884 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -104.18 -37.91 7.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 61.119999999999997 110.939 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 179.21 176.25 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 54.409999999999997 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -116.9 124.69 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.010000000000005 111.132 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 48' ' ' VAL . 1.0 OUTLIER -119.84 151.01 51.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.714 . . . . 73.409999999999997 111.17 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 156.03 64.26 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.717 2.278 . . . . 73.0 112.297 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.623 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -150.93 104.29 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.077 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 pttt -79.34 132.04 36.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.91 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.552 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -121.35 116.53 24.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.133 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.9 p -95.41 150.8 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 111.123 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.05 116.26 1.92 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.861 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 2.01 37.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.762 -0.733 . . . . 33.130000000000003 112.487 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.0 m -99.17 -176.15 3.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.945 0.402 . . . . 73.200000000000003 110.818 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -138.93 146.01 40.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 111.147 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -52.48 -62.38 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 111.111 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 ' CD1' HD12 ' A' ' 50' ' ' LEU . 4.3 mm? -53.81 -33.54 56.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 65.400000000000006 110.946 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -72.68 -27.27 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.883 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 38' ' ' THR . 94.4 t -76.87 -45.44 31.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.469 . . . . 61.210000000000001 111.119 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.745 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.51 -29.93 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.121 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -71.4 -37.99 71.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.894 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.16 -44.24 63.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.891 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.08 -25.2 61.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.903 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.2 -12.26 44.28 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.739 -0.743 . . . . 71.540000000000006 112.479 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 29' ' ' VAL . 35.8 t -53.36 129.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 41.020000000000003 111.119 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.691 ' O ' HG21 ' A' ' 119' ' ' THR . 31.5 t0 -77.3 80.67 3.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 75.209999999999994 110.915 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.631 HD12 ' CD1' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -110.59 106.71 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.176 -0.466 . . . . 70.430000000000007 110.926 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -129.0 113.93 15.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.878 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -135.5 110.76 0.84 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.715 -0.755 . . . . 24.25 112.505 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.959 ' HB1' ' HB1' ' A' ' 59' ' ' ALA . . . -51.89 103.11 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.818 0.342 . . . . 55.299999999999997 111.119 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.02 -27.56 9.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 72.329999999999998 110.905 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.18 119.68 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 64.450000000000003 110.903 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.47 -177.5 18.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.755 -0.736 . . . . 75.319999999999993 112.471 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -90.8 -73.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.871 0.367 . . . . 73.329999999999998 110.871 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.02 -29.33 28.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.140000000000001 110.933 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.959 ' HB1' ' HB1' ' A' ' 53' ' ' ALA . . . -68.3 -50.05 56.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 51.329999999999998 111.076 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 t -87.35 53.27 2.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 74.540000000000006 110.92 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -81.16 -170.49 2.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 65.319999999999993 110.92 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.83 100.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 62.32 111.159 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 59.6 m -57.28 146.31 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 25.530000000000001 110.844 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -135.94 77.26 1.65 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.176 -0.465 . . . . 65.439999999999998 110.851 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.0 t -128.73 157.64 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.135 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 85.4 mt -90.02 131.24 37.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.430000000000007 111.151 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.62 HD12 ' O ' ' A' ' 112' ' ' VAL . 22.2 tp -127.0 160.65 30.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 64.040000000000006 110.927 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -45.79 143.99 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.019999999999996 110.865 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.8 OUTLIER -58.11 -60.23 10.76 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.64 0.733 . . . . 73.040000000000006 110.908 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.78 -48.32 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.699 2.266 . . . . 54.219999999999999 112.348 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.578 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.81 -45.26 63.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 73.209999999999994 110.929 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 89.6 t80 -70.79 -49.61 44.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 110.904 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -54.09 -41.62 68.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.896 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -71.36 -46.27 60.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.578 HD23 HD13 ' A' ' 71' ' ' LEU . 2.4 mm? -63.35 -24.43 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.06 130.98 2.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.733 . . . . 71.329999999999998 112.505 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -115.78 157.66 44.03 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.648 0.737 . . . . 65.310000000000002 110.871 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -175.3 1.11 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.699 2.266 . . . . 62.009999999999998 112.356 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.3 m -104.12 -177.16 3.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 75.409999999999997 110.885 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -57.87 -44.12 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 72.409999999999997 110.877 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 mttm -53.58 -59.71 4.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 63.240000000000002 110.876 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' OE2' HD23 ' A' ' 98' ' ' LEU . 25.9 tt0 -62.73 -28.21 69.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 71.530000000000001 110.86 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -52.88 62.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.898 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.02 -39.2 75.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.133 -0.485 . . . . 71.120000000000005 110.891 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.2 -50.81 70.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 64.219999999999999 110.931 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.2 mt -74.96 -34.3 32.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 63.409999999999997 111.161 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -59.76 -20.0 53.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 74.030000000000001 110.898 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -75.84 -26.0 56.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.897 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.95 145.01 36.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.107 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -65.92 121.81 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.9 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.18 45.17 57.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.504 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.609 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -111.37 125.37 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.38 . . . . 70.219999999999999 111.075 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.06 147.66 38.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.119 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.49 -23.4 35.02 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 75.129999999999995 112.519 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 25.2 p -73.93 -1.81 21.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 64.239999999999995 111.15 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.1 t -88.95 -13.49 38.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 71.409999999999997 110.904 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -141.39 167.85 21.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 70.200000000000003 110.839 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.404 HD23 ' OE2' ' A' ' 82' ' ' GLU . 4.2 mm? 57.38 44.9 20.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 73.450000000000003 110.899 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.54 111.75 0.52 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 71.010000000000005 112.47 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.0 t -163.02 156.85 20.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.775 0.322 . . . . 61.43 110.871 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.671 ' O ' HD23 ' A' ' 102' ' ' LEU . 1.2 tp-100 -170.05 -179.53 3.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.439999999999998 110.913 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.717 ' C ' HG22 ' A' ' 38' ' ' THR . 7.2 mt -139.5 -61.22 0.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 65.25 110.931 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HD2' HD11 ' A' ' 14' ' ' ILE . 1.5 mtm180 -59.65 158.7 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.867 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.552 HG21 ' HB1' ' A' ' 33' ' ' ALA . 94.4 t -109.16 134.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 72.239999999999995 111.099 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -136.57 170.06 16.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.891 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.0 tttm -59.22 -34.16 71.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.903 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.495 ' O ' HD21 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -64.25 -20.2 65.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 64.510000000000005 110.878 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . 3.1 m-85 -87.38 6.59 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.834 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -58.32 124.48 19.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 62.219999999999999 110.879 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.95 24.32 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 53.450000000000003 110.915 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.1 126.76 30.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 33.329999999999998 111.139 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.62 ' O ' HD12 ' A' ' 67' ' ' LEU . 41.1 t -99.91 121.51 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.010000000000005 111.161 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -111.98 103.17 11.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 71.430000000000007 110.885 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 65' ' ' VAL . 52.7 m -96.08 119.41 34.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 111.124 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 50' ' ' LEU . 19.1 t -108.65 89.11 5.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.098 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -34.23 14.99 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 65.439999999999998 112.314 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -76.38 148.45 37.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.833 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.61 -176.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.109999999999999 111.111 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 49' ' ' ASP . 1.1 p -124.72 176.92 6.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 111.13 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 53' ' ' ALA . 16.6 mtpt -112.13 -171.83 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.895 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -106.49 167.33 9.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 73.329999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.5 mtt -104.23 179.27 4.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 110.845 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.43 172.82 16.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 62.43 111.058 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.9 146.38 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 44.350000000000001 111.145 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -175.25 149.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 71.030000000000001 110.818 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.62 -38.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.755 -0.736 . . . . 73.430000000000007 112.48 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 59.08 27.21 16.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.952 0.406 . . . . 74.310000000000002 110.891 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 40.1 tptt 57.35 73.63 0.75 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.592 0.711 . . . . 71.430000000000007 110.942 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 129.08 17.01 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.652 2.235 . . . . 73.120000000000005 112.355 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 tptm -172.09 69.19 0.43 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.594 0.712 . . . . 72.420000000000002 110.901 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -173.16 0.66 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 73.030000000000001 112.318 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.8 m170 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.859 179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.449 0.472 . . . . 71.299999999999997 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -174.73 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.74 2.293 . . . . 64.129999999999995 112.284 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -134.77 -117.07 1.7 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 41.340000000000003 112.453 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m 56.67 39.51 29.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.854 0.359 . . . . 73.310000000000002 110.864 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.1 132.04 43.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 110.901 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -104.19 30.8 4.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.16 -0.473 . . . . 71.420000000000002 110.898 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.9 mmm -136.62 -178.99 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 62.509999999999998 110.872 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -119.72 139.27 52.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 71.439999999999998 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.5 p -175.83 147.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 72.439999999999998 110.841 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -54.52 160.39 2.7 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.597 0.713 . . . . 71.340000000000003 111.118 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 53.1 Cg_endo -69.76 79.96 0.91 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.682 2.255 . . . . 63.229999999999997 112.301 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -118.46 25.11 10.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.906 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -130.79 116.02 17.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 110.864 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.9 mt -115.17 133.22 22.73 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.63 0.728 . . . . 72.400000000000006 111.122 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.6 Cg_endo -69.81 178.85 4.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.723 2.282 . . . . 71.329999999999998 112.288 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -51.83 157.51 1.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 73.310000000000002 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -73.45 145.59 45.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 43.299999999999997 110.922 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 108' ' ' PHE . 2.0 pp -118.18 171.2 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 130.11 56.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.868 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.8 pt -117.17 173.74 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 75.129999999999995 111.157 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -127.6 131.78 49.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 75.219999999999999 110.844 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.8 m-85 -103.22 102.95 12.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.329999999999998 110.915 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HD3' HG23 ' A' ' 114' ' ' THR . 4.5 tttp -94.82 140.02 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.898 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -140.48 175.79 9.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.418 . . . . 65.510000000000005 111.188 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 2.9 ttm -75.65 -11.67 60.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 73.099999999999994 110.877 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.25 -37.78 9.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 61.119999999999997 110.91 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 179.86 176.22 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 54.409999999999997 110.936 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG22 ' CG ' ' A' ' 23' ' ' LYS . 15.4 t -119.16 121.68 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 111.107 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -121.7 150.31 55.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 111.163 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.77 166.72 26.66 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.765 2.31 . . . . 73.0 112.343 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -154.86 145.06 21.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 53.340000000000003 111.078 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.5 pttm -111.78 121.95 46.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 53.43 110.9 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.525 ' HB1' ' CG1' ' A' ' 104' ' ' VAL . . . -95.11 116.63 28.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.269 -0.423 . . . . 74.420000000000002 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.8 t -91.38 153.8 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 111.097 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.3 p -62.94 121.61 13.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.088 -0.506 . . . . 52.539999999999999 110.891 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.685 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 86.38 0.64 86.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 33.130000000000003 112.473 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.93 -169.81 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.972 0.415 . . . . 73.200000000000003 110.847 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -142.23 154.46 44.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.19 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.8 t -51.8 -59.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 70.420000000000002 111.103 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.32 -34.26 60.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 65.400000000000006 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.68 -26.86 61.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.450000000000003 110.91 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' THR . 97.7 t -76.5 -45.79 33.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.105 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.77 -33.34 34.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 62.219999999999999 111.101 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -66.96 -35.14 79.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 110.893 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -66.88 -49.37 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.895 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -72.01 -24.56 61.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.857 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.94 -12.05 34.58 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.74 -0.743 . . . . 71.540000000000006 112.484 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 29' ' ' VAL . 25.5 t -55.86 129.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 41.020000000000003 111.136 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -86.23 80.85 8.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' CD2' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -79.08 121.0 24.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 70.430000000000007 110.898 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -59.35 140.12 56.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 53.100000000000001 110.905 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.24 -110.49 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.767 -0.73 . . . . 24.25 112.522 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 53.23 46.98 25.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.341 . . . . 55.299999999999997 111.099 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 26.7 p -88.42 -32.5 18.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 110.815 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 52.45 35.06 16.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 64.450000000000003 110.873 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -147.58 140.9 8.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.749 -0.739 . . . . 75.319999999999993 112.536 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -82.19 -27.55 32.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 73.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 58' ' ' LEU . 4.4 mm? -55.25 169.62 0.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.443 . . . . 72.140000000000001 110.91 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.59 133.67 41.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 51.329999999999998 111.062 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 75.2 m -114.63 179.68 3.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 74.540000000000006 110.865 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -170.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 65.319999999999993 110.868 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.579 HG22 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -57.61 99.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 62.32 111.158 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 1.2 m -98.94 116.07 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 25.530000000000001 110.9 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.579 ' CD2' HG22 ' A' ' 62' ' ' THR . 8.0 p80 -164.53 109.43 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.13 -0.486 . . . . 65.439999999999998 110.847 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG13 ' HA ' ' A' ' 115' ' ' VAL . 11.9 t -128.48 155.0 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 72.25 111.119 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.4 mt -90.76 129.44 41.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 64.430000000000007 111.139 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 112' ' ' VAL . 21.6 tp -124.5 161.8 25.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 64.040000000000006 110.937 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.95 143.7 1.41 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 71.019999999999996 110.846 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -58.31 -59.52 13.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.573 0.702 . . . . 73.040000000000006 110.808 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -47.92 0.82 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.661 2.241 . . . . 54.219999999999999 112.303 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.581 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -53.0 -42.59 65.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.915 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.658 ' CD1' HG22 ' A' ' 95' ' ' THR . 58.4 t80 -71.85 -54.11 11.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 74.450000000000003 110.851 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.34 -34.81 58.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 65.439999999999998 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -78.03 -41.8 34.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 75.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.8 mm? -63.15 -25.76 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.992 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 125.36 140.08 5.33 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 71.329999999999998 112.508 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -109.74 160.3 28.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.66 0.743 . . . . 65.310000000000002 110.9 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 166.62 27.01 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.661 2.241 . . . . 62.009999999999998 112.326 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.0 t -58.09 171.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.817 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -59.96 -37.32 79.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.858 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -62.57 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 110.92 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.2 mp0 -67.54 -35.63 79.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.837 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.27 -53.49 56.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.897 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.73 -42.58 90.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.936 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.504 HD13 ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -55.52 -37.44 67.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.857 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.606 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.0 mt -74.52 -52.04 20.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 63.409999999999997 111.172 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -58.68 -21.59 54.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 74.030000000000001 110.819 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -76.18 -24.16 54.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 74.109999999999999 110.908 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -74.15 164.28 26.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 71.129999999999995 111.132 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -74.47 113.69 12.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.907 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.22 40.56 52.64 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.506 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -107.58 114.87 29.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 70.219999999999999 111.112 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.67 142.82 27.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.178 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.36 -23.68 34.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.812 -0.709 . . . . 75.129999999999995 112.471 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.658 HG22 ' CD1' ' A' ' 72' ' ' TYR . 17.8 p -74.22 -0.93 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 64.239999999999995 111.105 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 45.3 t -90.63 -12.21 37.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.837 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.98 133.67 55.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.888 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 pp -179.06 -178.92 0.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.902 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.26 -133.12 4.75 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.695 -0.764 . . . . 71.010000000000005 112.501 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.4 m -144.78 -42.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 61.43 110.936 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.728 ' O ' HD22 ' A' ' 102' ' ' LEU . 44.9 mt-30 -60.33 101.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.913 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.728 HD22 ' O ' ' A' ' 101' ' ' GLN . 4.0 mm? -134.99 127.08 29.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.25 110.948 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.4 mtm-85 -84.41 168.95 15.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 70.209999999999994 110.86 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.525 ' CG1' ' HB1' ' A' ' 33' ' ' ALA . 57.5 t -102.45 119.24 50.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.239999999999995 111.111 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -136.05 172.98 12.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.040000000000006 110.866 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -29.7 68.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.834 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.8 m -65.65 -22.65 66.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 64.510000000000005 110.86 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 102' ' ' LEU . 3.1 m-85 -81.77 -0.15 41.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 71.209999999999994 110.857 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.65 123.77 16.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 62.219999999999999 110.92 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 36.5 m-20 59.75 27.18 16.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 53.450000000000003 110.915 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.513 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -68.19 151.07 47.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 33.329999999999998 111.024 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' LEU . 24.2 t -116.28 120.99 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 73.010000000000005 111.146 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -114.19 98.96 7.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.908 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.573 HG23 ' HD3' ' A' ' 23' ' ' LYS . 43.3 m -91.41 116.65 29.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.133 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.551 HG21 ' CD2' ' A' ' 50' ' ' LEU . 22.0 t -108.64 89.19 5.93 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.597 0.713 . . . . 72.129999999999995 111.132 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 -35.53 12.65 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.726 2.284 . . . . 65.439999999999998 112.354 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.08 108.84 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.842 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -163.09 179.48 7.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 53.109999999999999 111.077 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 t -99.25 173.51 6.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 73.409999999999997 111.09 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -54.05 173.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 73.349999999999994 110.863 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -153.5 146.61 24.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 73.329999999999998 110.892 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 1.8 mpp? -144.43 105.45 4.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.895 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.81 139.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 62.43 111.069 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.3 t -136.1 143.38 36.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 44.350000000000001 111.12 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -172.95 130.55 0.5 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 71.030000000000001 110.912 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 64.39 101.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.743 -0.741 . . . . 73.430000000000007 112.47 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -117.89 124.3 47.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 74.310000000000002 110.875 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -143.33 161.29 48.31 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.473 0.654 . . . . 71.430000000000007 110.928 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.86 94.18 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.636 2.224 . . . . 73.120000000000005 112.299 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -138.37 157.88 71.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.6 0.714 . . . . 72.420000000000002 110.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.83 174.67 9.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.757 2.305 . . . . 73.030000000000001 112.321 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 110.82 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 CA-C-O 121.466 0.481 . . . . 71.299999999999997 112.506 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 158.89 55.34 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.663 2.242 . . . . 64.129999999999995 112.318 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.05 145.08 9.68 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 41.340000000000003 112.464 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.45 -179.94 3.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.844 0.354 . . . . 73.310000000000002 110.832 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.1 tpt -120.85 -64.59 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 73.430000000000007 110.893 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -171.38 -179.93 2.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 71.420000000000002 110.872 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -131.07 168.98 16.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 62.509999999999998 110.847 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -155.56 161.11 40.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 71.439999999999998 110.816 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 p -73.15 166.15 23.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.487 . . . . 72.439999999999998 110.835 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.32 74.58 0.22 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.569 0.699 . . . . 71.340000000000003 111.051 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 78.05 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 63.229999999999997 112.334 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -121.55 25.31 9.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.858 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 tpp85 63.35 30.52 15.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 74.209999999999994 110.877 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.431 HD13 ' H ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER 64.72 148.58 0.11 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.616 0.722 . . . . 72.400000000000006 111.139 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -170.27 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.385 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -54.66 157.41 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 73.310000000000002 110.875 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -73.21 133.25 43.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 43.299999999999997 110.872 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.757 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.6 pp -124.12 176.96 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 64.439999999999998 111.098 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -113.79 140.9 47.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 75.340000000000003 110.861 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 pt -114.69 175.09 2.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 75.129999999999995 111.15 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -133.03 126.77 32.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.905 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.625 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 26.6 m-85 -108.77 103.16 12.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 71.329999999999998 110.882 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -88.69 132.15 34.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.9 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -115.32 176.3 5.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 65.510000000000005 111.136 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.0 tpt -75.64 -8.29 56.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 73.099999999999994 110.918 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -103.44 -37.95 7.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 61.119999999999997 110.826 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 179.39 176.43 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 54.409999999999997 110.966 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.538 HG22 ' HG2' ' A' ' 23' ' ' LYS . 23.1 t -79.62 147.63 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 111.148 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.752 ' CG1' HG22 ' A' ' 48' ' ' VAL . 67.6 t -141.38 87.79 10.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 73.409999999999997 111.169 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 152.59 69.71 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.612 2.208 . . . . 73.0 112.396 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -163.63 144.28 8.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.428 . . . . 53.340000000000003 111.079 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -81.88 147.87 29.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 53.43 110.857 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.681 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -116.75 143.58 45.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 111.078 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.3 t -100.45 151.4 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.200000000000003 111.117 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.0 p -53.38 116.29 2.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 52.539999999999999 110.841 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' H ' HD13 ' A' ' 14' ' ' ILE . . . 74.15 25.31 71.39 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.719 -0.753 . . . . 33.130000000000003 112.483 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.7 p -77.83 -169.91 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.839 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.734 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -136.87 143.1 42.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.085 -0.507 . . . . 73.140000000000001 111.149 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 96.2 t -53.11 -63.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 70.420000000000002 111.116 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.85 -32.84 54.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 65.400000000000006 110.927 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.72 -27.52 62.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 72.450000000000003 110.815 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 38' ' ' THR . 76.1 t -77.22 -44.93 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.121 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.16 -28.33 52.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 62.219999999999999 111.121 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -72.55 -26.39 61.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.78 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.31 -53.78 6.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 110.872 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.81 3.42 37.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.871 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 64.52 15.82 59.95 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.788 -0.72 . . . . 71.540000000000006 112.459 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.752 HG22 ' CG1' ' A' ' 29' ' ' VAL . 82.0 t -52.26 127.62 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 41.020000000000003 111.135 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -72.37 80.65 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 75.209999999999994 110.86 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.1 tt -126.63 105.13 8.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.430000000000007 110.938 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -106.41 141.17 38.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 53.100000000000001 110.805 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.35 66.39 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 24.25 112.496 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.03 120.73 5.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.859 0.362 . . . . 55.299999999999997 111.144 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -25.01 58.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 72.329999999999998 110.844 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -124.91 132.55 53.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.444 . . . . 64.450000000000003 110.897 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.26 163.73 12.39 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.767 -0.73 . . . . 75.319999999999993 112.491 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -63.76 125.09 23.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.915 0.388 . . . . 73.329999999999998 110.871 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 56.85 25.95 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 72.140000000000001 110.92 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.27 163.59 12.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 51.329999999999998 111.123 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.8 t 56.24 25.8 9.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 74.540000000000006 110.866 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 m -70.97 -46.37 62.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 65.319999999999993 110.866 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 p -131.16 99.77 4.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.515 . . . . 62.32 111.144 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.614 ' HB3' HD13 ' A' ' 98' ' ' LEU . 7.7 t -96.21 30.84 2.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 25.530000000000001 110.894 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -62.43 94.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.2 t -128.67 156.41 41.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.25 111.111 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 91.1 mt -89.98 131.59 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.430000000000007 111.15 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.696 HD12 ' O ' ' A' ' 112' ' ' VAL . 37.6 tp -127.77 159.74 33.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.937 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.403 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.54 141.23 2.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 71.019999999999996 110.891 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.51 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.1 mt-10 -57.48 -59.52 12.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.633 0.73 . . . . 73.040000000000006 110.901 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.79 -48.63 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.601 2.201 . . . . 54.219999999999999 112.38 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -51.83 -41.17 61.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.271 -0.422 . . . . 73.209999999999994 110.965 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.77 ' CD1' HG22 ' A' ' 95' ' ' THR . 93.2 t80 -73.37 -51.38 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 74.450000000000003 110.834 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -34.32 63.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 65.439999999999998 110.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -78.29 -44.65 24.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 75.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.7 mm? -63.23 -21.35 66.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.851 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.12 131.74 2.93 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.813 -0.708 . . . . 71.329999999999998 112.47 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -112.6 157.31 40.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 110.885 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -177.98 2.15 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.637 2.225 . . . . 62.009999999999998 112.332 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.1 m -101.09 -176.23 3.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 75.409999999999997 110.872 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -55.71 -44.03 77.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.084 -0.507 . . . . 72.409999999999997 110.894 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -53.93 -59.56 4.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 63.240000000000002 110.876 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -30.78 71.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 71.530000000000001 110.92 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -56.09 26.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 74.329999999999998 110.936 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.57 -39.44 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 71.120000000000005 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 mt -55.36 -52.32 63.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 64.219999999999999 110.897 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.536 HD11 ' CD ' ' A' ' 97' ' ' ARG . 63.5 mt -74.61 -34.42 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 63.409999999999997 111.149 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -61.54 -17.86 56.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 74.030000000000001 110.877 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -75.77 -26.06 57.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.906 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -69.29 164.03 23.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 111.065 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -82.87 113.66 20.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.896 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.94 41.15 51.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.129999999999995 112.478 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.718 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -105.66 126.48 52.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 70.219999999999999 111.069 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.18 148.34 24.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.059 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.63 -25.6 43.56 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.752 -0.737 . . . . 75.129999999999995 112.526 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.77 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -74.06 -1.38 19.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.818 0.342 . . . . 64.239999999999995 111.192 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.7 t -90.61 -11.87 38.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.838 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.536 ' CD ' HD11 ' A' ' 86' ' ' ILE . 20.6 ttt-85 -91.96 168.88 11.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.846 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 63' ' ' CYS . 23.3 tp -49.56 146.71 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.450000000000003 110.943 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 98' ' ' LEU . . . 177.89 33.22 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.778 -0.725 . . . . 71.010000000000005 112.519 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 18.5 p -110.98 138.81 46.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 61.43 110.818 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -114.43 7.86 16.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 64.439999999999998 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 51.91 55.64 8.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 65.25 110.928 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -152.39 126.53 9.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.91 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.681 HG11 ' HB1' ' A' ' 33' ' ' ALA . 47.3 t -97.39 120.07 46.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 72.239999999999995 111.085 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -176.78 4.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 72.040000000000006 110.878 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -56.9 -36.0 69.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.510000000000005 110.91 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 m -64.85 -24.05 67.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 64.510000000000005 110.804 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -82.2 0.72 39.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 71.209999999999994 110.915 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 18' ' ' ILE . 38.4 tt0 -55.01 119.2 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 62.219999999999999 110.86 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 61.61 22.01 12.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.885 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HA ' HD13 ' A' ' 71' ' ' LEU . . . -56.58 145.11 29.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.139 -0.482 . . . . 33.329999999999998 111.116 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.696 ' O ' HD12 ' A' ' 67' ' ' LEU . 18.4 t -116.27 115.47 49.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 73.010000000000005 111.15 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -111.08 98.15 7.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 31.0 m -87.47 119.22 27.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 73.439999999999998 111.128 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.455 ' HA ' HG13 ' A' ' 65' ' ' VAL . 21.0 t -108.73 88.25 5.14 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.6 0.714 . . . . 72.129999999999995 111.058 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -42.65 3.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.684 2.256 . . . . 65.439999999999998 112.4 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -108.46 141.85 39.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.472 . . . . 72.140000000000001 110.852 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -174.68 -177.97 1.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 53.109999999999999 111.139 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 82.3 m -62.17 135.42 57.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.409999999999997 111.129 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp 60.92 31.06 19.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.893 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 35.7 m120 -140.84 172.16 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 110.881 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -170.47 173.71 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.814 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.65 176.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 62.43 111.074 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.9 m -111.99 -36.79 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 44.350000000000001 111.19 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -175.37 -179.16 1.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.030000000000001 110.84 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 68.97 95.18 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.734 -0.746 . . . . 73.430000000000007 112.448 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -173.33 143.26 1.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 74.310000000000002 110.899 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.82 157.89 43.26 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.598 0.713 . . . . 71.430000000000007 110.878 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -170.97 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.699 2.266 . . . . 73.120000000000005 112.309 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.42 68.39 0.92 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.518 0.675 . . . . 72.420000000000002 110.894 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.79 -170.95 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.683 2.256 . . . . 73.030000000000001 112.302 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 26.2 p80 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 110.861 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 121.44 0.467 . . . . 71.299999999999997 112.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 109.89 2.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 64.129999999999995 112.37 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -140.42 71.05 0.43 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.791 -0.719 . . . . 41.340000000000003 112.537 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -108.92 140.65 42.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 73.310000000000002 110.822 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -157.28 178.5 10.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.954 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.854 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.6 ptp -88.9 -175.39 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 62.509999999999998 110.821 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -147.08 166.39 27.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 71.439999999999998 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.3 m -77.34 -178.64 5.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.856 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -109.44 160.36 28.01 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.567 0.699 . . . . 71.340000000000003 111.125 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 54.1 Cg_endo -69.69 -14.93 37.02 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.774 2.316 . . . . 63.229999999999997 112.39 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -95.72 25.06 4.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 110.86 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' O ' HD13 ' A' ' 14' ' ' ILE . 93.2 mtt180 -137.46 63.07 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.836 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.636 HD11 ' NH1' ' A' ' 103' ' ' ARG . 42.4 mm -137.96 133.11 17.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.661 0.743 . . . . 72.400000000000006 111.087 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.6 Cg_endo -69.72 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.629 2.219 . . . . 71.329999999999998 112.378 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -51.91 156.72 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 73.310000000000002 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -73.89 158.14 35.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.911 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.2 177.21 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.146 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -124.61 132.21 53.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.921 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.658 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.7 pt -114.36 169.51 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.129 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -124.88 129.0 49.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.901 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -99.49 103.38 15.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.093 -0.503 . . . . 71.329999999999998 110.866 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' CA ' HG23 ' A' ' 28' ' ' VAL . 5.5 ttmt -95.44 143.52 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.839 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 p -138.09 179.58 6.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.207 -0.451 . . . . 65.510000000000005 111.137 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -8.15 55.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.099999999999994 110.905 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -107.15 -38.03 6.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.242 -0.436 . . . . 61.119999999999997 110.853 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 179.36 176.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 54.409999999999997 110.925 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG23 ' CA ' ' A' ' 23' ' ' LYS . 10.5 p -118.04 134.86 60.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 72.010000000000005 111.137 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG21 HG22 ' A' ' 48' ' ' VAL . 0.6 OUTLIER -125.92 150.73 69.9 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.565 0.697 . . . . 73.409999999999997 111.179 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 153.21 68.96 Favored 'Trans proline' 0 C--N 1.34 0.12 0 C-N-CA 122.642 2.228 . . . . 73.0 112.292 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.658 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -149.55 105.74 3.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.079 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -70.13 125.16 25.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 53.43 110.911 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.066 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -99.91 123.2 43.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.113 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.6 t -101.21 147.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 75.200000000000003 111.19 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.8 p -52.89 114.76 1.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.86 19.79 52.57 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.815 -0.707 . . . . 33.130000000000003 112.465 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.2 p -93.18 -175.63 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.963 0.411 . . . . 73.200000000000003 110.785 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 42' ' ' VAL . 4.2 m -143.66 152.0 40.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 73.140000000000001 111.12 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.924 HG23 HD12 ' A' ' 40' ' ' LEU . 14.3 m -57.99 -45.79 87.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 70.420000000000002 111.153 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.924 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -63.87 -37.63 88.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 65.400000000000006 110.925 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.7 -27.99 62.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.874 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 38' ' ' THR . 72.1 t -77.39 -36.77 24.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 61.210000000000001 111.118 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.28 -34.09 55.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.027 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -73.7 -27.69 61.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.918 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -51.76 13.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 74.530000000000001 110.855 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' HG12 ' A' ' 42' ' ' VAL . 5.6 p30 -71.89 -25.73 62.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 74.420000000000002 110.861 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.05 -12.41 52.47 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.655 -0.783 . . . . 71.540000000000006 112.495 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 29' ' ' VAL . 86.9 t -51.5 135.15 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.775 0.321 . . . . 41.020000000000003 111.154 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -88.88 82.78 6.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.209999999999994 110.883 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.824 HD11 HG11 ' A' ' 115' ' ' VAL . 11.7 tp -139.49 123.03 17.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 70.430000000000007 110.931 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -135.17 147.86 49.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 53.100000000000001 110.843 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.67 35.13 0.21 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.719 -0.753 . . . . 24.25 112.477 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.81 155.04 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.834 0.35 . . . . 55.299999999999997 111.139 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.8 m -98.12 111.99 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.939 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.89 121.16 14.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 64.450000000000003 110.863 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.93 -177.98 21.97 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 75.319999999999993 112.481 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -103.6 27.76 7.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 73.329999999999998 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.0 mt -141.08 178.61 7.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 72.140000000000001 110.911 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.72 102.5 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 51.329999999999998 111.115 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 15.0 p -54.27 -36.02 63.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.540000000000006 110.89 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.7 t -174.42 162.26 3.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 65.319999999999993 110.864 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -53.27 123.47 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 62.32 111.169 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.9 m -97.18 25.65 5.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 25.530000000000001 110.822 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -102.38 96.76 7.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 65.439999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.7 t -128.69 157.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 72.25 111.129 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 89.9 mt -90.51 129.68 40.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 64.430000000000007 111.166 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.6 tp -125.33 163.02 23.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.155 -0.475 . . . . 64.040000000000006 110.912 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -44.81 147.2 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.877 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -61.33 -59.71 12.76 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.605 0.716 . . . . 73.040000000000006 110.9 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.76 -42.44 3.4 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.638 2.225 . . . . 54.219999999999999 112.349 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.5 OUTLIER -58.3 -44.52 88.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 110.929 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.619 ' CD1' HG22 ' A' ' 95' ' ' THR . 63.2 t80 -70.88 -52.34 20.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.883 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.17 -36.45 68.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.439999999999998 110.862 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.2 mttm -73.86 -44.32 55.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 75.0 110.927 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -63.25 -52.66 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 75.209999999999994 110.89 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 177.42 142.96 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.732 -0.747 . . . . 71.329999999999998 112.524 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -114.83 157.56 42.84 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.659 0.743 . . . . 65.310000000000002 110.874 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 173.63 10.67 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.64 2.227 . . . . 62.009999999999998 112.323 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 m -102.49 -169.84 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 75.409999999999997 110.855 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.71 -46.81 81.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.843 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.99 -59.55 4.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.240000000000002 110.854 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -62.09 -27.75 69.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.862 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.12 -53.75 48.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.918 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -69.74 -37.14 76.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 71.120000000000005 110.871 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 mt -62.49 -48.47 79.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.156 -0.474 . . . . 64.219999999999999 110.909 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD13 ' HA2' ' A' ' 94' ' ' GLY . 56.6 mt -73.91 -35.41 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 63.409999999999997 111.087 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.97 -20.68 64.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 74.030000000000001 110.904 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -76.15 -25.78 55.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.914 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.47 146.09 34.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 71.129999999999995 111.069 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -71.2 121.63 18.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.847 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 44.63 60.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.743 . . . . 73.129999999999995 112.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.581 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -103.29 129.38 50.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 70.219999999999999 111.143 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.14 144.5 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 75.109999999999999 111.095 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.602 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.44 -22.74 32.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 75.129999999999995 112.511 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.619 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.7 p -73.89 -2.25 23.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.086 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.9 t -88.43 -13.35 40.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 110.786 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.43 ' HD3' HD11 ' A' ' 86' ' ' ILE . 13.6 mtp85 -123.33 167.45 13.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 70.200000000000003 110.908 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 58.71 46.64 14.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 110.854 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.34 40.71 2.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.687 -0.768 . . . . 71.010000000000005 112.462 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 2.9 t -92.02 66.98 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.79 0.329 . . . . 61.43 110.855 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -110.13 138.29 46.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 110.927 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.54 35.37 2.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.25 110.896 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.636 ' NH1' HD11 ' A' ' 14' ' ' ILE . 17.2 mmt180 -132.96 135.95 45.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 70.209999999999994 110.907 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.066 HG11 ' HB1' ' A' ' 33' ' ' ALA . 26.3 t -109.61 119.58 59.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.239999999999995 111.117 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -136.46 178.73 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 72.040000000000006 110.891 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -58.31 -37.21 74.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 72.510000000000005 110.948 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -63.64 -19.44 64.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 64.510000000000005 110.862 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -89.62 9.92 25.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 71.209999999999994 110.851 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -58.87 125.76 24.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.219999999999999 110.889 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 60.52 21.9 11.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 53.450000000000003 110.872 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.436 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -59.71 136.33 57.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 33.329999999999998 111.088 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 67' ' ' LEU . 45.8 t -104.44 119.42 53.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.1 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -113.2 98.44 7.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.430000000000007 110.895 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.405 ' O ' HG12 ' A' ' 65' ' ' VAL . 46.4 m -93.8 119.82 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 73.439999999999998 111.133 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.824 HG11 HD11 ' A' ' 50' ' ' LEU . 20.2 t -108.87 88.57 5.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.165 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -36.26 11.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.274 . . . . 65.439999999999998 112.297 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -62.18 166.1 5.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.873 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.52 176.87 7.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 53.109999999999999 111.083 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 t -103.63 173.01 6.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 73.409999999999997 111.152 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -115.26 -64.12 1.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 73.349999999999994 110.863 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.5 p-10 -54.49 172.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 73.329999999999998 110.938 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.511 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.6 ptt? -122.21 -42.56 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 110.819 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 55.74 35.62 25.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 62.43 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 122' ' ' MET . 47.3 t -62.09 -33.66 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 44.350000000000001 111.074 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -54.99 -69.62 0.13 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 110.916 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 52.42 -139.39 30.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.698 -0.763 . . . . 73.430000000000007 112.545 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -158.97 172.98 17.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 74.310000000000002 110.886 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -122.36 68.72 29.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.604 0.716 . . . . 71.430000000000007 110.891 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -48.1 0.77 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.698 2.265 . . . . 73.120000000000005 112.288 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.4 tttp -157.9 137.71 8.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.552 0.691 . . . . 72.420000000000002 110.893 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -42.98 2.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 73.030000000000001 112.346 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 64.9 t60 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.222 -0.445 . . . . 72.120000000000005 110.837 179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 CA-C-O 121.458 0.477 . . . . 71.299999999999997 112.421 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 123.63 10.28 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.651 2.234 . . . . 64.129999999999995 112.342 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.35 87.76 1.3 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 41.340000000000003 112.499 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 t -161.78 160.52 28.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.798 0.332 . . . . 73.310000000000002 110.885 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.7 ttt -61.93 162.61 8.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 73.430000000000007 110.857 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -120.5 120.05 34.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 71.420000000000002 110.825 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 mtt -95.54 164.3 12.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 62.509999999999998 110.849 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -121.7 136.34 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 71.439999999999998 110.905 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.1 p -178.46 174.51 1.24 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.174 -0.466 . . . . 72.439999999999998 110.815 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.09 43.56 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 71.340000000000003 111.126 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -171.04 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.652 2.234 . . . . 63.229999999999997 112.341 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -118.37 25.06 10.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.266 -0.425 . . . . 73.209999999999994 110.902 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtt85 -137.45 121.82 18.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.855 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 36' ' ' GLY . 59.0 mt -98.53 132.99 23.09 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.592 0.711 . . . . 72.400000000000006 111.177 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.77 -174.4 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.689 2.259 . . . . 71.329999999999998 112.334 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -53.05 156.67 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.916 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.03 155.0 39.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 43.299999999999997 110.84 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.1 pt -132.85 176.82 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 111.103 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -122.8 138.63 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 75.340000000000003 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG13 ' HB3' ' A' ' 31' ' ' ALA . 1.3 pt -120.82 172.56 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 75.129999999999995 111.126 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -127.53 133.28 49.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.887 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.748 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 3.1 m-85 -104.52 106.03 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.819 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -97.25 144.26 27.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.086 -0.506 . . . . 75.340000000000003 110.975 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.9 p -139.1 178.72 6.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.113 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -8.1 55.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 73.099999999999994 110.88 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -106.31 -37.66 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 61.119999999999997 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 179.82 175.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 110.949 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.77 127.67 75.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 72.010000000000005 111.155 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 HG22 ' A' ' 48' ' ' VAL . 1.4 m -117.91 150.84 47.96 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.107 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 156.17 63.86 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.627 2.218 . . . . 73.0 112.334 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -145.97 138.2 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 53.340000000000003 111.089 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -100.54 130.67 46.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 53.43 110.902 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.89 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -110.73 117.04 32.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 111.115 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.4 t -104.61 141.09 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 75.200000000000003 111.122 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.7 p -51.74 116.2 2.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 52.539999999999999 110.849 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.539 ' N ' HD13 ' A' ' 14' ' ' ILE . . . 100.92 7.38 50.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 33.130000000000003 112.486 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -100.95 -169.97 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.995 0.426 . . . . 73.200000000000003 110.852 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.733 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -144.58 142.65 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 73.140000000000001 111.153 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 83.4 t -52.45 -63.31 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.271 -0.422 . . . . 70.420000000000002 111.1 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -53.49 -33.16 53.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 65.400000000000006 110.895 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.73 -27.4 62.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.845 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 38' ' ' THR . 92.2 t -76.82 -43.06 33.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.463 . . . . 61.210000000000001 111.151 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.06 -30.13 14.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -73.62 -37.8 65.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 110.855 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.54 -40.22 50.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 74.530000000000001 110.848 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -72.11 -21.78 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.437 . . . . 74.420000000000002 110.87 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.0 -12.26 55.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 71.540000000000006 112.558 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 29' ' ' VAL . 46.7 t -57.8 113.81 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.809 0.337 . . . . 41.020000000000003 111.135 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.47 80.84 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.929 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.748 HD13 ' CG2' ' A' ' 115' ' ' VAL . 11.3 tp -111.81 128.08 56.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 110.899 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' N ' HD12 ' A' ' 50' ' ' LEU . 8.0 tt0 -52.2 113.03 0.91 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.943 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -142.99 -108.68 0.67 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.712 -0.756 . . . . 24.25 112.428 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 51.76 47.6 24.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.749 0.309 . . . . 55.299999999999997 111.095 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.93 30.61 2.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 72.329999999999998 110.912 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -101.44 88.21 3.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 64.450000000000003 110.864 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.06 30.56 76.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.756 -0.735 . . . . 75.319999999999993 112.536 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -78.62 159.8 27.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 73.329999999999998 110.785 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.19 -35.15 5.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 72.140000000000001 110.931 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.67 57.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 51.329999999999998 111.114 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.74 82.9 1.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.540000000000006 110.903 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.6 m -73.89 175.72 7.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 65.319999999999993 110.87 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.8 t -51.54 136.65 25.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 62.32 111.116 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.7 p -122.38 121.58 37.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 25.530000000000001 110.857 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -100.8 118.35 36.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 65.439999999999998 110.848 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.23 155.53 39.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 72.25 111.17 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.589 HD12 ' HD3' ' A' ' 116' ' ' PRO . 5.1 mp -90.38 132.98 33.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.465 . . . . 64.430000000000007 111.195 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.7 tp -127.37 159.31 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 64.040000000000006 110.929 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.15 146.29 1.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.019999999999996 110.915 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.6 OUTLIER -59.38 -60.25 11.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.664 0.745 . . . . 73.040000000000006 110.914 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.86 -46.22 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.28 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -54.13 -48.32 70.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.909 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.582 ' CD1' HG22 ' A' ' 95' ' ' THR . 42.1 t80 -68.23 -47.43 67.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 74.450000000000003 110.881 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.7 mmm-85 -55.62 -43.7 76.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.917 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -78.16 -26.95 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 75.0 110.908 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.0 tp -72.83 -62.56 1.41 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.937 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.48 140.17 3.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.712 -0.756 . . . . 71.329999999999998 112.473 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -132.34 157.31 78.61 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.683 0.754 . . . . 65.310000000000002 110.871 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 166.28 28.25 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.691 2.261 . . . . 62.009999999999998 112.318 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.19 170.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.447 . . . . 75.409999999999997 110.874 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -58.78 -37.19 75.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 72.409999999999997 110.879 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -52.51 -62.64 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 63.240000000000002 110.898 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.7 -35.11 78.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 71.530000000000001 110.845 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -56.89 -53.34 59.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.945 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -65.95 -42.16 90.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.144 -0.48 . . . . 71.120000000000005 110.838 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.8 tp -55.8 -37.55 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 64.219999999999999 110.954 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.3 mt -74.57 -52.04 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 63.409999999999997 111.13 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -59.04 -21.67 59.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 110.854 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.6 mm100 -76.04 -24.99 55.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.933 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -76.05 162.96 27.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.053 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -70.23 117.34 11.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 75.519999999999996 110.883 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.07 42.84 55.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 73.129999999999995 112.497 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -113.61 121.86 45.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.865 0.364 . . . . 70.219999999999999 111.086 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.7 144.1 44.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 111.135 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.59 -23.47 36.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.488 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.582 HG22 ' CD1' ' A' ' 72' ' ' TYR . 22.6 p -73.92 -2.24 23.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 64.239999999999995 111.136 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 36.6 t -90.24 -13.97 34.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 71.409999999999997 110.841 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.55 158.31 34.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 70.200000000000003 110.854 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.5 tp 56.45 67.7 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 110.954 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.21 61.68 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 71.010000000000005 112.506 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 46.1 t -133.96 -74.85 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 61.43 110.91 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.27 93.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 110.844 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 38' ' ' THR . 15.6 mt -146.18 165.52 28.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.858 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -112.03 170.61 8.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 70.209999999999994 110.868 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.89 HG11 ' HB1' ' A' ' 33' ' ' ALA . 24.3 t -94.42 115.3 32.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.127 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -136.93 176.01 9.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 72.040000000000006 110.794 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -57.2 -36.25 70.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 72.510000000000005 110.873 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 -22.35 66.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 64.510000000000005 110.885 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.428 ' CE2' HD22 ' A' ' 75' ' ' LEU . 3.7 m-85 -85.76 5.27 33.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.111 -0.495 . . . . 71.209999999999994 110.922 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.456 ' N ' HD13 ' A' ' 18' ' ' ILE . 85.5 tt0 -58.8 123.0 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 62.219999999999999 110.898 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 63.37 22.58 13.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 53.450000000000003 110.939 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 133.64 52.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 33.329999999999998 111.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.625 ' O ' HD12 ' A' ' 67' ' ' LEU . 36.7 t -106.17 118.86 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.128 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 42.5 m-85 -109.4 102.97 11.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 71.430000000000007 110.889 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.7 m -95.2 125.77 40.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.182 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.748 ' CG2' HD13 ' A' ' 50' ' ' LEU . 59.5 t -100.59 133.33 21.33 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.602 0.715 . . . . 72.129999999999995 111.154 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.589 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.9 Cg_endo -69.75 -45.28 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.699 2.266 . . . . 65.439999999999998 112.304 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -129.45 130.18 45.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 72.140000000000001 110.841 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.73 119.24 12.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 53.109999999999999 111.032 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.72 100.57 7.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 73.409999999999997 111.144 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -62.25 138.18 58.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 73.349999999999994 110.903 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -140.47 61.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.835 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -118.19 -39.6 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 74.510000000000005 110.925 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -151.02 120.29 6.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 62.43 111.082 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -55.21 -29.92 23.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.23 -0.441 . . . . 44.350000000000001 111.158 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -122.57 170.18 10.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 110.861 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 110.74 91.03 2.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 73.430000000000007 112.495 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -130.8 28.25 4.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.901 0.381 . . . . 74.310000000000002 110.823 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.68 73.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.506 0.669 . . . . 71.430000000000007 110.856 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 120.79 7.51 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.668 2.245 . . . . 73.120000000000005 112.367 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -51.52 156.87 1.98 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 72.420000000000002 110.92 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -46.1 1.34 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.669 2.246 . . . . 73.030000000000001 112.305 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.3 t60 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 72.120000000000005 110.888 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 CA-C-O 121.381 0.434 . . . . 71.299999999999997 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -170.95 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.624 2.216 . . . . 64.129999999999995 112.35 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.19 -144.49 5.86 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.741 -0.743 . . . . 41.340000000000003 112.544 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 86.1 p -156.54 179.1 9.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 73.310000000000002 110.822 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 15.8 mmt -129.02 -171.6 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.824 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -127.73 29.52 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.420000000000002 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.4 mtt -144.83 -175.5 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 62.509999999999998 110.847 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -114.35 138.43 50.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.897 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.24 -179.17 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.954 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.43 73.98 0.47 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.545 0.688 . . . . 71.340000000000003 111.11 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -171.43 0.47 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.651 2.234 . . . . 63.229999999999997 112.368 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -106.29 24.74 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.865 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -103.71 2.89 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 74.209999999999994 110.839 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.449 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -136.33 133.18 19.25 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.63 0.729 . . . . 72.400000000000006 111.148 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.77 178.1 4.92 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.696 2.264 . . . . 71.329999999999998 112.353 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -51.68 156.25 1.42 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.249 -0.432 . . . . 73.310000000000002 110.856 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.91 149.52 41.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 43.299999999999997 110.939 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.604 HG21 ' HB2' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -129.07 175.84 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 64.439999999999998 111.186 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -124.98 139.17 54.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.877 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.71 HG13 ' HB3' ' A' ' 31' ' ' ALA . 30.1 pt -125.83 164.57 25.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 111.12 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -121.37 138.93 54.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 75.219999999999999 110.892 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 9.9 m-85 -117.0 102.76 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.917 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -84.44 144.48 28.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.937 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.9 p -114.4 -157.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 65.510000000000005 111.129 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.4 ttp -50.52 -50.35 53.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 73.099999999999994 110.904 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -138.09 -33.81 0.68 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 61.119999999999997 110.842 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.12 151.93 21.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 54.409999999999997 110.949 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 28' ' ' VAL . 6.7 p -122.9 120.62 61.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.292 -0.413 . . . . 72.010000000000005 111.095 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 48' ' ' VAL . 3.7 m -109.09 136.99 20.04 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.665 0.745 . . . . 73.409999999999997 111.216 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 169.57 18.67 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.638 2.225 . . . . 73.0 112.315 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.748 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -159.38 108.7 1.87 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 53.340000000000003 111.075 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -74.1 138.0 43.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 53.43 110.873 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.787 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -113.59 116.59 29.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 111.086 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.1 t -102.57 141.42 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.200000000000003 111.132 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -51.83 114.85 1.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 52.539999999999999 110.904 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.55 11.55 50.73 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 33.130000000000003 112.488 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.553 ' OG ' HG21 ' A' ' 104' ' ' VAL . 92.2 p -94.08 -175.92 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.979 0.419 . . . . 73.200000000000003 110.806 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.753 ' O ' HG23 ' A' ' 42' ' ' VAL . 17.2 p -142.65 154.78 44.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 73.140000000000001 111.149 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 50' ' ' LEU . 47.5 t -52.4 -59.62 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.420000000000002 111.15 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.943 HD23 HD12 ' A' ' 102' ' ' LEU . 0.8 OUTLIER -53.93 -34.94 61.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 65.400000000000006 110.903 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.81 -26.94 61.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 72.450000000000003 110.862 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 38' ' ' THR . 91.1 t -76.31 -47.13 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 61.210000000000001 111.104 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -55.61 -28.48 55.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 62.219999999999999 111.059 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -69.49 -32.93 72.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.419 . . . . 75.200000000000003 110.824 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.47 -53.76 21.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 74.530000000000001 110.918 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -72.38 -26.6 61.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.869 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.44 -4.26 40.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.813 -0.708 . . . . 71.540000000000006 112.483 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.569 HG22 HG21 ' A' ' 29' ' ' VAL . 38.8 t -51.79 141.41 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 41.020000000000003 111.127 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -88.3 80.79 7.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.832 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD2' HG12 ' A' ' 39' ' ' VAL . 10.6 tp -93.5 114.34 26.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 70.430000000000007 110.876 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.579 ' HB2' HG23 ' A' ' 62' ' ' THR . 48.0 mm-40 -62.43 151.51 36.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 53.100000000000001 110.876 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -142.72 23.73 2.31 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 24.25 112.445 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.33 112.6 25.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.804 0.335 . . . . 55.299999999999997 111.105 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.55 -26.02 41.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 72.329999999999998 110.958 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -75.91 -25.98 56.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 64.450000000000003 110.915 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -52.22 155.29 4.75 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.728 . . . . 75.319999999999993 112.457 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -101.51 -61.41 1.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 73.329999999999998 110.928 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 tp -53.19 -28.76 28.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 110.854 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.22 123.37 8.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 51.329999999999998 111.157 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 t -103.84 66.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.540000000000006 110.839 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m 57.73 36.11 26.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 65.319999999999993 110.924 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.579 HG23 ' HB2' ' A' ' 51' ' ' GLU . 14.5 p 49.93 43.3 25.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 62.32 111.118 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.6 t -58.64 -27.15 64.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 25.530000000000001 110.856 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -117.39 101.66 8.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 65.439999999999998 110.887 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 98' ' ' LEU . 10.7 m -129.54 164.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 72.25 111.105 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mt -88.84 133.2 31.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 64.430000000000007 111.148 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 112' ' ' VAL . 35.6 tp -126.55 153.93 44.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 64.040000000000006 110.907 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.8 146.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 71.019999999999996 110.852 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -54.86 -60.46 7.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.674 0.749 . . . . 73.040000000000006 110.829 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.69 -44.75 1.94 Allowed 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.7 2.267 . . . . 54.219999999999999 112.304 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -52.48 -45.31 66.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 73.209999999999994 110.951 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.618 ' HD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -72.79 -49.91 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.450000000000003 111.0 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ttp85 -53.14 -37.85 62.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.079 -0.509 . . . . 65.439999999999998 110.897 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.2 mttm -76.07 -46.21 30.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 75.0 110.944 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 71' ' ' LEU . 2.1 mm? -63.2 -22.81 67.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 110.869 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.7 136.17 3.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 71.329999999999998 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -112.2 157.41 39.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.634 0.73 . . . . 65.310000000000002 110.931 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -170.67 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.688 2.258 . . . . 62.009999999999998 112.379 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.5 t -120.94 -170.67 2.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 75.409999999999997 110.854 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -55.27 -46.4 76.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.898 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -54.43 -58.84 5.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 63.240000000000002 110.87 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.78 -28.18 69.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 71.530000000000001 110.874 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -55.48 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.488 . . . . 74.329999999999998 110.902 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.95 -40.91 87.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 110.861 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.07 -50.86 69.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 64.219999999999999 110.923 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.784 HD13 ' HA2' ' A' ' 94' ' ' GLY . 22.5 mt -74.08 -35.04 40.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.128 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.48 -17.65 60.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.915 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -76.18 -24.42 54.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.909 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.612 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -78.2 164.37 24.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 71.129999999999995 111.069 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -80.85 113.84 19.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.866 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.08 40.83 52.07 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 73.129999999999995 112.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -96.53 125.17 40.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.839 0.352 . . . . 70.219999999999999 111.12 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.68 143.8 30.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 111.203 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.784 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.35 -23.98 36.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.798 -0.715 . . . . 75.129999999999995 112.481 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.618 HG22 ' HD1' ' A' ' 72' ' ' TYR . 20.3 p -73.42 -3.27 26.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.146 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 t -86.83 -16.02 37.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.821 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -120.62 157.91 28.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 70.200000000000003 110.855 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 99' ' ' GLY . 4.1 pp -166.34 -179.46 5.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 110.933 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.546 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -76.82 -130.51 0.41 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 71.010000000000005 112.489 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.78 84.7 1.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 61.43 110.853 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.569 ' C ' HD22 ' A' ' 102' ' ' LEU . 37.9 mt-30 -122.45 132.77 54.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 64.439999999999998 110.968 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.943 HD12 HD23 ' A' ' 40' ' ' LEU . 4.6 mm? -126.84 67.25 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.272 -0.422 . . . . 65.25 110.885 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -152.26 160.25 43.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 70.209999999999994 110.819 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.787 HG11 ' HB1' ' A' ' 33' ' ' ALA . 99.4 t -105.5 129.89 57.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.239999999999995 111.132 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.39 167.94 20.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 72.040000000000006 110.883 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -57.05 -31.06 64.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 72.510000000000005 110.866 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.76 -28.24 69.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 110.851 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.626 ' O ' HG22 ' A' ' 20' ' ' ILE . 3.0 m-85 -75.98 -6.12 49.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.209999999999994 110.936 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.604 ' HB2' HG21 ' A' ' 18' ' ' ILE . 84.5 tt0 -58.72 124.15 18.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 62.219999999999999 110.893 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 61.01 22.85 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 53.450000000000003 110.915 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -79.15 138.32 37.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 33.329999999999998 111.091 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.706 ' O ' HD12 ' A' ' 67' ' ' LEU . 8.0 t -107.32 111.76 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 73.010000000000005 111.145 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 67' ' ' LEU . 77.9 m-85 -105.89 104.62 14.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 71.430000000000007 110.895 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.41 HG23 ' HD2' ' A' ' 23' ' ' LYS . 72.8 m -93.35 125.52 38.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 73.439999999999998 111.134 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.44 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.1 t -85.01 133.45 43.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 72.129999999999995 111.137 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.9 Cg_endo -69.75 -165.63 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.716 2.278 . . . . 65.439999999999998 112.374 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.55 149.84 23.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 110.926 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.02 103.2 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 53.109999999999999 111.094 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.5 t -138.19 172.61 12.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 73.409999999999997 111.128 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.18 169.12 18.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 73.349999999999994 110.882 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -122.22 -40.92 2.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.329999999999998 110.881 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.5 mtt 61.58 61.83 1.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.510000000000005 110.937 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.45 175.23 6.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 62.43 111.1 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.98 133.66 61.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 44.350000000000001 111.099 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -133.47 144.06 49.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 71.030000000000001 110.868 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -152.43 65.41 0.35 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 73.430000000000007 112.478 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -114.14 123.13 48.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 74.310000000000002 110.926 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.83 157.64 77.83 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.568 0.699 . . . . 71.430000000000007 110.951 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 150.73 68.21 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.321 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.6 tptm -139.89 70.46 36.09 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.496 0.665 . . . . 72.420000000000002 110.868 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -46.24 1.3 Allowed 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.651 2.234 . . . . 73.030000000000001 112.359 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.233 -0.439 . . . . 72.120000000000005 110.803 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-O 121.48 0.489 . . . . 71.299999999999997 112.514 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -44.87 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.681 2.254 . . . . 64.129999999999995 112.35 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 111.73 -152.3 17.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.776 -0.726 . . . . 41.340000000000003 112.474 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -172.04 158.17 4.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.872 0.368 . . . . 73.310000000000002 110.865 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -145.64 -177.65 5.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 73.430000000000007 110.855 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.02 107.04 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.9 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.5 tpp -145.63 119.47 9.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.509999999999998 110.891 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -149.84 166.56 29.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 71.439999999999998 110.937 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.5 t -115.07 -170.04 1.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 110.862 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -162.3 73.07 2.25 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.533 0.682 . . . . 71.340000000000003 111.128 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.82 -173.46 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.681 2.254 . . . . 63.229999999999997 112.298 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -120.78 25.09 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 110.876 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -156.17 131.75 9.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.909 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.704 HD11 ' HD2' ' A' ' 103' ' ' ARG . 43.5 mm -57.98 124.65 70.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.629 0.728 . . . . 72.400000000000006 111.131 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -169.64 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.659 2.239 . . . . 71.329999999999998 112.399 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -51.02 157.44 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.93 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.82 136.37 38.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 43.299999999999997 110.987 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.5 pp -124.58 176.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 64.439999999999998 111.142 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -120.42 136.78 54.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 75.340000000000003 110.819 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.519 HG13 ' HB3' ' A' ' 31' ' ' ALA . 12.6 pt -115.97 169.21 6.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.135 -0.484 . . . . 75.129999999999995 111.186 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.45 ' HD1' HG22 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -118.6 126.72 52.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.83 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 2.4 m-85 -96.56 103.12 15.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.855 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER -91.4 122.84 34.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 75.340000000000003 110.904 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.0 p -113.47 -178.12 3.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 65.510000000000005 111.124 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.737 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . 2.8 ttm -75.8 -8.18 56.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.871 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt -108.21 -37.89 5.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 61.119999999999997 110.893 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 179.79 176.18 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.932 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG22 ' HD1' ' A' ' 21' ' ' PHE . 13.7 p -108.46 132.76 55.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 111.086 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.638 HG21 HG22 ' A' ' 48' ' ' VAL . 1.7 m -122.48 151.03 59.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 73.409999999999997 111.161 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 147.26 62.48 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.687 2.258 . . . . 73.0 112.302 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.554 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -146.83 104.2 3.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 53.340000000000003 111.129 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt -76.46 132.22 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 53.43 110.953 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -109.64 133.65 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.052 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.08 152.2 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.079 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.6 t -52.4 111.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 52.539999999999999 110.932 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.16 17.15 35.54 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.765 -0.731 . . . . 33.130000000000003 112.49 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 104' ' ' VAL . 54.0 p -107.52 163.56 12.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.922 0.392 . . . . 73.200000000000003 110.879 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -123.4 154.07 39.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 73.140000000000001 111.126 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 20' ' ' ILE . 15.9 m -55.83 -44.72 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 70.420000000000002 111.111 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' HA3' ' A' ' 52' ' ' GLY . 15.5 mt -56.76 -44.17 81.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 65.400000000000006 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' CG ' HG23 ' A' ' 38' ' ' THR . 35.2 m-20 -72.72 -26.83 61.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 72.450000000000003 110.929 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 38' ' ' THR . 77.2 t -75.23 -31.17 23.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 61.210000000000001 111.164 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.0 -33.28 70.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 111.118 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -73.43 -35.83 65.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.839 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 mmmm -64.72 -46.96 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.832 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.31 -24.62 59.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.938 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.18 -11.85 40.37 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.742 -0.742 . . . . 71.540000000000006 112.471 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG22 HG21 ' A' ' 29' ' ' VAL . 39.0 t -51.48 136.24 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.78 0.324 . . . . 41.020000000000003 111.177 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -79.84 80.96 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.834 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.5 tp -144.18 109.51 5.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 70.430000000000007 110.93 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -106.47 138.84 41.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 53.100000000000001 110.888 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 40' ' ' LEU . . . -148.98 45.37 0.71 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.714 -0.755 . . . . 24.25 112.439 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.68 94.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 55.299999999999997 111.117 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.405 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.5 OUTLIER -94.29 41.25 1.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.329999999999998 110.926 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -106.93 124.55 49.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 64.450000000000003 110.887 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.39 -175.76 28.4 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.703 -0.761 . . . . 75.319999999999993 112.494 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -75.89 -42.58 48.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.922 0.392 . . . . 73.329999999999998 110.881 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.78 101.14 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.917 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 54' ' ' CYS . . . -171.4 174.34 4.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 51.329999999999998 111.055 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.5 p -58.62 162.58 3.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 74.540000000000006 110.839 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.0 m -131.38 -66.83 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 65.319999999999993 110.838 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -85.68 125.38 33.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 62.32 111.129 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.4 m -93.32 60.07 3.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 25.530000000000001 110.88 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -69.36 90.6 0.52 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.16 -0.473 . . . . 65.439999999999998 110.806 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 114' ' ' THR . 6.5 t -128.59 157.4 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 72.25 111.193 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.8 mp -89.63 134.72 27.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 64.430000000000007 111.137 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.3 tp -129.03 158.52 38.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 64.040000000000006 110.876 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.45 142.74 2.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.9 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.4 mt-10 -56.91 -60.16 10.33 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.708 0.766 . . . . 73.040000000000006 110.879 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.82 -48.95 0.6 Allowed 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.721 2.28 . . . . 54.219999999999999 112.288 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.616 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.58 -41.9 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.756 ' CD1' HG22 ' A' ' 95' ' ' THR . 68.7 t80 -72.51 -52.72 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.966 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 -35.26 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.086 -0.506 . . . . 65.439999999999998 110.83 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -77.94 -44.54 26.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.162 -0.472 . . . . 75.0 110.951 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 107' ' ' SER . 1.5 mm? -63.24 -24.3 67.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 75.209999999999994 110.874 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.24 156.31 6.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.811 -0.709 . . . . 71.329999999999998 112.493 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -119.99 157.62 52.33 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.609 0.719 . . . . 65.310000000000002 110.865 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 156.6 62.79 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.64 2.226 . . . . 62.009999999999998 112.296 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.9 t -90.36 -169.66 2.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.867 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.62 -47.51 76.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 72.409999999999997 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -54.02 -59.75 4.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 63.240000000000002 110.869 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.3 mp0 -61.11 -27.94 68.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 71.530000000000001 110.909 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -63.02 -56.35 17.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.924 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -65.98 -40.34 91.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 71.120000000000005 110.909 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 mt -56.93 -51.38 69.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 64.219999999999999 110.904 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.617 HD13 ' HA2' ' A' ' 94' ' ' GLY . 13.7 mt -73.59 -35.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 63.409999999999997 111.171 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -61.84 -18.07 58.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.863 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -76.01 -24.13 55.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.886 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -84.5 146.71 27.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.21 -0.45 . . . . 71.129999999999995 111.158 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -71.2 122.23 19.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.434 . . . . 75.519999999999996 110.859 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.98 45.08 56.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.736 -0.745 . . . . 73.129999999999995 112.479 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -100.8 124.86 47.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.89 0.376 . . . . 70.219999999999999 111.111 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 144.02 25.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 111.139 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.617 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.77 -24.82 42.24 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 75.129999999999995 112.423 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.756 HG22 ' CD1' ' A' ' 72' ' ' TYR . 28.2 p -74.09 -2.18 23.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.72 0.295 . . . . 64.239999999999995 111.071 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 1.3 t -90.72 -13.03 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.425 . . . . 71.409999999999997 110.933 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -144.05 136.67 26.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 70.200000000000003 110.947 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD13 ' NE2' ' A' ' 101' ' ' GLN . 4.3 tt -134.36 -61.25 0.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 73.450000000000003 110.889 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.17 -90.46 0.11 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.668 -0.777 . . . . 71.010000000000005 112.446 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.92 110.42 2.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.774 0.321 . . . . 61.43 110.916 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.458 ' NE2' HD13 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -131.17 118.79 20.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 64.439999999999998 110.894 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.2 37.18 3.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 65.25 110.904 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.704 ' HD2' HD11 ' A' ' 14' ' ' ILE . 7.8 mmt85 -137.22 147.81 46.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 70.209999999999994 110.908 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.698 HG21 ' HB1' ' A' ' 33' ' ' ALA . 88.3 t -104.18 129.94 55.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 111.128 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -136.74 164.16 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.894 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -54.84 -26.4 35.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 72.510000000000005 110.873 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.652 ' HB2' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -62.43 -29.2 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.510000000000005 110.825 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 21.3 m-85 -91.21 12.52 19.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.209999999999994 110.922 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HA ' HD13 ' A' ' 18' ' ' ILE . 69.3 tt0 -59.65 111.89 1.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.16 -0.473 . . . . 62.219999999999999 110.89 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 63.76 20.61 12.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 53.450000000000003 110.883 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.512 ' HB3' ' HE1' ' A' ' 113' ' ' PHE . . . -67.99 151.07 47.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 33.329999999999998 111.128 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.662 ' O ' HD12 ' A' ' 67' ' ' LEU . 22.2 t -105.73 115.73 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 111.178 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' HE1' ' HB3' ' A' ' 111' ' ' ALA . 34.6 m-85 -108.87 104.36 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.430000000000007 110.825 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.422 ' O ' HG12 ' A' ' 65' ' ' VAL . 88.2 m -95.08 130.86 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.187 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' HD2' ' A' ' 116' ' ' PRO . 59.3 t -97.48 133.21 23.98 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.591 0.71 . . . . 72.129999999999995 111.195 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.612 ' HD3' HD12 ' A' ' 66' ' ' ILE . 54.4 Cg_endo -69.6 -47.79 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.695 2.263 . . . . 65.439999999999998 112.423 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -80.56 128.34 33.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 72.140000000000001 110.862 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.737 ' HB3' ' HB2' ' A' ' 25' ' ' MET . . . -176.94 -179.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 53.109999999999999 111.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -52.55 117.5 2.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 111.155 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -110.23 109.53 20.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 73.349999999999994 110.926 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -108.05 54.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.879 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 9.0 ptm 39.62 41.56 0.79 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 74.510000000000005 110.836 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.64 79.84 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.316 -0.402 . . . . 62.43 111.076 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.11 123.08 50.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 44.350000000000001 111.136 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -172.5 115.14 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.147 -0.479 . . . . 71.030000000000001 110.894 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.79 -159.82 33.43 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.787 -0.721 . . . . 73.430000000000007 112.494 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -160.14 117.52 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.948 0.404 . . . . 74.310000000000002 110.846 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -100.44 136.13 20.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.508 0.67 . . . . 71.430000000000007 110.876 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 177.75 5.25 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.66 2.24 . . . . 73.120000000000005 112.398 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.58 73.74 2.13 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.528 0.68 . . . . 72.420000000000002 110.91 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -172.71 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.696 2.264 . . . . 73.030000000000001 112.319 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 110.848 179.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 121.407 0.448 . . . . 71.299999999999997 112.451 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -179.29 2.77 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.701 2.267 . . . . 64.129999999999995 112.433 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.32 -161.21 28.84 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.821 -0.704 . . . . 41.340000000000003 112.483 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.9 m -146.64 111.84 5.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.878 0.371 . . . . 73.310000000000002 110.813 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.3 tpp -107.79 160.68 15.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 73.430000000000007 110.855 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.45 99.24 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.886 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.1 mtm -140.96 151.4 44.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.264 -0.425 . . . . 62.509999999999998 110.903 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.35 136.07 37.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.439999999999998 110.851 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -170.56 -179.56 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.921 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.91 68.41 55.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.672 0.749 . . . . 71.340000000000003 111.123 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -171.24 0.45 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.63 2.22 . . . . 63.229999999999997 112.335 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -113.36 24.92 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 110.9 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 -165.0 136.65 4.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.896 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' A' ' 103' ' ' ARG . 39.7 mm -70.59 132.92 87.04 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.659 0.742 . . . . 72.400000000000006 111.133 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.3 Cg_endo -69.78 -170.34 0.39 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.627 2.218 . . . . 71.329999999999998 112.359 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -51.86 156.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 73.310000000000002 110.865 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.74 132.93 43.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 43.299999999999997 110.875 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.6 pp -120.12 177.27 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.137 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -112.18 151.78 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.872 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.629 HD12 ' HE1' ' A' ' 113' ' ' PHE . 2.2 pt -135.34 165.45 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.064 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' HB3' HG13 ' A' ' 112' ' ' VAL . 2.9 m-85 -112.2 125.17 53.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.949 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -91.29 103.14 15.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 71.329999999999998 110.899 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' CD ' HG22 ' A' ' 28' ' ' VAL . 32.0 tptt -101.35 118.3 36.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 75.340000000000003 110.843 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -124.6 171.2 10.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 65.510000000000005 111.158 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 58.4 mmm -75.83 -7.96 55.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 73.099999999999994 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -97.7 -38.04 9.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 61.119999999999997 110.93 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 179.45 176.25 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 54.409999999999997 110.933 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.674 HG22 ' CD ' ' A' ' 23' ' ' LYS . 17.9 t -111.74 124.56 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.010000000000005 111.113 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG23 ' HB3' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.62 150.49 76.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.111 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 155.38 65.92 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.65 2.233 . . . . 73.0 112.326 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' HG11 ' A' ' 42' ' ' VAL . . . -143.45 141.46 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 111.099 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -106.15 131.65 53.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 53.43 110.929 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.78 116.54 32.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 111.059 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.36 151.69 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.299 -0.409 . . . . 75.200000000000003 111.126 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.3 t -52.93 109.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 52.539999999999999 110.925 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.13 20.02 31.72 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.485 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.3 p -100.8 163.32 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.973 0.415 . . . . 73.200000000000003 110.877 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 p -130.99 152.92 49.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 73.140000000000001 111.146 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.596 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.02 -60.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 70.420000000000002 111.131 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.12 -34.25 59.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 65.400000000000006 110.922 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -72.46 -26.77 61.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 72.450000000000003 110.789 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 38' ' ' THR . 63.8 t -76.94 -45.06 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 61.210000000000001 111.142 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -51.64 -29.95 19.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 62.219999999999999 111.037 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -71.66 -36.77 70.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 110.943 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -79.38 -45.23 19.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.886 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -72.19 -25.4 61.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.66 -12.19 56.49 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 71.540000000000006 112.462 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.646 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 87.2 t -52.66 105.56 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.914 0.388 . . . . 41.020000000000003 111.136 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.644 ' O ' HD22 ' A' ' 50' ' ' LEU . 31.1 t0 -81.77 81.11 7.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 75.209999999999994 110.839 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 49' ' ' ASP . 2.0 mm? -135.3 105.67 6.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 70.430000000000007 110.907 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -55.54 130.36 42.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 53.100000000000001 110.826 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.32 26.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.655 -0.783 . . . . 24.25 112.457 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -76.11 158.92 31.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 55.299999999999997 111.132 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 3.0 t -94.38 56.4 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.896 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -175.45 142.47 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 64.450000000000003 110.874 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.86 -96.44 0.17 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.72 -0.753 . . . . 75.319999999999993 112.518 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -60.41 -179.47 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.893 0.378 . . . . 73.329999999999998 110.834 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 59' ' ' ALA . 3.6 pp -52.53 -29.62 26.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 72.140000000000001 110.89 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' N ' HD12 ' A' ' 58' ' ' LEU . . . -154.47 144.26 21.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 51.329999999999998 111.121 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 40.6 t -64.7 96.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 74.540000000000006 110.921 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.3 p -99.36 27.38 5.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 65.319999999999993 110.85 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.0 p -117.39 24.67 10.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 62.32 111.144 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.89 -25.62 40.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 25.530000000000001 110.91 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -84.88 113.77 21.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 65.439999999999998 110.875 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.38 157.16 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.073 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -89.81 137.54 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 111.058 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.46 158.36 37.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 64.040000000000006 110.865 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.52 142.4 4.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 71.019999999999996 110.863 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.516 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.8 mt-10 -58.64 -59.23 14.3 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.53 0.681 . . . . 73.040000000000006 110.876 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.81 -47.97 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 54.219999999999999 112.364 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -52.47 -48.78 65.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.957 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.425 ' CD1' HG22 ' A' ' 95' ' ' THR . 28.9 t80 -65.11 -51.7 59.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.924 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -30.11 44.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 65.439999999999998 110.843 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -75.49 -52.34 10.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 75.0 110.878 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.07 -23.19 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.451 . . . . 75.209999999999994 110.899 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.12 151.7 5.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 71.329999999999998 112.525 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -132.13 157.63 77.71 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 65.310000000000002 110.872 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -172.07 0.54 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.667 2.245 . . . . 62.009999999999998 112.334 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.2 p -111.24 -176.92 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 110.851 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -55.77 -44.84 78.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -53.79 -59.7 4.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 63.240000000000002 110.854 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.548 ' O ' HD12 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -62.33 -28.07 69.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.530000000000001 110.878 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.28 -55.16 31.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 110.949 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -67.94 -41.03 83.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.084 -0.507 . . . . 71.120000000000005 110.821 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mp -54.62 -52.24 62.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 110.917 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.768 HD13 ' HA2' ' A' ' 94' ' ' GLY . 10.9 mt -73.7 -35.02 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 63.409999999999997 111.101 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.79 -19.17 58.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 110.856 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -76.07 -24.0 55.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.924 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.96 151.44 27.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 71.129999999999995 111.061 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -69.73 120.26 15.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 75.519999999999996 110.916 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.67 44.09 54.15 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.726 -0.75 . . . . 73.129999999999995 112.537 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -112.11 132.64 54.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 70.219999999999999 111.082 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.41 153.93 44.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 75.109999999999999 111.145 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.768 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.86 -26.77 48.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 75.129999999999995 112.453 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.5 p -74.09 -0.99 18.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 64.239999999999995 111.133 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 25.5 t -90.89 -14.0 32.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 71.409999999999997 110.858 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 mtt-85 -102.93 160.81 14.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 70.200000000000003 110.887 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.621 HD12 HD22 ' A' ' 102' ' ' LEU . 0.2 OUTLIER -176.6 125.62 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.895 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' N ' HD13 ' A' ' 98' ' ' LEU . . . -61.13 -166.94 0.37 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.467 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 21.8 m -89.07 49.46 1.78 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.777 0.322 . . . . 61.43 110.887 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -128.92 41.89 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 64.439999999999998 110.919 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.621 HD22 HD12 ' A' ' 98' ' ' LEU . 4.4 mm? -76.88 65.05 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 65.25 110.911 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.422 ' HG2' HD11 ' A' ' 14' ' ' ILE . 5.1 tpp85 -109.46 158.43 17.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.457 . . . . 70.209999999999994 110.913 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.7 t -80.93 127.23 39.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.157 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 161.14 36.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 72.040000000000006 110.838 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.403 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -55.5 -36.82 67.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 72.510000000000005 110.885 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -21.44 66.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 64.510000000000005 110.849 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.73 1.82 40.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 71.209999999999994 110.845 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.88 124.14 17.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.914 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 59.11 26.26 14.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 53.450000000000003 110.895 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -88.07 130.42 35.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 33.329999999999998 111.03 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.746 HG13 ' HB3' ' A' ' 21' ' ' PHE . 15.3 t -97.91 126.78 50.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 73.010000000000005 111.099 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.629 ' HE1' HD12 ' A' ' 20' ' ' ILE . 31.9 p90 -120.74 132.61 55.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 71.430000000000007 110.867 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.47 HG23 ' HG3' ' A' ' 23' ' ' LYS . 89.8 m -104.72 130.9 52.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 111.16 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.6 t -93.31 133.3 28.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.571 0.701 . . . . 72.129999999999995 111.105 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.8 Cg_endo -69.82 -165.45 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.719 2.28 . . . . 65.439999999999998 112.355 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.61 104.15 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 72.140000000000001 110.794 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -91.56 -75.41 0.48 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.216 -0.447 . . . . 53.109999999999999 111.167 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.7 t -174.12 173.53 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 73.409999999999997 111.095 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -62.99 -171.83 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 73.349999999999994 110.876 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.34 179.27 8.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 73.329999999999998 110.842 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.1 ttm -131.45 157.96 42.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 74.510000000000005 110.831 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.9 173.47 2.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.117 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.6 t -107.95 141.6 22.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 44.350000000000001 111.059 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.65 172.98 2.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 71.030000000000001 110.929 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 169.3 -70.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.707 -0.758 . . . . 73.430000000000007 112.497 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -52.4 114.62 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.92 0.391 . . . . 74.310000000000002 110.888 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -174.15 71.56 0.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.548 0.689 . . . . 71.430000000000007 110.87 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -48.24 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.66 2.24 . . . . 73.120000000000005 112.374 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 tptp -175.66 73.6 0.28 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 72.420000000000002 110.852 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 122.17 8.83 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.615 2.21 . . . . 73.030000000000001 112.332 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.120000000000005 110.873 179.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 CA-C-O 121.454 0.475 . . . . 71.299999999999997 112.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 172.88 11.81 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.735 2.29 . . . . 64.129999999999995 112.332 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 94.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.811 -0.709 . . . . 41.340000000000003 112.549 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -130.39 133.3 46.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 110.878 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 5.2 ptp -146.87 135.51 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.075 -0.511 . . . . 73.430000000000007 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -86.47 165.51 16.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.852 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 34.8 mtt -55.34 171.63 0.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 62.509999999999998 110.844 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -141.81 141.47 33.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 71.439999999999998 110.854 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -137.98 140.19 40.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 72.439999999999998 110.841 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 14' ' ' ILE . . . -129.91 69.67 81.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.508 0.671 . . . . 71.340000000000003 111.074 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.74 -25.11 29.01 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.719 2.279 . . . . 63.229999999999997 112.353 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.17 25.11 11.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.881 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 ttm-85 58.39 54.71 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.851 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -81.61 133.0 53.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.591 0.71 . . . . 72.400000000000006 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.4 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.271 . . . . 71.329999999999998 112.308 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -52.3 156.76 1.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.244 -0.435 . . . . 73.310000000000002 110.883 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.04 159.27 32.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 43.299999999999997 110.859 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.7 pt -139.66 176.78 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.434 . . . . 64.439999999999998 111.134 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -124.08 130.59 52.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.836 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 108' ' ' PHE . 2.7 pt -114.5 162.66 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 75.129999999999995 111.103 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -114.5 136.18 53.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 75.219999999999999 110.847 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.571 ' HZ ' HG13 ' A' ' 39' ' ' VAL . 5.1 m-85 -106.18 108.31 19.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 71.329999999999998 110.896 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 134.56 38.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.483 . . . . 75.340000000000003 110.923 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -125.18 -178.95 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 65.510000000000005 111.175 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.1 ttp -75.78 -8.03 55.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.918 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.62 -37.97 6.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 61.119999999999997 110.911 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.661 ' OE1' HG12 ' A' ' 124' ' ' VAL . 2.0 pt20 179.26 176.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 54.409999999999997 110.93 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.5 p -110.42 135.78 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 72.010000000000005 111.113 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG13 HE21 ' A' ' 27' ' ' GLN . 0.4 OUTLIER -126.87 150.18 70.91 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.687 . . . . 73.409999999999997 111.183 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 150.75 68.66 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 73.0 112.348 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.639 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -148.5 116.22 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 53.340000000000003 111.054 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.1 mttm -74.22 131.52 41.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 53.43 110.898 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.011 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -107.1 127.98 53.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.102 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.93 147.09 12.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.133 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 p -52.41 113.89 1.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 52.539999999999999 110.884 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.44 25.19 51.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 33.130000000000003 112.468 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 104' ' ' VAL . 24.9 t -97.27 163.28 12.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.944 0.402 . . . . 73.200000000000003 110.891 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.1 p -121.14 165.28 15.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.087 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.571 HG13 ' HZ ' ' A' ' 22' ' ' PHE . 88.3 t -52.02 -56.26 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.420000000000002 111.137 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' H ' HD12 ' A' ' 40' ' ' LEU . 4.4 mp -56.77 -35.6 68.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 65.400000000000006 110.789 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.62 -26.76 61.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.262 -0.426 . . . . 72.450000000000003 110.893 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 88.4 t -76.67 -41.39 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 61.210000000000001 111.126 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 48' ' ' VAL . . . -54.96 -30.2 58.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 62.219999999999999 111.115 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -74.13 -24.84 59.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.834 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -76.62 -54.2 6.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 110.896 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.473 HD22 ' HB2' ' A' ' 31' ' ' ALA . 43.8 p30 -77.82 -14.22 59.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 74.420000000000002 110.883 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.76 -12.42 69.42 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.463 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 93.9 t -57.33 143.15 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 41.020000000000003 111.124 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -115.88 81.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.84 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD22 HG21 ' A' ' 115' ' ' VAL . 7.2 mt -85.68 114.99 23.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.869 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -70.6 113.42 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 53.100000000000001 110.913 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.88 95.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.679 -0.772 . . . . 24.25 112.448 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.88 125.6 25.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 55.299999999999997 111.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 5.7 p -122.23 76.17 1.29 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.879 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -114.7 -27.87 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 64.450000000000003 110.924 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -154.04 -52.87 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 75.319999999999993 112.531 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -61.82 -176.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.907 0.384 . . . . 73.329999999999998 110.881 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp -51.94 166.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.943 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.5 146.27 16.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 51.329999999999998 111.075 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 p -85.31 -170.4 3.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.884 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -104.27 53.96 0.74 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 110.857 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.839 HG21 HD21 ' A' ' 102' ' ' LEU . 96.1 m -115.23 -35.92 4.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.145 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 18.2 m -82.53 -67.65 0.77 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 25.530000000000001 110.837 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -77.13 78.69 3.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 65.439999999999998 110.791 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 114' ' ' THR . 5.7 t -128.46 157.92 40.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 72.25 111.17 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.484 HD12 ' HD3' ' A' ' 116' ' ' PRO . 3.2 mp -90.18 130.91 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 111.134 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 112' ' ' VAL . 15.7 tp -126.03 163.9 22.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 64.040000000000006 110.91 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -40.65 138.45 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.019999999999996 110.91 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.7 OUTLIER -60.77 -58.64 17.85 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.677 0.751 . . . . 73.040000000000006 110.945 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.4 Cg_endo -69.71 -49.1 0.6 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.749 2.299 . . . . 54.219999999999999 112.327 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.537 HD22 ' HB1' ' A' ' 111' ' ' ALA . 0.4 OUTLIER -52.25 -49.05 64.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.918 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.639 ' CD1' HG22 ' A' ' 95' ' ' THR . 52.6 t80 -64.9 -51.33 62.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 74.450000000000003 110.88 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -27.24 62.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 65.439999999999998 110.862 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.4 mttp -75.9 -54.66 6.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 75.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.5 mt -63.04 -21.48 66.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.965 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 145.02 142.77 3.89 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.742 -0.742 . . . . 71.329999999999998 112.508 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.51 157.57 77.05 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 65.310000000000002 110.872 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 157.27 60.86 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.635 2.223 . . . . 62.009999999999998 112.316 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.2 m -58.14 157.34 8.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.409999999999997 110.843 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -51.73 -35.78 44.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.143 -0.48 . . . . 72.409999999999997 110.896 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.45 -62.92 1.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 63.240000000000002 110.909 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -66.71 -35.82 81.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 71.530000000000001 110.923 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.61 -56.6 19.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.9 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -62.15 -41.29 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.908 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.2 tt -57.21 -38.26 73.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 64.219999999999999 110.936 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.479 HD13 ' HA2' ' A' ' 94' ' ' GLY . 12.5 mt -75.04 -36.75 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 111.078 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.18 -22.26 27.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 74.030000000000001 110.857 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.43 -29.7 59.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.891 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -75.67 131.09 39.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.041 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -54.44 130.08 38.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.48 48.18 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.718 . . . . 73.129999999999995 112.458 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.584 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -117.55 151.06 37.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.835 0.35 . . . . 70.219999999999999 111.162 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.74 153.01 22.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.174 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.479 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -27.39 48.84 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.67 -0.776 . . . . 75.129999999999995 112.453 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.9 p -73.94 -1.43 19.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 64.239999999999995 111.174 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.0 t -87.61 -13.88 41.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 71.409999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 131.92 24.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.814 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 tt -135.07 -64.25 0.66 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 166.94 -176.68 41.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.769 -0.729 . . . . 71.010000000000005 112.511 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.12 109.27 20.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.77 0.319 . . . . 61.43 110.866 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.576 ' C ' HD22 ' A' ' 102' ' ' LEU . 7.7 mt-30 -163.81 134.68 4.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 64.439999999999998 110.891 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 62' ' ' THR . 4.5 mm? -126.78 83.79 2.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 65.25 110.924 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -152.0 146.63 25.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.884 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.011 HG11 ' HB1' ' A' ' 33' ' ' ALA . 71.0 t -109.88 131.68 60.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.203 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.42 167.47 21.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.040000000000006 110.835 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -58.59 -22.05 54.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.926 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -29.46 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 64.510000000000005 110.853 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.453 ' O ' HG22 ' A' ' 20' ' ' ILE . 20.0 m-85 -90.78 7.54 39.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 71.209999999999994 110.868 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' HG21 ' A' ' 18' ' ' ILE . 61.4 tt0 -57.63 123.15 14.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 110.878 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.4 25.36 14.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 53.450000000000003 110.907 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.537 ' HB1' HD22 ' A' ' 71' ' ' LEU . . . -86.23 162.52 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 33.329999999999998 111.078 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.567 ' O ' HD12 ' A' ' 67' ' ' LEU . 13.5 t -112.72 125.29 69.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 111.175 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -111.76 94.72 5.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 71.430000000000007 110.904 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.434 ' O ' HG12 ' A' ' 65' ' ' VAL . 56.1 m -89.32 130.97 35.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 73.439999999999998 111.158 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.566 HG21 HD22 ' A' ' 50' ' ' LEU . 59.6 t -104.4 133.35 20.25 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.6 0.715 . . . . 72.129999999999995 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD3' HD12 ' A' ' 66' ' ' ILE . 53.3 Cg_endo -69.76 -41.15 4.53 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.702 2.268 . . . . 65.439999999999998 112.303 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.29 124.11 28.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.831 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -162.16 -170.5 2.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 53.109999999999999 111.097 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -140.23 143.5 36.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 73.409999999999997 111.053 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -174.25 158.59 2.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 110.888 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -126.67 69.4 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 110.909 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 75.5 mmm -141.72 -169.96 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.510000000000005 110.862 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.12 114.46 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 62.43 111.078 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.661 HG12 ' OE1' ' A' ' 27' ' ' GLN . 10.6 p -174.65 150.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 44.350000000000001 111.144 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -123.95 147.37 47.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 71.030000000000001 110.905 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 164.62 130.89 1.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.767 -0.73 . . . . 73.430000000000007 112.508 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -120.55 -172.28 2.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.96 0.41 . . . . 74.310000000000002 110.89 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -178.3 157.57 1.07 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 71.430000000000007 110.858 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.68 155.8 65.23 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.748 2.298 . . . . 73.120000000000005 112.353 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -173.93 70.68 0.34 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.601 0.715 . . . . 72.420000000000002 110.881 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -18.62 36.76 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.298 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 71.3 t60 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.817 179.927 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 CA-C-O 121.432 0.462 . . . . 71.299999999999997 112.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 168.05 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.612 2.208 . . . . 64.129999999999995 112.373 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -129.33 49.87 0.91 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 41.340000000000003 112.44 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.0 p -160.62 179.65 8.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.843 0.354 . . . . 73.310000000000002 110.901 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 143.38 50.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.865 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -165.11 179.51 6.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.815 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.3 mmt -80.48 82.84 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 62.509999999999998 110.853 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -116.06 163.3 16.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.199 -0.455 . . . . 71.439999999999998 110.847 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.7 m -100.28 -65.56 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.124 -0.489 . . . . 72.439999999999998 110.847 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 59.31 73.78 0.65 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.639 0.733 . . . . 71.340000000000003 111.114 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -35.23 12.79 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.764 2.309 . . . . 63.229999999999997 112.289 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -100.8 24.56 9.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.229 -0.441 . . . . 73.209999999999994 110.876 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -157.78 121.26 4.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 74.209999999999994 110.865 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 15' ' ' PRO . 56.3 mt -60.62 133.07 91.43 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.604 0.716 . . . . 72.400000000000006 111.088 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.69 -170.57 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 71.329999999999998 112.383 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.24 156.89 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 73.310000000000002 110.89 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -74.03 144.01 45.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 43.299999999999997 110.894 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 108' ' ' PHE . 2.5 pp -129.93 176.68 7.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 111.136 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -114.68 138.71 50.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 110.896 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.639 HD12 ' CE1' ' A' ' 113' ' ' PHE . 23.9 pt -114.22 167.81 6.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 75.129999999999995 111.189 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HB3' HG13 ' A' ' 112' ' ' VAL . 0.8 OUTLIER -113.08 125.3 54.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 75.219999999999999 110.865 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.37 101.87 13.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.879 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.51 128.56 43.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.926 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.9 p -127.23 175.85 7.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 65.510000000000005 111.171 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 6.1 tpt -74.42 -8.06 55.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.277 -0.42 . . . . 73.099999999999994 110.893 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HE2' HG13 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -105.08 -38.35 6.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 61.119999999999997 110.824 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 178.81 176.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.881 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.78 146.44 15.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.485 . . . . 72.010000000000005 111.129 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.3 t -142.51 129.78 11.15 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.631 0.729 . . . . 73.409999999999997 111.112 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 120.64 7.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.633 2.222 . . . . 73.0 112.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -121.21 115.94 23.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 111.064 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -73.91 137.22 43.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 53.43 110.898 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.458 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.22 145.87 37.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.420000000000002 111.138 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.01 152.36 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 75.200000000000003 111.117 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.9 t -53.51 109.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 52.539999999999999 110.833 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.47 23.49 33.79 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 33.130000000000003 112.495 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 p -97.19 177.52 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.983 0.42 . . . . 73.200000000000003 110.86 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.0 p -134.69 152.21 51.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 73.140000000000001 111.168 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -47.85 -61.11 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 70.420000000000002 111.073 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.01 -34.05 58.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 65.400000000000006 110.921 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.4 -27.07 62.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 72.450000000000003 110.805 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 56.4 t -77.0 -43.37 32.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 61.210000000000001 111.125 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.98 -28.13 49.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.471 . . . . 62.219999999999999 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -73.1 -27.43 61.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.806 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -53.4 7.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 74.530000000000001 110.884 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.486 ' HB3' HG23 ' A' ' 48' ' ' VAL . 13.7 t-20 -72.59 -24.73 61.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.433 . . . . 74.420000000000002 110.908 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.02 15.75 43.93 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.783 -0.722 . . . . 71.540000000000006 112.452 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 46' ' ' ASN . 24.8 t -66.31 147.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.809 0.338 . . . . 41.020000000000003 111.135 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.44 ' O ' HG21 ' A' ' 119' ' ' THR . 43.8 t0 -88.83 80.8 7.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 110.904 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD13 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -128.7 123.12 32.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 70.430000000000007 110.935 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' N ' HD13 ' A' ' 50' ' ' LEU . 4.9 pt-20 -116.12 149.68 38.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 53.100000000000001 110.903 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.94 83.89 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 24.25 112.453 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -69.54 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 55.299999999999997 111.101 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 1.9 t 53.13 44.78 29.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 72.329999999999998 110.877 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -63.64 -34.86 78.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 64.450000000000003 110.934 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.09 71.98 0.65 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 75.319999999999993 112.53 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.703 ' O ' HD12 ' A' ' 58' ' ' LEU . 15.6 p-10 -122.63 -47.04 2.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 73.329999999999998 110.921 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.703 HD12 ' O ' ' A' ' 57' ' ' ASN . 8.5 mp -138.4 158.19 44.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 72.140000000000001 110.967 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.67 112.26 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 51.329999999999998 111.114 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.8 p -106.4 163.02 13.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 74.540000000000006 110.932 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -128.97 73.91 1.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 65.319999999999993 110.894 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -133.4 29.7 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 62.32 111.177 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 60.3 m -102.14 32.33 3.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 25.530000000000001 110.886 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.9 p80 -146.68 112.99 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 65.439999999999998 110.832 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 9.3 t -128.32 156.66 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 72.25 111.133 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.3 mp -89.31 137.72 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 111.159 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 113' ' ' PHE . 6.8 tp -127.77 157.88 39.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.154 -0.475 . . . . 64.040000000000006 110.952 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.48 141.45 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 71.019999999999996 110.879 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.495 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.2 mt-10 -57.27 -59.63 12.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.608 0.718 . . . . 73.040000000000006 110.906 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.8 Cg_endo -69.79 -48.86 0.63 Allowed 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.744 2.296 . . . . 54.219999999999999 112.36 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.654 HD21 ' HB1' ' A' ' 111' ' ' ALA . 1.6 tp -51.83 -42.82 62.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 73.209999999999994 110.996 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.9 t80 -72.51 -51.64 19.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.87 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.96 -36.23 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 65.439999999999998 110.852 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -78.18 -43.06 29.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.0 110.929 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.3 mm? -63.26 -28.1 69.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.944 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.07 160.55 8.75 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.737 -0.744 . . . . 71.329999999999998 112.457 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -134.55 157.37 77.48 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.637 0.732 . . . . 65.310000000000002 110.876 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -174.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.698 2.265 . . . . 62.009999999999998 112.425 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -102.57 -175.7 2.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 110.871 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -56.45 -45.2 80.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.933 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -59.65 4.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 110.868 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.43 -28.55 69.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.530000000000001 110.886 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -56.96 13.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 74.329999999999998 110.901 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -42.09 89.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 71.120000000000005 110.822 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -54.08 -51.93 62.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 64.219999999999999 110.963 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.648 HD13 ' HA2' ' A' ' 94' ' ' GLY . 58.0 mt -73.74 -35.26 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 111.105 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -63.55 -17.04 62.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.83 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -76.28 -25.38 54.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.869 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -82.46 143.84 30.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.428 . . . . 71.129999999999995 111.087 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -64.03 123.17 18.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 75.519999999999996 110.874 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.93 43.92 55.51 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.711 -0.756 . . . . 73.129999999999995 112.551 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.615 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.9 118.02 35.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.36 . . . . 70.219999999999999 111.179 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 148.71 26.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 75.109999999999999 111.122 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.648 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.68 -24.82 41.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 75.129999999999995 112.45 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.69 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.1 p -73.96 -1.99 22.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.825 0.345 . . . . 64.239999999999995 111.171 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 7.7 t -91.05 -12.94 34.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 71.409999999999997 110.9 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 ttp85 -118.24 132.73 56.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 70.200000000000003 110.906 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.17 -69.58 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 73.450000000000003 110.874 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.36 -142.04 7.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.691 -0.766 . . . . 71.010000000000005 112.456 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.8 t -129.87 33.44 4.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.302 . . . . 61.43 110.884 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.584 ' C ' HD22 ' A' ' 102' ' ' LEU . 33.8 mt-30 -139.41 133.95 31.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.191 -0.459 . . . . 64.439999999999998 110.968 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 101' ' ' GLN . 4.6 mm? -128.82 109.15 11.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 65.25 110.918 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 tpp85 -137.4 145.35 43.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 70.209999999999994 110.863 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG21 ' HB1' ' A' ' 33' ' ' ALA . 22.1 t -92.94 130.18 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 111.106 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -136.48 167.53 21.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.932 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -41.76 79.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.27 -0.423 . . . . 72.510000000000005 110.874 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.64 -17.09 59.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 64.510000000000005 110.898 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.485 ' O ' HD13 ' A' ' 18' ' ' ILE . 1.1 m-85 -90.26 11.26 21.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.931 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -57.5 123.27 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 62.219999999999999 110.897 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 32.4 m-20 59.6 25.88 14.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 53.450000000000003 110.84 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB1' HD21 ' A' ' 71' ' ' LEU . . . -73.85 127.92 34.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 33.329999999999998 111.097 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.74 HG13 ' HB3' ' A' ' 21' ' ' PHE . 21.6 t -102.12 120.52 51.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 111.117 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.639 ' CE1' HD12 ' A' ' 20' ' ' ILE . 30.3 p90 -120.46 126.41 50.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 71.430000000000007 110.876 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 55.2 m -101.4 131.35 47.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.192 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.0 t -88.18 133.34 37.14 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.681 0.753 . . . . 72.129999999999995 111.089 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.0 Cg_endo -69.78 -43.56 2.58 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.709 2.273 . . . . 65.439999999999998 112.312 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -62.37 144.96 55.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.948 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.96 162.28 29.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 53.109999999999999 111.103 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 49' ' ' ASP . 10.0 m -160.51 136.25 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 111.149 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.74 136.71 54.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.349999999999994 110.922 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -144.03 166.36 25.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 73.329999999999998 110.885 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.2 ptp -59.47 -178.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.862 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 51.95 44.57 29.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.141 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.523 HG13 ' HE2' ' A' ' 26' ' ' LYS . 65.0 t -53.11 137.49 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 44.350000000000001 111.097 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.61 161.23 37.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 71.030000000000001 110.915 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -52.33 138.71 31.61 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.783 -0.722 . . . . 73.430000000000007 112.44 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -107.73 -179.61 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.945 0.403 . . . . 74.310000000000002 110.892 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.9 ptpp? -162.44 157.65 19.33 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 71.430000000000007 110.884 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.83 -170.95 0.43 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.675 2.25 . . . . 73.120000000000005 112.399 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -135.46 157.6 76.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.504 0.668 . . . . 72.420000000000002 110.929 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 127.29 14.37 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.713 2.276 . . . . 73.030000000000001 112.343 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 72.120000000000005 110.848 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 CA-C-O 121.433 0.463 . . . . 71.299999999999997 112.499 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -174.71 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.679 2.253 . . . . 64.129999999999995 112.322 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.88 -102.47 0.19 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.461 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -114.47 148.58 37.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.81 0.338 . . . . 73.310000000000002 110.88 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.3 mtm -153.16 135.67 15.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.895 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.6 179.15 7.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 110.9 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.0 ttp -145.29 128.83 17.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 62.509999999999998 110.856 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -137.88 165.69 25.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 71.439999999999998 110.896 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.1 114.97 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 110.876 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -177.57 160.4 1.36 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.535 0.683 . . . . 71.340000000000003 111.125 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 53.7 Cg_endo -69.78 -28.54 25.05 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.643 2.229 . . . . 63.229999999999997 112.362 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -107.69 25.03 12.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 31.1 mmm180 -148.01 128.39 13.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 110.899 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 15' ' ' PRO . 47.6 mm -62.52 133.06 94.58 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.658 0.742 . . . . 72.400000000000006 111.105 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.8 Cg_endo -69.77 -170.32 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.742 2.295 . . . . 71.329999999999998 112.293 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -51.74 156.75 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 73.310000000000002 110.876 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -73.94 144.41 45.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 43.299999999999997 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.568 HD11 HG13 ' A' ' 104' ' ' VAL . 2.5 pp -138.7 176.88 5.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 64.439999999999998 111.143 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -121.43 141.65 50.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 75.340000000000003 110.877 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.2 pt -114.39 164.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.05 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -120.77 130.36 53.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 110.877 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -100.35 102.95 14.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 71.329999999999998 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 124.33 30.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 75.340000000000003 110.934 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.9 p -113.8 -176.45 2.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 65.510000000000005 111.155 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.97 -8.6 57.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 110.924 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -110.6 -38.32 5.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 61.119999999999997 110.885 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 178.67 176.49 0.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 54.409999999999997 110.902 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -97.05 148.14 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.158 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.43 HG13 ' HD2' ' A' ' 30' ' ' PRO . 84.0 t -129.44 132.52 24.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 111.117 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 29' ' ' VAL . 54.7 Cg_endo -69.68 129.37 17.56 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.66 2.24 . . . . 73.0 112.382 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.67 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -138.01 107.51 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 53.340000000000003 111.105 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -66.94 149.06 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 53.43 110.91 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -130.68 121.67 25.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.069 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.3 152.7 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 75.200000000000003 111.145 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.0 p -51.21 111.84 0.63 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 52.539999999999999 110.852 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.84 14.16 35.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.825 -0.703 . . . . 33.130000000000003 112.429 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 16.1 p -95.01 -178.92 4.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.009 0.433 . . . . 73.200000000000003 110.83 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.686 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -145.9 159.86 42.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.12 -0.491 . . . . 73.140000000000001 111.124 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.909 HG23 HD12 ' A' ' 40' ' ' LEU . 15.7 m -58.73 -45.3 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 70.420000000000002 111.069 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 39' ' ' VAL . 6.5 mp -66.75 -36.07 81.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 65.400000000000006 110.937 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.66 -27.44 62.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 72.450000000000003 110.892 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 38' ' ' THR . 72.0 t -77.08 -49.9 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.092 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 111.082 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -69.74 -34.19 73.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 110.854 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -87.12 -37.41 17.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.445 . . . . 74.530000000000001 110.973 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' HB3' HG23 ' A' ' 48' ' ' VAL . 2.2 m-80 -72.26 -24.92 61.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.912 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.9 -12.13 70.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 71.540000000000006 112.542 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.419 HG23 ' HB3' ' A' ' 46' ' ' ASN . 46.9 t -51.54 130.83 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 41.020000000000003 111.206 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' CG ' HG23 ' A' ' 119' ' ' THR . 20.0 t70 -71.59 81.29 0.82 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.854 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -76.08 131.26 39.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.43 . . . . 70.430000000000007 110.887 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' N ' HD13 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -51.99 112.1 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 53.100000000000001 110.901 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.29 134.32 0.4 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 24.25 112.455 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -88.09 -26.67 22.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.822 0.344 . . . . 55.299999999999997 111.095 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 63.38 44.21 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 72.329999999999998 110.899 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -113.02 -35.14 5.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 64.450000000000003 110.904 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.85 19.66 2.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 75.319999999999993 112.535 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.0 t30 53.43 63.32 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 73.329999999999998 110.849 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.0 mt -123.55 -41.18 2.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.917 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -116.37 -29.66 6.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 51.329999999999998 111.14 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.9 t -82.63 59.96 4.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 110.949 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 p -100.1 28.05 5.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 65.319999999999993 110.849 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.02 140.19 18.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 62.32 111.133 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 4.2 m -126.78 79.42 1.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 25.530000000000001 110.917 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -161.95 112.09 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 110.864 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 114' ' ' THR . 9.7 p -128.92 157.39 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 72.25 111.133 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 3.1 mt -89.79 132.37 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 64.430000000000007 111.099 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 112' ' ' VAL . 25.0 tp -127.28 159.87 33.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.040000000000006 110.946 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.79 142.06 1.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 71.019999999999996 110.864 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -57.5 -59.83 11.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.599 0.714 . . . . 73.040000000000006 110.867 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.6 Cg_endo -69.77 -48.81 0.64 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.61 2.206 . . . . 54.219999999999999 112.379 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.477 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 0.6 OUTLIER -51.47 -43.33 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 73.209999999999994 110.892 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CD1' HG22 ' A' ' 95' ' ' THR . 56.1 t80 -71.44 -51.63 22.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.945 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.72 -35.39 61.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 65.439999999999998 110.873 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -78.1 -40.84 37.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -63.28 -26.33 68.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.877 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.7 167.57 11.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.23 157.82 77.0 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.577 0.703 . . . . 65.310000000000002 110.91 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -178.1 2.18 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.702 2.268 . . . . 62.009999999999998 112.334 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.1 t -98.32 -173.3 2.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.879 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -58.5 -43.8 89.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 72.409999999999997 110.858 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -53.93 -59.65 4.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 63.240000000000002 110.899 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -28.16 69.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 71.530000000000001 110.958 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -61.92 -52.36 64.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 110.892 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -41.83 70.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 71.120000000000005 110.89 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.87 -50.01 69.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.219999999999999 110.954 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.574 HD13 ' HA2' ' A' ' 94' ' ' GLY . 64.2 mt -73.29 -42.58 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.138 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.51 -23.11 62.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -76.13 -24.17 54.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -83.56 142.17 31.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 71.129999999999995 111.049 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 130.99 43.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.904 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 40.36 59.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 73.129999999999995 112.56 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.445 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.64 123.61 49.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 70.219999999999999 111.127 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.32 144.2 32.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.424 . . . . 75.109999999999999 111.1 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.574 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.91 -26.11 47.09 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 75.129999999999995 112.445 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.654 HG22 ' CD1' ' A' ' 72' ' ' TYR . 20.3 p -74.07 -1.23 19.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.781 0.324 . . . . 64.239999999999995 111.155 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 5.9 t -90.76 -12.71 35.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.869 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -112.59 143.57 43.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 70.200000000000003 110.879 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -167.36 130.63 1.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 110.948 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -65.46 -159.59 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 71.010000000000005 112.515 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 16.6 m -101.44 27.69 6.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.784 0.326 . . . . 61.43 110.911 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.21 59.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 110.889 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.665 ' O ' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -98.4 112.56 24.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.25 110.889 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.1 mtm-85 -119.21 136.36 54.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.95 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' A' ' 33' ' ' ALA . 39.3 t -80.06 115.43 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.137 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 178.54 6.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 72.040000000000006 110.819 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.9 ttmt -54.88 -40.28 69.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 72.510000000000005 110.889 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 t -64.44 -25.09 67.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.914 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 75' ' ' LEU . 12.8 m-85 -79.85 -2.21 42.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.869 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.473 ' HA ' HD13 ' A' ' 18' ' ' ILE . 18.8 tt0 -58.15 124.94 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 62.219999999999999 110.935 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.3 m120 58.72 23.81 11.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 53.450000000000003 110.902 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -65.63 151.24 46.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 33.329999999999998 111.147 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.701 ' O ' HD12 ' A' ' 67' ' ' LEU . 23.6 t -107.07 113.02 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 73.010000000000005 111.184 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -108.95 95.06 5.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.804 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 65' ' ' VAL . 51.6 m -87.82 130.91 34.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 111.169 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.441 HG13 ' HD2' ' A' ' 116' ' ' PRO . 58.3 t -95.53 133.4 25.82 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.631 0.729 . . . . 72.129999999999995 111.165 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.441 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.73 -41.89 3.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.76 2.306 . . . . 65.439999999999998 112.321 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -132.79 120.25 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 72.140000000000001 110.843 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -140.85 -176.14 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 53.109999999999999 111.122 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.446 HG23 ' CG ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -57.55 112.18 1.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 111.144 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -173.96 139.16 0.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 73.349999999999994 110.88 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -80.19 -26.81 39.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.88 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.2 mtt -117.41 -171.05 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.918 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -158.51 126.57 5.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.296 -0.411 . . . . 62.43 111.138 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 m -82.4 -177.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 44.350000000000001 111.09 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -98.94 -174.71 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 71.030000000000001 110.924 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 144.77 86.51 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 73.430000000000007 112.504 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -123.44 126.26 46.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 74.310000000000002 110.925 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -115.4 73.76 4.0 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.557 0.694 . . . . 71.430000000000007 110.923 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 82.93 0.72 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.673 2.249 . . . . 73.120000000000005 112.317 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 131' ' ' PRO . 2.9 mtpp -67.75 -60.39 5.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.585 0.707 . . . . 72.420000000000002 110.888 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 130' ' ' LYS . 53.5 Cg_endo -69.75 170.34 16.8 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.745 2.297 . . . . 73.030000000000001 112.307 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.877 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.516 0.509 . . . . 71.299999999999997 112.458 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 179.71 3.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.724 2.283 . . . . 64.129999999999995 112.345 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.38 170.84 12.86 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.781 -0.723 . . . . 41.340000000000003 112.506 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.59 -174.87 3.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.822 0.344 . . . . 73.310000000000002 110.868 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 50.7 tpp -126.46 138.64 53.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 73.430000000000007 110.859 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -158.29 -178.47 7.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.420000000000002 110.883 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.13 173.12 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 62.509999999999998 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -116.01 166.11 12.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 71.439999999999998 110.881 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -100.82 -175.05 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.838 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.8 71.5 29.73 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.594 0.711 . . . . 71.340000000000003 111.189 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 177.88 5.16 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.646 2.231 . . . . 63.229999999999997 112.341 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -119.1 24.7 10.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.839 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -108.76 102.4 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.264 -0.426 . . . . 74.209999999999994 110.859 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.429 HG23 ' HD2' ' A' ' 15' ' ' PRO . 5.2 mp -109.61 132.96 21.04 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.691 0.758 . . . . 72.400000000000006 111.071 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.1 Cg_endo -69.71 -168.09 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.677 2.251 . . . . 71.329999999999998 112.412 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -50.25 157.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 110.86 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.44 147.0 44.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.493 . . . . 43.299999999999997 110.95 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.25 177.11 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 64.439999999999998 111.205 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -122.75 136.79 54.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.340000000000003 110.946 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.734 HG13 ' HB3' ' A' ' 31' ' ' ALA . 46.8 pt -117.44 172.02 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 111.13 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -118.74 128.74 54.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.219999999999999 110.894 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.49 ' HD1' ' HB2' ' A' ' 31' ' ' ALA . 4.1 m-85 -105.31 104.18 13.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 71.329999999999998 110.922 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -93.64 122.25 35.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 75.340000000000003 110.851 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.0 p -113.36 -177.83 3.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 65.510000000000005 111.074 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -75.95 -9.36 58.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 110.846 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -106.09 -37.74 6.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 61.119999999999997 110.944 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 179.13 176.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 54.409999999999997 110.911 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.36 134.58 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 72.010000000000005 111.102 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG21 HG23 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -129.41 150.66 76.21 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.63 0.729 . . . . 73.409999999999997 111.101 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 155.06 66.96 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.654 2.236 . . . . 73.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.734 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.92 136.18 25.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 53.340000000000003 111.141 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -96.78 134.56 39.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.47 . . . . 53.43 110.88 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -115.35 125.66 53.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.123 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 35' ' ' CYS . 8.1 t -95.23 156.72 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 75.200000000000003 111.114 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' HG12 ' A' ' 34' ' ' VAL . 58.5 m -55.55 99.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.458 . . . . 52.539999999999999 110.802 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.95 24.6 11.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 33.130000000000003 112.476 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 104' ' ' VAL . 2.4 m -94.83 174.04 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.908 0.385 . . . . 73.200000000000003 110.844 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -131.73 146.71 52.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 73.140000000000001 111.133 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG23 HD23 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -48.52 -62.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 111.158 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 HG23 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -54.45 -32.98 58.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 65.400000000000006 110.876 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -72.25 -27.02 62.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.450000000000003 110.863 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 38' ' ' THR . 60.8 t -77.55 -43.89 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.108 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' HB1' HG12 ' A' ' 48' ' ' VAL . . . -52.82 -27.8 19.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.484 . . . . 62.219999999999999 111.131 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -73.36 -34.66 65.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 75.200000000000003 110.822 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -83.28 -40.73 19.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.898 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -72.02 -26.95 62.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.812 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.91 -1.69 83.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 71.540000000000006 112.438 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.577 HG12 ' HB1' ' A' ' 43' ' ' ALA . 0.8 OUTLIER -53.66 156.47 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 41.020000000000003 111.135 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' O ' HD12 ' A' ' 50' ' ' LEU . 35.6 t70 -72.1 80.02 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 75.209999999999994 110.859 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.004 HD11 HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -159.95 146.81 16.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 70.430000000000007 110.829 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.9 141.0 50.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 53.100000000000001 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -132.29 155.51 21.54 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.702 -0.761 . . . . 24.25 112.519 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.99 23.8 11.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.81 0.338 . . . . 55.299999999999997 111.068 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.5 t 51.93 50.53 18.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 72.329999999999998 110.853 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -51.8 129.21 25.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 64.450000000000003 110.941 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -168.99 99.76 0.15 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.715 -0.755 . . . . 75.319999999999993 112.478 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -54.5 -28.41 44.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 73.329999999999998 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 mt -125.16 -71.17 0.72 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 72.140000000000001 110.923 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.71 -176.9 6.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 51.329999999999998 111.08 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.5 m -122.67 114.92 21.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 74.540000000000006 110.924 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.83 -62.46 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.886 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 t -171.1 157.05 5.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 62.32 111.135 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.23 98.7 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 25.530000000000001 110.893 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -94.55 112.21 23.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 65.439999999999998 110.87 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 114' ' ' THR . 6.4 t -128.66 157.45 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 72.25 111.074 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 63.9 mt -90.08 132.79 33.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 64.430000000000007 111.134 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 112' ' ' VAL . 36.0 tp -125.63 159.63 31.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.463 . . . . 64.040000000000006 110.902 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.78 142.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 71.019999999999996 110.815 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mt-10 -60.11 -58.67 17.69 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.636 0.731 . . . . 73.040000000000006 110.965 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.85 -47.58 0.87 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.741 2.294 . . . . 54.219999999999999 112.299 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.446 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.8 tp -53.24 -51.16 63.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 110.957 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.3 t80 -63.46 -53.74 47.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 74.450000000000003 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.35 -31.63 54.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 65.439999999999998 110.809 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -71.13 -53.78 13.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.0 110.878 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.8 mt -63.3 -23.59 67.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.835 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.14 148.04 4.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.478 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.44 157.45 78.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.636 0.731 . . . . 65.310000000000002 110.842 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 165.45 30.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.648 2.232 . . . . 62.009999999999998 112.343 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 m -93.68 -170.92 2.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 75.409999999999997 110.842 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -56.96 -45.23 82.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 72.409999999999997 110.837 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt -53.76 -59.79 4.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 63.240000000000002 110.887 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.57 -29.98 70.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 71.530000000000001 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -54.0 50.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.908 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.02 -41.07 82.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 71.120000000000005 110.905 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.6 tp -53.82 -51.95 61.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.936 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.691 HD13 ' HA2' ' A' ' 94' ' ' GLY . 11.5 mt -74.92 -34.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 111.089 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.76 -20.02 45.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.030000000000001 110.799 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -75.52 -16.31 60.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 110.918 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.67 144.31 26.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 71.129999999999995 111.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -64.96 122.28 16.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.934 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.5 45.1 53.91 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 73.129999999999995 112.539 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.616 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -108.06 143.93 36.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.902 0.382 . . . . 70.219999999999999 111.092 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.43 150.56 50.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 111.149 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.691 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.76 -27.18 49.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.743 -0.742 . . . . 75.129999999999995 112.479 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.581 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.9 p -73.92 -1.28 19.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.905 0.384 . . . . 64.239999999999995 111.154 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 11.3 t -89.34 -13.61 37.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 110.879 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 56.0 mtp85 -111.22 165.65 11.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.200000000000003 110.848 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.0 tp 63.65 65.88 0.71 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.03 19.88 10.88 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.753 . . . . 71.010000000000005 112.438 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.66 165.18 16.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 61.43 110.897 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.7 mp0 56.67 42.11 27.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 64.439999999999998 110.913 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.682 ' O ' HG23 ' A' ' 38' ' ' THR . 2.5 tp -98.25 156.56 16.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.211 -0.45 . . . . 65.25 110.879 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 78.2 mmt-85 -118.55 163.47 16.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.209999999999994 110.833 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.542 HG11 ' HB1' ' A' ' 33' ' ' ALA . 88.0 t -102.03 122.71 54.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 111.107 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.28 173.61 11.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 110.927 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -59.26 -36.02 74.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 110.919 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.6 t -65.81 -19.53 65.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 64.510000000000005 110.909 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -82.02 -0.19 43.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 71.209999999999994 110.831 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -59.01 124.28 19.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 62.219999999999999 110.904 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 64.38 22.73 12.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 53.450000000000003 110.881 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.446 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -64.91 141.99 58.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 33.329999999999998 111.127 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.629 ' O ' HD12 ' A' ' 67' ' ' LEU . 21.6 t -103.05 116.77 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 73.010000000000005 111.116 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 39' ' ' VAL . 79.8 m-85 -112.26 100.31 8.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 110.905 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 65' ' ' VAL . 39.5 m -88.22 124.83 34.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.1 -0.5 . . . . 73.439999999999998 111.174 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 1.004 HG21 HD11 ' A' ' 50' ' ' LEU . 20.4 t -116.89 92.27 38.21 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.66 0.743 . . . . 72.129999999999995 111.097 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 115' ' ' VAL . 53.5 Cg_endo -69.77 -35.59 12.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.728 2.285 . . . . 65.439999999999998 112.336 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -87.47 150.38 23.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 72.140000000000001 110.843 -179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -97.07 175.56 6.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 53.109999999999999 111.113 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.54 -19.99 62.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 73.409999999999997 111.126 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -51.26 113.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 73.349999999999994 110.853 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -146.39 174.11 11.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.935 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.496 ' HB3' HG13 ' A' ' 124' ' ' VAL . 14.6 mmt -117.75 -32.15 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.153 -0.476 . . . . 74.510000000000005 110.887 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . 57.79 49.61 11.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 62.43 111.147 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 122' ' ' MET . 26.6 m -89.64 175.05 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 44.350000000000001 111.118 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 58.26 41.53 23.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 71.030000000000001 110.956 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -123.22 -10.47 5.6 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 73.430000000000007 112.428 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -53.18 123.13 10.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.863 0.363 . . . . 74.310000000000002 110.834 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -83.22 159.21 62.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.569 0.699 . . . . 71.430000000000007 110.921 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -21.98 32.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.648 2.232 . . . . 73.120000000000005 112.354 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -154.35 162.66 26.42 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.598 0.713 . . . . 72.420000000000002 110.881 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -172.09 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.682 2.255 . . . . 73.030000000000001 112.378 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 72.120000000000005 110.926 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.496 0.498 . . . . 71.299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -171.01 0.43 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.77 2.313 . . . . 64.129999999999995 112.329 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.03 -19.69 0.65 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 41.340000000000003 112.506 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.55 66.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 73.310000000000002 110.832 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -175.36 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.081 -0.509 . . . . 73.430000000000007 110.922 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.97 179.45 4.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 71.420000000000002 110.871 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -115.95 -176.08 2.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 62.509999999999998 110.817 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -142.94 161.36 38.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.252 -0.431 . . . . 71.439999999999998 110.923 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.9 t -99.36 -171.43 2.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.842 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -137.27 160.36 65.99 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.569 0.7 . . . . 71.340000000000003 111.058 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 53.2 Cg_endo -69.83 -11.26 30.39 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 63.229999999999997 112.344 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.93 -23.11 66.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.209999999999994 110.848 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -169.16 140.37 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.273 -0.422 . . . . 74.209999999999994 110.905 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.591 HD13 ' HA2' ' A' ' 36' ' ' GLY . 2.7 mp -112.76 133.06 22.0 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.603 0.716 . . . . 72.400000000000006 111.062 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.443 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.78 -170.63 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.732 2.288 . . . . 71.329999999999998 112.364 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -51.54 156.64 1.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 73.310000000000002 110.893 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -73.98 158.99 33.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 43.299999999999997 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.2 176.43 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 64.439999999999998 111.091 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.3 127.59 53.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.798 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.27 163.0 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 111.112 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -119.53 127.53 53.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 75.219999999999999 110.851 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' A' ' 48' ' ' VAL . 3.2 m-85 -99.26 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.882 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.751 ' HG2' HG22 ' A' ' 28' ' ' VAL . 12.3 tmtt? -86.1 115.17 23.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.340000000000003 110.926 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.7 p -103.91 -179.29 3.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.292 -0.413 . . . . 65.510000000000005 111.167 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 1.5 mpp? -76.01 -17.14 59.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 73.099999999999994 110.946 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -93.98 -39.11 10.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 61.119999999999997 110.889 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 176.31 176.45 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 54.409999999999997 110.879 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.751 HG22 ' HG2' ' A' ' 23' ' ' LYS . 20.7 t -86.77 142.69 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 111.085 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -135.75 129.78 18.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 73.409999999999997 111.133 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 146.71 60.54 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.668 2.246 . . . . 73.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -154.84 113.31 3.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 53.340000000000003 111.118 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -79.44 122.97 27.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.848 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -100.27 116.42 32.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.029 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 m -87.8 144.38 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 75.200000000000003 111.109 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.2 p -54.78 121.35 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 52.539999999999999 110.889 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.591 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 106.0 -7.74 41.56 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.79 -0.719 . . . . 33.130000000000003 112.494 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.8 p -99.42 -178.06 3.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.993 0.425 . . . . 73.200000000000003 110.85 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -133.93 154.77 50.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 73.140000000000001 111.135 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.954 HG23 HD12 ' A' ' 40' ' ' LEU . 14.9 m -57.91 -45.55 87.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.420000000000002 111.118 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 39' ' ' VAL . 7.4 mp -64.33 -37.35 87.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.931 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -72.73 -27.3 61.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 72.450000000000003 110.886 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 38' ' ' THR . 73.0 t -76.42 -43.59 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 61.210000000000001 111.077 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 50' ' ' LEU . . . -51.36 -29.96 17.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 62.219999999999999 111.108 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -73.42 -36.84 66.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 110.848 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -40.84 40.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 74.530000000000001 110.909 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' HB3' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -72.1 -25.45 61.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 74.420000000000002 110.903 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.8 -8.88 76.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.777 -0.725 . . . . 71.540000000000006 112.449 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 46' ' ' ASN . 48.2 t -51.5 137.99 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.919 0.39 . . . . 41.020000000000003 111.052 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.13 80.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 50' ' ' LEU . 8.9 tt -107.92 107.67 18.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 70.430000000000007 110.884 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.36 112.49 8.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 53.100000000000001 110.862 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 159.99 38.66 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 24.25 112.474 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.22 73.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 55.299999999999997 111.08 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 56.79 26.53 11.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.945 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -127.82 163.09 25.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.450000000000003 110.863 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.24 -162.19 53.13 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.729 -0.748 . . . . 75.319999999999993 112.531 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -69.28 163.04 25.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 110.931 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 54.79 62.88 2.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.140000000000001 110.87 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.73 143.01 33.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 51.329999999999998 111.12 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.7 p -102.35 147.05 27.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 110.947 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -92.21 -28.13 17.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 65.319999999999993 110.818 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 t -140.95 150.41 43.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.471 . . . . 62.32 111.111 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.633 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.2 p -130.67 81.73 2.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 25.530000000000001 110.855 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -60.81 117.27 5.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.137 -0.483 . . . . 65.439999999999998 110.858 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 63' ' ' CYS . 9.8 t -128.2 155.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 72.25 111.105 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 70.3 mt -91.07 133.77 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 64.430000000000007 111.096 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 112' ' ' VAL . 20.3 tp -125.67 162.54 24.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.933 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -41.0 139.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 71.019999999999996 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.517 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.8 mt-10 -60.1 -59.38 14.04 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.638 0.732 . . . . 73.040000000000006 110.866 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.7 Cg_endo -69.75 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.723 2.282 . . . . 54.219999999999999 112.318 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD13 HD23 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -51.76 -48.83 63.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.941 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.558 ' CD1' HG22 ' A' ' 95' ' ' THR . 30.3 t80 -66.99 -51.08 59.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 74.450000000000003 110.929 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -51.52 -51.66 53.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.494 . . . . 65.439999999999998 110.881 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -61.62 -48.55 80.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.51 HD23 HD13 ' A' ' 71' ' ' LEU . 3.3 mm? -62.94 -18.68 63.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 75.209999999999994 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 147.03 130.35 2.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.79 -0.719 . . . . 71.329999999999998 112.507 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.22 157.75 60.21 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.668 0.747 . . . . 65.310000000000002 110.866 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -172.94 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.392 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 67.9 m -104.79 -174.89 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.852 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.9 -49.16 78.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 72.409999999999997 110.896 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -47.69 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 63.240000000000002 110.914 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.83 -28.38 64.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 71.530000000000001 110.836 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -53.3 55.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.851 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -70.94 -43.28 68.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 71.120000000000005 110.819 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.22 -49.07 70.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.219999999999999 110.88 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.595 HD13 ' HA2' ' A' ' 94' ' ' GLY . 57.8 mt -75.06 -34.4 31.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 63.409999999999997 111.089 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.42 -15.64 58.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 110.85 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -75.33 -22.86 57.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.858 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.63 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -89.1 137.08 32.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 71.129999999999995 111.133 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -56.97 126.6 27.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.13 41.33 53.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.697 -0.763 . . . . 73.129999999999995 112.484 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.63 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -110.48 139.03 46.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.361 . . . . 70.219999999999999 111.068 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.81 155.0 44.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.135 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.595 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.87 -27.08 49.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 75.129999999999995 112.427 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.558 HG22 ' CD1' ' A' ' 72' ' ' TYR . 14.9 p -73.79 -1.92 21.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.716 0.293 . . . . 64.239999999999995 111.158 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 39.1 t -87.88 -14.9 38.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 71.409999999999997 110.884 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 23.4 mtp180 -111.8 168.27 9.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 70.200000000000003 110.857 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 62.06 97.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 73.450000000000003 110.947 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -175.95 32.01 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 71.010000000000005 112.504 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 22.4 t -97.24 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.79 0.329 . . . . 61.43 110.871 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -88.26 51.7 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 64.439999999999998 110.911 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.513 HD11 ' CZ ' ' A' ' 108' ' ' PHE . 7.1 tt -91.37 114.51 27.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.93 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 27.0 mtt-85 -85.33 134.93 34.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 110.934 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG21 ' HB1' ' A' ' 33' ' ' ALA . 83.8 t -59.76 122.05 8.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 72.239999999999995 111.091 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -137.07 160.2 39.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 72.040000000000006 110.884 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.6 ttpt -53.95 -27.24 29.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 72.510000000000005 110.888 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.489 ' HB3' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -62.66 -29.29 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.243 -0.435 . . . . 64.510000000000005 110.866 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.513 ' CZ ' HD11 ' A' ' 102' ' ' LEU . 22.0 m-85 -89.99 12.07 18.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 71.209999999999994 110.898 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.22 120.74 10.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 62.219999999999999 110.873 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 63.71 21.26 12.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.105 -0.498 . . . . 53.450000000000003 110.887 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.2 153.39 36.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 33.329999999999998 111.104 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.584 ' O ' HD12 ' A' ' 67' ' ' LEU . 4.1 t -105.51 127.16 60.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 111.091 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.783 ' CE2' HG11 ' A' ' 39' ' ' VAL . 12.1 m-85 -113.16 98.48 7.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 71.430000000000007 110.887 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.0 m -85.21 124.86 32.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 73.439999999999998 111.145 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.32 92.48 8.21 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.687 0.756 . . . . 72.129999999999995 111.124 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.84 -34.2 14.78 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.663 2.242 . . . . 65.439999999999998 112.273 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.09 144.08 56.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 72.140000000000001 110.842 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.89 166.73 20.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 53.109999999999999 111.125 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.8 t -69.9 131.93 45.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 73.409999999999997 111.182 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -175.33 171.59 2.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 110.887 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -93.77 -29.14 15.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 73.329999999999998 110.9 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.71 151.03 41.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 74.510000000000005 110.809 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.97 140.11 58.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.208 -0.451 . . . . 62.43 111.096 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.2 t -144.22 149.67 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.464 . . . . 44.350000000000001 111.139 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -55.15 172.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 71.030000000000001 110.902 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -99.52 -150.43 25.31 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.704 -0.76 . . . . 73.430000000000007 112.463 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -150.2 -174.11 4.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.893 0.378 . . . . 74.310000000000002 110.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.7 pttp 37.55 67.89 1.81 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.587 0.708 . . . . 71.430000000000007 110.861 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 138.82 38.78 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.696 2.264 . . . . 73.120000000000005 112.402 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -132.57 160.77 66.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.568 0.699 . . . . 72.420000000000002 110.914 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -44.01 2.29 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.663 2.242 . . . . 73.030000000000001 112.312 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 72.120000000000005 110.879 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 CA-C-O 121.383 0.435 . . . . 71.299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -175.95 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.681 2.254 . . . . 64.129999999999995 112.38 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -146.7 -177.92 21.67 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 41.340000000000003 112.439 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -129.56 -179.16 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.864 0.364 . . . . 73.310000000000002 110.89 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.9 mtm -143.57 165.71 26.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 73.430000000000007 110.866 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.24 178.46 8.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 110.826 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.1 mtp -106.2 176.6 5.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 62.509999999999998 110.855 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -152.02 156.56 40.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 71.439999999999998 110.838 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.5 m -91.09 -172.35 3.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 72.439999999999998 110.836 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 63.94 73.76 0.46 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.522 0.677 . . . . 71.340000000000003 111.15 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 81.9 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.611 2.207 . . . . 63.229999999999997 112.361 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -117.61 25.29 10.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.43 . . . . 73.209999999999994 110.85 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -124.15 -166.93 1.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 74.209999999999994 110.858 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HA2' ' A' ' 36' ' ' GLY . 4.1 mt -51.65 133.2 36.23 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.635 0.731 . . . . 72.400000000000006 111.136 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.2 Cg_endo -69.77 -169.97 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.64 2.227 . . . . 71.329999999999998 112.346 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -59.02 157.45 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 110.902 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -73.41 143.58 46.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 43.299999999999997 110.864 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 109' ' ' GLU . 2.7 pp -127.92 176.88 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 64.439999999999998 111.062 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.3 ttp180 -114.2 136.83 52.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 75.340000000000003 110.872 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 31' ' ' ALA . 14.6 pt -120.23 169.4 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 111.111 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -121.17 137.91 54.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.882 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.4 m-85 -108.81 103.12 12.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 71.329999999999998 110.852 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -90.19 130.0 36.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 75.340000000000003 110.887 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 118' ' ' ALA . 11.1 p -119.08 -177.51 3.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 65.510000000000005 111.156 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 13.9 ptm -75.9 -8.13 56.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 73.099999999999994 110.871 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -38.51 5.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 61.119999999999997 110.913 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.725 ' OE1' ' HB3' ' A' ' 123' ' ' ALA . 5.0 pt20 -178.56 176.27 1.03 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 54.409999999999997 110.947 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -109.94 135.48 48.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 111.163 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.09 150.9 60.7 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.598 0.713 . . . . 73.409999999999997 111.099 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 146.67 60.98 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.699 2.266 . . . . 73.0 112.377 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -147.8 108.46 4.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 53.340000000000003 111.111 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -74.83 128.0 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 53.43 110.986 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.061 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -106.31 119.97 40.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 111.047 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 t -85.4 154.43 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 75.200000000000003 111.161 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.8 t -56.21 109.8 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 52.539999999999999 110.849 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.577 ' HA2' HD13 ' A' ' 14' ' ' ILE . . . 100.47 -17.35 56.85 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.745 -0.74 . . . . 33.130000000000003 112.489 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -66.25 142.11 57.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 73.200000000000003 110.818 -179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.767 ' O ' HG23 ' A' ' 42' ' ' VAL . 72.8 p -96.82 158.38 15.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 111.07 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.86 -58.27 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 70.420000000000002 111.103 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -54.18 -33.63 58.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 65.400000000000006 110.856 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -73.06 -27.59 61.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.22 -0.445 . . . . 72.450000000000003 110.796 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.767 HG23 ' O ' ' A' ' 38' ' ' THR . 25.7 t -76.13 -45.85 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 111.082 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.18 -28.2 25.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.042 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -71.74 -38.93 70.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 75.200000000000003 110.916 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -66.46 -50.69 62.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.530000000000001 110.893 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.17 -32.86 67.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.444 . . . . 74.420000000000002 110.862 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.7 44.01 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.638 -0.791 . . . . 71.540000000000006 112.51 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.0 t -51.82 142.44 4.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 41.020000000000003 111.222 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.43 81.07 1.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 110.851 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.98 112.28 17.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 70.430000000000007 110.924 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -52.04 145.36 10.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 53.100000000000001 110.847 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.66 32.83 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.78 -0.724 . . . . 24.25 112.517 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.8 86.45 2.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.773 0.321 . . . . 55.299999999999997 111.172 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 35.0 m -90.01 -40.58 12.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.852 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.41 138.41 46.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 64.450000000000003 110.925 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 129.46 -103.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 75.319999999999993 112.493 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -131.31 -171.87 2.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.841 0.353 . . . . 73.329999999999998 110.913 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.4 mt -76.44 68.93 2.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 72.140000000000001 110.899 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -115.54 -45.32 2.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 51.329999999999998 111.079 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 45.1 t -76.96 72.56 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 74.540000000000006 110.903 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -54.81 -65.9 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 65.319999999999993 110.856 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -159.88 146.68 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.124 -0.489 . . . . 62.32 111.145 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 10.3 p -116.75 155.31 29.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 25.530000000000001 110.88 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -145.56 125.14 13.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 65.439999999999998 110.853 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.754 HG12 HD22 ' A' ' 98' ' ' LEU . 14.0 p -127.94 149.76 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.25 111.166 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 17.3 mt -91.2 133.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.106 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.438 HD12 ' O ' ' A' ' 112' ' ' VAL . 13.9 tp -120.11 158.97 25.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.47 . . . . 64.040000000000006 110.878 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.09 137.46 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.816 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.575 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.8 mt-10 -59.72 -55.81 42.02 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.67 0.748 . . . . 73.040000000000006 110.921 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.9 Cg_endo -69.81 -32.71 17.83 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.63 2.22 . . . . 54.219999999999999 112.326 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 tp -63.01 -46.64 86.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 73.209999999999994 110.882 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -72.32 -48.62 40.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 74.450000000000003 110.942 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.21 -36.65 68.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 65.439999999999998 110.905 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -76.37 -45.19 33.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 75.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.488 HD21 ' HB3' ' A' ' 107' ' ' SER . 1.9 mm? -63.04 -62.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.209999999999994 110.965 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 179.05 158.29 21.16 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.787 -0.721 . . . . 71.329999999999998 112.522 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -130.75 157.63 77.24 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.649 0.738 . . . . 65.310000000000002 110.904 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.62 2.4 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.249 . . . . 62.009999999999998 112.352 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -95.93 -176.24 3.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 75.409999999999997 110.848 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -56.94 -44.39 82.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 72.409999999999997 110.803 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -53.49 -60.12 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 63.240000000000002 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -62.02 -28.43 69.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 110.902 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.48 -55.68 28.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.329999999999998 110.944 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.61 -43.59 84.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 71.120000000000005 110.857 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 tp -53.66 -46.9 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 64.219999999999999 110.895 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.651 HD13 ' HA2' ' A' ' 94' ' ' GLY . 70.1 mt -74.84 -34.63 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 63.409999999999997 111.103 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.53 -15.41 60.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.885 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -75.89 -6.05 48.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.981 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.65 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -105.59 135.6 46.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.129 -0.487 . . . . 71.129999999999995 111.059 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -55.14 124.89 18.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 75.519999999999996 110.891 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.41 42.49 50.56 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.47 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.65 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -101.06 147.44 26.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 70.219999999999999 111.166 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.7 153.56 43.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 111.155 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.651 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.2 -38.37 67.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 75.129999999999995 112.468 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -73.98 -0.85 17.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.828 0.347 . . . . 64.239999999999995 111.153 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 8.7 t -88.24 -16.52 32.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.409999999999997 110.873 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 44.1 ttp85 -118.31 148.62 42.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 70.200000000000003 110.845 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.754 HD22 HG12 ' A' ' 65' ' ' VAL . 1.1 pt? -121.4 -175.09 3.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 73.450000000000003 110.888 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -132.0 7.57 5.44 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.718 . . . . 71.010000000000005 112.542 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . 0.433 ' H ' HD12 ' A' ' 98' ' ' LEU . 17.2 m 61.5 167.85 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 61.43 110.931 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 54.59 43.55 30.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 64.439999999999998 110.888 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.34 92.33 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 65.25 110.939 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' NH1' HD11 ' A' ' 14' ' ' ILE . 0.0 OUTLIER -59.49 168.42 1.59 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.44 . . . . 70.209999999999994 110.845 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 1.061 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.4 t -90.77 143.65 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.123 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.44 171.24 14.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 72.040000000000006 110.808 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.44 -38.42 77.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 72.510000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.488 ' HB3' HD21 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -63.85 -17.71 63.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 64.510000000000005 110.898 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.5 9.68 30.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.209999999999994 110.842 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.541 ' HA ' HD13 ' A' ' 18' ' ' ILE . 59.2 tt0 -59.33 124.88 21.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 62.219999999999999 110.906 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 60.81 21.25 11.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 53.450000000000003 110.895 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.511 ' HB1' ' CD2' ' A' ' 71' ' ' LEU . . . -62.9 129.74 41.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 33.329999999999998 111.157 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.438 ' O ' HD12 ' A' ' 67' ' ' LEU . 12.9 t -93.1 118.73 39.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 73.010000000000005 111.187 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -106.29 99.87 9.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.929 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.6 m -87.06 131.2 34.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.169 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.4 132.64 21.71 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 72.129999999999995 111.125 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -41.35 4.37 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.692 2.262 . . . . 65.439999999999998 112.371 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 -125.22 103.53 8.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 72.140000000000001 110.84 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 24' ' ' THR . . . -139.03 -175.32 4.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 53.109999999999999 111.078 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 p -111.02 -173.83 2.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 111.173 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -81.98 -173.48 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 73.349999999999994 110.906 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -168.33 179.24 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.882 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 8.3 tpt -84.87 109.2 17.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.510000000000005 110.877 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.725 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . . . -176.38 168.99 2.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 62.43 111.128 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.3 m -89.6 151.73 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 44.350000000000001 111.134 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -175.54 176.33 1.96 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 71.030000000000001 110.922 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -143.66 155.15 25.99 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.693 -0.765 . . . . 73.430000000000007 112.468 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -160.19 179.71 8.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.924 0.392 . . . . 74.310000000000002 110.894 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -91.06 160.59 37.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.587 0.708 . . . . 71.430000000000007 110.87 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -48.15 0.79 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.679 2.253 . . . . 73.120000000000005 112.407 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.48 73.47 0.86 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.549 0.69 . . . . 72.420000000000002 110.893 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 142.87 49.39 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.64 2.227 . . . . 73.030000000000001 112.406 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 72.120000000000005 110.834 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 CA-C-O 121.395 0.442 . . . . 71.299999999999997 112.443 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 169.38 19.08 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.678 2.252 . . . . 64.129999999999995 112.373 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.04 120.49 0.65 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.771 -0.728 . . . . 41.340000000000003 112.503 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 11.6 m -130.55 159.18 37.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.858 0.361 . . . . 73.310000000000002 110.903 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mtt -125.94 161.5 27.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 73.430000000000007 110.917 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -122.21 119.97 32.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 71.420000000000002 110.901 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -134.03 168.93 17.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 62.509999999999998 110.885 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -129.97 136.48 49.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 71.439999999999998 110.862 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.8 p -134.14 175.8 9.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 72.439999999999998 110.855 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 53.13 69.82 2.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.512 0.672 . . . . 71.340000000000003 111.098 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 111.36 2.78 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.754 2.303 . . . . 63.229999999999997 112.315 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -103.18 24.93 10.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 110.821 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.4 42.73 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.88 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 15' ' ' PRO . 49.1 mm -54.26 132.95 61.12 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.647 0.737 . . . . 72.400000000000006 111.179 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 14' ' ' ILE . 54.0 Cg_endo -69.74 -171.44 0.47 Allowed 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.711 2.274 . . . . 71.329999999999998 112.435 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -52.28 157.22 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.318 -0.401 . . . . 73.310000000000002 110.881 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -73.82 148.78 42.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 43.299999999999997 110.887 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.9 pp -130.38 177.11 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 64.439999999999998 111.07 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -123.35 144.62 49.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.797 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 113' ' ' PHE . 1.9 pt -125.75 170.59 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 111.087 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' HB2' HG22 ' A' ' 112' ' ' VAL . 10.1 m-85 -114.5 125.32 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.887 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.647 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -92.48 103.37 15.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.329999999999998 110.877 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HG2' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.78 127.28 45.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.340000000000003 110.907 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 p -114.36 -167.45 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 65.510000000000005 111.131 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 19.7 mmm -54.34 -54.85 34.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.862 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 mmtt -141.03 27.68 1.95 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 61.119999999999997 110.963 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.3 128.45 20.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 54.409999999999997 110.915 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 23' ' ' LYS . 94.7 t -119.34 109.86 27.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 72.010000000000005 111.138 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG21 HG22 ' A' ' 48' ' ' VAL . 0.1 OUTLIER -123.11 150.27 59.21 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 111.175 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 159.55 53.02 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.703 2.269 . . . . 73.0 112.389 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.79 136.51 25.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 53.340000000000003 111.119 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.21 133.5 43.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 53.43 110.924 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.588 ' HB1' ' CG2' ' A' ' 104' ' ' VAL . . . -110.37 117.48 33.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.155 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.49 149.58 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.305 -0.407 . . . . 75.200000000000003 111.168 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.04 117.99 3.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 52.539999999999999 110.805 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.91 19.7 64.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.72 -0.752 . . . . 33.130000000000003 112.457 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -94.57 -169.42 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.931 0.396 . . . . 73.200000000000003 110.857 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.728 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -148.02 142.92 26.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.083 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.7 t -52.38 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 70.420000000000002 111.147 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HG ' HD13 ' A' ' 102' ' ' LEU . 6.2 mt -53.5 -36.27 61.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.400000000000006 110.859 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -72.67 -26.81 61.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 72.450000000000003 110.87 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 38' ' ' THR . 98.4 t -76.44 -39.9 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 61.210000000000001 111.086 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.35 -32.18 24.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 62.219999999999999 111.15 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -73.66 -35.94 65.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 110.863 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.98 -40.31 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.530000000000001 110.942 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -72.08 -24.95 61.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.409 . . . . 74.420000000000002 110.937 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.8 -11.67 38.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.737 . . . . 71.540000000000006 112.514 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 29' ' ' VAL . 99.9 t -61.59 110.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.347 . . . . 41.020000000000003 111.169 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -71.79 80.7 0.87 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.88 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -123.76 146.43 48.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.28 -0.418 . . . . 70.430000000000007 110.896 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -93.98 152.06 19.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 53.100000000000001 110.845 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' HD13 ' A' ' 40' ' ' LEU . . . -94.52 147.25 18.52 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.726 . . . . 24.25 112.516 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.78 -75.43 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.854 0.359 . . . . 55.299999999999997 111.098 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 8.6 m -57.74 142.72 44.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.887 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.495 ' HB3' HD21 ' A' ' 58' ' ' LEU . 3.4 tp10 -100.37 -66.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 64.450000000000003 110.953 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.18 -94.05 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.736 -0.745 . . . . 75.319999999999993 112.422 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -87.29 -58.21 2.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 73.329999999999998 110.84 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 55' ' ' GLU . 2.2 pt? -55.07 135.31 49.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 72.140000000000001 110.841 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.53 164.27 2.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 51.329999999999998 111.122 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.0 p -121.99 -176.97 3.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 110.868 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.7 m -76.61 -175.84 3.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 65.319999999999993 110.843 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 t -52.32 140.52 21.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.117 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 5.4 p -122.67 146.32 47.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 25.530000000000001 110.912 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -177.0 114.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 65.439999999999998 110.835 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.4 155.91 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 72.25 111.146 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mp -90.45 137.46 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 64.430000000000007 111.11 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 113' ' ' PHE . 9.0 tp -128.51 161.54 29.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 64.040000000000006 110.917 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.26 141.7 1.74 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 71.019999999999996 110.924 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.6 mt-10 -58.47 -59.51 13.3 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.609 0.718 . . . . 73.040000000000006 110.894 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.4 Cg_endo -69.81 -48.73 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.703 2.269 . . . . 54.219999999999999 112.279 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.7 tt -51.73 -46.77 64.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.944 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.699 ' CD1' HG22 ' A' ' 95' ' ' THR . 46.5 t80 -68.41 -50.43 52.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.866 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.82 -43.98 66.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 65.439999999999998 110.875 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.0 mttm -77.83 -28.01 50.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 75.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 75' ' ' LEU . 2.1 tp -70.88 -61.41 1.77 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.937 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.41 132.79 1.61 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.754 -0.736 . . . . 71.329999999999998 112.482 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -91.91 160.31 36.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.701 0.762 . . . . 65.310000000000002 110.859 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 156.93 62.14 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.719 2.28 . . . . 62.009999999999998 112.333 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 m -86.45 -169.85 2.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.898 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -56.96 -48.57 78.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.409999999999997 110.833 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 tptp -53.52 -59.44 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.240000000000002 110.924 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.46 -27.61 68.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 71.530000000000001 110.887 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.67 -55.74 24.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.99 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.7 -37.88 82.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.069 -0.514 . . . . 71.120000000000005 110.869 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 mt -59.97 -47.24 86.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 64.219999999999999 110.909 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.732 HD13 ' HA2' ' A' ' 94' ' ' GLY . 43.6 mt -73.0 -35.17 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 111.159 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.27 -20.89 60.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 74.030000000000001 110.857 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -76.25 -24.37 54.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.926 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -81.36 148.79 29.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.089 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -76.65 120.39 21.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 75.519999999999996 110.872 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.5 44.15 59.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.695 -0.765 . . . . 73.129999999999995 112.443 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 89' ' ' ALA . . . -99.37 130.56 45.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 70.219999999999999 111.064 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.84 146.22 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.109999999999999 111.136 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.732 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.8 -24.97 43.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.686 -0.769 . . . . 75.129999999999995 112.539 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.699 HG22 ' CD1' ' A' ' 72' ' ' TYR . 18.9 p -74.01 -2.26 23.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.896 0.379 . . . . 64.239999999999995 111.189 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 3.4 t -91.35 -13.42 32.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 71.409999999999997 110.903 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.583 ' CB ' HD11 ' A' ' 86' ' ' ILE . 7.0 tpt85 -108.53 161.79 14.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.863 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt 64.9 110.6 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 110.879 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.69 25.65 0.18 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.010000000000005 112.462 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 59.4 m -78.25 -171.28 2.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 61.43 110.894 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 63.09 61.51 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 110.876 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.546 HD13 ' HG ' ' A' ' 40' ' ' LEU . 72.6 mt -65.87 89.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.91 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -152.02 149.7 29.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 70.209999999999994 110.873 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.588 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 94.2 t -83.5 133.57 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 111.139 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -136.55 155.92 49.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.215 -0.448 . . . . 72.040000000000006 110.912 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -57.07 -37.49 71.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 72.510000000000005 110.904 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.1 m -65.08 -18.54 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 64.510000000000005 110.778 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.413 ' C ' HD13 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -85.59 1.21 50.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.88 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -58.0 124.41 19.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 62.219999999999999 110.844 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 59.34 24.66 13.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 53.450000000000003 110.907 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.76 165.43 24.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 33.329999999999998 111.121 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.597 HG22 ' HB2' ' A' ' 21' ' ' PHE . 13.3 t -138.25 124.82 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.010000000000005 111.105 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 20' ' ' ILE . 12.8 p90 -125.06 129.23 49.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 110.879 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 79.5 m -100.97 131.83 46.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 73.439999999999998 111.16 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 50' ' ' LEU . 29.1 t -91.95 132.7 32.04 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.63 0.729 . . . . 72.129999999999995 111.107 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 -39.89 5.92 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 65.439999999999998 112.382 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -86.52 166.37 15.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.83 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -167.57 173.99 8.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 53.109999999999999 111.112 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.6 p -102.42 144.54 30.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 73.409999999999997 111.122 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.13 88.68 2.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.877 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -88.64 62.57 6.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 73.329999999999998 110.895 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 58.5 mtt 57.92 49.65 11.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.510000000000005 110.944 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.66 -178.91 3.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 62.43 111.125 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.3 141.71 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 44.350000000000001 111.132 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -123.22 101.08 7.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.030000000000001 110.88 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -101.93 163.21 17.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.704 -0.76 . . . . 73.430000000000007 112.489 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -144.07 118.69 9.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 110.977 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.15 69.21 1.74 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.609 0.719 . . . . 71.430000000000007 110.937 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 -21.21 33.87 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.667 2.244 . . . . 73.120000000000005 112.385 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.7 mttm -123.44 160.69 49.42 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.53 0.681 . . . . 72.420000000000002 110.901 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -37.82 8.65 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.669 2.246 . . . . 73.030000000000001 112.333 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.5 t60 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.861 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 CA-C-O 121.391 0.439 . . . . 71.299999999999997 112.55 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 173.43 10.96 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.618 2.212 . . . . 64.129999999999995 112.382 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -178.3 158.09 22.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.742 . . . . 41.340000000000003 112.488 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 t -142.9 164.36 30.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.881 0.372 . . . . 73.310000000000002 110.837 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 74.7 mtp -117.44 -175.9 2.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 110.884 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -133.04 141.96 48.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 71.420000000000002 110.887 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.79 177.31 4.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 62.509999999999998 110.865 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -151.0 138.72 19.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 71.439999999999998 110.949 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.7 t -99.36 -28.63 13.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.135 -0.484 . . . . 72.439999999999998 110.84 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -105.87 160.58 25.65 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.571 0.7 . . . . 71.340000000000003 111.088 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 54.0 Cg_endo -69.73 80.75 0.85 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.719 2.279 . . . . 63.229999999999997 112.371 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -121.3 24.94 9.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 73.209999999999994 110.835 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.8 mtt-85 -136.52 121.26 18.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 110.89 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 38.2 mm -71.45 132.72 85.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 72.400000000000006 111.097 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 -169.99 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.734 2.29 . . . . 71.329999999999998 112.307 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -50.96 157.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 73.310000000000002 110.875 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.55 ' CD ' HG23 ' A' ' 34' ' ' VAL . 37.9 mt-30 -73.6 155.35 39.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 43.299999999999997 110.892 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.89 176.88 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 64.439999999999998 111.178 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -130.48 137.19 49.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.869 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.647 HG13 ' HB3' ' A' ' 31' ' ' ALA . 13.3 pt -114.57 173.4 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 75.129999999999995 111.118 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' HD2' HG12 ' A' ' 28' ' ' VAL . 2.0 m-85 -122.55 130.36 52.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.926 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 2.2 m-85 -97.86 109.0 21.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.837 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' CD ' HG22 ' A' ' 28' ' ' VAL . 36.7 tptt -92.5 107.28 19.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.468 . . . . 75.340000000000003 110.894 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -103.63 176.93 4.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.328 -0.396 . . . . 65.510000000000005 111.182 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.2 ttt -75.76 -8.08 55.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 73.099999999999994 110.831 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -38.28 6.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 61.119999999999997 110.866 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 178.44 176.4 0.5 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 54.409999999999997 110.977 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 ' CD ' ' A' ' 23' ' ' LYS . 20.0 t -105.15 121.92 57.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 72.010000000000005 111.129 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 m -117.03 150.39 45.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.607 0.718 . . . . 73.409999999999997 111.162 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 153.97 67.97 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.709 2.273 . . . . 73.0 112.299 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' HB1' ' CG1' ' A' ' 42' ' ' VAL . . . -150.2 103.74 3.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 53.340000000000003 111.09 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -75.58 137.44 40.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 53.43 110.887 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -126.33 116.47 21.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.420000000000002 111.064 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.55 HG23 ' CD ' ' A' ' 17' ' ' GLN . 14.4 p -94.42 149.63 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 75.200000000000003 111.164 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.7 p -49.13 112.78 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 52.539999999999999 110.927 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.83 7.56 33.42 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.721 -0.752 . . . . 33.130000000000003 112.465 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.8 m -96.08 -178.38 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.933 0.397 . . . . 73.200000000000003 110.883 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.738 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -139.16 147.82 42.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.198 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 HG11 ' CE2' ' A' ' 113' ' ' PHE . 44.6 t -52.23 -62.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 70.420000000000002 111.102 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.77 HD11 HD12 ' A' ' 50' ' ' LEU . 4.4 mm? -54.04 -33.65 57.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 65.400000000000006 110.886 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -72.67 -27.16 61.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.829 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 38' ' ' THR . 95.3 t -76.94 -43.3 32.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 111.118 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -54.73 -28.28 47.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 62.219999999999999 111.106 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -73.75 -27.91 61.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.87 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.76 -52.19 12.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.868 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.21 -25.22 61.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 74.420000000000002 110.916 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -6.96 43.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.688 -0.768 . . . . 71.540000000000006 112.52 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.642 HG21 ' CB ' ' A' ' 22' ' ' PHE . 78.1 t -51.4 144.47 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 41.020000000000003 111.09 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -96.17 83.93 3.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.891 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.77 HD12 HD11 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -89.7 129.08 36.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 110.844 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' N ' HD13 ' A' ' 50' ' ' LEU . 10.8 tm-20 -53.41 112.63 0.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 53.100000000000001 110.878 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.42 36.7 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 24.25 112.426 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.87 71.22 9.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.788 0.328 . . . . 55.299999999999997 111.072 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 64.8 m -55.91 -26.4 47.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.329999999999998 110.887 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -84.01 -176.19 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 64.450000000000003 110.937 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.01 -172.88 29.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 75.319999999999993 112.473 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -99.4 26.91 5.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 73.329999999999998 110.888 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.0 mt -149.69 115.6 5.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.946 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.18 129.39 31.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 51.329999999999998 111.127 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.7 p -55.43 120.8 7.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 110.877 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.1 p -65.86 -172.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 65.319999999999993 110.871 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -51.89 139.54 21.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 62.32 111.086 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 93.5 m -91.77 86.17 5.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 25.530000000000001 110.897 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -124.49 113.55 18.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.903 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.411 HG13 ' HA ' ' A' ' 115' ' ' VAL . 8.4 t -128.62 157.01 41.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 72.25 111.087 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 5.2 mt -90.17 130.43 39.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 111.157 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.589 HD12 ' O ' ' A' ' 112' ' ' VAL . 18.0 tp -125.07 164.7 19.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.49 . . . . 64.040000000000006 110.901 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -39.12 137.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 71.019999999999996 110.891 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.4 OUTLIER -60.89 -58.7 17.4 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.684 0.754 . . . . 73.040000000000006 110.922 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.3 Cg_endo -69.72 -49.6 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.75 2.3 . . . . 54.219999999999999 112.284 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.752 HD11 ' O ' ' A' ' 107' ' ' SER . 5.4 tp -51.96 -51.9 53.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 73.209999999999994 111.002 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CD1' HG22 ' A' ' 95' ' ' THR . 34.7 t80 -63.58 -41.97 98.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.450000000000003 110.925 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 ttp85 -52.03 -62.0 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 65.439999999999998 110.895 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -63.9 -26.82 68.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.961 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -62.15 -57.25 12.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.182 -0.463 . . . . 75.209999999999994 110.918 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 153.13 142.12 3.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.826 -0.702 . . . . 71.329999999999998 112.508 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -107.33 160.34 26.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.678 0.751 . . . . 65.310000000000002 110.862 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.68 172.16 13.06 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.249 . . . . 62.009999999999998 112.364 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -58.0 167.81 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.899 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -56.81 -39.74 74.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.409999999999997 110.819 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.487 ' O ' HD13 ' A' ' 85' ' ' LEU . 38.1 mttm -52.33 -62.75 1.44 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 63.240000000000002 110.869 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -67.04 -35.2 79.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.283 -0.417 . . . . 71.530000000000001 110.848 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.59 -53.63 55.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.158 -0.474 . . . . 74.329999999999998 110.863 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -65.56 -41.72 92.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 71.120000000000005 110.859 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 81' ' ' LYS . 4.4 mp -56.45 -37.35 70.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 64.219999999999999 110.908 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.522 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.1 mt -74.61 -51.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 63.409999999999997 111.087 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.24 -23.13 45.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.834 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 -32.49 25.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.899 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -61.78 163.89 6.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.293 -0.412 . . . . 71.129999999999995 111.066 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.65 114.81 17.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 75.519999999999996 110.9 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.55 41.56 56.6 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 73.129999999999995 112.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -106.69 117.36 33.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.871 0.367 . . . . 70.219999999999999 111.085 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.57 142.4 31.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 75.109999999999999 111.068 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.64 -24.95 41.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 75.129999999999995 112.488 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.515 HG22 ' CD1' ' A' ' 72' ' ' TYR . 19.0 p -73.91 -2.03 22.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.858 0.361 . . . . 64.239999999999995 111.209 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 10.3 t -89.12 -12.45 41.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 71.409999999999997 110.867 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 9.8 ttm-85 -94.06 154.51 17.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 70.200000000000003 110.785 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.7 tp -147.48 167.64 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 73.450000000000003 110.856 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -120.02 19.14 9.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.674 -0.774 . . . . 71.010000000000005 112.467 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 1.9 t 60.38 25.73 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 61.43 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -147.41 136.47 22.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 64.439999999999998 110.925 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tp -177.13 129.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 65.25 110.877 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -103.66 170.31 8.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 70.209999999999994 110.848 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.579 HG11 ' HB1' ' A' ' 33' ' ' ALA . 39.2 t -100.62 120.44 50.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 111.103 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -136.71 173.61 11.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.167 -0.469 . . . . 72.040000000000006 110.874 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -59.66 -33.87 72.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 72.510000000000005 110.922 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.752 ' O ' HD11 ' A' ' 71' ' ' LEU . 47.3 m -64.91 -19.32 65.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 64.510000000000005 110.855 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.74 5.69 38.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.095 -0.502 . . . . 71.209999999999994 110.907 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -59.58 124.31 19.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 62.219999999999999 110.862 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 63.53 20.29 12.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 53.450000000000003 110.848 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.59 149.23 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 33.329999999999998 111.074 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.8 t -113.51 119.86 61.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.254 -0.43 . . . . 73.010000000000005 111.165 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.434 ' CE2' HG11 ' A' ' 39' ' ' VAL . 21.5 m-85 -110.61 94.81 5.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 71.430000000000007 110.815 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.9 m -88.26 126.37 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 111.116 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.561 HG22 HD22 ' A' ' 50' ' ' LEU . 57.9 t -96.45 133.25 25.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.136 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.439 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.75 -41.64 4.1 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.686 2.257 . . . . 65.439999999999998 112.36 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 -80.93 167.69 19.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 72.140000000000001 110.865 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.39 -170.59 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 53.109999999999999 111.116 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.8 p -87.48 177.75 7.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.174 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.58 175.27 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 73.349999999999994 110.908 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.43 HD21 HG13 ' A' ' 124' ' ' VAL . 2.5 t30 -68.72 103.89 1.86 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.853 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 2.6 ttp -76.05 175.29 9.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 74.510000000000005 110.889 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.2 103.42 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 62.43 111.082 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 127' ' ' PHE . 33.8 m -65.99 -176.92 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 44.350000000000001 111.17 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -112.07 -43.22 3.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.030000000000001 110.913 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -157.78 35.7 0.54 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.725 -0.75 . . . . 73.430000000000007 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.527 ' O ' HG11 ' A' ' 124' ' ' VAL . 32.3 p90 -158.13 119.61 3.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 74.310000000000002 110.851 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -147.07 73.34 12.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.55 0.69 . . . . 71.430000000000007 110.995 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 92.24 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.732 2.288 . . . . 73.120000000000005 112.299 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -123.21 137.7 28.73 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.574 0.702 . . . . 72.420000000000002 110.919 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 151.62 68.76 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.689 2.259 . . . . 73.030000000000001 112.348 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.8 t60 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 110.837 179.987 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 CA-C-O 121.453 0.474 . . . . 71.299999999999997 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.79 179.13 3.93 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.686 2.258 . . . . 64.129999999999995 112.326 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.12 170.16 32.5 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 41.340000000000003 112.479 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.0 m -147.26 148.59 31.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.348 . . . . 73.310000000000002 110.847 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 18.6 mtm -152.05 -175.64 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 73.430000000000007 110.887 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -169.88 162.13 9.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 71.420000000000002 110.873 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -129.97 109.07 10.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 62.509999999999998 110.878 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -154.89 164.16 39.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 71.439999999999998 110.922 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.2 t -52.59 131.48 34.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 72.439999999999998 110.843 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 13' ' ' ARG . . . -159.05 71.57 3.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 71.340000000000003 111.103 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.77 -16.63 37.6 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 63.229999999999997 112.394 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -114.09 24.92 11.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 73.209999999999994 110.864 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' HB2' ' HB1' ' A' ' 10' ' ' ALA . 21.0 mtp85 -158.04 134.28 9.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.209999999999994 110.9 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.9 mp -51.87 133.19 38.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.686 0.755 . . . . 72.400000000000006 111.148 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.79 -170.05 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.76 2.307 . . . . 71.329999999999998 112.256 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -51.5 157.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.89 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.29 151.52 28.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 43.299999999999997 110.889 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 2.0 pp -130.35 176.81 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 111.099 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -120.33 133.91 55.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.479 HG13 ' HB3' ' A' ' 31' ' ' ALA . 2.0 pt -114.34 172.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 75.129999999999995 111.087 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.46 128.39 45.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.219999999999999 110.9 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.71 ' CB ' HG21 ' A' ' 48' ' ' VAL . 2.5 m-85 -97.12 103.17 15.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.834 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HD2' HG23 ' A' ' 114' ' ' THR . 0.2 OUTLIER -97.53 136.15 38.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 75.340000000000003 110.92 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.4 p -130.43 177.25 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 65.510000000000005 111.158 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 7.8 tpt -73.56 -8.76 57.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 73.099999999999994 110.898 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -104.98 -37.57 6.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 61.119999999999997 110.882 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -179.63 176.13 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 54.409999999999997 110.937 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -117.87 131.43 70.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.010000000000005 111.188 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.35 151.03 58.64 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 73.409999999999997 111.154 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 151.22 68.8 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.611 2.207 . . . . 73.0 112.304 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -144.0 139.49 29.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.03 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 29.9 tttp -100.68 128.9 46.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.455 . . . . 53.43 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.783 ' HB1' HG11 ' A' ' 104' ' ' VAL . . . -106.67 116.37 31.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.137 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.1 t -97.33 139.16 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.200000000000003 111.149 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.1 p -51.7 111.1 0.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 52.539999999999999 110.881 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.43 13.81 34.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 33.130000000000003 112.493 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.443 ' OG ' HG21 ' A' ' 104' ' ' VAL . 86.6 p -101.63 -169.78 1.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.951 0.405 . . . . 73.200000000000003 110.844 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.744 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -147.04 143.46 28.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 73.140000000000001 111.128 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.45 -59.41 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 111.127 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.38 -35.53 60.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.464 . . . . 65.400000000000006 110.922 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.76 -27.5 62.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 110.912 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 38' ' ' THR . 91.6 t -76.56 -35.55 26.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 61.210000000000001 111.095 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.63 -25.88 29.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 62.219999999999999 111.129 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -67.11 -32.61 73.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.464 . . . . 75.200000000000003 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.05 -34.8 14.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.530000000000001 110.895 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.471 ' HB3' HG23 ' A' ' 48' ' ' VAL . 3.3 m120 -75.04 -24.4 58.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 110.951 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 -11.68 66.41 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 71.540000000000006 112.529 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 22' ' ' PHE . 93.9 t -51.31 138.72 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 41.020000000000003 111.202 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -73.48 80.81 1.44 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.851 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 115' ' ' VAL . 28.3 tp -127.05 144.35 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 70.430000000000007 110.913 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' HB3' HG21 ' A' ' 62' ' ' THR . 4.8 pt-20 -54.3 143.68 22.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 53.100000000000001 110.856 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -130.94 -42.84 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 24.25 112.499 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -114.05 122.62 47.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.842 0.353 . . . . 55.299999999999997 111.121 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 4.8 t -54.62 -58.74 6.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.433 . . . . 72.329999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -52.33 131.5 33.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 64.450000000000003 110.85 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.4 -135.82 2.54 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.715 -0.755 . . . . 75.319999999999993 112.472 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.69 -47.51 3.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.831 0.348 . . . . 73.329999999999998 110.849 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.2 177.74 4.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.881 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -53.69 161.56 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 51.329999999999998 111.086 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.8 m -67.72 105.82 2.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 74.540000000000006 110.911 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -115.72 -26.7 7.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 65.319999999999993 110.834 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.594 HG23 ' HA ' ' A' ' 118' ' ' ALA . 6.6 m -82.5 73.09 9.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 62.32 111.176 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 23.5 m -131.15 -46.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 25.530000000000001 110.88 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -71.21 111.79 6.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 65.439999999999998 110.862 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 115' ' ' VAL . 6.6 t -128.62 157.28 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 72.25 111.187 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 88.5 mt -90.37 130.84 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.091 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 112' ' ' VAL . 29.8 tp -124.65 159.37 30.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 64.040000000000006 110.908 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.56 146.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 71.019999999999996 110.883 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 3.5 mt-10 -59.27 -59.94 12.21 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.631 0.729 . . . . 73.040000000000006 110.896 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.5 Cg_endo -69.79 -46.78 1.09 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.653 2.235 . . . . 54.219999999999999 112.346 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -53.38 -49.15 67.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 73.209999999999994 110.927 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.634 ' CD1' HG22 ' A' ' 95' ' ' THR . 57.4 t80 -64.34 -51.01 65.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 74.450000000000003 110.916 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -25.53 61.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.112 -0.495 . . . . 65.439999999999998 110.809 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -77.31 -50.54 12.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 75' ' ' LEU . 4.2 mt -62.91 -21.83 66.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 75.209999999999994 110.932 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.58 158.96 9.49 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.763 . . . . 71.329999999999998 112.497 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -134.31 157.53 77.29 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.642 0.734 . . . . 65.310000000000002 110.877 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.03 32.34 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.725 2.284 . . . . 62.009999999999998 112.296 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.8 p -58.09 158.52 6.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -52.43 -36.06 53.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 72.409999999999997 110.926 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -52.33 -62.57 1.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 63.240000000000002 110.892 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.67 -35.79 79.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.167 -0.47 . . . . 71.530000000000001 110.922 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -56.14 -53.33 58.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.871 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -65.9 -42.97 89.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 110.878 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -55.2 -37.51 67.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 64.219999999999999 110.898 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.663 HD13 ' HA2' ' A' ' 94' ' ' GLY . 14.4 mt -74.53 -51.92 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 63.409999999999997 111.124 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -61.18 -18.59 58.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 110.869 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -76.14 -23.17 54.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.927 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . . . -81.22 164.34 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 71.129999999999995 111.043 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -71.75 119.59 16.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 75.519999999999996 110.86 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.0 43.89 55.92 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.635 -0.793 . . . . 73.129999999999995 112.516 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -118.58 116.04 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.811 0.339 . . . . 70.219999999999999 111.123 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.87 144.77 39.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 75.109999999999999 111.233 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.663 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.27 -23.88 35.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 75.129999999999995 112.459 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.634 HG22 ' CD1' ' A' ' 72' ' ' TYR . 37.9 p -73.96 -1.56 20.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 64.239999999999995 111.151 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 47.7 t -89.36 -12.83 39.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 71.409999999999997 110.91 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.658 ' HD2' HD11 ' A' ' 86' ' ' ILE . 7.1 ptm180 -112.07 144.21 41.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 70.200000000000003 110.864 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.5 tp -166.47 164.05 17.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 110.989 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.06 -167.13 39.9 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.463 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.2 m -104.16 64.49 0.77 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 61.43 110.857 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.564 ' C ' HD12 ' A' ' 102' ' ' LEU . 10.5 mt-30 -162.84 124.33 2.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 64.439999999999998 110.908 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 101' ' ' GLN . 4.8 mp -156.13 150.9 26.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.244 -0.435 . . . . 65.25 110.924 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.8 mtm180 -146.0 129.94 17.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.192 -0.458 . . . . 70.209999999999994 110.9 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.783 HG11 ' HB1' ' A' ' 33' ' ' ALA . 58.6 t -64.84 117.62 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 72.239999999999995 111.13 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -136.83 178.36 7.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 72.040000000000006 110.911 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.03 -37.16 76.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 72.510000000000005 110.93 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.427 ' O ' HD21 ' A' ' 71' ' ' LEU . 6.3 t -65.54 -19.73 66.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 64.510000000000005 110.903 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.505 ' O ' HD13 ' A' ' 18' ' ' ILE . 11.4 m-85 -83.41 2.23 37.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 71.209999999999994 110.848 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.402 ' HA ' HD13 ' A' ' 18' ' ' ILE . 34.5 tt0 -56.94 123.59 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 62.219999999999999 110.836 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 59.29 27.08 16.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 53.450000000000003 110.865 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 20' ' ' ILE . . . -69.95 135.36 49.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.446 . . . . 33.329999999999998 111.128 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.565 ' O ' HD12 ' A' ' 67' ' ' LEU . 27.3 t -104.2 122.39 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.010000000000005 111.16 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -112.9 104.27 12.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 71.430000000000007 110.857 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.495 HG23 ' HD2' ' A' ' 23' ' ' LYS . 40.6 m -92.83 117.99 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 111.155 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 50' ' ' LEU . 20.0 t -108.68 88.83 5.6 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.525 0.679 . . . . 72.129999999999995 111.13 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -36.24 10.96 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.698 2.265 . . . . 65.439999999999998 112.296 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 83.4 mtm-85 -139.51 125.45 19.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 72.140000000000001 110.839 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.594 ' HA ' HG23 ' A' ' 62' ' ' THR . . . -171.73 179.97 2.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 53.109999999999999 111.157 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.8 p -134.0 -174.17 3.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 111.091 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 tptt -105.81 154.83 19.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 73.349999999999994 110.888 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.7 p-10 -97.8 -173.94 2.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 73.329999999999998 110.886 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.1 tpt -80.27 -44.63 19.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 74.510000000000005 110.91 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.71 111.92 0.74 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 62.43 111.066 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.9 p -165.56 151.63 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 44.350000000000001 111.093 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 61.64 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.439 . . . . 71.030000000000001 110.919 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.95 -107.76 0.28 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.509 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -151.92 134.05 15.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.892 0.377 . . . . 74.310000000000002 110.927 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -140.42 159.28 63.97 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.588 0.708 . . . . 71.430000000000007 110.85 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 130' ' ' LYS . 53.0 Cg_endo -69.74 150.06 67.83 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.675 2.25 . . . . 73.120000000000005 112.318 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 129' ' ' PRO . 10.0 ptmt 37.51 67.86 1.81 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 110.911 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -171.71 0.5 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.673 2.249 . . . . 73.030000000000001 112.338 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.5 t60 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.803 179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 CA-C-O 121.408 0.449 . . . . 71.299999999999997 112.508 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 79.58 0.95 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.653 2.235 . . . . 64.129999999999995 112.393 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -143.9 -96.27 0.22 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 41.340000000000003 112.497 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 m -110.37 82.98 1.68 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.889 0.376 . . . . 73.310000000000002 110.843 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 3.9 mmt -142.46 123.81 14.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.934 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -76.32 85.46 3.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 71.420000000000002 110.872 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.4 ptm -145.02 164.83 29.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 62.509999999999998 110.919 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -124.58 166.54 15.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.439999999999998 110.909 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 m -149.22 176.25 10.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.822 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.78 69.93 0.89 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.607 0.718 . . . . 71.340000000000003 111.161 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -171.12 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 63.229999999999997 112.3 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -99.23 25.2 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 73.209999999999994 110.887 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -136.4 -167.18 2.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 110.918 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.0 mm 63.5 136.8 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.558 0.694 . . . . 72.400000000000006 111.143 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 -178.78 2.52 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 71.329999999999998 112.362 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -52.07 157.02 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 110.878 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -73.75 143.7 45.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 43.299999999999997 110.956 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 109' ' ' GLU . 1.3 pt -128.75 176.8 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 64.439999999999998 111.094 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.81 136.26 52.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 75.340000000000003 110.801 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.878 HD11 HG11 ' A' ' 42' ' ' VAL . 1.8 pt -116.98 157.73 17.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 111.118 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -119.98 126.5 50.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 75.219999999999999 110.926 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.75 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 4.5 m-85 -105.0 102.9 12.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 71.329999999999998 110.927 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 117.78 26.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.95 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.8 p -105.33 175.04 5.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 65.510000000000005 111.112 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 29.8 mmt -75.72 -7.99 55.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 73.099999999999994 110.921 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtm -102.97 -38.39 7.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 61.119999999999997 110.889 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 178.28 176.53 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 54.409999999999997 110.925 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.3 t -79.1 147.95 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 72.010000000000005 111.058 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.93 87.84 9.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.64 0.734 . . . . 73.409999999999997 111.113 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 135.0 29.33 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.707 2.271 . . . . 73.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.22 159.93 40.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.23 -0.441 . . . . 53.340000000000003 111.085 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -99.7 127.98 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.943 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -95.3 131.81 40.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 74.420000000000002 111.115 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -104.85 146.51 11.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.200000000000003 111.107 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.2 p -57.49 119.8 7.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 52.539999999999999 110.892 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 106.41 -7.01 39.46 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.758 -0.734 . . . . 33.130000000000003 112.473 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.32 161.02 13.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 73.200000000000003 110.859 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 42' ' ' VAL . 24.9 p -114.46 159.23 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 111.116 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.3 t -52.27 -58.4 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 70.420000000000002 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.54 -35.82 63.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 65.400000000000006 110.968 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.61 -26.49 61.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.450000000000003 110.881 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG11 HD11 ' A' ' 20' ' ' ILE . 97.7 t -76.43 -44.05 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 61.210000000000001 111.167 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.75 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -55.13 -29.22 57.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 62.219999999999999 111.055 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -73.37 -26.6 61.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 75.200000000000003 110.869 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -69.73 -52.15 27.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.9 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -72.86 -25.1 60.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.863 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.07 -12.22 34.23 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.677 -0.773 . . . . 71.540000000000006 112.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -52.64 115.58 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 41.020000000000003 111.087 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -71.84 80.92 0.89 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.878 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.3 tt -76.1 119.71 20.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 70.430000000000007 110.924 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -51.93 118.03 3.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 53.100000000000001 110.861 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 176.37 112.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.689 -0.767 . . . . 24.25 112.456 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.782 0.325 . . . . 55.299999999999997 111.127 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.64 97.38 6.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.449 . . . . 72.329999999999998 110.966 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -138.3 153.48 49.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 64.450000000000003 110.863 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.24 154.85 1.26 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.753 . . . . 75.319999999999993 112.493 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -68.86 104.54 2.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.877 0.37 . . . . 73.329999999999998 110.856 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.3 mp 52.88 56.52 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 72.140000000000001 110.935 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.21 31.4 4.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 51.329999999999998 111.12 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 5.8 p -121.34 77.72 1.35 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.939 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.01 34.43 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 65.319999999999993 110.866 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 49.9 p -116.26 34.99 4.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 62.32 111.139 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 13.0 m -99.81 69.94 1.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 25.530000000000001 110.931 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -152.06 109.75 3.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.805 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 66' ' ' ILE . 8.1 t -128.62 157.02 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 72.25 111.144 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.6 mt -90.12 131.23 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.486 . . . . 64.430000000000007 111.127 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.718 HD12 ' O ' ' A' ' 112' ' ' VAL . 28.7 tp -129.45 162.3 28.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.168 -0.469 . . . . 64.040000000000006 110.928 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -39.62 139.55 0.59 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.917 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.7 mt-10 -59.58 -59.05 15.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.696 0.76 . . . . 73.040000000000006 110.904 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.1 Cg_endo -69.78 -49.16 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.735 2.29 . . . . 54.219999999999999 112.319 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tt -52.09 -48.53 64.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 110.932 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.476 ' CD1' HG22 ' A' ' 95' ' ' THR . 45.3 t80 -66.89 -42.71 85.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.450000000000003 110.93 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttm180 -51.88 -58.11 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 65.439999999999998 110.869 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -70.03 -28.73 65.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 75.0 110.902 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.9 tp -63.56 -61.23 2.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.209999999999994 110.944 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.32 143.59 4.08 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 71.329999999999998 112.482 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -134.67 157.27 77.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.574 0.702 . . . . 65.310000000000002 110.886 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 166.69 26.71 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.743 2.295 . . . . 62.009999999999998 112.32 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.4 m -58.17 171.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 110.864 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -58.59 -38.13 77.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.409999999999997 110.874 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -52.3 -62.43 1.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.438 . . . . 63.240000000000002 110.89 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -67.53 -35.41 79.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 71.530000000000001 110.872 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -56.42 -53.04 62.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 110.904 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -66.07 -42.37 89.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 71.120000000000005 110.832 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.13 -36.91 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 110.959 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 14.8 mt -74.61 -54.85 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 111.113 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.95 -24.53 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.452 . . . . 74.030000000000001 110.855 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.15 -25.62 55.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 74.109999999999999 110.908 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.458 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -80.59 151.07 29.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 111.084 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -67.37 128.71 37.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 110.805 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.46 54.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 73.129999999999995 112.489 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -119.66 117.16 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.358 . . . . 70.219999999999999 111.056 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.99 143.9 44.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.109999999999999 111.196 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.62 -24.68 40.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 75.129999999999995 112.491 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.476 HG22 ' CD1' ' A' ' 72' ' ' TYR . 21.2 p -73.94 -1.73 21.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 64.239999999999995 111.188 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 23.2 t -89.79 -12.6 38.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.854 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' HD2' HD11 ' A' ' 86' ' ' ILE . 14.9 mtt-85 -106.6 139.87 40.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 70.200000000000003 110.892 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.3 tp -158.87 164.89 35.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 73.450000000000003 110.878 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.94 -131.67 5.44 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 71.010000000000005 112.485 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 84.7 m -122.62 -54.5 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 61.43 110.915 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -52.11 139.26 23.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.495 . . . . 64.439999999999998 110.909 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.6 tp -176.64 140.54 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.898 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.412 ' HD3' HG22 ' A' ' 38' ' ' THR . 7.8 tpp180 -141.94 154.07 44.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 70.209999999999994 110.848 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 37' ' ' SER . 92.3 t -74.7 124.97 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.211 -0.449 . . . . 72.239999999999995 111.131 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -136.67 168.15 20.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.137 -0.483 . . . . 72.040000000000006 110.88 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -57.22 -39.35 75.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 72.510000000000005 110.909 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.1 m -64.02 -20.46 65.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 64.510000000000005 110.895 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.75 7.67 29.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 71.209999999999994 110.851 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.433 ' N ' HD13 ' A' ' 18' ' ' ILE . 33.2 tt0 -59.14 125.19 22.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 62.219999999999999 110.839 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 60.0 22.19 11.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 53.450000000000003 110.897 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.38 136.63 57.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 33.329999999999998 111.061 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.718 ' O ' HD12 ' A' ' 67' ' ' LEU . 10.0 t -98.76 117.08 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 73.010000000000005 111.134 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -109.39 94.82 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.926 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 65' ' ' VAL . 34.2 m -89.42 130.92 35.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.172 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.423 HG13 ' HD2' ' A' ' 116' ' ' PRO . 60.6 t -104.44 133.29 20.27 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 72.129999999999995 111.086 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.423 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.6 Cg_endo -69.84 -41.25 4.33 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 65.439999999999998 112.308 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -143.29 138.75 29.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.854 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -92.76 -51.66 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 53.109999999999999 111.063 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 32.2 p -51.94 126.57 18.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 111.158 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -52.88 -60.61 3.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 73.349999999999994 110.939 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.29 -173.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 73.329999999999998 110.86 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 3.5 ptm -51.79 115.4 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 74.510000000000005 110.952 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' A' ' 117' ' ' ARG . . . -52.91 167.52 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 62.43 111.092 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.1 134.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 44.350000000000001 111.172 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.36 44.22 12.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 71.030000000000001 110.832 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -109.98 144.28 16.85 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -53.94 105.0 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 74.310000000000002 110.851 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.2 tttm -115.21 72.97 3.39 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.588 0.709 . . . . 71.430000000000007 110.916 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -177.09 1.74 Allowed 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.677 2.252 . . . . 73.120000000000005 112.312 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.52 71.28 13.4 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.598 0.713 . . . . 72.420000000000002 110.951 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 -170.74 0.41 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.695 2.263 . . . . 73.030000000000001 112.363 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.927 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 121.406 0.448 . . . . 71.299999999999997 112.466 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 129.04 16.93 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.68 2.253 . . . . 64.129999999999995 112.407 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.07 -169.56 33.39 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 41.340000000000003 112.472 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 t -103.05 138.5 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.878 0.371 . . . . 73.310000000000002 110.887 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.0 ttm -175.07 134.0 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.912 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.58 -175.39 4.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 71.420000000000002 110.917 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.3 tpt -86.2 118.17 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 62.509999999999998 110.881 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -155.23 160.69 41.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 71.439999999999998 110.905 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -89.77 -174.06 4.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 72.439999999999998 110.808 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.596 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -136.2 160.46 66.95 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.541 0.686 . . . . 71.340000000000003 111.081 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.596 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 54.1 Cg_endo -69.8 -170.76 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.741 2.294 . . . . 63.229999999999997 112.362 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -95.61 25.04 4.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.843 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -134.88 119.43 18.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 74.209999999999994 110.913 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.419 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.7 mp -94.53 133.14 27.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.675 0.75 . . . . 72.400000000000006 111.104 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 14' ' ' ILE . 53.5 Cg_endo -69.73 -170.34 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.746 2.297 . . . . 71.329999999999998 112.358 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -51.46 156.99 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.892 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -73.84 156.45 37.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 43.299999999999997 110.9 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.03 176.97 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 64.439999999999998 111.132 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.0 ttm180 -118.1 135.83 53.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.836 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.773 HG13 ' HB3' ' A' ' 31' ' ' ALA . 32.0 pt -114.36 171.83 4.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 75.129999999999995 111.142 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -119.19 126.72 52.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 75.219999999999999 110.895 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 43' ' ' ALA . 1.7 m-85 -97.93 103.18 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.856 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' CD ' HG22 ' A' ' 28' ' ' VAL . 15.8 tptm -85.66 106.67 17.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 75.340000000000003 110.887 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.3 p -101.9 178.61 4.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 65.510000000000005 111.168 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 ttm -75.7 -8.05 55.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 73.099999999999994 110.933 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -106.05 -38.62 6.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 61.119999999999997 110.933 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 178.34 176.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 54.409999999999997 110.846 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' CD ' ' A' ' 23' ' ' LYS . 21.3 t -102.45 123.11 55.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.010000000000005 111.068 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.85 150.54 45.11 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.169 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.76 153.22 69.2 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.656 2.237 . . . . 73.0 112.349 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.773 ' HB3' HG13 ' A' ' 20' ' ' ILE . . . -143.51 135.56 26.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 53.340000000000003 111.131 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -97.64 118.68 34.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 53.43 110.911 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 104' ' ' VAL . . . -111.64 116.52 30.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 111.105 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -94.16 148.05 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 75.200000000000003 111.11 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.8 p -51.32 110.11 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.539999999999999 110.917 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.48 14.42 30.13 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.75 -0.738 . . . . 33.130000000000003 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -97.64 -170.61 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.887 0.375 . . . . 73.200000000000003 110.878 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.746 ' O ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -141.91 140.92 32.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 73.140000000000001 111.15 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.1 t -52.41 -59.51 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 70.420000000000002 111.081 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD11 ' A' ' 50' ' ' LEU . 6.4 mt -53.72 -35.57 61.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 65.400000000000006 110.872 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -72.7 -26.75 61.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 72.450000000000003 110.883 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 38' ' ' THR . 97.4 t -76.54 -42.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 61.210000000000001 111.136 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . . . -51.83 -29.71 20.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.072 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -70.23 -36.77 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 75.200000000000003 110.871 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -82.82 -34.9 26.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.879 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.404 ' ND2' HG23 ' A' ' 48' ' ' VAL . 43.4 t30 -72.35 -28.25 62.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.935 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.0 -12.25 34.39 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.743 . . . . 71.540000000000006 112.537 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG21 ' CB ' ' A' ' 22' ' ' PHE . 98.9 t -59.94 141.06 17.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.862 0.363 . . . . 41.020000000000003 111.161 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -78.79 80.7 5.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.901 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.588 HD23 HG21 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -118.31 108.51 15.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 70.430000000000007 110.911 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -52.88 116.72 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 53.100000000000001 110.86 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -113.13 22.31 16.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 24.25 112.529 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.46 105.12 16.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 55.299999999999997 111.073 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.0 -27.84 61.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 72.329999999999998 110.859 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -119.09 128.26 54.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.123 -0.49 . . . . 64.450000000000003 110.89 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.94 -73.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.757 -0.735 . . . . 75.319999999999993 112.482 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -97.79 31.76 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 73.329999999999998 110.802 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 30.1 mt 56.44 33.02 21.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.911 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -172.98 128.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 51.329999999999998 111.055 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.91 75.81 5.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 74.540000000000006 110.865 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -102.38 27.14 7.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 65.319999999999993 110.865 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 p -110.62 -25.88 9.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 62.32 111.12 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.419 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.3 m -55.3 -29.75 58.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 25.530000000000001 110.849 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.3 m170 -68.81 100.02 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.499 . . . . 65.439999999999998 110.841 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 114' ' ' THR . 4.7 t -128.63 159.04 40.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 72.25 111.15 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 96' ' ' SER . 4.9 mt -89.86 130.46 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 64.430000000000007 111.165 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 68' ' ' GLU . 16.8 tp -119.29 166.4 13.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 64.040000000000006 110.882 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 71' ' ' LEU . 5.9 mp0 -36.8 135.87 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 71.019999999999996 110.913 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.553 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.3 tt0 -65.26 -56.73 18.09 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.595 0.712 . . . . 73.040000000000006 110.867 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 54.2 Cg_endo -69.69 -51.82 0.37 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 54.219999999999999 112.387 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.473 ' CB ' ' HB2' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -51.93 -48.35 64.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.893 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.608 ' CD1' HG22 ' A' ' 95' ' ' THR . 20.2 t80 -64.94 -53.57 44.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 110.918 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.6 -47.96 63.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.127 -0.488 . . . . 65.439999999999998 110.816 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -66.31 -36.62 83.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 75.0 110.934 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.28 -62.54 1.62 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.209999999999994 110.85 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 160.35 20.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.747 -0.74 . . . . 71.329999999999998 112.429 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.99 157.55 77.44 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.658 0.742 . . . . 65.310000000000002 110.928 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 166.82 26.33 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.709 2.273 . . . . 62.009999999999998 112.309 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.7 t -57.95 171.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.792 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -59.97 -37.48 79.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.053 -0.521 . . . . 72.409999999999997 110.898 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -52.35 -62.55 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 110.912 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -67.59 -35.54 79.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 71.530000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -56.34 -53.19 60.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.914 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -65.97 -42.79 89.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 71.120000000000005 110.858 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.1 tp -55.48 -37.14 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 64.219999999999999 110.919 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 15.1 mt -74.74 -52.68 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 111.152 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -59.3 -21.08 59.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.875 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -75.94 -23.27 55.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.924 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HB3' ' CB ' ' A' ' 92' ' ' ALA . . . -77.48 164.18 25.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 71.129999999999995 111.144 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -74.4 118.99 17.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.424 . . . . 75.519999999999996 110.847 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.66 43.73 53.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.678 -0.772 . . . . 73.129999999999995 112.52 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 86' ' ' ILE . . . -106.98 143.5 34.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.866 0.365 . . . . 70.219999999999999 111.083 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 130' ' ' LYS . 0.2 OUTLIER -133.85 145.72 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 111.125 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 86' ' ' ILE . . . -55.97 -28.59 53.67 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 75.129999999999995 112.473 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' CD1' ' A' ' 72' ' ' TYR . 16.0 p -73.53 -3.31 26.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.8 0.333 . . . . 64.239999999999995 111.149 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 66' ' ' ILE . 48.1 t -85.44 -13.77 48.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 71.409999999999997 110.857 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -119.74 143.26 47.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 70.200000000000003 110.87 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -170.23 142.38 2.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.145 -0.479 . . . . 73.450000000000003 110.96 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -52.76 158.14 3.86 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.788 -0.72 . . . . 71.010000000000005 112.467 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 4.6 t -55.62 -26.97 47.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.776 0.322 . . . . 61.43 110.885 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.58 114.19 1.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 64.439999999999998 110.901 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.8 mt -141.78 95.34 2.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.25 110.945 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.99 147.47 35.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 70.209999999999994 110.936 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 33' ' ' ALA . 90.6 t -96.02 128.31 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 72.239999999999995 111.169 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -136.56 167.77 20.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.483 . . . . 72.040000000000006 110.899 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -55.49 -42.01 73.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 72.510000000000005 110.904 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -18.97 58.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 64.510000000000005 110.863 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -93.34 17.14 11.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 71.209999999999994 110.813 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -57.68 126.97 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 62.219999999999999 110.977 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 m120 58.85 24.23 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 53.450000000000003 110.884 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -58.61 126.14 26.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 33.329999999999998 111.144 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.4 ' HB ' ' HG3' ' A' ' 68' ' ' GLU . 12.4 t -84.98 118.76 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 73.010000000000005 111.117 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.489 ' CE1' ' HB3' ' A' ' 111' ' ' ALA . 74.5 m-85 -113.01 102.74 10.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 71.430000000000007 110.88 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.486 ' O ' HG12 ' A' ' 65' ' ' VAL . 23.9 m -88.55 130.14 35.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 73.439999999999998 111.205 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.588 HG21 HD23 ' A' ' 50' ' ' LEU . 60.6 t -101.06 133.24 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.666 0.746 . . . . 72.129999999999995 111.065 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 115' ' ' VAL . 53.4 Cg_endo -69.8 -165.58 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.649 2.233 . . . . 65.439999999999998 112.328 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -70.35 103.71 2.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 110.89 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -106.58 -175.83 2.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 53.109999999999999 111.124 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.2 p 49.96 40.28 20.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.27 -0.423 . . . . 73.409999999999997 111.182 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -146.48 -176.19 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 73.349999999999994 110.924 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 121' ' ' ASN . 2.8 m-80 -61.17 -170.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 73.329999999999998 110.863 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 6.6 ptm -59.87 -174.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 74.510000000000005 110.919 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.74 113.08 0.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 62.43 111.122 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.44 148.83 25.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 44.350000000000001 111.117 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.45 171.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 71.030000000000001 110.873 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.01 -113.31 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 73.430000000000007 112.479 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -163.36 103.22 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.854 0.359 . . . . 74.310000000000002 110.855 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -174.75 73.63 0.31 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.522 0.677 . . . . 71.430000000000007 110.93 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 125.36 12.03 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.594 2.196 . . . . 73.120000000000005 112.335 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.548 ' O ' HG23 ' A' ' 93' ' ' THR . 12.9 ttmm -167.94 73.08 0.91 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.54 0.686 . . . . 72.420000000000002 110.92 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 -21.77 32.83 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.692 2.261 . . . . 73.030000000000001 112.302 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.2 m80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 72.120000000000005 110.837 179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_